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The structural complexity and biological activity of marine natural products have made them attractive 
targets for synthetic chemists. In cases where their relative and/or absolute configuration is unknown, total 
synthesis becomes a powerful method to enable their structural elucidation, as highlighted in Part I. This 
thesis discusses synthetic efforts towards two marine natural products, hemicalide (1) and phormidolide A 
(2), with the end goal of establishing and/or confirming the compound’s full stereochemistry. 
 
Hemicalide’s low isolation yield from its marine sponge source meant that none of the 21 stereocenters 
were assigned in the original patent literature. Previous computational and synthetic work by Ardisson and 
Cossy, as well as the Paterson and Goodman groups, have narrowed down the possibilities for the C1-C15, 
C16-C25 and C35-C46 fragments to a single diastereomer with reasonable confidence. However, the 
relative configuration between fragments and the absolute stereochemistry remains unknown. Part II 
describes the synthesis of the C16-C28 dihydroxylactone fragment, which was used to successfully assemble 
a diastereomer of the C1-C28 truncate. Comparisons with the alternative configuration synthesised by Han 
enabled the definitive assignment of the relative configuration between the C1-C15 and the C16-C25 region 
of hemicalide. These studies also illuminated the nature of the C1 carboxyl group in the natural product. 
Phormidolide A possesses several fascinating structural motifs. Its terminal bromomethoxydiene (BMD) 
motif in particular, is unprecedented among natural products. Furthermore, inconclusive stereochemical 
evidence presented in the literature meant that a synthesis-guided stereochemical evaluation is required. 
Part III discusses synthetic efforts to the natural product, involving the expedient synthesis of the C18-C23 
vinyl iodide and the C25-C33 side chain bearing the unique BMD motif. Towards the end goal of a total 
synthesis, this chapter also illustrates the evolution of the fragment coupling strategy, which led to the 












































Phormidolide A (2): Reported structure
Hemicalide (1)
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Nomenclature 
Compound numbering 
The numbering system used for hemicalide and its associated fragments follows that of Carletti et al..1 
Substituents are defined by the skeletal carbon to which they are attached. The complete numbering scheme 
for hemicalide is shown in Figure 1.  
 
Figure 1. Numbering scheme for hemicalide 
 
The numbering system used for the carbon skeleton of phormidolide A follows that of Williamson et al.2, 
with the exception of skeletal substitutions (e.g. hydroxyl, methyl, methoxy and methylene groups), which 
are denoted by the skeletal carbon to which they are attached. The complete numbering scheme for 
phormidolide A is shown in Figure 2. 
 

































































































Metal enolate and olefin geometry 
The geometry of olefins and metal enolates are assigned based on the accepted IUPAC convention. E olefins 
are defined by having the highest priority groups located on opposite sides of the double bond. Z olefins are 
defined by having the highest priority groups located on the same side. Metal enolates follow an analogous 




Figure 3. General examples of enolate and olefin geometries 
 
Stereochemical relationships 
The relative stereochemical relationship between two substituents are defined by the convention set out by 
Masamune.3 A syn relationship has the two substituents pointing in the same direction relative to the plane 
of the carbon skeleton when drawn in a linear fashion, whereas an anti relationship has the two substituents 
pointing in opposite direction (Figure 4). 
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Part I – Introduction 
 
1.1. Marine Natural Products and their Characterisation 
The marine environment accounts for over 70% of the Earth’s total area, and in it harbours a plethora of 
biodiversity.4 This breadth of marine flora and fauna flows down into the breadth of secondary metabolites 
many of these organisms produce. In facing the inherent problem of efficacy in high dilution, many of these 
secondary metabolites produced by marine organisms have evolved over time to be highly potent binders 
of specific biological targets, or incredibly toxic towards other living organisms.5  
Throughout history, humankind’s interdependence with nature has led to the extensive use of terrestrial 
natural products in treating ailments.6 Largely owing to their inaccessibility, marine natural products have 
only recently started to enter the medicinal repertoire.7 Though marine natural products have 
comparatively occupied a minute period of history as compared to terrestrial compounds, over 20,000 
marine natural products have been discovered in the last fifty years.8 Indeed, their diverse range of 
bioactivities have resulted in the clinical validation of many promising compounds.9  Underpinning any 
further discovery however is the successful structural elucidation of these compounds of interest. In order 
for these compounds to be realised as clinical candidates, or for any further activity-guided optimisation to 
occur, their 2D and 3D structures must be unambiguously determined. This is by no means a simple task 
given the often-complex architectures underscored by a non-trivial isolation procedure that often only 
generates meagre amounts of the novel compound from a huge amount of biomass.10  
As such, isolation chemists are often faced with the daunting task of determining the structure of a complex 
compound and ascertaining its biological activity, all from tiny amounts of material. In the past, with 
limited experimental data, the unambiguous structural elucidation was often only achieved through X-ray 
diffraction studies of single crystals. Nowadays, complex structures can be routinely solved by chemists 
employing an array of spectroscopic (especially NMR) techniques, elucidating complex structures that 
previously would have in the past, taken a team of eminent scientists many years to achieve.11 It is to no 
surprise that the overall advancement in natural product research has evolved symbiotically with advances 
in characterisation techniques, such that it is now possible to fully solve a structure with ever smaller 
amounts of material. In particular, advances in long-range NMR techniques,12 along with detailed 
conformational analyses from coupling constant data of these molecules13 can often be used synergistically 
to unambiguously reveal the relative configuration of a novel compound. 
  2 
However, these inferential experimental techniques are often insufficient to allow for the full structural 
determination. To alleviate these problems, many state-of-the-art computational techniques, such as the 
DP4 algorithm,14 have been developed to allow the application of statistical methods in assigning likely 
candidate structures for a natural product. Beyond this, recent advances in cryo-electron microscopy 
(EM)15 has meant that these techniques are becoming more relevant for small molecules, rather than large 
biomolecules for which they have found a niche. In the realm of natural products research, the increased 
ease of genome mining has allowed for the use of DNA sequence information to help identify enzymes that 
catalyse similar reactions in related compounds which can often aid in the structural elucidation of natural 
products.16,17  
These aforementioned contemporary structural elucidation tools do not provide all the solutions and ab 
initio methods, including DP4, become prohibitively costly to run on large and especially flexible 
molecules;14,18,19 the nascent cryo-EM technology for small molecules rely on the sample being a solid and 
abundant in reasonable quantities often not feasible after an isolation campaign,15 and the use of 
bioinformatics as a prospective tool can seldom fully rationalise the stereochemistry of a natural product. 
For these reasons, synthesis still remains the undisputed arbiter of structural proof. Beyond chemical 
derivisation and degradation, a total synthesis of a natural product followed by its spectroscopic 
comparison gives an unambiguous proof of a compound’s overall constitution and 3D structure. 
1.2. The Role of Synthesis in Correcting Stereochemical Misassignments 
As characterisation techniques become more advanced and the analytical toolkit becomes more diverse, it 
should logically follow that assignment errors should accordingly decrease. Interestingly, however, taking 
what arguably is the most powerful tool for characterisation – the NMR spectrometer, the continual 
improvement of an NMR magnet’s field strength over the last few decades correlates positively to the 
number of misassignments reported in the literature.20 This seemingly contradictory observation reflects 
that the improvement in sensitivity does not fundamentally alter how analyses are conducted. Rather than 
increasing the accuracy of spectroscopic assignments, the correlation is attributed to better spectrometers 
enabling the elucidation of increasingly limited amounts from extracts, leading to a greater number of new 
natural products isolated.20 Additionally, these structural misassignments often reflect on the inherent 
weaknesses of each technique, some of which cannot be resolved even if a combination of techniques are 
used.11 By way of example, even the seemingly infallible X-ray crystallographic technique has its drawbacks; 
the fact that crystallographic techniques struggle to discern between atoms that do not contain hydrogen   
atoms led to the structural misassignment of the antibiotic kinamycin C (3, Figure 5a).21  
In these cases, the nature of inferential structural elucidation methods, such as NMR spectroscopy, are 
limited in its ability to definitively resolve stereochemical ambiguities, as a diverse set of structural outcomes 
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could plausibly be accounted for by the same set of spectra.22 Because of this, comparative methods enabled 
by synthesis remain as the crowning method for stereochemical determination. The power of synthesis 
shines through when discerning between diastereomers, especially ones containing distal stereoclusters. In 
cases where the molecule is particularly flexible, ab initio NMR methods often cannot generate meaningful 
predictions for which structures are likely to be correct, as the plurality of low energy conformers often 
precludes accurate NMR predictions.14 In these cases, the unambiguous stereochemical assignment of a 
natural product is achieved through its total synthesis. Prominent examples in which the total synthesis of 
a compound has resulted in their structural reassignment include the marine natural products callipeltoside 
A (4, Figure 5b) by Trost23 and azaspiracid-1 (5, Figure 5c) by Nicolaou.24   
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Callipeltoside A (4): Trost (2002)





































Azaspiracid-1 (5): Nicolaou (2006)
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These synthesis-enabled assignments and reassignments have continued to the present day; a cursory 
search on a literature database containing the terms “synthesis” and “stereochemical revision/reassignment” 
generated over 30 results from January 2016 until present (August 2019) across a wide range of terrestrial 
and marine natural products. To demonstrate the crucial role of synthesis in enabling such reassignments, 
three recent examples from the marine natural product literature are highlighted below. 
One prominent class of compound that has garnered a lot of research attention is the mandelalide family 
of natural products, with four research groups reporting its successful total synthesis since 2013.25–28 In 
particular, the most potent congener, mandelalide A, registered mid-nM activity across a range of cancer 
cell lines, and consequentially has been the focal point of synthetic effort across research groups. In 2014, 
Fürstner et al. reported a first total synthesis of the originally reported structure for mandelalide A (6, 
Figure 6), which revealed spectroscopic inconsistencies that signified the misassignment of several 
stereocentres.29 Later that year, the Ye group also achieved a total synthesis of the proposed structure, which 
corroborated Fürstner’s claims.25 At this point, Ye noted that mandelalide A was structurally homologous 
to a related natural product, madeirolide A (7),30 which contains a different THF configuration compared 
to mandelalide A. Speculating that both natural products have a common biosynthetic origin, Ye revised 
the configuration of the THF fragment and generated further diastereomers of mandelalide A for 
spectroscopic comparisons. In doing so, Ye found structure 6a to closely match the natural product, which 
formed the basis of the reassignment. The ambiguities with mandelalide A did not stop here however, as 
the different groups that have achieved successful total syntheses have recorded disparate biological 
activities for the compound. While the general consensus in the community affirms the cytotoxicity of the 
mandelalides, it goes to show biological studies even in the same cell lines may not be an absolute indication 
of a compound’s activity.31 
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First reported in 2015, iriomoteolide-2a was isolated from a dinoflagellate found off the coast of Japan, and 
was determined to exhibit nanomolar activity across a range of cancer cell lines.32 In the quest for its total 
synthesis, Fuwa et al. found spectroscopic anomalies after the successful synthesis of its originally reported 
structure 8 (Figure 7).33 To probe the source of this incongruity, Fuwa et al. were able to systematically 
generate model substructures to verify the configuration within each of the regions of the natural product. 
This led to identifying the tetrahydrofuran (THF) motif, as well as a single carbinol stereocentre being 
misassigned, to which the incorporation of revised fragments led to a structure (8a) that was 
spectroscopically identical to the natural product.34 Notably, this feat of a wholly synthesis-enabled 
stereochemical reassignment of iriomoteolide-2a was enabled by the highly modular synthesis of the 
natural product, allowing for the facile incorporation of fragments to rapidly verify the veracity of its 
configuration. Owing to the isolated stereoclusters, it is unsurprising that traditional elucidation techniques 
failed to pinpoint the correct diastereomer, and it ultimately required a synthetic proof to confidently 
determine its overall 3D structure. In fact, Fuwa et al. harnessed the power of synthesis to prove the absolute 
configuration of iriomoteolide-2a (8b) through synthesising both enantiomers and comparing their chiral-
HPLC retention times with the natural product. 
 
Figure 7. Reported structure for iriomoteolide-2a (8) and the process leading to the revision of relative configuration to 8a, and 
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The final example pertains to the baulamycin family of natural products, which perhaps best represents the 
synergistic role synthesis plays, among other contemporary techniques, in the unambiguous stereochemical 
elucidation of a natural product. Towards their ongoing campaign for the discovery of novel antibiotic 
agents, Sherman et al. reported the baulamycin family of siderophore antibiotics from a library of marine 
microbes in 2014.35 Owing to the scarcity of material, no attempt was made at ascertaining its absolute 
configuration, though the relative configuration was initially determined by J-based coupling constant 
analysis. Its promising bioactivity has drawn interest from at least two research groups, with Goswami et al. 
achieving a total synthesis of the reported structure for baulamycin A (9) in early 2017.36 However, the clear 
deviations from the reported NMR values for the natural product suggested that the structure was 
misassigned. 
Later in 2017, Aggarwal et al. disclosed a comprehensive stereochemical reassignment of the baulamycins, 
correcting five out of seven stereocentres and definitively assigning the absolute configuration of the natural 
product (Figure 8).37 This was initially achieved through a combination of ab initio NMR predictions and 
statistical analyses, which allowed for the reassignment of C10-C1’. The elucidation of the remaining methyl 
configured stereocentres nominally would be challenging using spectroscopy, but in this case, an elegant 
synthesis enabled by Aggarwal’s lithation-borylation methodology allowed for its facile determination. By 
using a pre-encoded mixture of enantiomers, a statistically defined mixture of four diastereomers was 
generated, which could be compared with the natural product to readily determine its relative configuration. 
A final optical rotation comparison further allowed the unambiguous absolute stereochemical assignment 
of the baulamycins, that was unable to be achieved by the isolation chemists. Overall, this resulted in the 
reassignment of baulamycin A and B from 9 and 10, to 9a and 10a respectively. 
These examples are among many in the chemical literature on the decisive role synthesis has played in the 
unambiguous stereochemical assignment of natural products. In cases where related natural products have 
been isolated, homology from biosynthetic proposals can guide a synthesis-enabled reassignment, as 
evidenced by the reassignment of mandelalide A. Developing modular syntheses where major groups of 
stereocentres are isolated in single fragments also contributes to the expeditious identification of 
stereochemical anomalies, which was exemplified in iriomoteolide-2a. Finally, the reassignment of the 
baulamycins represents the power in incorporating elegant syntheses with computational techniques in 
tackling what otherwise would be an intractable number of candidates. Each of these examples highlight 
the multifaceted problems stereochemical inconsistencies bring, which demand multifaceted solutions in 
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1.3. Summary 
The continual advances in characterisation techniques have facilitated a much greater structural diversity 
of compounds to be isolated and elucidated from nature. This in turn, has inspired the development of 
state-of-the-art analytical methods for their elucidation, as well as novel synthetic methods for their 
synthesis. However, these methods are not perfect, and mistakes still happen. In many cases, advanced 
techniques are unable to resolve ambiguities, and a judicious synthetic chemistry campaign can still be used 
as the final tool to definitively pin down a compound’s true identity, as exemplified by the three recent case 
studies illustrated in this section. 
This thesis will highlight the prominent role synthesis has played in the stereochemical elucidation of two 
marine polyketides, hemicalide and phormidolide A. Chapter two discusses work towards the natural 
product hemicalide, a potent cytotoxin that possesses a seemingly intractable stereochemical problem. 
Chapter three furthers this with results presented for phormidolide A, a compound that has evolved into a 
continually moving target. Both sections ultimately will highlight the decisive role synthesis has played in 









2.1. Isolation, 2D structural elucidation and biological activity of hemicalide 
First appearing in the patent literature in 2011, hemicalide (1) was isolated from the marine sponge 
Hemimycale sp. around the Torres Islands of Vanuatu by CNRS-Pierre Fabre Laboratories and the Institut 
de Recherche pour le Développement. A bioassay-guided fractionation from 5 kg of Hemimycale sp. 
afforded 0.5 mg of the active component hemicalide.1 ESI-MS identified a [M–H]– pseudomolecular ion 
signal at m/z = 1061.6780, which corresponded to a molecular formula of C59H97O16. The planar structure 
of hemicalide was assigned from extensive 1D- and 2D-NMR studies, which revealed a 46-carbon skeleton 
bearing 21 stereocentres. Major features observed include a conjugated trienic acid (C1-C7), a contiguous 
polyproprionate stereohexad (C8-C13), a conjugated diene (C14-C17), an a,b-dihydroxylactone (C19-C23) 
and an a-hydroxylactone (C37-C41) (Figure 9).1 Unfortunately, further derivatisation or degradation 
studies to ascertain both the relative and absolute stereochemistry of the molecule were not conducted 
owing to the scarce supply of the material, leaving all 21 stereocentres unassigned. 
 
Figure 9. Planar structure of hemicalide, with major structural features highlighted 
Hemicalide was found to be highly cytotoxic across a number of cell lines (Table 1). Preliminary attempts 
at elucidating hemicalide’s mechanism of action pointed towards microtubule destabilisation.1 At a dose of  
5-50 nM, immunohistochemical labeling of a-tubulin in HeLa cells found no microtubule skeleton for cells 
in interphase. Mitotic cells additionally were found arrested in prometaphase without microtubules.1 Other 
well-known antimitotic natural products, such as paclitaxel, epothilone B and discodermolide inhibit 
microtubule polymerisation during the metaphase/anaphase boundary.38 These observations suggest that 
hemicalide inhibits the formation of the microtubule network in a novel manner; a valuable property as a 
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Hemicalide presents itself as an attractive natural product for synthetic chemists and biologists due to its 
structural complexity, stereochemical uncertainty, and more importantly, the need for further biological 
studies into its novel mechanism of action. Additionally, with the advent of targeted anticancer therapies 
such as antibody-drug conjugates (ADC), hemicalide’s picomolar potency and novel mode of action make 
it a prime candidate as a potential payload in an ADC context.40  
Table 1. Antiproliferative activity of hemicalide across six different cancer cell lines 
Cell line Disease IC50 (nM) 
A549 Non small cell lung cancer 0.82 
BxPC3 Pancreatic cancer 0.47 
LoVo Colon cancer 0.081 
MCF7 Breast cancer 0.011 
Namalwa Burkitt’s lymphoma 1.1 
SK-OV-3 Ovarian cancer  0.33 
 
2.2. Current progress towards the stereochemical assignment of hemicalide 
Despite the promising biological effects exhibited by hemicalide from nascent investigations, further 
elucidation of its mode of action and subsequent development cannot occur if its 3D architecture is left 
undetermined. In this case, the 21 unassigned stereocentres of hemicalide produce 221 possible 
stereoisomers. To simplify the task of ascertaining the relative configuration of the molecule, the Ardisson 
group began by examining isolated stereoclusters, notably the C1-C15 polypropionate (11), the C18-C24 
dihydroxylactone (12) and the C36-C46 hydroxylactone (13) regions (Figure 10). An overview of the 
current progress towards the complete stereochemical assignment of hemicalide is presented below. 
 







































2.2.1. Assignment of the C1-C15 polypropionate stereohexad 
On initial examination of the 13C NMR spectrum for hemicalide, Ardisson noticed that the chemical shift 
for the signal attributed to Me12 was unusually low (7.6 ppm). Comparisons with typical polyketide motifs 
pointed to Me12 as being part of a C10-C13 syn-syn stereotriad.41 The same phenomenon was not observed 
for Me10, ruling out a syn-syn relationship for the substituents across C9-C11 and indicating that the 
stereotriad must likely to contain a syn-anti, anti-syn or an anti-anti configuration (Figure 11a). These two 
observations allowed Ardisson to reduce the number of diastereomers to consider from 32 down to six. 
Following the synthesis of all six candidate diastereomers and detailed spectroscopic comparisons with the 
natural product, Ardisson concluded diastereomer 11a was the best match to hemicalide. During the course 
of this study, Ardisson noticed significant deviations in chemical shifts in the C1-C7 trienoic acid region of 
their fragments from hemicalide, though notably, the perturbations did not extend into the aliphatic region 
(C8 onwards). By deprotonating a model acid 14 to form 15, Ardisson speculated that these deviations may 
be attributed to hemicalide being isolated as the carboxylate salt rather than the free acid (Figure 11b). 
 
Figure 11. a) Diagnostic spectroscopic data for the C1-C15 polypropionate region, leading to diastereomers 11a-f analysed by 
Ardisson to determine 11a as the most likely candidate structure. b) Synthesis of model carboxylate salt 15 by Ardisson to conclude 
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Using the DP4 Gauge-including atomic orbital (GIAO)-NMR shift prediction methodology, Smith and 
Goodman independently arrived at the same conclusion regarding relative stereochemistry of the 
stereohexad in the C1-C15 fragment.14 The DP4 method allows the prediction of a compound’s relative 
stereochemistry from a given set of diastereomers. This is achieved through ab initio calculations of 1H and 
13C NMR chemical shifts for each candidate diastereomer. Comparing the differences between the 
theoretical shifts with the experimental data via the DP4 algorithm gives rise to an overall probability for 
the candidate diastereomer fitting the experimental NMR data. As enantiomers show identical chemical 
properties and thus, display identical NMR spectra, the DP4 method cannot be used to assign the absolute 
stereochemistry of a compound.14  
2.2.2. Assignment of the C18-C24 dihydroxylactone  
For the C18-C24 region, Ardisson narrowed down the set of possible diastereomers to four based on NOE 
and coupling constant analyses (Figure 12a).42 Synthesis of all four diastereomers (16a-d) and comparing 
their NMR data to hemicalide led to the conclusion that the diastereomer 16c, containing the 18,19-anti 
relationship, was the most likely candidate (Figure 12b). Interestingly, DP4 calculations performed in the 
Paterson group by MacGregor for the C18-C25 region identified diastereomer 17 (Figure 12c) as the most 
likely candidate (99%),43 which contradicted Ardisson’s assignment with its key 18,19-syn relationship. 
Ardisson’s 18,19-anti assignment hinged upon a qualitative comparison of the H19 proton signal, reasoning 
that the 18,19-anti diastereomer, which exhibited a ddd multiplicity, was a closer match for the 
experimental hemicalide data compared to the 18,19-syn relationship. This was not considered to be 
conclusive by MacGregor given that the analogous H37 oxymethine proton appeared as a ddd in the C36-
C42 fragment 18 (Figure 12d),44 which exhibited a 36,37-syn relationship. Furthermore, Ardisson’s 
synthesis of the C1-C25 fragment involved an intermediate 19, which, despite the 18,19-anti relationship, 
exhibited a dt multiplicity for the H19 proton.45  
A recent synthesis by the Paterson group of a model C16-C28 fragment 20, with structural features more 
similar to the natural product than that synthesised by Ardisson, reinforced MacGregor’s findings. The 
chemical shift, multiplicity and J values for the model C16-C28 fragment 20 proved to be a better match to 
the natural product, thus providing a more confident assignment of the relative stereochemistry in the C18-









Figure 12. a) Original spectroscopic data for the C18-C25 region, highlighting the relative chemical assignment of the d-lactone  
b) Diastereomers analysed by Ardisson to determine 16c as the most likely candidate structure c) DP4 predicted diastereomer 17 
and model fragment 20 as synthesised by MacGregor et al. d) Late stage intermediates 18 and 19 that appeared to contradict 
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2.2.3. Assignment of the remainder of hemicalide: the C25-C46 region 
The C36-C46 hydroxylactone contains the final stereochemically dense fragment present in hemicalide. 
Analogous to the assignment of the C18-C25 dihydroxylactone, observation of key NOE correlations and 
coupling constants allowed Ardisson/Cossy to reduce the number of diastereomers to consider from 32 to 
eight (Figure 13a).44 During the course of their study, it became apparent that the distal nature of the C45 
carbinol stereocentre relative to the C36-C42 hydroxylactone meant that the two candidate C45 epimers 
could not be differentiated spectroscopically. By arbitrarily defining the C45 stereocentre, Ardisson/Cossy 
further reduced the number of candidate diastereomers to four, whereby spectroscopic comparisons with 
the natural product revealed 21a to be the best match with hemicalide (Figure 13b). In parallel, DP4 
calculations performed by MacGregor on a model C36-C46 fragment (22, Figure 13c) corroborated the 
relative configuration proposed by Ardisson/Cossy.46  
 
Figure 13. a) Original spectroscopic data for the C36-C42 region, highlighting the relative chemical assignment of the d-lactone  
b) Diastereomers analysed by Ardisson/Cossy to determine 21a as the most likely candidate structure. c) DP4 predicted diastereomer 
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At this stage, the relative configuration of 16 of the 21 stereocentres in hemicalide have been assigned, 
corroborated both by synthesis and computational studies. Aside from C45, which remains 
configurationally elusive despite attempts at synthetic verification, the four remaining unassigned 
stereocentres are contained within the C25-C34 polyacetate region. MacGregor attempted DP4 calculations 
to determine the most likely diastereomer for the C25-C34 region. However, the region’s inherent flexibility 
led to multiple low energy conformations, which could not be further refined as the chemical shifts for the 
methylene protons in this region were obscured in a 22H multiplet in the 1H NMR spectrum for hemicalide. 
These limitations meant that overall, no candidate C25-C34 diastereomers could be assigned with high 
confidence.46  
Recently, Ardisson and Cossy reported the synthesis of a structure 23 corresponding to the full carbon 
skeleton of hemicalide, bearing the revised 18,19-syn configuration in the C18-C24 dihydroxylactone 
(Figure 14).47 While the Ardisson and Cossy were unable to achieve a full deprotection in 23, the large 
chemical shift deviations between 23 and hemicalide, in particular in the C28-C32 polyacetate region 
provided compelling evidence that the natural product is likely to not contain the published configuration. 
In particular, the large 13C chemical shift deviations (>1.0 ppm) recorded for C26, C28, Me32 and C33 is a 
diagnostic indication that hemicalide probably possesses the opposite relative configuration, namely 27,29-
anti and 31,32-syn, to the structure published by Ardisson and Cossy. 
 
 
Figure 14. Structure of 23 as synthesised by Ardisson and Cossy, highlighting the C26-C36 polyacetate region and the large chemical 
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2.2.4. Relative configuration between the C1-C15 and C16-C25 region 
With the relative configuration established within the three regions, the next unanswered question was the 
diastereomeric relationship between each stereocluster. Initial forays into this were undertaken by the 
Ardisson and Cossy groups, who first reported a synthesis of the C1-C27 truncate 24 featuring the incorrect 
18,19-anti configuration in the dihydroxylactone fragment.45 After MacGregor’s reassignment, the 
Ardisson and Cossy groups revised their synthesis of their C1-C27 fragment to contain the updated 18,19-
syn configuration in 25,48 and incorporated this updated configuration in their synthesis of the full carbon 
skeleton 23.47 Analysis of the NMR deviations between truncates 24, 25 (containing the revised 18,19-syn 
configuration) and 23 pleasingly affirmed our reassignment, with compounds 23 and 25 bearing the revised 
stereochemistry resulting a far closer fit to the spectroscopic data for hemicalide (23: (S|DdH| = 0.20 ppm; 
S|DdC| = 4.3 ppm; 25: S|DdH| = 0.26 ppm; S|DdC| = 3.8 ppm)* compared with truncate 24  (S|DdH| = 0.76 
ppm; S|DdC| = 10.9 ppm) (Figure 15). 
In the three aforementioned cases (23, 24 and 25), the Ardisson and Cossy groups targeted the synthesis of 
the C1-C27 truncate containing a 13,18-anti relationship between the two fragments; one of the two 
possible permutations present in hemicalide. Considering that both fragments represent over half of the 
carbon skeleton of the natural product, the comparatively large total 1H and 13C deviations seen in 23 
(|SDdH| = 0.20 ppm; S|DdC| = 4.3 ppm) and 25 (S|DdH| = 0.26 ppm; S|DdC| = 3.8 ppm) and  and the absence 
of the alternative 13,18-syn diastereomer for comparison led us to suspect that the reported 13,18-anti 




* Comparisons were made between H/C8 to H/C24 owing to the variability in the C1-C7 trienoic region due to the protonation state of C1, and 






Figure 15. Bar graphs showing the 1H (top) and 13C (bottom) chemical shift difference between truncate 24 (blue), truncate 25 
(orange) and hemicalide, highlighting the improved correlations after reassigning to the 18,19-syn configuration 
 
  




Figure 16. Bar graphs showing the 1H (top) and 13C (bottom) chemical shift difference between truncate 25, 23 and hemicalide, 






2.3. Previous synthetic work towards hemicalide 
As highlighted in section 2.2, to date, two research groups have reported ongoing synthetic efforts towards 
the total synthesis of hemicalide, namely the Ardisson/Cossy groups working in collaboration, and the 
Paterson group. This section will outline the major synthetic routes each group has achieved towards the 
synthesis of key fragments. 
2.3.1. Synthesis of the C1-C15 region 
The C1-C15 region can be further divided into two subregions, the C1-C7 trienoic acid fragment and the 
C8-C15 polypropionate stereohexad. Both the Ardisson and Paterson groups approached this fragment by 
disconnecting across C6-C7 via an HWE olefination to deliver the 6E olefin geometry (Scheme 1a). This 
reveals a C1-C6 phosphonate and the C7-C15 aldehyde. The dense oxygenation as typified in polyketides 
within the C7-C15 fragment can be readily constructed via a series of highly diastereoselective 
aldol/reduction sequences, which retrosynthetically reveals Roche ester 26 and oxazolidinone 27 as the 
chiral building blocks for this fragment. 
Ardisson’s synthesis of the C1-C15 polypropionate region commenced from (S)-Roche ester (S)-26, which 
was derivatised into aldehyde 27 following a three-step sequence involving TBS protection, DIBAL 
reduction and Swern oxidation (Scheme 1b). At this point, a diastereoselective Paterson boron-mediated 
aldol reaction49 with lactate-derived ketone 28 and aldehyde 27 gave 29, where the newly formed hydroxyl 
centre was methylated. Reduction of the ketone and the benzoyl ester with LiBH4, followed by an oxidative 
cleavage of the intermediate diol reveals aldehyde 30, which engaged in an Evans’ aldol reaction50 with 
oxazolidinone 27 to afford the 1,2-syn adduct diastereoselectively. The oxazolidinone auxiliary was 
transformed to Weinreb amide 31, and the free hydroxyl group transiently protected as the TMS ether in 
32 to allow for the addition of the lithiated species derived from 33 into Weinreb amide 32 to give ketone 
34. The final stereocentre in this fragment was set by a 1,3-syn reduction mediated by Zn(BH4)2, following 
the deprotection of the TMS ether in 34 on treatment with Amberlyst-15 resin. The resulting diol was 
protected as the cyclic siloxane, the vinyl silane treated with NIS to effect a Si/I exchange and the terminal 
TBS ether cleaved to reveal the C7 alcohol 35. Dess-Martin oxidation of alcohol 35 afforded aldehyde 36, 
which could undergo an HWE olefination with phosphonate 37 to furnish the full C1-C15 fragment 38. 
The Ardisson synthesis of the C1-C15 fragment proceeds in 19 steps in the longest linear sequence from 
(S)-26, with 17.5% overall yield. 
  20 
 
Scheme 1. a) General retrosynthesis of the C1-C15 fragment. b) Ardisson's synthesis of the C1-C15 fragment 38.  
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Analogously, the Paterson approach to the C1-C15 fragment 39 commenced with an Evans’ aldol reaction 
between oxazolidinone ent-27 and aldehyde 40, itself obtained in four steps from diethyl methylmalonate 
via ester 41 (Scheme 2).51 Subsequent TES protection of aldol adduct 42 and reductive auxiliary cleavage 
revealed aldehyde 43, which engaged with (S)-Roche ester derived ketone 44 in a boron-mediated aldol 
reaction with excellent diastereoselectivity (>20:1 dr). The aldol adduct was protected as the TES ether and 
followed by a diastereoselective reduction with DIBAL to afford the 1,3-syn product 45. Methylation to give 
46 followed by PMB deprotection, subsequent oxidation and HWE olefination with phosphonate 47 gave 
the full C1-C15 carbon skeleton 39. Overall, the Paterson synthesis of the C1-C15 fragment proceeded in 
11 steps in the longest linear sequence from aldehyde 40, in 11% overall yield. Notably, all of the key 
stereoinducing processes in the Paterson synthesis were highly selective; generating a single diastereomer 
in all instances. As the synthesis is diastereoselective from ent-27 and (S)-44 as its chiral sources, the 
enantiomer can be readily accessed, and the synthesis is scalable to generate gram-scale quantities of 
intermediate 46. 
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2.3.2. Synthesis of the revised C16-C25 region 
Alongside the C1-C15 fragment, both the Ardisson/Cossy groups, as well as the Paterson group have 
reported on the synthesis of the C16-C25 region. A key feature in the C16-C25 dihydroxylactone fragment 
is the 21,22-syn diol motif, which can be generated from a substrate-controlled dihydroxylation of a cyclic 
enoate intermediate. At this point, the 1,4-syn relationship between Me24 and OH19 allows for a substrate-
controlled addition of a suitable carbon nucleophile into a chiral aldehyde. These features are highlighted 
in the general retrosynthesis shown in Scheme 3a. 
To experimentally validate the DP4 predicted structure bearing the 18,19-syn relationship, the Paterson 
group disclosed a synthesis of the C16-C25 region commencing with a diastereoselective Ipc-boron-
mediated aldol reaction between ketone 48 and aldehyde 49 (Scheme 3b), both of which derived from the 
same enantiomer of Roche ester (S)-26. From the aldol adduct 50, a four-step sequence involving TBS 
protection, enolate addition, silyl deprotection and dehydration gave the key cyclic enoate intermediate 51. 
MacGregor et al. found that the pivotal dihydroxylation step to yield diol 52 could not be allowed to proceed 
to completion owing to competing oxidation at the C16 vinyl iodide. Following a bis-TES protection, PMB 
deprotection and Dess-Martin oxidation, the fragment could then be elaborated via an HWE olefination 
and conjugate reduction to afford the C16-C28 fragment 53. For NMR comparisons, MacGregor 
intercepted intermediate 52 and subjected that to a Stille coupling with stannane 54 to give triol 20. This 
was used to confirm that the revised C16-C25 dihydroxylactone with the 18,19-syn relationship was indeed 
a closer match to the natural product by detailed NMR comparison than that reported by the 
Ardisson/Cossy groups. 
During the dihydroxylation step, MacGregor attributed the competing oxidation of the C16 vinyl iodide to 
the electronic similarity between the enoate olefin and the vinyl iodide. This was identified as a potential 
bottleneck, and as such, a second approach by intercepting the electronically deactivated vinyl dibromide 
55 as an intermediate was investigated by Thompson (Scheme 3c).52 While the planned dihydroxylation 
step was able to proceed to completion without observing any unwanted oxidation at the vinyl dibromide, 
this synthesis suffered from the intractability of aldehyde derived from PMB ether 55, with Thompson 
noting that it was highly prone to degradation, as well as the poor efficiency of the trans-selective Stille cross 
coupling, proceeding in an unoptimised 16% yield from intermediate 56. The shortcomings Thompson 
observed in this revised route did not appear to outweigh the singular weakness of the original route, and 





Scheme 3. a) General retrosynthetic analysis for the C16-C25 dihydroxylactone fragment. b) The Paterson synthesis of the C16-C28 
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Following the disclosure of our group’s reassignment and synthesis, the Ardisson/Cossy group reported 
two routes to the reassigned C16-C25 region. The first iteration commenced with a Dias allylation53 of 
allylsilane 57 and the analogous bromoaldehyde 58 (both derived from (S)-Roche ester (S)-26) to give 
alcohol 59 (9:1 dr) (Scheme 4). Subsequent ozonolysis of the C21 olefin followed by acetylation gave ester 
60, which underwent an intramolecular Reformatsky reaction (SmI2), elimination and dihydroxylation 
sequence to configure all the stereocentres present in the C16-C25 lactone (61). 
 
 
Scheme 4. Ardisson/Cossy's synthesis of the C16-C25 fragment 61 
 
Subsequent to this initial sequence, Cossy disclosed an alternative ring-closing metathesis (RCM) route 
towards the synthesis of the dihydroxylactone fragment that obviates the need for the ozonolysis of the C21 
olefin as well as the subsequent elimination step to reform the cyclic enoate system. Synthesis of the 
allylation precursor proceeded in eight steps from (S)-citronellol 62. The sequence began with a silyl 
protection, ozonolysis followed by a reduction to afford alcohol 63. The C27 alcohol was benzyl protected, 
and the primary TES ether subjected to Swern conditions, resulting in the concomitant desilylation and 
oxidation of the TES ether to the aldehyde. This intermediate was then a-methylenated under Mannich 
conditions to afford intermediate 64 (Scheme 5). To transform this to the allylation precursor, a reduction 
followed by esterification installed the allylic ester 65, whereby a Tsuji-Trost-like displacement of the allylic 
ester via an in situ generated Bu3SnAlEt2 reagent under Pd catalysis installed the stannane handle in 66. 
Subsequent allylation was effected under Williams’ conditions to give the adduct 67 in 7.3:1 dr. 
Subsequently, the acrylate ester was installed on C19 to give 68, where the use of Nolan’s metathesis catalyst 
facilitated the required ring closure to form enoate 69. Employing the improved dihydroxylation conditions 
reported in the Paterson synthesis allowed the facile conversion to the dihydroxylactone fragment, which 
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Scheme 5. Ardisson/Cossy's second synthesis of the C16-C27 fragment 70 via an RCM approach 
2.3.3. Synthesis of the C35-C46 region 
The C34-C46 hydroxylactone fragment is structurally homologous to the C16-C25 dihydroxylactone 
except for three aspects, namely the absence of an olefinic methyl substitution at C34, the lack of 
oxygenation at C39, as well as the all syn-configuration across the C36-C42 stereocentres.  
Alongside the report on the stereochemical assignment of the C34-C46 region, the Cossy group disclosed 
an 11-step synthesis of the C35-C46 region, where the major disconnection involves a diastereoselective 
Rh-catalysed conjugate addition of the ‘ate’-complex derived from boronate 71 into cyclic enoate 72 
(Scheme 6). The synthesis of cyclic enoate 72 commenced with (S)-Roche ester (S)-26. A four-step sequence 
involving PMB protection, transformation to the corresponding Weinreb amide, reduction and allylation 
using the Duthaler allyltitanium reagent provided alcohol 73, which after esterification and an RCM 
afforded the cyclic enoate 72. Synthesis of the boronate partner 71 commenced with the TBS ether 74, 
where cross metathesis with alkene 75 gave vinyl boronate 71 in a 5.7:1 ratio of Z/E isomers favouring the 
desired geometry. The required Rh-catalysed conjugate addition was achieved with moderate 
diastereoselection (4.9:1 dr) to give the full C35-C46 skeleton 76. Next, an a-oxidation mediated by Davis 
oxaziridine installed the C40 stereocentre in 77 with excellent diastereoselectivity (>20:1 dr). The final C42 
stereocentre was set by a hydroxyl-directed hydrogenation catalysed by Crabtree’s catalyst of the 
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Scheme 6. Cossy's synthesis of the C35-C46 fragment 78. COD = cyclooctadiene 
 
While the poor selectivity of the olefin reduction was useful for the flexible generation of diastereomeric 
candidates in a ‘diversity-oriented’ manner, the confident assignment of this region now necessitates a 
focused ‘target-oriented’ approach. Recognising the structural homology between the C16-C25 
dihydroxylactone with the C35-C46 fragment, the as-yet unreported Paterson synthesis conducted by 
Stockdale utilises methodology from the previously reported synthesis of the C16-C25 dihydroxylactone to 
allow the use of common starting materials (Scheme 7). An analogous Ipc-boron-mediated aldol reaction 
between aldehyde 79 and ketone (R)-48, both synthesised in three-steps from (S)-26 and (R)-26 respectively, 
gave adduct 80 diastereoselectively (>20:1 dr). Protection as the TBS ether followed by the addition of the 
lithium enolate derived from ester 81 enabled an in situ Peterson olefination that afforded enoate 82 
primarily as a single geometric isomer. At this point, TBS deprotection enabled a hydroxyl-directed 
hydrogenation of the enoate olefin, catalysed by Crabtree’s catalyst, to install the C39 stereocentre with 
useful selectivity (ca. 4:1 dr), which can be lactonised under acidic conditions to give lactone 83. An a-
oxidation mediated by Davis oxaziridine followed by silyl protection and PMB deprotection reveals the free 
alcohol 84, which after oxidation could be homologated via an HWE olefination. At this point, a CBS 
reduction can selectively install the C45 stereocentre, and the olefin and benzyl groups could be reduced 
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2.3.4. Fragment union studies: Ardisson/Cossy’s synthesis of the full carbon skeleton of hemicalide 
With the major fragments synthesised and reported by the Ardisson and Cossy groups, the next synthetic 
goal is to realise a suitable fragment coupling strategy to construct the complete carbon backbone of 
hemicalide. Concurrent with the Paterson group’s ongoing campaign, the Ardisson/Cossy groups have 
recently reported a synthesis of the carbon backbone of hemicalide,47 details of which are outlined below. 
Ardisson/Cossy proposed to disconnect hemicalide across C15-C16 via a Suzuki coupling, C27-C28 via an 
aldol reaction and the C34 olefin via a Julia-Kocienski olefination (Scheme 8). Retrosynthetically, this 
reveals the C1-C15 fragment 38, the C16-C27 fragment 86 and the C35-C46 fragment 87, where details of 
the synthetic route have been previously discussed. Additionally, the retrosynthetic analysis reveals the 
previously undisclosed C28-C34 ketosulfone unit 88 bearing the two of the five undefined stereocentres 
proposed to bridge the C16-C27 and the C35-C46 fragments together. 
 
Scheme 8. The Ardisson/Cossy approach to hemicalide, revealing four major fragments 
Synthesis of the C28-C34 ketosulfone commenced with a Duthaler-type crotylation of aldehyde 89 to give 
alcohol 90 diastereoselectively (Scheme 9). Subsequent protection of C31 as the PMB ether followed by a 
9-BBN-mediated hydroboration/oxidation sequence installs the C34 alcohol in 91, which can be displaced 
in a Mitsunobu manner to afford sulfide 92. At this point, Ardisson/Cossy curiously reports a silyl 
protecting group switch, deprotecting the C29 TBS ether under fluorous conditions and reinstalling a TES 
ether. Following this sequence, an mCPBA-mediated oxidation of the intermediate sulfide generates the 
sulfone coupling partner 93 in anticipation of the planned olefination reaction. 
The required aldehyde functionality on the C35-C46 fragment was attained by a three-step sequence from 
intermediate 78 (synthesis described in 2.3.3). Subjecting aldehyde 94 and sulfone 93 under Julia-Kocienski 
olefination conditions delivered the C28-C46 fragment 95 in a moderate yield but with excellent geometric 




















































the C29 ketone 96. This was subjected to a boron-mediated aldol reaction with the C16-C27 aldehyde 97 
(synthesised in two steps from the reported intermediate 70). While in this instance the diasteroselection 
of the aldol addition was not reported, in a previous communication, it was indicated that the 1,5-anti 
adduct proceeded in moderate stereocontrol (ca. 4:1 dr).48 In this account, the intermediate boron aldolate 
intermediate was not isolated and immediately subjected to a LiBH4-mediated reduction to deliver the 
29,31-syn diol diastereoselectively. After a bis-methylation to give 98, Ardisson/Cossy reported a two-step 
protecting group switch at C31 from a PMB to a TES ether. While the electron-rich PMB ether is better able 
to promote the remote 1,5-stereocontrol during the aldol step,54 presumably this switch was conducted to 
streamline the eventual global deprotection. At this point, intermediate 99 bearing the C16-C46 fragment 
was transformed to the requisite boronate in 100, in anticipation of the planned Suzuki coupling with the 
full C1-C15 truncate 38.  
While Ardisson/Cossy have previously employed a Suzuki coupling for the synthesis of their C1-C27 
truncate, via the boronate derivative of the C16-C27 fragment 61,45,48 this two-step sequence (C16 
borylation followed by cross-coupling) was poor yielding (13% over two steps), which the authors 
attributed to the inefficiency of the borylation step. Attempts at conducting a global deprotection was 
carried out using a two-step procedure (TASF; HF·py), but the authors were unable to remove the TBS 
protecting group at either C40 or C45. As discussed in section 2.2.4, the large NMR shift deviations, 
alongside with the lack of a suitable alternative model for comparison led us to suspect that this published 
structure, in particular between the C1-C15 and the C16-C25 regions, as well as the C27-C32 polyacetate 
region, did not reflect the true stereochemical nature of hemicalide. 
At this point, it is worth noting that the lack of further experimental and spectroscopic data from the 
isolation group means that a synthesis-based stereochemical elucidation of hemicalide is the only method 
to conclusively ascertain its overall configuration. Towards this end goal, the key weakness in the strategy 
presented is the reliance of the pre-installed C31 stereocentre to singularly configure the C27 stereocentre 
(via a 1,5-anti aldol). The diastereoselective nature of this transformation means that it is far more 
challenging to install the alternative, but equally probable 27,31-syn configuration. Therefore, our approach 
needed to pay particular attention in developing a flexible strategy in configuring all as-yet unknown 
stereocentres in an efficient and predictable manner. 
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Scheme 9. Ardisson/Cossy's synthesis of the carbon backbone of hemicalide 23. Note that the final global desilylation could not 
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As a highly potent and a mechanistically unique cytotoxic polyketide natural product, hemicalide has 
garnered the interest of chemists and biologists alike for its potential as a novel anticancer agent. Owing to 
its scarce supply, the isolation team were unable to determine the relative and absolute configuration of all 
21 stereocentres, leaving NMR data as the only available evidence for researchers to piece together its 
stereochemical identity.  
Through focusing their analyses to selected stereochemically rich regions, the Ardisson and Cossy groups 
have established the stereochemistry of the C1-C15 polypropionate and the C36-C42 hydroxylactone 
region, as well as proposing the 18,19-anti relationship for the C18-C24 dihydroxylactone (Figure 17). 
Independently, the Paterson group corroborated two of the three assignments through the DP4 algorithm 
but reassigned the dihydroxylactone region from an 18,19-anti to an 18,19-syn relationship. These results 
were experimentally confirmed with an improved correlation shown for truncate 20 to the natural product 
relative to truncate 16c as synthesised by Ardisson and Cossy. 
Furthermore, the Ardisson/Cossy and the Paterson groups have reported on synthetic studies towards 
various fragments. This included a synthesis of the C1-C15 region as well as the revised C16-C25 region. 
On top of this, Ardisson/Cossy have reported a synthesis of the C36-C42 hydroxylactone as part of the 
stereochemical assignment of the aforementioned region. Towards achieving a total synthesis, 
Ardisson/Cossy have also shown an iteration of their fragment union strategy between the three major 
fragments to afford the full carbon skeleton of hemicalide. However, the large NMR shift deviations 
between several major fragments, and the absence of alternative configurations for comparison hints 
towards the conclusion that fragment 23 is unlikely to bear the correct configuration between C1-C15 and 
C16-C25 regions, as well as within the C27-C32 polyacetate region. 
Overall, this section outlined how 16 of the 21 stereocentres present within the three stereoclusters in 
hemicalide were assigned and the routes taken to achieve fragment synthesis; these are summarised in 
Figure 17. The knowledge obtained from preliminary stereochemical elucidation, as well as the strength 
and deficiencies of previous studies forms the basis for the next section in the ongoing study towards a 




























































































3. Results and Discussion 
 
The work described in this section was carried out in collaboration with Bing Yuan Han. His results were 
crucial to the project and are presented alongside the author’s results. Unless otherwise stated, all reactions 
described were performed by the author and all stated yields are those obtained by the author. 
 
3.1. The Paterson approach to hemicalide 
In order to facilitate investigations towards determining the relative configuration between each known 
cluster, a convergent and stereoflexible approach is required, especially towards accessing the unassigned 
C27-C34 polyacetate region. The Paterson approach towards hemicalide proposes an enantioselective 
boron-mediated aldol reaction/diastereoselective reduction/bis-methylation sequence to configure the four 
possible diastereomers arising from C27 and C29 stereocentres at a late stage. Retrosynthetically, this 
reveals a C1-C28 fragment 101, and a C29-C46 fragment 102.  The success of this end-game strategy 
depends on the complete reagent-control enforced by the chiral ligands on the boron Lewis acid; therefore, 
it is important to employ a silyl protecting group at C31, known to be a poorer contributor to 1,3-
stereoelectronic effects as a measure to minimise any stereoinduction by the substrate in the closed aldol 
transition state.55 The C29-C46 fragment 102 can be further disconnected at C33-C34 via cross-metathesis 
to give the C34-C46 alkene 103 and C29-C33 alkene 104 containing the remainder of the unknown 
stereocentres (Scheme 10). 
The poor efficacy in installing the requisite Bpin handle for the C15-C16 cross coupling, alongside with the 
harsher conditions employed for the Suzuki reaction served as a cautionary tale for our synthetic design of 
the C1-C28 fragment 101. Disconnecting at the same C15-C16 bond, our fragment union needed to be mild 
and highly efficient, and flexible enough to enable the facile access of either permutation of coupling handles. 
With promising results obtained from a model Stille coupling to afford model truncate 20, the Stille 
coupling was adopted, which retrosynthetically reveals the C1-C15 polypropionate 39 and the C16-C28 
dihydroxylactone 53. Notably, the required stannyl handle could be flexibly installed at either C15 or C16 
vinyl iodide through a Wulff-Stille reaction. The Stille coupling has proven to be a highly robust Csp2-Csp2 
bond forming strategy in the context of natural product synthesis in the Paterson group,56 and was 
anticipated to provide efficient entry to the C1-C28 truncate of hemicalide. 
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Scheme 10. Overall disconnection strategy for hemicalide. PG denotes an unspecified protecting group. 
As highlighted in the previous section, previous work directed towards determining the relative 
configuration between the C1-C15 and the C16-C25 fragments have singularly targeted the 13,18-anti 
configuration, of which in the absence of the alternative 13,18-syn configuration, did not provide a 
compelling argument for the definitive assignment of the C1-C28 fragment of hemicalide. Thus, the short-
term goal involves synthesising both possible diastereomers (102 and 103) of the reassigned C1-28 
fragment as shown in Figure 18 to ascertain the relative configuration between each fragment. Additionally, 
since the C1-C28 truncate constitutes over 60% of the natural product, it was hypothesised that this truncate 
may also exhibit bioactivity. Without any further characterisation that points towards the absolute 
stereochemistry of hemicalide, being able to biologically screen both enantiomers of the correct C1-C28 
diastereomer could hint towards the absolute configuration of hemicalide, with the enantiomer 
corresponding to the one present in hemicalide putatively being more active than the other. Therefore, in 
light of this end goal of a synthesis-enabled elucidation of the C1-C28 region, as well as an activity-guided 
determination of the putative absolute configuration, both enantiomers of the C1-C15 and C16-C28 
fragments are required. Concurrently with this work, Han developed a scalable approach to both 
enantiomers of the C1-C15 fragment, leaving the synthesis of the enantiomeric C16-C28 fragment ent-53 
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Figure 18. Proposed workflow towards assigning the relative and absolute configuration of C1-C28 of hemicalide, highlighting the 













































Activity-guided biological testing of candidate 
C1-C28 diastereomer to reveal more active enantiomer
NMR comparisons with hemicalide
Fragment union
X1 = I (53 and ent-53); X2 = SnMe3 X1 = SnMe3; X2 = I (39 and ent-39)
Both enantiomers synthesised by Han
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3.2. Synthesis of the opposite enantiomeric series for the C16-28 fragment 
 
3.2.1. Synthesis of the aldol adduct ent-50 
Synthesis of the enantiomeric C16-C28 fragment ent-53 commenced with PMB protection of (R)-Roche 
ester (R)-26 to afford PMB ether 104 in excellent yield (99%). This was followed by reduction with LiAlH4 
to yield the primary alcohol 105 (93%). A subsequent Swern oxidation afforded the aldehyde 106, which 
was directly submitted to the Corey-Fuchs reaction57 to avoid racemisation of the aldehyde (80% over two 
steps). Vinyl dibromide ent-55 was then treated with nBuLi and MeI to afford the alkyne 107 (98%) 
(Scheme 11a). 
Transformation of alkyne 107 to vinyl iodide 108 was achieved by hydrozirconation with the Schwartz 
reagent (Cp2Zr(H)Cl)58 (109) generated in situ from Cp2ZrCl2 and DIBAL, followed by trapping of the 
organozirconium species with iodine. The regio- and stereoselectivity of this reaction arises from a  
syn-stereospecific addition of the hydrozirconium species across the alkyne (TS-I and II), with the large 
[Cp2ZrCl] species adding on the least hindered end.59 In theory, employing an excess of the Schwartz 
reagent improves the regioselectivity by a reversible second addition of the hydrozirconium species across 
the vinylzirconium intermediates (TX-III and IV). s-bond rotation followed by a b-hydride elimination of 
the more hindered organozirconium species favours the formation of the major regioisomer as the 
thermodynamic product (Scheme 11b).58 In the author’s hands, this transformation was capricious and 
particularly dependent on reagent quality, where older supplies of Cp2ZrCl2 additionally afforded 
appreciable amounts of the regioisomeric vinyl iodide. 
Subsequent PMB deprotection with DDQ afforded alcohol 110 (93%), which was oxidised with DMP to 
afford the required aldehyde ent-49. Due to its volatility and risk of racemisation at the C18 centre, aldehyde 






Scheme 11. a) Synthesis of aldehyde ent-49 from (R)-Roche ester (R)-26. 
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The required methyl ketone ent-48 was synthesised from a methylation of Weinreb amide 111 with 
MeMgBr. Grignard additions into Weinreb amides circumvent the issue of over-addition through the 
formation of a stable tetrahedral chelate 112 that does not decompose until aqueous workup, thereby 
avoiding the formation of the more electrophilic ketone under the reaction conditions. With ent-48 and 
ent-49 in hand, the required 1,4-syn boron aldol reaction was conducted employing the chiral boron 
reagent (+)-DIPCl (Scheme 12a). The reaction proceeds via a six-membered transition state (Scheme 
12b),60 where aldehyde ent-49 and the boron enolate derived from ent-48 are thought to sit in a boat 
conformation to facilitate the formation of the stabilising formyl-H bond between the electron-rich oxygen 
and the activated aldehyde.60 Two diastereomeric transition states TS-V and TS-VI can then be drawn. TS-
V is favoured as the allylic strain between C20 and Me24 on the enolate is minimised.61 Additionally, TS-V 
also has the enolate approaching the aldehyde in a Felkin-Anh manner.  The Ipc ligands enhances the 
selectivity by destabilising TS-VI with the unfavoured steric interaction between the Ipc Me group and the 
boron enolate, leading to the 1,4-syn diastereomer ent-50 as the anticipated major product.61 
The absolute configuration of the C19 stereocentre was confirmed by Mosher ester analysis. Compounds 
113 and 114 were formed by reaction of ent-50 with (S)- and (R)-MTPA respectively under Steglich 
esterification conditions (DCC, DMAP) (Scheme 13).62 MTPA derivatives of secondary alcohols 
preferentially adopt a conformation in which the carbinol proton, ester carbonyl and CF3 groups on the 
MTPA ester lie in the same plane (Figure 19a).63 This results in the protons lying on the same side as the 
MTPA Ph group to be diamagnetically shielded (shifted upfield) relative to the protons lying on the same 
side as the OMe group. Thus, the protons lying adjacent to the (S)-MTPA Ph group will be shielded 
compared to the analogous protons in the (R)-MTPA derivative.64 Thus, proton signals with Dd < 0 (Dd = 
DdS – DdR) would lie on the left-hand side of the (R)-MTPA plane from the perspective of the CF3 group, 
and vice versa for Dd > 0 (Figure 19b).65 Calculating Dd (Table 2) and applying the model described in 
Figure 19 showed that the C21 center had the desired S configuration, which corroborated the assignments 






Scheme 12. a) Synthesis of ent-50 from ent-48 and ent-49  
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Scheme 13. Synthesis of (R)- and (S)-MTPA derivatives of ent-50 
 
 
Figure 19. a) Diagram highlighting the preferred conformation of the MTPA derivative  
b) Model to assist the absolute configuration of a carbinol centre 
 
Table 2. List of chemical shifts for MTPA derivatives 113 and 114 
Proton dH (S)-MTPA (ppm) dH (R)-MTPA (ppm) DdS-R (ppm) 
H25a 3.49 3.52 –0.03 
H25b 3.41 3.44 –0.03 
H24 (2.75) (2.84) –0.09 
Me24 0.93 0.99 –0.06 
H20a 2.84 (2.84) 0.00 
H20b 2.75 (2.84) –0.09 
H19 5.42 5.42 0.00 
H18 (2.87) (2.81) +0.06 
Me18 0.91 0.86 +0.05 
H17 5.98 5.86 +0.12 
Me16 2.39 2.32 +0.07 
















































3.2.2. Synthesis of the dihydroxylactone ent-52 
Subsequent TBS protection of ent-50 afforded TBS ether 115, which was subjected to a lithium aldol 
reaction with the enolate generated from EtOAc and LDA to furnish ester 116 in excellent yields (99% and 
98% respectively) as an inconsequential 3.5:1 mixture of diastereomers, as the formed hydroxyl group 
would eventually be dehydrated (Scheme 14). On a multigram scale, the material can be telescoped from 
ent-50 to ester 116 without chromatographic purification, as all byproducts generated from these two steps 
are either volatile or chemically inert.  
At this point, the TBS ether needed to be removed to facilitate the formation of lactone 117. While the 
transformation of ent-50 to 117 could, in theory, be performed without intermediary silyl protection, 
MacGregor found that any attempts at effecting the lithium aldol reaction with the free C19 OH resulted in 
elimination or retro-aldol processes occurring. In the original route, MacGregor and Han employed 
fluorous conditions (HF·py) to cleave the TBS ether and effect an in situ lactonisation, but this procedure 
was difficult to execute on scale. The required deprotection/lactonisation sequence was found to best 
proceed under acidic conditions (TsOH, MeOH), although careful monitoring was required as the 
unselective E1 dehydration of C21 was found to be the side product if the reaction was left for too long. 
Under optimised conditions developed by Han, lactone 117 could then be selectively dehydrated via an 
intermediate tertiary acetate into the cyclic enoate ent-51, where the combination of a weak base and a 
poorer leaving group promoted the E1cb-like pathway over other unselective pathways. Pleasingly, all 
transformations up until this point can be carried out on a multigram scale to ensure a sustainable supply 
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The final two stereocentres in this fragment were installed by a modified Upjohn dihydroxylation from the 
in situ generation of OsO4 (Scheme 15a). After optimisation, Han found that the addition of citric acid, 
employed by Sharpless to improve the yield of dihydroxylations of electron deficient alkenes, led to the 
more efficient conversion to the desired diol ent-52.66 Notably, a sub-stoichiometric amount of the terminal 
oxidant NMO (0.5 eq. relative to enoate ent-51) was required to prevent the overoxidation to the undesired 
hydroxyketone 118, attributed to electronic similarities between the enoate and vinyl iodide olefins. This 
was not observed in Ardisson/Cossy’s case, as their vinyl bromide resulted in a more electron deficient 
olefin, which allowed for the complete selectivity for the enoate olefin. However, both diol ent-52 and the 
unreacted starting material could be reliably isolated and resubmitted (79% brsm), and the reaction could 
be carried out on a one-gram scale without significant loss in material throughput. 
Under the reaction conditions, K2OsO4·2H2O is oxidised by NMO from OsVI to the active OsVIII species, 
which engages in a [3+2] cycloaddition with the olefin to deliver the osmate ester syn-stereospecifically. 
Under heterogeneous conditions, water is able to slowly displace the osmate complex to liberate the syn-
diol product, which upon catalyst reoxidation by NMO closes the catalytic cycle (Scheme 15b). A catalyst 
deactivation pathway involves a second [3+2] cycloaddition with another equivalent of olefin to afford the 
diester 119, which could be hydrolysed to form complex 120 and subsequently deprotonated to afford the 
kinetically inert dianion 121. As this is resistant to diester hydrolysis, dianion 121 functionally cannot 
reenter the catalytic cycle and is a deleterious pathway for this reaction. In particular, electron withdrawing 
groups on the olefin reduce the pKa for complex 120, allowing for weak bases, such as N-methylmorpholine 
(NMM) generated from NMO reduction, to deprotonate 120 to result in the unwanted dianion 121.66  
The addition of citric acid promotes catalyst turnover in two ways: Firstly, citric acid serves as a ligand for 
the Os complex; its enhanced hydrophilicity accelerates the rate limiting hydrolysis step and reduces the 
rate of the second [3+2] cycloaddition, suppressing the catalyst from entering the deactivation pathway. 
Secondly, the acidic conditions suppresses the unwanted deprotonation of complex 120 to form the inert 
dianion 121; both of which help promote the catalytic efficiency of the Os catalyst in the dihydroxylation 
of electron poor olefins.66 
This transformation uniformly delivers a single diastereomer of the desired product. The excellent 
diastereoselectivity of this transformation can be rationalised by drawing the lactone as the half-chair 
conformer, where the lowest energy conformer places the C16-C18 side chain pseudoequatorial. In this 
conformer, the active OsO4 species is disfavoured from a bottom face by the pendant side chain to result in 
the syn-dihydroxylation installing the OHs on the top face (Scheme 15c). As the enoate bears the E 
geometry and therefore possesses two low energy conformers, the Houk model67 predicts that the C24 allylic 




Scheme 15. a) Dihydroxylation of ent-51 to form ent-52. b) Mechanism of the OsO4-catalysed dihydroxylation, and the mechanism 
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3.2.3. Completion of the enantiomeric C16-C28 fragment ent-53 
With diol ent-52 in hand, bis-TES protection followed by oxidative PMB removal in 122 gave alcohol 123, 
which underwent Dess-Martin oxidation to afford aldehyde 124 (Scheme 16a). To avoid the risk of 
epimerisation at C24, aldehyde 124 was immediately used in the Ba(OH)2-mediated HWE olefination with 
ketophosphonate 125. Upon treatment of 125 with Ba(OH)2, the Ba2+ is able to coordinate between the 
carbonyl and phosphoryl oxygens, which reduces the pKa of the methylene protons. This allows for facile 
deprotonation to generate the corresponding carbanion, which rapidly and reversibly adds into aldehyde 
124 to generate a mixture of syn and anti diastereomers (Scheme 16b). The subsequent cyclisation to form 
the oxaphosphatane intermediate is a much slower process, but is reversible and is faster for the anti 
diastereomer. At this point, the oxaphosphatane collapses irreversibly to give the E olefin. Owing to the 
slow oxaphosphatane formation that favours the anti configuration coupled with the fast collapse to form 
the olefin, the equilibrium mixture of syn and anti-126 favours the formation of anti-126, which leads to 
the preferential formation of the E over the Z olefin configuration. With aldehyde 124 and ketophosphonate 
125, the HWE olefination proceeded smoothly (77% over two steps) to deliver the enone 127 as a single 
geometric isomer. 
The completion of the enantiomeric C16-C28 fragment ent-53 was achieved by a conjugate reduction of 
the enone using Stryker’s reagent (70%). Han found that optimal results were achieved by using a freshly 
prepared solution of the reagent, where the active copper hydride species was generated in situ. Although 
only a catalytic amount of Cu was required, Han found better results employing a stoichiometric amount 
of Cu in this reaction. Mechanistically, the copper hydride species undergoes a conjugate addition into the 
enone. The resulting copper enolate can then be reduced by TMDS present in solution to regenerate the 
active catalyst, as well as liberating the silyl enol ether 128, which upon protonation forms the product 
(Scheme 16c).  
Overall, the enantiomeric fragment ent-53 was synthesised in 18 steps in 5.5% overall yield from (R)-Roche 
ester (R)-26, which was comparable to Han’s synthesis of 53 (4.4%). Notably, multigram quantities of the 
key cyclic enoate intermediate have been prepared, enabling the goal of achieving fragment union to give 







Scheme 16. a) Synthesis of the enantiomeric C16-C28 fragment ent-53 from diol ent-52. b) Mechanism of the Ba(OH)2-mediated 
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3.3. Fragment union, derivatisation of the C1-C28 truncate and NMR comparisons 
With adequate supplies of the C16-C28 vinyl iodide ent-53 in hand, and access to both enantiomers of the 
C1-C15 fragment 39, the synthesis of both diastereomers of the C1-C15 and C16-C25 fragment was within 
reach. During exploratory studies, Han found that the corresponding stannane derived from the C16-C28 
vinyl iodide was highly unstable, being prone to protodestannylation processes. Alongside this, Han was 
able to transform the C1-C15 vinyl iodide 39 to the corresponding stannane 129 via a Wulff-Stille reaction 
(Scheme 17a).69 These two results pointed towards employing the C1-C15 vinyl stannane and the C16-C28 
vinyl iodide as the two coupling handles for the Stille cross coupling to synthesise the full C1-C28 truncate.  
Employing Fürstner’s modified Stille conditions (Pd(PPh3)4, CuTC), vinyl iodide ent-53 and stannane 129 
were smoothly reacted to form the full C1-C28 truncate 101a bearing the 13,18-syn configuration. The 
Fürstner modification of the Stille coupling has been a general and reliable method of executing cross-
couplings of complex substrates in the context of natural product synthesis, successfully used in the context 
of leiodermatolide,70 iejimalide B71 and rubriflordilactone A.72 The proposed catalytic cycle for the copper-
mediated palladium-catalysed Stille cross coupling begins by the oxidative addition of palladium into a 
carbon-halogen bond, followed by a transmetallation event and an irreversible reductive elimination to 
release the cross-coupled product and regenerate the catalyst (Scheme 17b). The exact role of copper is not 
fully elucidated, but it is known that the addition of CuI accelerates the rate of reaction by equilibrating the 
poorly nucleophilic organostannane into the more nucleophilic organocuprate. The transient 
organocuprate allows for a more facile transmetallation event onto the PdII centre, accelerating what 
otherwise is the rate-determining step of the catalytic cycle. However, as this exchange is in dynamic 
equilibrium, the accumulation of tin disfavours the formation of the organocuprate as the reaction proceeds 
and overtime, reduces the beneficial effect promoted by Cu. To circumvent this, Fürstner reported a 
solution by employing a thiocarboxylate ligand on the copper to sequester the tin species formed.73 
Additionally, Fürstner reported that the thiocarboxylate ligand alone was insufficient for the complete 
removal of tin, and further added the phosphinate salt [nBu4N][Ph2PO2] to help drive the equilibrium 
towards the right hand side. This was a notable improvement to employing fluoride sources74 as the 
terminal sequestering agent for its improved functional group tolerance, especially towards silyl groups. In 
the author’s hands, the omission of the phosphinate salt did not impair the efficacy of this reaction, and was 
able to deliver the coupled product 101a (72%) from near equimolar amounts of both reaction partners. 
The remainder of this section will detail with the synthesis of the 13,18-syn diastereomeric series. Towards 
the end goal of achieving a detailed NMR comparison between the two diastereomers, the alternative 13,18-





Scheme 17. a) The Stille coupling of ent-53 and 129 to form the C1-C28 truncate 101a. The corresponding 13,18-anti diastereomer 
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3.3.1. Derivatisation of the C1-C28 fragment for NMR comparison 
The C1-C28 ketone fragment 101a represents a major branching point for the total synthesis of hemicalide, 
as the methyl ketone handle can be used for the planned aldol/reduction/methylation endgame sequence. 
For purposes of NMR comparisons however, the silyl protecting groups needed to be removed. While it 
may seem like a tempting solution to globally desilylate truncate 101a, earlier studies by MacGregor and 
Han on the C16-C28 ketone 53 showed that desilylation resulted in the concomitant hemiacetal 
engagement to give 130, an unrelated structure that would complicate spectroscopic analyses (Scheme 18a). 
Furthermore, noting that the natural product contains a methyl ether at C27, it was therefore sensible to 
transform the C27 ketone to the corresponding methyl ether to aid NMR comparisons. 
Initial efforts were directed towards asymmetrically reducing C27 to obtain the configurationally pure 
alcohol. However, attempts at reducing ketone 101a mediated by the CBS reagent were met with poor 
selectivity (Scheme 18b), presumably arising from the poor discrimination of two similarly sized 
substituents around the ketone. Arising from this was the observation that both C27 epimers exhibited 
quasi identical 1H and 13C NMR spectra in the C1-C24 region; an observation echoed by Cossy during their 
investigation of C45 relative to the C35-C42 region.44 While minute differences were seen near C27, the 
distal stereocentre appeared to minimally affect the spectra arising from the remainder of the truncate.  
As such, for ease of material throughput, an unselective reduction mediated by NaBH4 was conducted. 
Initial attempts at effecting this transformation were met with what appeared to be the concomitant 
conjugate reduction of the trienoate system. This was found to be attributed to residual amounts of 
Pd(PPh3)4 that coeluted with the ketone product, which upon treatment with NaBH4, could catalytically 
reduce the trienoate via an intermediary palladium-hydride species. Rechromatographing ketone 101a 
appeared to solve this problem, and alcohol 131 was cleanly delivered in 95% yield as a mixture of epimers 
at C27. Alcohol 131 could then be methylated using Meerwein’s salt to deliver methyl ether 132. 
Gratifyingly, despite the epimeric mixture at C27, intermediates 131 and 132 exhibited clear NMR signals 
in the C1-C24 region that allowed for their facile characterisation. Using an analogous sequence, Han 
synthesised the corresponding 13,18-anti methyl ether 133 in comparable yields. 
3.3.2. Global silyl deprotection of the C1-C28 truncate 
At this point, all that remained was the global desilylation of four TES ethers, and the hydrolysis of the C1 
methyl ester to give the model C1-C28 truncates. Unexpectedly, the global desilylation of 132 to afford 
tetraol 134 proved to be a much bigger challenge than anticipated. While MacGregor and Han reported the 
facile deprotection of 5343 (Scheme 18a) and C1-C15 truncate ent-39 to give 130 and 135 respectively75 
using HF·py, the same conditions led to only partial deprotection for the full truncate, with increasing 




Scheme 18. a) Desilylation of 53 results in the formation of hemiacetal 130 as observed by MacGregor. b) Synthesis of the 13,18-syn-
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Using model fragments 122 and ent-39 as a surrogate for the C1-C15 and the C16-C28 region respectively, 
three curious observations were found: Firstly, there were no common reagents (acidic, acidic fluorous or 
basic fluorous) that could deprotect all four silyl protecting groups simultaneously (Table 3). Secondly, 
acidic conditions (TsOH) or acidic fluorous conditions (i.e. HF·py and HF/MeCN) appeared to 
chemoselectively deprotect the C11 and C13 bearing OTES groups, leaving the C21 and C22 OTES groups 
intact that degraded upon prolonged exposure at high concentration. Thirdly, basic fluoride-mediated 
deprotection conditions (unbuffered TBAF and TASF) appeared to chemoselectively deprotect the C21 and 
C22 OTES groups, with degradation observed in the C1-C15 fragment upon prolonged exposure. 
Working with what appeared to be a razor-thin margin of reactivity, a cross-over experiment was conducted 
to establish the stability of the respective diols to the various deprotection conditions (Table 4). Knowing 
that a suitable buffered solution of HF·py could cleanly deprotect the C1-C15 region, attention turned 
towards establishing a set of conditions that could cleanly deprotect the C16-C28 region without degrading 
the free C1-C15 diols. From this, it appeared that TASF was the reagent of choice to effect this deprotection 
whilst preserving the integrity of the remainder of the molecule, and as such, a two-step procedure involving 
a short exposure of the full truncate to HF·py to cleave the C11,C13 TES ethers, followed by treatment with 
TASF to remove the C21 and C22 TES ethers was implemented. Notably, this set of condition is the exact 
reverse sequence to what Ardisson/Cossy employed.45,48 While TASF is a common reagent required for the 
deprotection of trimethylsilylethyl esters (the ester present in Ardisson/Cossy’s truncate),76–78 no rationale 
was given in their report on why this exact sequence was necessary.  
Frustratingly, using what appeared to be the optimised conditions on the fully protected C1-C28 fragment 
132 gave irreproducible results. While the HF·py deprotection was facile, delivering the C11,C13 diol 
quantitatively, the subsequent treatment with TASF was capricious; at best, the deprotection proceeded to 
give tetraol 134 with 50% yield, but in worst cases, the deprotection degraded the entire fragment (Scheme 
19). With no apparent reason for this observation and a need for a reliable deprotection strategy, a better 
solution was clearly required to deliver not just the C1-C28 truncate, but for the eventual global 
deprotection of the fully protected hemicalide in the total synthesis campaign. 
 











132: R = TES
134: R = H
1) HF•py/py (1 : 3), THF;
2) TASF, THF/DMF (1 : 1)
Quantitative
Irreproducible, best case: 50%
 
 51 
Table 3. Summary of conditions for model deprotection studies of the protected C1-C15 truncate ent-39 and the protected C16-C25 
truncate 122 
 
Conditions 122  ent-52: Results (a) ent-39  135: Result (b) 
HF·py/py (1 : 2), 3 – 24 h No reaction (24 h) Complete conv. to diol (3 h) 
HF·py/py (1 : 1), 3 – 24 h No reaction (24 h) Complete conv. to diol (3 h) 
HF·py (neat), 3 - 6 h No reaction (3 h) Degradation (6 h) 
Complete conv. to diol (3 h) 
Degradation (6 h) 
TsOH, MeCN, H2O, 3 h No reaction (3 h) Complete conv. to diol (3 h) 
HF (aq.), MeCN, 5 – 30 min No reaction (30 min) Complete conv. to diol (5 min) Degradation observed (30 min) 
PPTS, MeOH, 24 h No reaction (24 h) No reaction (24 h) 
TBAF, 3 h Variable results Degradation (3 h) 





Table 4. Summary of conditions for model deprotection studies of C1-C15 diol 134 and the protected C16-C25 truncate 122 
 
 
Conditions 122  ent-52: Results (a) 135: Result (b) 
TBAF, 1 – 3 h No reaction. Degradation upon prolonged exposure No reaction 
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Faced with this obstacle, reversing the sequence of steps was attempted, as reported by Ardisson/Cossy, to 
observe if this gives a better result. Interestingly, treatment with TASF (2 eq.) on the full truncate gave a 
mixture of mono/bis/tris and tetrakis deprotected silyl groups, but attempts at pushing this reaction with 
additional equivalents of TASF only served to degrade the fragment. As expected from exploratory studies, 
the first two silyl groups to come off were reliably from C21 and C22, and it was reasoned that if this bis-
desilylation was allowed to proceed to completion, then treatment with HF·py should cleanly remove the 
remaining silyl groups. Pleasingly, by using 5 eq. of TASF (1.25 eq. per TES group) followed by treatment 
with buffered HF·py, this sequence not only provided a reliable means for global desilylation, but was able 
to reproducibly give the tetraol in very good yields over two steps (95% over two steps) (Scheme 20). It is 
worth noting that on model systems, treatment of the protected C1-C15 truncate with TASF resulted in 
apparent degradation, serving a reminder that results from model studies may not translate into the real 
system. To date, the reason why these two sets of silyl group are apparently chemically orthogonal to each 
other remain unclear. 
With the tetraol 134 in hand, the final ester hydrolysis could be conducted. Initial attempts at using KOTMS 
gave complex mixtures, but employing Ba(OH)2·8H2O in MeOH reliably gave the 13,18-syn free acid 103 
(50%) (Scheme 20). The modest yield was attributed to the high hydrophilicity of the free acid making 
purification difficult. In an analogous sequence from 133, Han was able to effect the global deprotection 
using the aforementioned conditions to give tetraol 136 (67% over two steps) followed by methyl ester 
hydrolysis (50%) to afford the 13,18-anti truncate 102. This represents the first time both diastereomers of 
the C1-C28 region of hemicalide has been made to enable NMR comparisons with the natural product. 
 
3.4. NMR comparisons of the C1-C28 truncates with hemicalide 
During the course of synthesising free acid 103, it was encouraging to observe noticeable chemical shift 
differences between the 13,18-syn and the 13,18-anti diastereomers of all intermediates in CDCl3. These 
served as promising indicators that a synthesis-enabled elucidation of the relationship between the C1-C15 
and the C16-C25 fragment of hemicalide was indeed possible, despite the distal 1,6-relationship between 




3.4.1. NMR comparisons between the 13,18-syn and 13,18-anti acids 
Due to the lack of structural homology beyond H25, as well as the fluctuating chemical shifts of the C1-C7 
trienoic acid region which was attributed to the ‘salt effect’ claimed by Ardisson,41 NMR comparisons were 
restricted to the C8-Me24 region of the truncate. Initially, a comparison with the 13,18-anti truncate with 
previously published structures by Ardisson/Cossy was made to corroborate the synthesised structure. 
Pleasingly, truncate 102 displayed good homology to previously published structures bearing the 13,18-anti 
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95% over 2 steps
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Figure 20. Bar graph comparing 1H NMR shift difference between 23, 25(Ardisson/Cossy) 102 (Han) and hemicalide 
 
 









































































































While comparison of the 13,18-syn and 13,18-anti methyl ester truncates 134 and 136 seemed to suggest 
that the 13,18-anti diastereomer was a better fit for the natural product, upon ester hydrolysis, the 13,18-
syn diastereomer 103 possessed remarkable homology to hemicalide (S|DdH|: 0.05 ppm, S|DdC|: 0.8 ppm; 
Table 5, entry 1), compared to the 13,18-anti diastereomer 102 (S|DdH|: 0.22 ppm, S|DdC|: 4.1 ppm; Table 
5, entry 3). For 103, the maximum chemical shift deviation did not exceed 0.01 and 0.1 ppm for 1H and 13C 
respectively, with many signals aligning exactly with the chemical shifts reported for hemicalide (i.e. Dd = 
0 ppm). This is in contrast with the 13,18-anti truncate 102, where the maximum 1H and 13C deviations 
recorded were 0.04 and 0.6 ppm. In particular, several large deviations that were unaccounted for in the 
13,18-anti truncate 102 exhibited a perfect match in the 13,18-syn truncate 103. These included C11 (DdC 
= 0.6 ppm for 102, DdC = 0.0 ppm for 103), C15 (DdC = –0.4 ppm for 102, DdC = 0.0 ppm for 103) and C17 
(DdC = –0.4 ppm for 102, DdC = 0.0 ppm for 103). These results are graphically represented in Figure 22 for 
1H, and Figure 23 for 13C chemical shift differences. 
3.4.2. NMR comparisons between the 13,18-syn and 13,18-anti salts 
From preliminary studies published by Ardisson, the natural product was reported to be isolated as the 
carboxylate salt. Because of this, it was thought that improved correlations could be achieved between both 
diastereomers with the natural product across the whole molecule by deprotonating the C1 acid. This was 
achieved by treating truncates 103 and 102 in d4-MeOD with Na2CO3 to give 137 and 138 respectively 
(Scheme 21). Interestingly, both truncates exhibited poorer correlations in C8-Me24 regions (13,18-syn 
137: S|DdH|: 0.09 ppm, S|DdC|: 1.7 ppm - Table 5 entry 2; 13,18-anti 138: S|DdH|: 0.22 ppm, S|DdC|: 4.3 ppm 
- Table 5 entry 4) to the natural product, with no improved correlations observed in the C1-C7 trienoic 
acid region for both 1H (Figure 24) and 13C chemical shifts (Figure 25). 
Table 5. Summary of 1H and 13C shift differences, represented as total sum of errors and maximum errors, between truncates 103, 
137, 102, 138, 25, 23 and hemicalide (1) 
 S|DdH| (ppm)† Max |DdH| (ppm) S|DdC| (ppm) Max |DdC| (ppm) 
1. 13,18-syn acid 103 0.05 0.01 0.8 0.1 
2. 13,18-syn salt 137 0.08 0.02 1.7 0.2 
3. 13,18-anti acid 102 0.22 0.04 4.1 0.6 
4. 13,18-anti salt 138 0.22 0.04 4.3 0.7 
5. Cossy 13,18-anti acid 25 0.26 0.04 3.8 0.5 
6. Full skeleton (13,18-anti) 23 0.20 0.03 4.3 0.8 
  
 
† Absolute errors taken from H/C8 to Me24. |D| = d(experimental) – d(reported) 




Figure 22. Bar graph comparing 1H NMR shift difference between 103, 102 (Han), 25 (Ardisson/Cossy) and hemicalide (1) 
 
 








































Scheme 21. Transforming 13,18-syn acid 103 and 13,18-anti acid 102 to their corresponding carboxylate salts 137 and 138 
 
Figure 24. Bar graph comparing 1H NMR shift difference between 103, 102 (Han), 137, 138 (Han) and hemicalide (1) for H2-H7 
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Initially, the poorer correlations were attributed to the unknown nature of the C1 counterion, but this was 
quickly dismissed as a plausible explanation for two reasons: Firstly, the choice of a polar ‘protic’ NMR 
solvent (d4-MeOD), suggests that any counterion would not remain strongly bound to the C1 carboxylate. 
Secondly, the presence of a counterion would have minimal effects on the overall electronics of the C1-C7 
system, which was what was indirectly observed by inspecting the NMR shifts. At this point, it was noted 
that the trienoic acid 1H NMR resonances acquired during the purification of the free acid appeared to 
linearly move following HCl workup, chromatographic purification (with MeOH/AcOH), during drying 
and finally in its fully deprotonated state (Figure 26). This highlighted a chemical shift dependence of the 
C1-C7 trienoic acid region on the protonation state of C1. The implications of this points towards the fact 
that hemicalide was likely isolated as the free acid, which upon several rounds of chromatographic 
purification, was spectroscopically analysed in its partially deprotonated state rather than isolating the 
parent natural product as its carboxylate salt. Importantly, as this effect did not extend beyond the C1-C7 
trienoic acid region, all the conclusions obtained from the NMR studies for the C8-C24 region of the 13,18-
syn and 13,18-anti free acids 103 and 102 can be taken with confidence.  
Overall, the excellent homology of 13,18-syn truncate 103 points towards the 13,18-syn configuration 
between the C1-C15 and the C16-C25 region in hemicalide, contrary to what was reported. Additionally, 
these findings refuted Ardisson’s original claim that hemicalide was isolated as the carboxylate salt, 
suggesting instead that the natural product was isolated as the free acid and spectroscopically analysed in 
its partially deprotonated state. However, a full confirmation of its stereochemistry must wait until the 
natural product has been synthesised and its biological activity compared. 
 
Figure 26. Series of 1H NMR spectra highlighting the chemical shift dependence of the C1-C7 trienoic acid region on the protonation 
state of C1. Note that signals beyond C8 do not exhibit this effect on various C1 protonation states  
13,18-syn acid 103 
post HCl work up
13,18-syn acid 103 
post chromatography
13,18-syn acid 103 
during drying
13,18-syn acid 103 
(dried)
13,18-syn salt 137
H3 H5 H4 H6 H2 H7
H15 H17 H19 H22 H13 H11
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4. Hemicalide: Conclusions and Future Work 
 
4.1. Conclusions 
The results described in this chapter detail the successful synthesis of a model 13,18-syn C1-C28 truncate 
of hemicalide for spectroscopic comparisons with the natural product, as summarised in Scheme 22. This 
was enabled by a scalable synthesis of the enantiomeric C16-C28 fragment ent-53 in 5.5% overall yield over 
18 steps in the LLS from (R)-Roche ester (R)-26. Alongside with the corresponding 13,18-anti diastereomer 
as synthesised by Han, this resulted, for the first time, in a detailed NMR comparison between the two 
possible configurations for the C1-C15 and the C16-C25 regions of the molecule. In doing so, this revealed 
that the 13,18-syn diastereomer was a far closer fit to hemicalide as opposed to the 13,18-anti configuration 
reported by Ardisson/Cossy.51 This conclusion was made more robust with the good homology of Han’s 
13,18-anti truncate 102 with both the C1-C27 truncate 25 and the full carbon skeleton 23 by Cossy, giving 
confidence that the 13,18-anti configuration is clearly an incorrect diastereomer for hemicalide. In light of 
the previous work conducted by the Ardisson/Cossy and Paterson groups described at the beginning of this 
chapter, this result further reduces the number of candidate diastereomers of hemicalide from over 2 
million down to 128. This fortunate result arising from the assignment of the distal 1,6-related 
stereoclusters augurs well for the synthesis-enabled stereochemical elucidation of hemicalide. 
Secondly, the synthesis of the diastereomeric acids has allowed the interrogation of the claim that 
hemicalide was isolated as the carboxylate salt. The observed chemical shift dependence of the C1-C7 region 
of the molecule to the C1 protonation state along with poorer correlations for the salts of both truncates led 
to the conclusion that hemicalide was isolated as the free acid instead.  
Moreover, this synthesis validated several key steps in the endgame that are useful for the ongoing synthetic 
campaign towards hemicalide. Notably, the highly effective Stille coupling as a fragment union strategy 
between the C1-C15 and the C16-C28 regions of the molecule, as well as providing useful intelligence into 
the endgame of the synthesis, including the seemingly inexplicable silyl deprotection step. Finally, the 
scalable synthesis of the enantiomeric C16-C28 fragment has ensured a ready supply of advanced 
productive intermediates that will be useful for the ongoing total synthesis campaign by Stockdale. 
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4.2. Future work 
The successful synthesis of the C1-C28 truncate, while validating and confirming several key steps 
important in the planned total synthesis of the natural product, marks a significant milestone towards the 
end goal of a synthesis-enabled stereochemical elucidation of hemicalide. As such, this section will detail 
the immediate future work pertaining to the C1-C28 truncate, as well as how key lessons in this synthesis 
can inform how best to tackle the remaining regions of the molecule. 
4.2.1. Future work in the C1-C28 fragment 
The inability to remove all silyl protecting groups in one operation merits further attention in the continued 
strategy evolution. The peculiar reactivity may be partly attributable to the hindered nature of the TES 
groups in the dihydroxylactone compared to ones on the C1-C15 region. While a degree of chemical 
orthogonality could be useful for the site-selective incorporation of covalent modification, such as linkers 
in an ADC context, the lack of a common set of deprotection conditions across all silyl groups, especially 
right at the end of a synthetic campaign, only serves to hinder efforts in total synthesis. To this end, an 
immediate improvement that may benefit the desilylation efficiency could be the incorporation of more 
labile TMS groups (as exemplified in 139) rather than TES groups in this region (Scheme 23a). The strategic 
use of TMS groups has proven instrumental in the context of several total syntheses, such as 
leiodermatolide70 and rhizopodin,79 and perhaps would allow the facile deprotection at the end of the 
synthesis. Here, the judicious choice of protecting groups is a particularly important consideration in light 
of Ardisson/Cossy’s recent failures at the global deprotection of the full skeleton of hemicalide.47  
The stereochemical elucidation of the C1-C28 truncate marks an important proof-of-concept study for the 
ability to assign the relative configuration of hemicalide from only the listed 1H and 13C NMR chemical 
shifts. However, for a full elucidation of its stereochemistry as well as looking ahead towards analogue 
design, the absolute configuration of hemicalide needs to be determined.  Given that direct NMR techniques 
are unable to ascertain a molecule’s absolute configuration, the only piece of information that could aid 
determining the absolute configuration of hemicalide is its biological activity. As the C1-C28 fragment 
constitutes over 60% of the natural product, it is hypothesised that this truncate may exhibit activity in 
cancer cell lines. Here, the synthesis of the enantiomeric 13,18-syn C1-C28 truncate ent-103 would allow a 
comparison with 103. By identifying the more active truncate from enantiomers of the C1-C28 region, this 
can give an indication towards which enantiomeric series to pursue for a total synthesis (Scheme 23b). If 
these truncates prove to be active, 103 and ent-103 can also serve as probes towards ascertaining the as-yet 
unknown biological mode of action and begin to develop a comprehensive SAR study for this otherwise 
elusive natural product. Altogether, beginning to examine the biological properties of the C1-C28 truncate 
can be a revealing exercise in the context of developing hemicalide as a novel anticancer agent. 
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Scheme 23. a) Replacing the inert C21 and C22 TES ethers for more labile TMS ethers in 139 should allow for a more facile global 
deprotection. b) Assessing the biological activity of truncates 103 and its enantiomer ent-103 can help illuminate the likely correct  
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4.2.2. Beyond the C1-C28 region: towards the stereochemical elucidation of hemicalide 
The C32-C46 region of hemicalide contains a hydroxylactone motif that is structurally analogous to the 
synthesised C16-C25 fragment. Therefore, intelligence gathered from exploratory studies during the 
synthesis of the C16-C25 dihydroxylactone was anticipated to be broadly useful towards developing a 
robust synthesis of the terminal C35-C46 hydroxylactone.  
During the synthesis of model truncate 102 and 103, exploratory studies were conducted to see what the 
best method was to configure C27 relative to the dihydroxylactone. Unsurprisingly, enantioselective 
methods (e.g. MeCBS-catalysed borane reductions) proved ineffective owing to the poor steric 
differentiation around the prochiral carbonyl. This outcome was deemed unimportant as the resulting C27 
stereocentre was planned to be set via an enantioselective aldol reaction, but the same process cannot be 
applied to the analogous C45 stereocentre. The steric hypothesis led to a test scale CBS reduction on enone 
127, posited to be a better substrate owing to the ‘larger’ alkene unit compared to the methyl group, which 
delivered the allylic alcohol 140 in useful selectivities (5:1 dr) (Scheme 24a). This outcome resulted in the 
overall retrosynthetic analysis for the C35-C46 region (141), where the distal C45 alcohol can be set in either 
configuration via a CBS reduction using the appropriate catalyst (Scheme 24b). While it was originally 
thought that a directed hydrogenation mediated by a suitable homogenous catalyst may allow the selective 
removal of the allylic olefin to give 142, test scale studies on model substrates failed to deliver any activity. 
This led to the incorporation of a benzyl protecting group at C35, anticipated to be concomitantly cleaved 
alongside with the reduction of the C43 double bond over Pd/C under hydrogenative conditions. To this 
end, Stockdale has obtained promising results validating this route towards the C32-C46 hydroxylactone 
(see Scheme 7 in section 2.3.3) and has highlighted how the observations made during the synthesis of the 
C16-C25 fragment have assisted us in the strategy development for the C35-C46 hydroxylactone. 
 
Scheme 24. a) Attempt at the enantioselective reduction of C27. b) Results from preliminary studies guiding the Paterson group 
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The configurationally elusive C27-C32 polyacetate region, containing four stereocentres, ideally needs to 
be elucidated before coupling with either the C1-C25 region, or the C35-C46 hydroxylactone. To this end, 
Han has completed preliminary efforts towards building a library of model compounds for spectroscopic 
comparisons with the natural product (Figure 27), which, in comparison with the data presented by Cossy 
(see Figure 14 in section 2.2.3), should allow for the clear elimination of unlikely diastereomers in this 
region. Here, even eliminating a few possibilities drastically reduces the number of diastereomeric 
possibilities to consider.  
 
Figure 27. Preliminary efforts by Han in generating a library of diastereomers for the C27-C32 region, compared with 
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To probe the diastereomeric relationship between the C27-C32 and the C35-C46 regions, a modular 
approach can be developed by employing a cross-metathesis disconnection across C34-C35, which 
thermodynamically favours the formation of E-olefins (Scheme 25).80 In doing so, this allows the facile 
appendage of alkene 103a with candidate C27-C32 truncates, deemed to contain the most probable 
configuration in hemicalide. This can help rapidly narrow down the possibilities for the remaining segment 
of hemicalide down to a more tractable number. Once the likely diastereomers for the C27-C46 region are 
identified, a focused synthesis of the C29-C46 aldehyde can take place. In this case, the cross-metathesis 
partner – alkene 143 – contains two stereocentres, that can be set up by an enantioselective crotylation of a 
suitably protected aldehyde 144, followed by a hydroboration/oxidation/Wittig olefination sequence. 
Alkene 143 can then engage in a cross-metathesis reaction with the C35-C46 alkene 103a, of which the 
resulting truncate can be treated under Swern conditions, anticipated to result in the concomitant primary 
TES group cleavage and oxidation81 to give the required C29-C46 aldehyde 145 in anticipation for the 
planned endgame sequence. 
The C1-C28 ketone 146 and the C29-C46 aldehyde 145 can then be subjected to the enantioselective DIPCl-
mediated aldol reaction to configure C29, followed by either a 1,3-syn or 1,3-anti reduction to configure 
C27 – marking the assembly of all 21 stereocentres in hemicalide. Bis-methylation of the resulting diol gives 
the fully protected skeleton of hemicalide 147. A global deprotection mediated by HF·py/py would then 
remove all silyl protecting groups, including the now more labile C21 and C22 TMS ethers, followed by 
methyl ester hydrolysis to give diastereomeric candidates of hemicalide.  
At this point, detailed NMR comparisons with hemicalide can then be undertaken to further refine the 
number of diastereomeric candidates. Any particularly close matches with the natural product can be tested 
in cancer cell lines, which alongside with the biological data obtained for enantiomers of the C1-C28 
fragment, can help point towards the likely absolute stereochemistry of hemicalide. 
The present chapter detailing the synthesis-enabled stereochemical elucidation of the C1-C28 truncate of 
hemicalide, while representing a milestone towards the overall narrative, exemplifies the power of synthesis 
and spectroscopic analysis in discerning a molecule’s relative configuration. These preliminary results give 
confidence that a full stereochemical assignment of a molecule as complex as hemicalide, from sparse initial 
NMR data, is indeed possible. 
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Scheme 25. Illustration of the proposed workflow for the stereochemical elucidation of hemicalide (1), and a proposal for the 
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5.1. Isolation and biological activity of phormidolide A 
Phormidolide A (2) was reported by Williamson et al. in 2001, as part of a campaign to discover novel 
natural product anticancer leads.2 The compound was isolated from the marine cyanobacteria Leptolyngbya 
sp.82‡ collected off the coast of Sulawesi, Indonesia.2 Culture of the bacteria, extraction and chromatography 
yielded 10–20 mg of phormidolide A from 7–10 g of wet biomass.  
During its isolation, Williamson et al. found that the crude cyanobacteria extract showed potent and specific 
inhibitory activity towards the Ras-Raf protein-protein interaction.2 Such interaction is an important 
component within the mitogen-activated signal transduction cascade mediating cell division, which is often 
upregulated in various cancers, making the active compound attractive as a drug target.83 While separation 
of the mixture gave phormidolide A as the major component, interestingly, it was found to be inactive in 
the National Cancer Institute (NCI) in vitro 60-cell line assay, though it did exhibit potent brine shrimp 
toxicity (LD50 = 1.5 µM).2,84 Instead, activity-guided isolation revealed a novel, but as-yet unreported, 
chlorophyll-type pigment completely unrelated to phormidolide A.2 
For a compound of this architectural complexity, present in relatively abundant quantities in the organism, 
to exhibit no significant in vitro activity is an intriguing observation. As the cyanobacteria must expend a 
significant proportion of its metabolic resource in its biosynthesis, Williamson et al. surmised that 
phormidolide A must have an adaptive significance for the organism,2 perhaps playing a role in deterring 




‡ The original isolation paper stated that the cyanobacteria Phormidium sp. produced phormidolide A; hence the etymology of the compound’s name. A later 
analysis published by Bertin et al. showed that the producing cyanobacteria was misclassified, and was in fact derived from the Leptolyngbya sp.82 
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5.2. Structural and stereochemical determination of phormidolide A 
The planar structure of phormidolide A was determined using a combination of HRMS, 1D- and 2D-NMR 
experiments. Recognising that type I polyketides are synthesised endogenously from acetate and propionate 
building blocks,85 a 13C-enriched sample of phormidolide A was obtained by supplementing the 
cyanobacteria culture with 13C-enriched acetate. This allowed the elucidation of its skeletal connectivity by 
observing 13C-13C couplings through Incredible Natural Abundance Double Quantum Transfer Experiment 
(INADEQUATE) NMR experiments. At this point, the authors noted the homology in NMR data 
compared to a related natural product oscillariolide (148), discovered a decade prior by Murakami et al., 
both containing the unique bromomethoxydiene motif not found in any other natural products (Figure 
28a).2,86 For the internal olefins of phormidolide A, the double-bond geometry was determined to be all E 
through the combination of coupling constant analysis (large 3JHH value for C4-C5) and diagnostic NOE 
correlations (for all remaining olefins) (Figure 28b). NOE correlations within the C13-C16 THF ring 




Figure 28. a) The planar structure of oscillariolide (148). Note that the original isolation report did not assign the relative and 
absolute configuration of the macrolactone and side chain.86 b) NOE correlations observed in phormidolide A used to determine 













































5.2.1. Relative configuration of C18-C33 region of phormidolide A 
The relative stereochemistry for the remainder of the molecule was determined by a combination of J-based 
configurational analysis and chemical derivatisation. The 1,3-syn relative stereochemistry of the OH groups 
on C21, C23, C25 and C27, was determined through forming the diacetonide derivative 149 of 
phormidolide A with 2,3-dimethoxypropane and PPTS (Figure 29a). Rychnovsky’s 13C NMR analysis87 of 
the diacetonide and the observed NOE enhancements led to the syn assignment within the C21-C23, and 
C25-C27 stereoclusters in accordance with the characteristic 13C NMR signals observed for syn 1,3-diols. 
Here, the syn-acetonide occupies a chair conformation, where the axial and equatorial methyl groups on 
the acetonide resonate at ca. 19.5 and 30.0 ppm respectively, as shown in Figure 29a. Notably, the 
alternative 1,3-anti diol forces the acetonide into a twist-boat geometry, where both methyl groups are in a 
pseudoequatorial environment and resonate at ca. 25.0 ppm.87 
The relative configuration of the polyol side chain was then determined and corroborated by detailed 
coupling constant analysis. This was conducted with the assumption that acyclic systems exist in a series of 
staggered rotamers. Murata’s J-based configurational analysis was then applied to determine the favoured 
conformer by taking into account NOE correlations, 2,3JCH and 3JHH coupling constants.13,88 3JHH and 3JCH 
coupling constants follow the Karplus relationship, such that substituents with small torsion angles (i.e. a 
gauche relationship) give smaller J values, whereas large torsion angles (i.e. an anti relationship) give larger 
J values.13,89,90 2JCH shows the relationship between a proton and an oxygen on the adjacent carbon, where 
small and large 2JCH values indicate anti and gauche respectively.13  The combination of J values and NOE 
correlations then allow the unambiguous determination of the favoured rotamer and hence the relative 
configuration at a specific carbon.  
By way of example, the assignment of C29 relative to C27 can be obtained by observing a large 3JHH coupling 
constant between H28b and H29, placing the two protons anti to each other. An additional NOE 
enhancement between H28b with Me26 supports a syn relationship between Me26 and H28b, which is 
substantiated by NOE enhancement of H28a to H29, H28 and H26 but not to Me26. Finally, the smaller 
3JHH values for H28a supports a gauche arrangement between H27, H28a and H29, giving the syn 
configuration of C29 relative to C27; these diagnostic spectroscopic observations for the assignment of H29 
are highlighted in Figure 29b. In combination with the acetonide analysis described above, the J-based 
analysis conclusively ascertained the all-syn relative configuration between C21, 23, 25, 26, 27 and C29 
stereocentres. 
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Figure 29. a) Diacetonide derivative 149, showing the diagnostic chemical shifts and NOE correlations, as well as the relative 
configuration between the C19-C21, and C23-C25 acetonides. b) Murata’s J-based configurational analysis applied to the 
assignment of C29 relative to C27 
5.2.2. Relative and absolute configuration of C1-C18 region of phormidolide A 
At this point, Williamson et al. extended the J-based methodology for the assignment of the remainder of 
the molecule, namely relaying the stereochemical information from C7 to the C13-C16 THF region, and 
onto the pendant side chain of phormidolide A. While there is strong evidence for the relative configuration 
of the C18-C33 side chain, the relative configuration between the macrolactone and the side chain is 
ambiguous based on the analysis presented. Williamson et al. assumed that stereochemical information can 
be relayed across planar sp2 regions of the molecule, an assumption that is inconclusive unless there are 
direct long-range correlations between adjacent sp3 centers on either side of the double bond. In the case of 
C7, the analysis tentatively predicted the reported relative configuration of C7 to the THF ring owing to the 
conformational requirement imposed by the macrolactone, eliminating the alternative configuration as a 
possibility (Figure 30a). While it appeared that there was conclusive evidence presented for the relative 
stereochemistry of C17 to the THF ring, the absence of a crucial long range interaction between the 
immediately adjacent sp3 centers of the C18-19 olefin precluded a conclusive relative assignment of the 
macrolactone and the side chain (Figure 30b).   
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Figure 30. a) Determination of the stereochemistry at C7 relative to C13 b) Determination of the stereochemistry at C17 relative to 
C15 and C16. Key 1H-1H and 13C-1H coupling constants used to determine the relative configuration are highlighted, with large 
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In the initial isolation report, the absolute stereochemistry of phormidolide A was determined by variable 
temperature NMR experiments on the di-(R)-methoxyphenylacetate (MPA) ester derivative 150 of the 
previously formed diacetonide, without requiring the synthesis of the diastereomeric ester (Figure 31).91 
As the stereochemistry of C7 was determined relative to the macrolactone, the absolute stereochemistry for 
the C1-C17 portion was assigned to be 7R, 13S, 15R, 16R and 17R. Williamson et al. extended the absolute 
configurational assignment to the remainder of the polyol side chain as 21R, 23S, 25R, 26R, 27S, 29S. 
However, the inconclusive evidence from the published J-based analysis (vide supra) precludes what we 
believe to be the definitive absolute stereochemical assignment of the C18-C33 region of phormidolide A 
relative to the macrolactone. 
 
Figure 31. Fragment of the di-MPA ester derivative 150 of phormidolide A diacetonide shown, highlighting the assignment of the C7 
stereocentre without requiring the diastereomeric ester as described by Latypov et al.91 
5.2.3. The biosynthesis of phormidolide A and its stereochemical implications  
A subsequent publication from the Gerwick group elucidated the biosynthetic mechanism for the synthesis 
of phormidolide A through a combination of feeding experiments and bioinformatics.82 As described 
previously, the carbon skeleton for phormidolide A is primarily derived from acetate metabolism, with 13C 
NMR enhancements observed for C1-C30 when the cyanobacteria was supplemented with 13C-carboxyl 
labelled acetate (Figure 32). The alternative 13C-methyl labelled acetate on the other hand, showed 
enhancements at Me3, =CH29, Me11 and Me19, indicating that these centres were installed via the action 
of 3-hydroxy-3-methyl-glutaryl (HMG)-CoA synthase/dehydration sequence.92 Furthermore, additional 
supplementation of 13C-18O-acetate indicated 18O incorporation for all oxygens in the natural product 
except for the oxygen bridging C13 and C15 in the THF ring, indicating that the THF oxygen is not acetate 
derived. Finally, a feeding experiment conducted with S-(13C-methyl)-methionine indicated that Me16, 
Me20a/b, Me26 and OMe32 arose from methyltransferase action with S-adenosoylmethionine as the 
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Figure 32. Overview of atom sources of phormidolide A as determined by feeding studies (excluding the palmitoyl group) 
At this stage, only the THF ether oxygen and the atoms as part of the C31-C33 region of phormidolide A 
were left unaccounted for. To probe the source for C31-C33, the authors conducted additional feeding 
experiments with various carbon sources. While no incorporation was observed with labelled alanine, 
glycine and propionate, 13C enrichment was observed with uniformly 13C glucose. Surmising that the three-
carbon fragment in this region was derived from metabolites from glycolysis,93 the authors conducted 
additional feeding experiments with 13C-labelled glycerate and pyruvate, though no further enrichment was 
observed in both cases. This putatively suggested that an upstream glycolytic intermediate from glycerate94 
was responsible for the C31-C33 region of phormidolide A (Figure 33a). 
The observations obtained from the feeding experiments were used to guide the full characterisation of the 
gene cluster responsible for the biosynthesis of phormidolide A. Through sequence homology analysis, the 
authors found, among other enzymes, ten ketoreductases – responsible for setting the configuration of all 
carbinol stereocentres, four methyltransferases – responsible for Me16, Me20a/b, Me26 and OMe32 and an 
additional region containing HMG-CoA synthase and related tailoring enzymes, responsible for the 
installation of Me3, =CH29, Me11 and Me19. Finally, four enoyl-CoA hydratases were predicted to 
configure the C2, C4, C10 and C18 olefins. On top of this, the authors found a region encoding for a 
monooxygenase, explaining the origin of the THF ether oxygen, and a domain that specifically shuttles 1,3-
bisphosphoglycerate into polyketide synthase pathways, pointing towards the biogenesis of the C31-C33 
region. This allowed for the biosynthesis of phormidolide A to be proposed: following the 
dephosphorylation of 1,3-bisphosphoglycerate, the intermediate is transferred to the acyl carrier protein 
(ACP), where the substrate is dehydrated and O-methylated. An HMG-CoA synthase/decarboxylase 
sequence installs the C31 methylene before the chain is elaborated towards C1 from the action of 
ketosynthases and other modifying enzymes. The THF motif is postulated to be formed from a C-H 
hydroxylation at H16, followed by a cyclisation to close the five-membered ring. Finally, the full carbon 
skeleton of phormidolide A is released from the ACP via macrolactonisation onto C1, where further 
tailoring enzymes, including a halogenase and a fatty acid ligase, installs the terminal vinyl bromide and the 
C29 palmitoyl chain to complete the biosynthesis of phormidolide A (Figure 33b). 
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Figure 33. a) The glycolysis pathway (enzymes coloured in orange) and the conclusions obtained from feeding studies to determine 
the source of the C31-C33 unit. Note that glycerate enters the glycolytic pathway via glycerate kinase.94 b) Overview of the 
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The full elucidation of the biosynthesis of phormidolide A was seen to be noteworthy for the resolving the 
stereochemical ambiguities previously identified. In polyketide natural products, the configuration at 
carbinol centres are set by the action of ketoreductases, of which specific amino acid residues in the enzymes’ 
active site are considered to be particularly diagnostic for setting the absolute configuration of the carbinol 
centre.95 Generally, Type A ketoreductases containing a conserved tryptophan (W) motif at the active site 
predictably generate L-configured hydroxyacyl motifs. Type B ketoreductases on the other hand, contain a 
conserved leucine-aspartate-aspartate (LDD) motif at the active site, of which the second aspartate located 
at residue 1758 (D1758) is considered to be particularly diagnostic for the generation of D-configured 
hydroxyacyl motifs (Figure 34a).96 Analysis of the ketoreductase sequences showed that nine out of ten 
ketoreductases present contained the D1758 residue as typified in Type B ketoreductases, although none 
contained the signature LDD motif. The remaining ketoreductase – responsible for configuring C15 – did 
not contain signature amino acid residues that allowed for a straightforward classification. This data would 
have predicted that at least 90% of the carbinol stereocentres present in phormidolide A would be D-
configured, directly challenging the proposed stereochemical assignment of the natural product (Figure 
34b). 
To investigate this incongruity, the authors synthesised the triacetonide derivative of phormidolide A (151) 
and generated the diastereomeric Mosher esters at C7, which were reported to confirm the 7R (7L) 
configuration originally reported by Williamson et al.. The authors resolved this contradiction by noting 
that several ketoreductases, despite containing the predictive D1758 residue, can anomalously give L-
configured carbinol centres.95 This logic was extended to the remainder of the natural product, citing that 
the D1758 residue was not considered to be predictive for generating the L-carbinol configuration in the 
biosynthesis of phormidolide A. This chain of reasoning however, in the author’s opinion, fails to deliver a 
convincing argument for the stereochemistry of phormidolide A, especially when underscored by the 
ambiguous J-based analyses presented by in the original isolation paper. 
  





Figure 34. a) General scheme highlighting the differential stereochemical outcome from Type A and Type B ketoreductases on a 
growing polyketide chain. b) Excerpt from the ketoreductase sequence responsible for the biosynthesis of phormidolide A82, 
highlighting the presence of the diagnostic D1758 residue predictive for D-OH. This is presented alongside an annotated diagram of 
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5.3. Related congeners to phormidolide A: oscillariolide and phormidolides B-D 
As previously noted, phormidolide A shares a close structural homology with oscillariolide (vide supra), 
consisting of a near identical polyol side chain (minus the pendant C29 fatty acid) linked to a macrolactone 
containing an embedded tetrasubstituted THF ring.86 Here, the main structural differences lie in the 
macrolactone ring; oscillariolide possesses a 14-membered macrolactone with a different substitution and 
unsaturation pattern compared to the 16-membered macrolactone of phormidolide A. The relative and 
absolute stereochemistry for the macrolactone ring of oscillariolide has, to date, not been determined. 
In 2015, Lorente et al. reported the isolation of phormidolide B and C from sponges of the Petrosiidae family 
collected off the coast of Tanzania.84 Phormidolide B (152) and C (153) differ only by the fatty acid 
appended on the side chain (Figure 35a). Their homology to phormidolide A and oscillariolide, both 
produced by cyanobacteria, suggest that both compounds were produced by symbiotic bacteria in the 
sponge.82 Analogous to phormidolide A and oscillariolide, both phormidolide B and C contain the 
conserved polyol side chain, complete with the bromomethoxydiene motif at its terminus. Similar to 
oscillariolide, phormidolide B and C contain a 14-membered macrolactone with an embedded THF ring, 
differing in its oxygenation, substitution and unsaturation patterns. Notably, the THF ring for 
phormidolide B and C possesses a different relative configuration of its substituents and lacks the 
quaternary centre seen in both oscillariolide and phormidolide A.  
In the original isolation report, the configuration of C3 in the macrolactone, alongside the C19-C27 side 
chain of phormidolide B and C were undefined. However, a later publication (and all subsequent 
publications thereafter) by the Álvarez group arbitrarily defined C3 in an anti relationship to C7 (Figure 
35b) with no explicit justification given for their assignment.97 Perhaps noting the structural homology to 
phormidolide A, the remainder of the side chain was defined in the same publication, with an analogous 
15,19-syn relative configuration across the C16 double bond. While the authors claimed that the NMR data 
for macrocycle 154 were “in accordance with the (NMR shifts from the macrocycle) described (in) 
phormidolide B and C”, with any “small difference” attributed to the absence of the side chain, a cursory 
inspection of their published data showed large 13C NMR shift deviations from the natural product that 
likely points towards a different macrocyclic configuration for phormidolides B and C (Figure 36).§ To date, 
there have been no reports attempting to elucidate the absolute configuration for phormidolides B and C. 
 
§ The analysis conducted was limited by the fact that neither the 1H or 13C data published was assigned to any proton or carbon signals of the natural 
product.97 Hence, a rudimentary 13C NMR comparison was the only way to assess whether or not the published configuration was correct 
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Figure 35. a) Structures of phormidolide A, as compared with oscillariolide and the initially reported structures for phormidolides B 
and C. b) Subsequent reports by the Álvarez group gave an arbitrary assignment of C3 (relative to C7), as well as C19 relative to 
C15. 
 
Figure 36. Bar chart showing the 13C NMR difference between macrocycle 154 with phormidolide B (152) (orange) and C (153) 
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While untested on cancer cell lines, oscillariolide was found to inhibit the division of fertilised starfish eggs 
at a concentration of 0.5 µg/mL, and higher concentrations resulted in uneven cell division.86 Compared 
with phormidolide A’s lack of observed cytotoxicity in the NCI 60 cell line assay, phormidolide B and C 
demonstrated low micromolar activity against lung (A-549), colon (HT-29) and breast (MDA-MB-231) 
cancer cell lines (Table 6), making them to date, the only compounds from the family to kill cancer cells. 
However, like phormidolide A and oscillariolide, the mechanism of action with which these molecules exert 
their cytotoxicity remains unelucidated.97 
Table 6. IC50 values (in µM) for phormidolide B and C in cancer cell lines 
 A-529 (lung) HT-29 (colon) MDA-MB-231 (breast) 
Phormidolide B 1.4 1.3 1.0 
Phormidolide C 1.3 0.8 0.5 
 
Finally, the latest publication from the Álvarez group disclosed the identity of phormidolide D (155) as a 
synthetic target (Figure 37), despite no prior reference to its isolation or characterisation.98 Phormidolide 
D is structurally identical to phormidolide C, differing only on the acyl chain, with phormidolide D 
containing a vinyl dichloride rather than a vinyl chlorobromide. Additionally, phormidolide D is 
structurally identical to phormidolide B except for an extra degree of saturation on the pendant acyl chain. 
While no explicit reference was made to its isolation, phormidolide D is a plausible congener given its very 
high degree of structural homology to related compounds, implying that all the synthetic machinery 
required for its biosynthesis is present. There was no biological data associated with phormidolide D, 
although one might assume that it would exhibit similar bioactivities to phormidolides B and C. 
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5.4. Previous synthetic efforts towards congeners of phormidolide A 
To the best of our knowledge, phormidolide A and oscillariolide have not been the target of a synthetic 
campaign since their isolation over a decade ago. The first members of the family to be synthetically targeted 
were phormidolides B-D, with initial studies reported by the Álvarez group in 2015.84 This section will 
outline the synthetic efforts as reported by the Álvarez group towards phormidolides B-D. 
5.4.1. Álvarez’s synthesis of the macrolactone region in phormidolides B-D 
As part of the initial isolation report, the Álvarez group disclosed a synthetic approach towards the 14-
membered macrolactone present in phormidolides B, C (and D) to probe the configuration of the THF 
motif (Scheme 26). From 2-deoxy-D-ribose (156), a sequence involving a Wittig olefination/cyclisation as 
the main steps gave the substituted THF motif as a 1:1.5 mixture of C11 epimers, with the desired product 
157 as the minor component. The required C9 stereocentre was installed via a diastereoselective conjugate 
addition of MeMgBr (>20:1 dr) into 158 to afford adduct 159, with the facial selectivity of the addition 
dictated by the phenylalanine-derived oxazolidinone. Next, the C7 stereocentre was configured via a 
Paterson (–)-DIPCl-mediated aldol reaction between aldehyde 160 and the enolate derived from acetone, 
giving the aldol adduct 161 in 7:1 dr. The required Julia-Kocienski olefination was conducted with sulfone 
162 and aldehyde 163 to give the trisubstituted olefin 164 in modest geometric control (2.3:1 Z/E). 
Subsequent manipulations revealed the seco acid, which was subjected to Yamaguchi macrolactonisation 
conditions to give the protected macrocycle 165 in modest yields (39%). Following the same sequence of 
reactions, the C14 epimer of the macrocycle could be obtained starting from 2-deoxy-L-ribose 166, 
although curiously, the same macrolactonisation step generated a 5:1 mixture of C13 macrolactone epimers 
167 and 168.  
The first-generation approach to the phormidolide B-D macrolactone was achieved in a modest 0.2% 
overall yield over 21 steps LLS from deoxyribose. In a later communication, the Álvarez group disclosed a 
second-generation synthesis of the same macrolactone,97 employing a diastereoselective allylstannane 
addition as its key step (Scheme 27). Addressing the poorly selective cyclisation step in the synthesis of the 
THF core, the revised route employed a diastereoselective Sakurai allylation of 169 (itself derived in five 
steps from deoxyribofuranose 170) to give alkene 171. After ozonolysis of alkene 171, an analogous route 
was employed to give aldehyde 172. The synthesis of the allylstannane coupling partner started from the 
previously reported aldehyde 163. A three-step procedure afforded xanthane 173, whereby a [3.3]-
sigmatropic rearrangement followed by stannylation under radical conditions gave allylstannane 174 as a 
mixture of isomers. Employing SnCl4 as the Lewis acid allowed for a remarkably selective 1,5-anti allylation 
onto aldehyde 172 (>20:1 dr), configuring the trisubstituted olefin in 175 as a single geometry. This step 
was rationalised by the geometrically convergent trans-stannylation step with SnCl4, affording a chelated 
structure 176. Upon aldehyde addition, the Sn moiety could then chelate and activate aldehyde 172, 
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enforcing a closed transition state where the aldehyde R group lies equatorial, and the bulky OTIPS group 
is projected away from the ring. Though undiscussed, it is also conceivable that additional selectivity in this 
reaction can be conferred through further chelation of the C1 acyloxy group onto the Sn Lewis acid, 
rigidifying the overall transition state geometry. Finally, improvements to the overall macrolactonisation 
process were achieved by using Shiina’s protocol (67%) to give the protected macrocycle 177 in 3.7% overall 
yield over 16 steps LLS from D-deoxyribose. Across both routes, the Álvarez group did not report any 
evidence for the definitive assignment of C3, which appears to be inconclusive based from the data 
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Scheme 27. Second-generation route by the Álvarez group employing a diastereoselective allylstannane addition to generate 























171: X = CH2























































































5.4.2. Álvarez’s approach towards the side chain of the phormidolides 
More pertinent to the planned total synthesis of phormidolide A was a recent publication from the Álvarez 
group, which highlighted their efforts towards synthesising the conserved polyol side chain common to 
oscillariolide, and phormidolide A, B and C.  
Focusing on what arguably appears to be the most delicate portion of the polyol side chain, the Álvarez 
group achieved the synthesis of the conserved bromoenol ether moiety based on chemistry developed by 
Edvardsen et al.,99 and demonstrated its coupling to a model side chain fragment (Scheme 28a).100 
Beginning with 1,3-dibromo-2,2-dimethoxypropane (178), treatment with acetyl bromide followed by 
dehydrobromination yielded the bromoenol ether as a 1:1 E/Z mixture.99 UV irradiation successfully 
isomerised the double bond to the required E geometry in a 49:1 E/Z ratio. The methyl ketone E-179 was 
installed through acetoxylation followed by a series of redox adjustments and functional group 
manipulations to give ketone E-179. Despite what effectively is an eight-step ‘functional group 
interconversion’ sequence from acetone, the overall process requires only three chromatographic 
purifications, and is claimed to be workable on gram scale. The same report also disclosed more direct 
routes that failed to give the desired E geometry; the direct acid-mediated dehydromethoxylation of 180 
gave the Z enol ether Z-179 exclusively. Similarly, the base-mediated dehydrobromination of intermediate 
181 singly gave the Z-179 and attempts to isomerise Z-179 either failed to give any reactivity or resulted in 
its degradation. 
Using this chemistry, the Álvarez group published a follow-up account on employing fragment E-179 as a 
productive precursor for their approach towards the common polyol sidechain across all phormidolide 
congeners (Scheme 28b).101 Starting with oxazolidinone ent-27, an Evans’ syn-aldol followed by mono-PMB 
protection gave 182, which after a two-step cleavage of the auxiliary gave aldehyde 183, that underwent a 
Mukaiyama aldol reaction to give the major product 184 as dictated by Felkin-Anh control (6:1 dr). A four-
step sequence then revealed aldehyde 185, which engaged with the silyl enol ether 186 derived from ketone 
E-179 to give the undesired C27** configuration 187 with excellent diastereoselectivity (>20:1 dr). At this 
point, two transformations were required to generate the protected side chain; a C29 ketone methylenation 
and configurational inversion at C27. To achieve this, Álvarez resorted to a three-step sequence (silyl 
protection, methylenation, silyl deprotection) to install the olefin in 188, followed by a further three steps 
to invert C29 and acylate to give the protected C18-C31 fragment of phormidolide 189. Overall, a synthesis 
of a representative side chain of the phormidolide congeners took 18 steps LLS and 19% yield from propan-
 
** Compound numbering for phormidolide B-D. This would correspond to C29 in phormidolide A  
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1,3-diol, with the installation of the methylene olefin and inversion and derivation of C29 accounting for 
six of those steps.  
 
Scheme 28. a) Synthesis of E-179 as reported by the Álvarez group, presented alongside shorter routes that failed to deliver the same 
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Importantly, Álvarez’s synthesis of the bromoenol ether fragment highlighted the reaction conditions this 
potentially delicate moiety can withstand. These included prolonged heating under basic conditions 
towards the synthesis of E-179 (Scheme 28a), and as demonstrated in the synthesis of 189, a surprising 
tolerance to both Lewis acidic and Brønsted acidic conditions. These results echoed the results from the 
Gerwick group where during the synthesis of the triacetonide derivative of phormidolide A, Bertin et al. 
showed that the parent natural product remained stable during prolonged acidic treatment with TsOH.82  
5.4.3. Attempted endgame for phormidolide C and D as reported by Álvarez 
With the synthesis of the two major fragments of phormidolides B-D reported, the Álvarez group disclosed 
two further reports on their attempts at effecting a fragment union between the side chain of the 
phormidolides with the macrocycle. A preliminary publication presented a study on the addition of 
vinylmetallic reagents into chiral formyltetrahydrofuran motifs present in phormidolides B and C †† 
highlighted that a Nozaki-Hiyama-Kishi (NHK) reaction between model aldehyde 190 with vinyl iodide 
191 was the most effective (Scheme 29a). This gave the adduct 192 in moderate yields (but modest isolated 
yields) with moderate diastereocontrol favouring the reported C15 geometry, which was deemed acceptable 
for a fragment coupling strategy.102 
A more recent paper published concurrently with our group’s ongoing campaign reported an attempted 
synthesis of phormidolides C and D.98  In this report, the Álvarez group disclosed their overall 
retrosynthesis for the natural products, where an NHK reaction between aldehyde 193 and vinyl iodide 194 
was proposed to elaborate the macrocycle and configure C15 (Scheme 29b). A Mukaiyama aldol reaction 
dictated by Felkin-Anh control was proposed to append on the C23-C31 side chain (195) and form the full 
carbon skeleton of phormidolide C-D, as previously demonstrated in the synthesis of 184. The synthesis of 
vinyl iodide 194 required six steps from aldehyde 196, involving a resolution of racemate 197 by the 
chromatographic separation of the diastereomeric (R)-methoxyphenylacetate esters of 197 (Scheme 29c). 
Despite its prior efficacy, the NHK reaction between aldehyde 193 and vinyl iodide 194 to afford 198 proved 
to be low yielding and delivered the undesired configuration. Finally, an attempt was made to realise the 
Mukaiyama aldol reaction between the silyl enol ether derivative of 198 and 199, although no reaction was 
observed despite the analogous synthesis of 184 proceeding in high yield (see Scheme 28b). No concrete 
explanation was given for this disparate observation, although the authors did tentatively attribute the lack 
of reactivity to steric factors prohibiting silyl enol ether from being an effective nucleophile. 
 
†† This publication predated the disclosure of phormidolide D, but these results were employed in their studies towards the synthesis of 
phormidolides B and D 
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Scheme 29. a) Model vinylmetal addition into aldehyde 190 identified that the NHK reaction was the most effective for fragment 
union. b) The Álvarez approach to the phormidolides C and D. c) Attempted total synthesis as disclosed by Álvarez highlighting their 














OHPhormidolide B (152): R = Cl, Δ49
Phormidolide C (153): R = Br


























































































































5.5. Phormidolide A: a summary 
Phormidolide A is a complex marine natural product that contains a breadth of intriguing structural 
features, including a unique THF-embedded macrolactone core and an all-syn polyol backbone terminating 
in the signature bromomethoxydiene motif (Figure 38). Perhaps owing to the apparent lack of bioactivity, 
phormidolide A has received little interest from the synthetic community since its isolation, though it is 
clear from its potent brine shrimp toxicity that the natural product has a distinct, but unknown eukaryotic 
target, with its production conferring some evolutionary advantage for its producer. Additionally, a 
reexamination of the original J-based analysis has raised questions on the stereochemical veracity of the 
structural assignment, that remained unresolved despite achieving a full elucidation of its biosynthesis.  
All of these contrary observations have generated more questions than answers for this intriguing natural 
product. This has resulted in phormidolide A becoming an increasingly attractive target, particularly in 
order to resolve the stereochemical contradictions that were presented by the Gerwick group. Furthermore, 
a reliable synthetic route towards phormidolide A would enable us to interrogate the conundrum of its 
apparent lack of biological activity, especially in the presence of moderately active congeners isolated from 
discrete locations worldwide. These unanswered questions posed by phormidolide A could therefore all be 
addressed by its successful total synthesis. 
This section highlighted the only other research group to date that has published work on synthetic studies 
towards the phormidolides. The Álvarez group has demonstrated that the bromomethoxydiene is indeed 
synthetically tractable, although the installation of this motif is marred with significant amounts of 
seemingly redundant protecting group and redox manipulations. Additionally, the deficiencies discussed 
in the previous studies have demonstrated the need for high yielding and highly stereoselective fragment 
union strategies in appending the polyol side chain onto the macrolactone. Encouragingly however, the 
initial work Álvarez laid out towards the synthesis of the conserved polyol side chain points to the 
unexpected robustness of the bromoenol ether moiety, which augurs well that such a motif could be 
installed early on and withstand the demands imposed by a total synthesis campaign. 
In light of these aforementioned challenges and opportunities, the following sections will detail the author’s 
eventful journey towards the total synthesis of phormidolide A, highlighting the unexpected obstacles and 
discoveries we encountered, and the implications this has on the continual strategy evolution towards this 
intriguing class of natural product.  
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6. Results and Discussion 
 
6.1. Overview of initial synthetic plan 
The synthetic campaign towards phormidolide A is a collaboration between the Paterson group and the 
Britton group at Simon Fraser University. Recognising that phormidolide A contains two structural 
domains of similar complexity, the initial synthetic effort was evenly divided, with the Britton group 
tackling the C1-C17 macrolactone, and the Paterson group approaching the C18-C33 polyol side chain 
(Scheme 30a). 
The initially planned endgame strategy for phormidolide A was anticipated to be a chelation-controlled 
vinylmetal addition to forge the C17-C18 bond, and a Mukaiyama aldol reaction to form the C24-C25 bond. 
These two reactions were expected to configure C17 and C25 selectively (Scheme 30b); the vinylmetal 
addition was expected to proceed with the nucleophile approaching from the small Me group, to give the 
reported C17 configuration selectively.103 Based on extensive literature precedent, a similar Mukaiyama 
aldol reaction to one reported by the Álvarez group98,101 was envisioned to deliver the Felkin-Anh product, 
with the bulky nucleophile overriding the competing 1,3-Evans’ polar product.104 Taking into account the 
inconsistent result reported by the Álvarez group for the Mukaiyama aldol addition, employing a smaller 
silyl protecting group was hoped to improve the outcome of this reaction. Retrosynthetically, this reveals 
the macrocycle 200, the C18-C24 vinyl iodide 201 and the C23-C33 aldehyde 202. The chelation-controlled 
vinylmetal addition will have to arise from a lithiated intermediate, and transmetallated to a suitable 
metallic reagent to generate the active nucleophile. Noting that the relative configuration between the C1-
C17 macrolactone and the C18-C33 polyol side chain requires verification, a stereoflexible synthesis of the 
C18-C33 fragment is needed to readily access both enantiomeric series of the fragments constituting the 
polyol side chain. This is not a necessary requirement for the macrolactone as the absolute configuration 
has been determined in previous studies. 
For completeness, the planned Britton group’s synthetic approach towards the C1-C17 macrolactone is 
included and shown in Scheme 30c. The C1-C17 macrolactone 200 can be disconnected into three key 
fragments by various C-C coupling reactions and a Mitsunobu macrolactonisation. Of the three fragments, 
the C13-C17 THF moiety 203 can be constructed from dioxanone 204 and aldehyde 205 by employing 
tandem a-chlorination L-proline-catalysed aldol chemistry that the Britton group has developed.105,106  
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Scheme 30. a) Proposed endgame strategy for the synthesis of phormidolide A b) Stereochemical rationalisation for the chelation-
controlled vinylmetal addition, and for the Mukaiyama aldol reaction. c) Proposed retrosynthesis of the C1-C17 macrolactone by the 
















































































































Rationalising the stereochemical outcome at C25 from a Mukaiyama aldol reaction
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from Evans’ 1,3-polar model
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6.2. Synthesis of the C18-C24 fragment 
Noting that the planned total synthesis hinges on the successful bidirectional fragment union of the C18-
C24 fragment to both the macrocycle and the remainder of the side chain, it was prudent therefore to 
commence our synthetic campaign with the linchpin that joins the two fragments together. Here, a 
synthesis of the C18-C24 fragment would allow an early verification on the feasibility of the proposed 
endgame strategy. The C18-C24 fragment 201 can be disconnected across the C21-C22 bond via either an 
Ipc boron-mediated aldol reaction or an enantioselective Mukaiyama aldol reaction. Retrosynthetically, 
this reveals aldehyde 196 and an enolate equivalent 207 or 208 as the required building block (Scheme 31) 
 
 
Scheme 31. Retrosynthesis of the C18-C24 fragment 
 
Following a modified protocol by Wipf,107 the synthesis of aldehyde 196 commenced with a syn-
stereospecific Negishi carboalumination108 of 3-butyn-1-ol (208) catalysed by zirconocene dichloride 
(Scheme 32). The regioselectivity of the reaction can be rationalised by TS-VII, where the bulky 
zirconocene dichloride is thought to act as a Lewis base to both activate the Me3Al species and enforce the 
terminal regioselectivity of the addition. The addition of stoichiometric amounts of water is known to 
dramatically accelerate the rate of carboalumination although the exact mechanism in which this occurs is 
unknown.107 Wipf noted this phenomenon and putatively attributed the increased reactivity to TS-VIII, 
where hydrolysis of TS-VII replaces the bridging Cl with an O; a better Lewis base for Me3Al, which results 
in the rate enhancement for the formation of intermediate 209. The intermediate can then be trapped in 
situ by the addition of iodine to afford the vinyl iodide 210 in 87% yield.108,109 Screening a series of oxidation 
conditions found DMP oxidation to afford the desired aldehyde 196 cleanly, with other reagents resulting 
in either isomerisation to the conjugated enal or decomposition of the olefinic system. As aldehyde 196 is 
volatile and highly prone to degradation, it was always freshly prepared and stored in dry CH2Cl2 over 4 Å 
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Scheme 32. Synthesis of aldehyde 196 from 3-butyn-1-ol (208) via a Negishi carboalumination 
To configure the C21 stereocentre, initial investigations focused on employing Roush’s reductive boron 
aldol conditions.110 The rationale behind this methodology involves an in situ generation of an Ipc boron 
enolate from a 1,4-reduction of an acrolyl morpholinamide derivative, cited as a Weinreb amide 
substitute.110,111 Addition of an aldehyde facilitates an Ipc boron-mediated aldol reaction, with the facial 
selectivity dictated by the steric interaction between the methyl group on the Ipc ligand and the axial 
morpholinamide moiety on the boron enolate (Scheme 33). For the enolate derived from treating 
carboxamide 211 with (+)-(Ipc)2BH, the aldol reaction proceeds via TS-IX to afford the aldol adduct 212 
as the major product. TS-X is disfavoured due to destabilising steric interactions as previously described 
(see Scheme 12), resulting in ent-212 as the minor product. However, this strategy was quickly found to be 
intractable given problems encountered with reproducing the Roush group’s results on a published 
substrate (Scheme 34). Specifically, employing hydrocinnamaldehyde under reoptimised conditions gave 
at best a 10% yield of the expected product 213, compared with the 61% yield reported for the same reaction. 
 























Me3Al, H2O (1.5 eq.)
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208, CH2Cl2
–20 °C → r.t., 16 h
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Scheme 34. Attempted replication of Roush's reductive boron-mediated aldol methodology on a published substrate 
 
Deciding that this approach was not viable, attention then turned towards utilising a Mukaiyama aldol 
reaction between silyl enol ether 207 and aldehyde 196 to furnish the C18-24 fragment. Silyl enol ether 207 
was synthesised under published conditions from methyl isopropyl ketone,112 yielding a 9:1 mixture of silyl 
enol ethers 207 and 214. Employing achiral Lewis acids such as BF3·OEt2 or TiCl4 afforded racemic aldol 
adduct 197 in good yields (64–68%) (Scheme 35). As both boron- and titanium-based Lewis acids gave 
good results in the racemic reaction, initial attempts at effecting an enantioselective Mukaiyama aldol 
reaction were focused on employing chiral boron and titanium Lewis acids. Two examples that have been 
employed in total syntheses are Kiyooka’s valine-derived oxazaborolidinones113,114 and the catalytic use of 
Ti(BINOL) complexes derived from a 1:1 mixture of either TiCl4 or Ti(OiPr)4 with (R)- or (S)-BINOL.115,116 
Mechanistically, Kiyooka’s oxazaborolidinone-mediated Mukaiyama aldol reaction proceeds via a 
bidentate coordination of the carbonyl oxygen and formyl hydrogen to the oxazaborolidinone boron and 
oxygen respectively.117 The isopropyl group of the valine skeleton sets up a concave and a convex face for 
the complex. Additionally, the phenyl ring on the tosyl group faces away from the isopropyl group to further 
block the concave face. As a result, incoming nucleophiles preferentially attack from the more accessible 
convex face syn to the isopropyl group (Scheme 36a).113,117 The Ti-BINOL catalytic process is, on the other 
hand, less defined. Studies have failed to pinpoint a specific catalyst structure for the TiCl4 or Ti(OiPr)4 
derived BINOL complexes,116 though contrary to the prevailing paradigm for the Mukaiyama aldol 
reaction,118 proposals have been put forth suggesting that the complex participates in a closed transition 























211 213(Literature: 66%, 91% ee)
10% isolated yield
46%
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(+)-Ipc2BH (2 eq.), Et2O;
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Et2O, 40 °C, 16 h
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Scheme 35. Synthesis of racemic aldol adduct 197 from aldehyde 196 and silyl enol ether 207 
 
 
Scheme 36. a) Stereochemical rationalisation for Mukaiyama aldols with Kiyooka’s oxazaborolidinone complex  
b) Speculative mechanism for a Ti-BINOL-mediated Mukaiyama aldol reaction 
 
Attempts to replicate these conditions on silyl enol ether 207 and aldehyde 196 employing Kiyooka’s 
complex derived from L-tosylvaline (215) only resulted in reducing aldehyde 196 to the alcohol 210 
(Scheme 37a). Exchanging the boron reagent to BCl3 on the other hand returned a mixture of starting 
material and isomerised aldehyde E- and Z-216. Similar results were observed upon employing Ti-BINOL 
systems, where the 1:1 combination of TiCl4 and (S)-BINOL at various catalytic loadings either did not 
result in any conversion or returned the isomerised aldehyde (Scheme 37b). The same reaction carried out 
with 1:1 Ti(OiPr)4 and (S)-BINOL did not result in any conversion. Observing the isomerisation of aldehyde 
196 into enals E- and Z-216 suggested that these Lewis acids activated the carbonyl enough to result in 
double bond migration, but were not strong enough to facilitate the nucleophilic attack of the silyl enol 
ether onto the carbonyl centre.  
At this point, it was thought that the silyl enol ether 207 was not electron-rich enough, and therefore 
nucleophilic enough to facilitate an asymmetric Mukaiyama aldol reaction. This was reinforced by Mayr et 
O TMSCl, Et3N
DMF, 120 °C, 90 h
OTMS
I
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al., who claimed that silyl enol ether 207 was of the order of 103 to 104 fold less nucleophilic than the silyl 
ketene acetal derived from methyl isobutyrate.119 Coupled with the fact that literature applications of these 
asymmetric methodologies used the more nucleophilic silyl ketene acetal suggested employing the silyl 
ketene acetal 217 to effect the asymmetric Mukaiyama aldol reaction, followed by the conversion of ester 
218 to ketone 201 via Weinreb amide 219 would be a more productive approach (Scheme 37c).  
 
Scheme 37. Attempted synthesis of 197 using a) Kiyooka's oxazaborolidinone complex b) Ti-BINOL complex.  
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Silyl ketene acetal 217 can be readily derived from ethyl isobutyrate in good yield (88%).120 Gratifyingly, 
submitting silyl ketene acetal 217 and aldehyde 196 with Kiyooka’s complex derived from L-tosylvaline 
(215) afforded the aldol adduct 218 in 67% yield and in 91% ee via TS-XI (Scheme 38a). Attempts to 
employ a Ti-BINOL catalyst for this reaction afforded no conversion for the catalyst derived from Ti(OiPr)4, 
and poor yields and selectivity (29%, 2% ee) for the catalyst derived from TiCl4. The elucidation of the 
absolute stereochemistry at C21 was attempted by forming diastereomeric Mosher esters, however the 
subsequent analysis proved to be inconclusive due to inconsistent signs around the carbinol H21 proton. 
At this stage, the anticipated stereochemical outcome was assumed by comparison with analogous reactions 
in the literature, which suggested the (R) configuration was obtained at the C21 centre from using L-
tosylvaline 215.114,121 With a view to probing the diastereomeric relationship between the macrolactone and 
the side chain, the enantiomeric ester ent-218 can be readily synthesised by using the enantiomeric D-
tosylvaline ent-215 as the chiral promoter. 
TES protection of the aldol adduct 218 afforded the TES ether 220 in excellent yield, though the subsequent 
conversion to the Weinreb amide proved to be stubborn for both the protected and the unprotected 
substrate, resulting in no conversion or degradation under a variety of basic (iPrMgCl or nBuLi) or Lewis 
acidic (Me3Al) conditions. Instead, an alternative approach to convert ester 220 directly into ketone 201 as 
described by Kikkawa and Yorifuji was employed.122,123 Subjecting ester 220 directly with MeMgBr in excess 
Et3N at 80 °C cleanly afforded the required methyl ketone 201 in excellent yield (92%), with no sign of Mg/I 
exchange or double addition occurring (Scheme 38b). As with typical Grignard addition to esters, the first 
equivalent of MeMgBr adds to form the ketone. For esters with no a-protons, conducting the reaction in 
excess Et3N enolises the newly formed methyl ketone. This prevents the second equivalent of Grignard 
adding to the more electrophilic ketone carbonyl, thus enabling the selective transformation of esters into 
ketones without over-addition to form the undesired tertiary alcohol (Scheme 38c).122  
Overall, the C18-C24 fragment 201 was synthesised enantioselectively in five steps from 3-butyn-1-ol 
alcohol in 53% overall yield, or in 60% yield over three steps from aldehyde 196. This is in contrast with the 
17% reported yield over six steps from aldehyde 196 by the Álvarez group (Scheme 38d). Notably, this 
result represents over a 3.5-fold improvement in yield compared with the analogous route, is executed in 
half the number of steps and does not contain a resolution step where half the material is discarded in the 
process.  
At this point, the tentatively assigned absolute configuration at C21 could be confirmed by Mosher ester 
analysis. TBAF deprotection of TES ether 201 afforded alcohol (R)-197 in good yield (79%). The crude 
alcohol (R)-197 was then esterified with (S) or (R)-MTPA under Steglich conditions (DCC, DMAP)62 to 




Scheme 38. a) Synthesis of 218 using a) Kiyooka's oxazaborolidinone complex. Results from employing the Ti-BINOL complex for 
an enantioselective Mukaiyama aldol reaction are also shown. b) Completing the synthesis of the C18-C24 fragment 201.  
c) Mechanism for the direct conversion of ester 220 to ketone 201. d) Comparison with the Álvarez route towards ketone 194, noting 
the 3.5-fold improvement in yield 
MTPA derivatives of secondary alcohols preferentially adopt a conformation in which the carbinol proton, 
ester carbonyl and CF3 groups on the MTPA ester lie in the same plane (Figure 19a).63 This results in the 
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relative to the protons lying on the same side as the OMe group. This means that the protons lying adjacent 
to the (S)-MTPA Ph group will be shielded compared to the analogous protons in the (R)-MTPA 
derivative.64 Thus, proton signals with Dd < 0 (Dd = DdS – DdR) would lie on the left-hand side of the (R)-
MTPA plane from the perspective of the CF3 group, and vice versa for Dd > 0 (Figure 19b).65 Calculating 
Dd (Table 7) and applying the model described in Figure 19 showed that the C21 centre had the desired R 
configuration, which corroborated the assignments based on mechanistic predictions and analogous 
literature reactions. 
 
Scheme 39. Synthesis of Mosher esters 221 and 222 
 
Figure 39. a) Diagram highlighting the preferred conformation of the MTPA derivative  
b) Model to assist the absolute configuration of a carbinol center 
Table 7. List of chemical shifts for MTPA derivatives 221 and 222. The carbinol proton H21 is excluded from the analysis 
Proton dH (S)-MTPA (ppm) dH (R)-MTPA (ppm) DdS-R (ppm) 
H24 2.11 2.13 –0.02 
Me22a 1.13 1.17 –0.04 
Me22b 1.12 1.15 –0.03 
H21 5.69 5.66 +0.03 
H20a 2.45 2.43 +0.02 
H20b 2.32 2.31 +0.01 
Me19 1.94 1.93 +0.01 
H18 5.95 5.94 +0.01 
(R)-201: R = TES
(R)-197: R = H
(S)-MTPA
(R)-MTPA
DCC, DMAP (cat.), 













































6.2.1. Fragment union investigations with a model side chain 
With the C18-C24 fragment 201 in hand, an investigation into the proposed Mukaiyama aldol addition 
with a suitable model aldehyde was conducted. While ketone 201 was inert to standard silyl enol ether 
formation conditions (LDA, TMSCl), employing TMSOTf and Et3N allowed the quantitative formation of 
the corresponding silyl enol ether 223. Interestingly, the planned Mukaiyama aldol reaction between 223 
and model aldehyde 224 was unsuccessful in generating adduct 225, consistently returning ketone 201 and 
its deprotected variant (R)-197 across a variety of reaction conditions. Similarly, attempts at varying the 
enolate metal substituent by employing a Cy2BCl-mediated aldol reaction also produced no product 
(Scheme 40).  
 
 
Scheme 40. Investigations into the planned Mukaiyama aldol reaction between silyl enol ether 223 and model aldehyde 224 
 
These results echoed Álvarez’s observations, where no reactivity was observed for an analogous Mukaiyama 
aldol reaction between the silyl enol ether derived from ketone 198 and aldehyde 199 (see Scheme 29 in 
section 5.4.3). Noting that perhaps the problem lay with the steric encumbrance of any enolate derivatives 
of ketone 201, an alternative C23-C24 disconnection was envisaged, with the nucleophilic component being 
the enolate derivative of ketone 226 attacking into a C18-C23 aldehyde 227 (Scheme 41a). This 
transformation has been employed in Menche’s studies towards the total synthesis of rhizopodin,124 where 
a 1,4-syn diastereocontrol was enhanced by the use of the DIPCl reagent to configure the carbinol oxygen 
next to a gem-dimethyl group (Scheme 41b). Notably, this route also presents the opportunity of effecting 
an in situ 1,3-syn reduction of the boron aldolate intermediate, to configure two stereocentres selectively. 
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Scheme 41. a) The original and revised retrosynthesis for phormidolide A. b) DIPCl-mediated aldol as performed by Mench in 

























































































































To test this proposal, ester 220 was selectively reduced to the corresponding aldehyde 227 by treatment 
with DIBAL at –78 °C (Scheme 42). After the initial hydride attack, the formed tetrahedral intermediate 
228 is stable at low temperatures, preventing the over addition of the reducing agent into what would be 
aldehyde carbonyl centre. This tetrahedral intermediate is then hydrolysed upon workup to selectively give 
aldehyde 227. The DIPCl-mediated aldol reaction was trialed with model ketone 229 and aldehyde 227. 
Promisingly, the reaction forged the C-C bond to give adduct 230 in modest yields and demonstrates a 
viable proof-of-concept that such a fragment union strategy is possible. Due to the small scale of the test 
reaction, an attempt at corroborating the stereochemistry at C23 was not conducted. 
 
 
Scheme 42. Model DIPCl-mediated aldol reaction between aldehyde 227 and model ketone 229 
 
The expeditious synthesis of the C18-C24 fragment 201 has demonstrated that the planned Mukaiyama 
aldol reaction was not a viable method for the synthesis of phormidolide A. Aided by the functional group 
flexibility of ester intermediate 220, the alternative C18-C23 aldehyde 227 was also readily synthesised. As 
the planned chelation-controlled vinylmetal addition would now have to discriminate between two 
aldehyde carbonyl groups, it was deemed inappropriate to maintain the aldehyde functionality for the C18-
C23 fragment. Thus, the revised retrosynthesis for phormidolide A reveals alcohol 231 (or a protected 
variant thereof) in the C18-C23 fragment and macrolactone 200 (Scheme 43a). These compounds were 
readily accessed again from ester 220; conducting the aforementioned DIBAL reduction with warming to 
–40 °C reliably gave alcohol 232, which could be TMS protected in high yields to give 233 (Scheme 43b). 
Similarly, the same sequence of reactions can be conducted for the enantiomeric series. After silyl protection 
of alcohol ent-218, an analogous reduction of ent-220 and silyl protection of ent-232 gave silyl ether ent-
233. The stereochemical integrity of ent-233 was verified relative to 233 by their optical rotation data, which 
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Scheme 43. a) Original and revised retrosynthesis for phormidolide A, taking into account the key lessons learnt from preliminary 
fragment union studies. b) Synthesis of alcohol 232 and silyl ether 233 from ester 220. The synthesis of the enantiomeric fragment 
ent-233 from ent-218 is also described  
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6.3. Fragment union studies with the C10-C17 THF fragment 
 
The work described in this section was carried out in collaboration with Garrett Muir and Venugopal Rao 
Challa at Simon Fraser University. Their results were crucial to the project and are presented alongside the 
author’s results. Unless otherwise stated, all reactions described were performed by the author and all stated 
yields are those obtained by the author. 
 
With some understanding gained for a suitable fragment union strategy between a C18-C23 fragment and 
the remainder of the side chain, attention now turned towards investigating the planned chelation-
controlled vinylmetal addition. To facilitate this, a synthesis of a suitable model THF aldehyde was required. 
To this end, Muir and Rao Challa developed a scalable route towards constructing the substituted THF core 
present in phormidolide A; an overview of which is described below: 
The synthesis commenced with a Negishi carboalumination of alkyne 234 to give vinyl iodide 235. 
Subsequent Dess-Martin oxidation afforded aldehyde 205, which was engaged in a tandem a-chlorination 
L-proline-mediated desymmetrising aldol reaction with dioxanone 204 (Scheme 44). The initial a-
chlorination, mediated by NCS, generates an epimeric mixture of a-chloroaldehyde 236. In the presence of 
L-proline and dioxanone 204, an enantiodefined enamine forms, which selectively reacts with one 
enantiomer of a-chloroaldehyde at a faster rate as shown in TS-XII. This preferentially generate one 
enantiomer of the product, with the diastereoselectivity of the reaction defined by the preferred geometry 
of the substituents following the Houk-List model.106,125 As a-chloroaldehyde is readily epimerisable under 
the reaction conditions, a dynamic kinetic resolution occurs to result in the convergent formation of a single 
enantiomer 237 from a racemic mixture of 236. In Muir’s hands, this afforded chlorohydrin 237 in 
moderate yields and diastereoselectivity, but with excellent enantiocontrol.  
Subsequent methyl Grignard addition into 237 followed by a microwave-assisted intramolecular SN2 
cyclisation/acetal deprotection gave triol 238 comprising the full skeleton of the THF motif, though 
containing an extra degree of oxygenation at C14. This was removed through a three-step sequence, where 
triol 238 was selectively protected as the siloxane alcohol. The C14 hydroxyl group could then be removed 
via triflation followed by hydride displacement to give siloxane 239. Removal of the cyclic silyl protecting 
group followed by mono-TBS protection at C17 then gave alcohol 203.  
In alcohol 203 however, the C15 configuration is epimeric to the natural product. Recognising that a 
suitable model for the vinylmetal addition would require a functionality reminiscent of the macrolactone, 
  104 
it was decided that appending a dimethylacrylate ester would allow for an adequate representation. In 
particular, this would mean that the chosen organometallic reagent would have to tolerate the presence of 
the C15 ester, an important variable to control in terms of chemoselectivity. Muir attempted to correct the 
C15 geometry via a Mitsunobu inversion, using either dimethylacrylic acid or p-nitrobenzoic acid as the 
nucleophile. However, both attempts failed to give any reaction, which was presumed to be attributed to 
the steric constraints imposed by the proximate C16 quaternary centre. With the intermolecular variant 
failing to deliver any reactivity, this result has also meant that the planned Mitsunobu macrolactonisation 
strategy was unlikely to be a feasible reaction for the synthesis of the phormidolide A macrocycle. 
 
 












































































































6.3.1. Derivatisation of the C10-C17 THF fragment 
The inability to concomitantly invert and esterify to form the desired dimethylacrylate ester meant that the 
configuration at C15 in 203 would have to be corrected in a more circuitous manner, involving an 
oxidation/reduction sequence via ketone 240. Fortunately, oxidation to ketone 240 was readily 
accomplished under Dess-Martin conditions (Scheme 45). Here, it was surmised that a hydride reduction 
would preferentially occur on the convex face of ketone 240 as defined by the pseudoequatorial C13 and 
C16 substituents shown in TS-XIII. A screen of reducing agents (results summarised in Table 8) found 
that DIBAL (entry 6) was able to cleanly invert the configuration of C15 in an efficient manner, proceeding 
to give 241 in near quantitative yields over two steps. 
 
 
Scheme 45. Inversion of alcohol 203 via ketone 240 
 
Table 8. Summary of reducing agents trialled for the reduction of ketone 240 
Entry Hydride source Conditions Yield and ratio of 241:203 
1. NaBH4‡‡ EtOH, r.t., 3 h Yield unreported, 3:1 dr 
2. NaBH4 iPrOH/CH2Cl2 (1:1), –60 °C, 98%, 5:1 dr 
3. NaBH4, CeCl3·7H2O EtOH, –78  10 °C, 2.5 h 62%, 5:1 dr 
4. L-Selectride THF, –78 °C, 1 h No reaction 
5. K-Selectride THF, –78 °C, 1 h No reaction 
6. DIBAL CH2Cl2, –78 °C, 1 h 99%, >20:1 dr 
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Presumably due to the steric congestion surrounding the C15 hydroxyl group, the subsequent esterification 
of 241 with acid 242 did not proceed under standard Steglich conditions (DCC, cat. DMAP). Gratifyingly, 
trialling both Keck126 and Yamaguchi127 esterification protocols efficiently delivered the desired ester 243 
(Scheme 46a). While notionally a straightforward transformation, the esterification reaction can be 
challenging especially in the context of macrolactone formation. The demands of requiring mild conditions, 
high reactivity yet low substrate concentration has resulted in the development of wide-ranging 
esterification conditions, though the majority of these proceed via an activated acyl-DMAP intermediate.128  
Developed in response to the poor efficacy sometimes observed for the Steglich conditions, Keck extended 
the Steglich protocol through the addition of stoichiometric amounts of DMAP·HCl, noting that the 
proton-transfer step towards the formation of the active acyl-DMAP intermediate can become prohibitively 
rate-limiting, especially under high dilution conditions (Scheme 46b).126 The Yamaguchi esterification 
involves the initial formation of a mixed anhydride with the reacting acid and TCBC. The subsequent 
addition of DMAP to this mixture selectively acylates the less hindered non-aromatic carboxyl group, 
liberating trichlorobenzoic acid as the stoichiometric byproduct (Scheme 46c).127 The formation of the 
highly electrophilic acyl-DMAP intermediate enables the alcohol to attack as the nucleophile to generate 
the required ester linkage. As the Keck protocol was operationally more straightforward than the 
Yamaguchi esterification, this was selected for the synthesis of ester 243. 
Subsequent C17 silyl deprotection to form alcohol 244 using TsOH/MeOH proceeded in moderate yields 
that were unable to be improved by using alternative desilylation conditions. The final Dess-Martin 
oxidation of 244 into aldehyde 245 proved stubborn and could not be pushed to completion, and in the 
author’s hands, caused a degree of protodeiodination of the C10 vinyl iodide that was not ameliorated by 
added base or conducting the reaction in the dark. However, a screen of alternative oxidation conditions 
conducted by Muir highlighted the instability of the C10 vinyl iodide motif towards other oxidising agents. 
In particular, oxidations proceeding via a sulfonium-based mechanism such as those developed by Swern129 
and Parikh-Doering130 caused extensive degradation. This meant that while suboptimal, the Dess-Martin 
oxidation provided an adequate solution to generate the required aldehyde 245 for investigations into the 
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6.3.2. Investigation into the vinylmetal addition to the C10-C17 aldehyde 
With both the model C10-C17 aldehyde 245 and the C18-C23 vinyl iodide 233 in hand, the pivotal 
vinylmetal addition could now be evaluated. Taking inspiration from Evans’ total synthesis of phorboxazole 
B, which included a chelation-controlled Grignard addition of 246 into 247 to generate adduct 248 as one 
of the critical fragment union step (Scheme 47a),103 an analogous procedure was adopted. This procedure 
involves the generation of a vinyl lithium species arising from Li/I exchange, to which this can be 
transmetallated onto a suitable metallic reagent – in this case MgBr2·OEt2 to generate a vinyl Grignard 
species. To improve the efficacy of this reaction, the highly reactive vinyl lithium reagent could ostensibly 
be transmetallated onto a variety of alternative metals, such as titanium and zinc, to generate a diverse range 
of organometallic reagents. In Evans’ study, alternative organometallic reagents were inferior in terms of 
chelation control and reactivity as compared to the generated Grignard reagent, and as such, the in situ 
generation of the vinyl Grignard was considered to be the most promising strategy towards forming the 
C17 stereocentre and the C17-C18 bond. 
The study commenced by treating vinyl iodide 233 with two eq. of tBuLi, followed by the addition of a 
freshly prepared solution of MgBr2·OEt2 and aldehyde 245. As the initial Li/I exchange generates an alkyl 
halide species, which itself is prone to base-mediated elimination reactions, two equivalents of tBuLi are 
necessary to ensure that the formed vinyl lithium species does not get quenched through competing 
protodelithiation resulting from the elimination reaction of tBuI (Scheme 47b). The use of one equivalent 
of 233 and two equivalents of tBuLi failed to give complete Li/I exchange and only minimal amounts of the 
addition product was formed. Reasoning that this was due to adventitious moisture quenching either the 
tBuLi reagent, or the vinyl lithium intermediate, it was necessary to therefore increase the number of 
equivalents of vinyl iodide 233. Gratifyingly, employing 6.5 eq. of vinyl iodide 233 relative to aldehyde 245, 
13 eq. of tBuLi and 19 eq. of MgBr2·OEt2 (or 2 eq. of tBuLi and ca. 2.9 eq. of MgBr2·OEt2 relative to vinyl 
iodide 233) effected a clean addition to afford adduct 249 (77%), in 5:1 dr, with no competing addition into 
the C15 ester. Operationally, the excess alkene 250 formed as the byproduct of the reaction can be easily 
separated by chromatographic elution with neat PE 40-60, allowing for the facile isolation of the desired 
product 249.  
At this point, an opportunity to streamline the procedure by saving two steps was recognised by using vinyl 
iodide with the C23-bearing alcohol 232 as the vinylmetal addition precursor (Scheme 47c). Here, treating 
vinyl iodide 232 with excess NaH, followed by the above sequence of events failed to generate any of the 
required adduct 251, surmised as due to incomplete alcohol deprotonation followed by the self-quenching 
of the lithiated species. As there was already a functional solution, this higher-risk/higher-reward strategy 




Scheme 47. a) Excerpt from Evans' synthesis of phorboxazole B, employing a chelation-controlled vinyl Grignard addition. b) 















b) Schematic for the chelation-controlled vinylmetal addition of 233 into 245
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With the requisite bond formed, the next immediate goal was ascertaining the stereochemical outcome of 
the addition. Noting that the configuration at C15 was conclusively proved by Muir through Mosher 
analysis and NOE studies of previous intermediates, a proof of the configuration at C17 can be obtained 
through Rychnovsky’s analysis of the corresponding C15,C17-acetonide. Additionally, the Gerwick group 
has reported the detailed the spectroscopic data for the phormidolide A triacetonide derivative (151), which 
fortuitously allows for further corroboration of the stereochemical outcome at C17, as well as giving 
supporting evidence for the configuration in this region of the natural product. To do this, adduct 249 was 
deprotected under acidic conditions and the crude triol subjected to basic hydrolysis conditions to cleave 
the C15 ester. The corresponding diacetonide 252 can then be readily generated from the crude tetraol on 
treatment with (MeO)2CMe2 and PPTS (Scheme 48). 
As discussed in section 5.2.1, Rychnovsky’s acetonide analysis provides a reliable method for the 
stereochemical assignment of 1,3-related diols. Unexpectedly, applying the aforementioned analysis to 
diacetonide 252 gave diagnostic 13C chemical shifts for the 1,3-anti acetonide, corresponding to the 
undesired C17 epimer (i.e. 253) as the major product arising from the Grignard addition (Scheme 48). This 
result was corroborated by NOE analysis of the acetonide, with the NOE enhancements conforming to the 
expected twist-boat geometry for the 1,3-anti acetonide (Figure 40). These incongruous observations led 
to the initial consideration that perhaps the rigid THF ring conformationally locks the acetonide in an 
atypical conformation, though a literature search of similar 1,3-anti systems on THF rings showed very 
similar NMR shifts to diacetonide 252,131 giving further support for the relative configuration of diacetonide 
252. 
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Figure 40. Observed NOE correlations for 252. Irradiated signals are denoted in orange, while observed NOE correlations from the 
irradiated signals are denoted in grey. The expected twist boat geometry imposed by the 1,3-anti diol is supported by observing a 
strong correlation between H15 and Me16 to one of the acetonide Me, and H17 showing a correlation to the other acetonide Me. 
This indicates that H15 and Me16 sit on one side of the acetonide, while H17 sits on the other, placing H15 and H17 anti to each 
other in this ring. 
 
Postulating that perhaps chelation-control was inoperative in this reaction, a control experiment for the 
vinylmetal addition was conducted where MgBr2·OEt2 was omitted. It was hypothesised that if the omission 
of MgBr2·OEt2 (i.e. a direct vinyl lithium addition into aldehyde 245) gave a similar result to the inclusion 
of MgBr2·OEt2, then it was suggestive that in practice the reaction was proceeding under polar Felkin-Anh 
control. The exclusion of MgBr2·OEt2 gave the epimeric C17 adduct as the major product in 4:1 dr (Scheme 
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with the vinyl lithium species in the reaction. Again, the stereochemical outcome of this addition was 
corroborated by synthesising the corresponding acetonide 254, which was determined to be in a 1,3-syn 
relationship according to diagnostic 13C NMR shifts and reinforced by NOE enhancements (Figure 41). 
This outcome was supported by synthesising the diastereomeric Mosher esters of 249 and analysed 
following desilylation. Calculating the Dd values obtained from esters (R)- and (S)-255 established the 17S 
configuration of 249 as anticipated from the polar Felkin-Anh controlled addition of the vinyl lithium to 
aldehyde 245 (see Scheme 49 and Table 9). 
 
 
Scheme 49. The vinyl lithium addition of 233 into aldehyde 245, and the synthesis of the corresponding diacetonide 254. The 



























1) PPTS, CH2Cl2/MeOH 
   (1:1), r.t., 16 h
2) K2CO3, MeOH, r.t., 16 h
3) PPTS, (MeO)2CMe2/CH2Cl2
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Figure 41. Observed NOE correlations for 254. Irradiated signals are denoted in orange, while observed NOE correlations from the 
irradiated signals are denoted in grey. The expected chair geometry imposed by the 1,3-syn diol is supported by a strong 
enhancement of one of the acetonide Me with all of H15, Me16 and H17. This signifies that all three substituents are sitting on the 
same side of the ring. Additionally, the other acetonide Me does not show any NOE enhancements to H15, Me16 and H17. This 
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Table 9. Diagnostic 1H NMR signals for the configurational assignment of 17S 
Proton dH (S)-MTPA (ppm) dH (R)-MTPA (ppm) DdS-R (ppm) 
H13 4.18 4.09 +0.09 
H14A 2.43 2.13 +0.30 
H14B 1.65 1.10 +0.55 
H15 5.04 4.95 +0.09 
Me16 1.17 1.14 +0.03 
H17 5.81 5.73 +0.08 
H18 5.14 5.33 -0.19 
Me19 1.75 1.76 -0.01 
H20A 2.11 2.17 -0.06 
H20B 1.94 1.97 -0.03 
H21 3.48 3.53 -0.05 
These results revealed that chelation-control was indeed operative in the vinyl Grignard addition, although 
unexpectedly, the result suggested that the ‘small’ group where the nucleophile traverses over was not the 
methyl group, but in fact over the THF ester as shown in TS-XIV (Scheme 50a). Additionally, it highlights 
that the proximate Me16 was exerting a disproportionately large influence against the incoming nucleophile. 
Conversely, it affirms the polar Felkin-Anh approach for the vinyl lithium addition in the synthesis of 249 
via TS-XV. Related examples in the literature, as reported by Myers et al. do indeed have nucleophiles 
traversing over a methyl substituent as the small group under chelation control (Scheme 50b).132 In a 
structurally more similar example by Wolfrom and Hanessian,133 the expected chelation-control product 
for a THF-containing aldehyde (omitting the analogous Me group) gave the major product as expected, 
highlighting that the outcome for the Grignard addition into aldehyde 245 to give 253 is indeed anomalous. 
To rationalise this counterintuitive outcome, a DFT optimisation of a model chelated structure 256 was 
conducted. Interestingly, the lowest energy conformers all position the carbonyl C=O bond and the ether 
oxygen coplanar to each other, leading to a lowest-energy conformation where Me16 was projected 
perpendicularly away from the plane (Figure 42). A cursory analysis of this structure revealed that there 
was in fact a clear pocket where the nucleophile could readily traverse, which was located towards C15 and 
the THF. A similar approach on the opposite side is blocked by the protruding Me16 group, leading to the 
observed product as the major diastereomer under chelation-control. This model however, must be 
considered preliminary as solvated organomagnesium reagents rarely exist as a single species in their 
monomeric forms,134 and proximal Lewis basic groups such as the C15 acyloxy group could further 
participate in chelation.135 All these factors mean that the true transition state structure is likely to be more 




Scheme 50. a) Transition state schematics rationalising the major products observed in the chelation-controlled vinyl Grignard 
addition, and the polar Felkin-Anh dictated vinyl lithium addition leading to adduct 253 and 249 respectively, b) Relevant 
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Figure 42. B3LYP 6-31G(d,p) optimised structure of a model Mg-chelated structure 256, rationalising the observed 
diastereoselectivity for the chelation-controlled vinyl Grignard addition 
6.3.3. The stereochemical reassignment of phormidolide A and the implication for its biosynthesis 
With the two diastereomeric acetonides 252 and 254 and the NMR data for phormidolide A triacetonide 
151 in hand, a further stereochemical corroboration was sought for the C10-C23 region of phormidolide 
A. Interestingly however, diacetonide 252 (arising from the counterintuitive chelation-controlled addition), 
rather than diacetonide 254 (which has the reported configuration for C15 and C17) proved to be the better 
match to the triacetonide derivative of phormidolide A! In particular, the phormidolide A triacetonide 
derivative 151 appeared to display excellent homology to the 1H and 13C shifts for the acetonide regions, 
with the 13C signals for the acetonide methyl groups diagonistic for what appeared to the anti acetonide, rather 
than the reported syn acetonide (Figure 43). 
Because the clear spectroscopic observations that were presented unambiguously determined the 
configuration of diacetonide 252 and 254, this perplexing observation vis-à-vis phormidolide A 
triacetonide 151 led to the conclusion that either C15 or the C17 centre was missassigned. A thorough 
review of NOE data of the natural product and comparison with known synthetic intermediates towards 
aldehyde 245 ruled out C15 as the suspect stereocentre. Specifically, all intermediates bearing the reported 
15R geometry contain 1H signals at ca. 2.30-2.40 ppm, and 1.60-1.70 ppm for the diastereotopic protons of 
H14 (N.B.: in phormidolide A, these resonate at 2.33 and 1.57 ppm, and in phormidolide A triacetonide 
151 at 2.32 and 1.75 ppm). The alternative 15S configuration on the other hand, shows 1H signals for H14 
at ca. 1.95 and 1.90 ppm, which do not agree with the natural product (Figure 44). Alongside this, key NOE 
correlations observed by Muir in these intermediates were also in strong support for the reported C15 




Figure 43. Diagnostic NMR signals for diacetonides 252 and 254 as compared with the phormidolide A triacetonide derivative 151, 
highlighting the large chemical shift deviations recorded between the reported 17S configuration 
 
 
Figure 44. The 1H NMR and NOE comparisons of alcohols 203 and 243 with phormidolide A and phormidolide A triacetonide 151 






























Originally proposed structure for Phormidolide A 

































































for H13/H15 to H14b
and H14b to Me16
NOE observed for H13 and 
H15-Me16, and H15-H14a
















NOE observed for H13 to Me16
and for H15 to H12 and H17
No NOEs observed
H15-Me16
  118 
At this point, a thorough re-examination of the 2/3J and NOE data as reported in the isolation paper was 
conducted. A reanalysis of the reported NOE enhancements, taking into account all J values gave two 
possible conformers for the C16-C18 region. In the isolation paper, Williamson et al. presented one of two 
possible conformations surrounding C17 (Table 10 and Figure 45).2 While taking into account all J values, 
the reported conformation places H18 and Me16 too far away to observe the reported NOE enhancement. 
Instead, the alternative C17 epimer that takes into account all reported J values positions H18 in a proximal 
geometry to Me16, which accounts for the strong observed NOE correlation. This reanalysis, alongside with 
the interpretation of the data obtained by comparing 252, 254 to phormidolide A triacetonide 151, 
reinforces the proposed reassignment from 17S to 17R.  
Table 10. Excerpt of the NOE and 3J data used for the assignment of C17 from the original isolation paper. The key strong NOE 
enhancement between Me16 (C37 in the original isolation paper) and H18 is highlighted in orange. St = strong; Wk = weak 
Atom # 13C (ppm) 1H (ppm) NOESY COSY (Hz) HMBC (Hz) 
13 76.7 4.48 12b, 14b, Me11, Me16 14a (0.0), 14b (ovlp), 12a 
(14.0), 12b (5.0) 
11 (<0.5), 16 (10.6) 
14 34.8 1.57 15 15 (0.0), 13 (0.0) 13 (<0.5), 12 (4.1) 
  2.33 13, 15, 2 15 (4.8), 13 (ovlp) 13 (<0.5), 12 (4.5) 
15 79.6 5.15 12a, 14a, 17 (st), Me16 (wk), 18 (wk) 14a (0.0), 14b (4.8) 17 (<0.5), Me16 (5.5) 
16 86.9 -    
17 69.7 4.70 Me19, 15 (st), Me16 (wk) 18 (9.0) 19 (3.7), 16 (5.6), 15 
(5.5), Me16 (5.0) 
18 127.0 5.40 Me16 (st), 20a, 15 (wk) 17 (9.0) 20 (6.0), 16 (0.8), Me19 
(10.0) 
19 137.4     
Me16 21.0 1.19 13, 17 (wk), 15, 18 (st)   
 
 
Figure 45. Conformers taking into account all published J values for phormidolide A, highlighting an unconsidered conformer for 
17R that better explains the observed strong NOE between H18 and Me16 
 
 119 
As previously discussed in section 5.2.2, the inconclusive evidence presented for the J-based configurational 
analysis between C17 and C21 meant that the relative configuration for the C1-C18 region to the side chain 
was considered to be uncertain. In light of this reassignment, it was prudent to check whether or not C21 
was configured correctly by synthesising the alternative C21 epimer of adduct 253 and its corresponding 
diacetonide. Taking note of the lessons learnt from hemicalide (see section 3.4), it was hoped that the distal 
1,5-related stereocentres would exhibit clear NMR differences for the diacetonide to allow for the 
unambiguous assignment of the configuration between these two regions. Starting with ent-233 and 
aldehyde 245, an analogous chelation-controlled vinyl Grignard addition delivered adduct 256, which 
could then be transformed to the corresponding diacetonide 257 containing the epimeric C21 stereocentre. 
The Grignard addition gave the now expected 17R configuration, as confirmed by Rychnovsky’s acetonide 
analysis of 257 (Scheme 51). 
 
Scheme 51. Synthesis of adduct 256, and the corresponding diacetonide 257, confirming the 17R configuration arising from the 
chelation-controlled Grignard addition 
With the three diastereomeric acetonide 252, 254 and 257 in hand, a detailed spectroscopic comparison 
with phormidolide A triacetonide 151 was conducted. On initial inspection, diacetonide 254 containing 
the reported 17S and 21S configuration was immediately eliminated as a plausible diastereomer for 
phormidolide A on the basis of the large chemical shift deviations (data summarised in Table 11 and Figure 
46, graphical comparisons in Figure 47 and Figure 48). For the remaining diacetonides containing the 
revised 17R configuration but differing in the configuration of C21, the 13C NMR shift differences were 
particularly diagnostic, revealing that diacetonide 252 was a poorer fit for the natural product compared to 
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C17 and C21 from the reported 17S and 21S configuration, to their corresponding epimers: 17R and 21R. 
As the configuration of the remainder of the side chain was conclusively relayed back to C21 via J-based 
analysis and corroborated by the diacetonide derivative, these results mean that the reported 17S, 21S, 23R, 
25S, 26R, 27R, 29R configuration present in the natural product needs to be revised to their corresponding 
epimers (Figure 46), i.e. a reassignment of seven of the 11 stereocentres present in phormidolide A. 
Noteworthily, this revelation was enabled through the unexpected and serendipitous stereochemical 
outcome from the chelation-controlled vinyl Grignard addition of vinyl iodide 233 and aldehyde 245. 
Table 11. Summary of 1H and 13C shift differences, represented as total sum of errors and maximum errors between 252, 254, 257 
and phormidolide A triacetonide 151. Absolute errors taken from H/C10-H/C21, inclusive of acetonide proton and carbon signals. 
 S |DdH| (ppm)* Max |DdH| (ppm) S |DdC| (ppm)* Max |DdC | (ppm) 
257 (21-epi-15,17-anti) 0.24 0.08 3.2 1.5 
252 (15,17-anti) 0.32 0.11 8.2 2.7 
254 (15,17-syn) 1.34 0.37 30.0 8.2 
 
*|D| = d(Experimental) – d(Reported) 
 
Figure 46. Comparison between diacetonides 252, 254 and 257 with phormidolide A triacetonide 151, leading to the reassignment 
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Figure 47. Bar chart showing 1H NMR shift differences of diacetonides 252, 254 and 257 between H13-H21.(Legend in Figure 46) 
 
Figure 48. Bar chart showing 13C NMR shift differences of diacetonides 252, 254 and 257 between C13-C21 (Legend in Figure 46) 
 
Figure 49. Bar chart showing 1H NMR shift differences of 252 and 257 between H13-H21 (Legend in Figure 46) 
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The revised configuration of phormidolide A from 2  to 2a may now be accounted for by the proposed 
biosynthetic hypothesis put forth by Bertin et al. (Figure 51).82 In this paper, Bertin et al. highlighted that 
all ketoreductase-configured stereocentre present in phormidolide A were L-configured, despite the fact 
that the ketoreductases responsible for its configuration appeared to predict the formation of D-configured 
hydroxyl groups (for a detailed discussion, see section 5.2.3). The reassignment of the carbinol 
stereocentres at C17, C21, C23, C25 and C29 leads to the corresponding D epimer. This revelation is now 
concordant with the observation that the type B-like ketoreductases present in the biosynthesis of 
phormidolide A catalyse the formation of D-OHs, leaving OH7 as the single anomalous L-OH formed by 
a D1758-containing ketoreductase, rather than all the ketoreductases being anomalous. 
Importantly, this present section leads to the resolution of the stereochemical conundrum for phormidolide 
A at the outset of this work. Thus, through the synthesis of three diastereomeric acetonides, conclusive 
evidence was provided for the reassignment of both C17 and C21, and therefore the remainder of the side 
chain relative to the macrolactone. Gratifyingly, this stereochemical reassignment was justified by the 
reported biosynthesis of the natural product, giving further support for the conclusions from this study. 
 
 
Figure 51. Annotation of the configuration and the ketoreductases (KRs) responsible for setting the carbinol stereocentres in 
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6.4. Revised retrosynthetic analysis of phormidolide A 
The previous section detailed the expeditious synthesis of the C18-C23 vinyl iodides 233 and ent-233, 
which has enabled the verification of a key fragment coupling strategy as well as the crucial stereochemical 
reassignment of the natural product. At this point, the cumulative lessons learnt from the journey so far 
merit a further discussion of the proposed retrosynthetic analysis for phormidolide A. 
The revised endgame for phormidolide A involves a (+)-DIPCl-mediated aldol reaction with the C25-C33 
ketone ent-226 and a suitable aldehyde intermediate, followed by an in situ 1,3-syn reduction (Scheme 52). 
As the configuration of phormidolide A was now deemed to be secure, pursuing both enantiomers of the 
side chain was no longer necessary. The planned chelation-controlled Grignard addition has proven to be 
effective at installing the now desired configuration at C17 with model aldehyde 245. However, this 
unexpected and serendipitous result, ostensibly resulting from the nucleophile attacking into the carbonyl 
from the same face as the C15 ester (TS-XIV), meant that the stereocontrol in of this addition was likely to 
diminish with the full macrocycle in place. This was anticipated to be case as the full macrocycle would 
result in greater steric hindrance for the desired nucleophile trajectory (TS-XVI), whereas fortuitously in 
our model studies, the C15 dimethylacrylate ester appeared to minimally contribute to the steric bulk. The 
outcome of this would diminish, if not completely overturn the facial selectivity for the addition. Balancing 
the opportunities that had arisen from the model chelation-controlled vinyl Grignard addition and the risk 
of poor selectivity with the macrocycle in place, it was clear that the installation of the C18-C23 region 
should precede macrocyclisation, ideally with a C15 ester moiety in place. 
Additionally, the lack of reactivity arising from the intermolecular Mitsunobu inversion at C15 means that 
a Mitsunobu macrolactonisation process was unlikely to succeed. With the success of both the Keck and 
Yamaguchi conditions, the ring-closing step for the C1-C17 macrolactone was revised to a Yamaguchi 
macrolactonisation, a reaction successfully employed in the synthesis of many complex macrolide natural 
products within the Paterson group. The synthesis of this seco acid would arise from a basic hydrolysis of a 
methyl ester precursor. Considering that the dimethylacrylate ester was proven to undergo facile basic 
hydrolysis (K2CO3), the appendage of the dimethylacrylate ester at C15 served both as a protecting group 
and as a functionality to help maintain the diastereoselectivity in the Grignard addition. Retrosynthetically, 
this reveals the linear C1-C17 aldehyde 258 and the C18-C23 vinyl iodide ent-233 as the chosen precursors 
for the planned chelation-controlled Grignard addition. 
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Scheme 52. Revised retrosynthesis for reassigned phormidolide A 
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6.5. Synthesis of the C24-C33 side chain 
The C24-C33 fragment ent-226 contains three stereocentres and terminates in the signature 
bromomethoxydiene motif characteristic of the phormidolide family of natural products. Leveraging the 
1,4-syn relationship between Me26 and the oxygen bearing stereocentre at C29 in 259, the fragment can be 
disconnected across C28-C29 via a diastereoselective boron-mediated aldol reaction followed by a 1,3-syn 
reduction to configure both C27 and C29, to reveal known ketone (S)-48 and aldehyde 260 as the requisite 
starting material (Scheme 53). 
With many examples, including those from the Paterson group of similar types of 1,4-syn aldol reactions, 
the challenge here is to develop a concise synthesis of aldehyde 260 containing the bromomethoxydiene 
motif. At the upper limit, one could intercept Álvarez’s synthesis of ketone E-179, itself requiring eight 
steps, and homologate to generate aldehyde 260. However, this solution was deemed circuitous and 
attempts at developing a more concise method towards installing this motif were investigated. 
 
Scheme 53. Retrosynthesis of the C24-C33 fragment ent-226 to reveal aldehyde 260 and ketone (S)-48 
 
6.5.1. Initial approach: towards a more efficient manner of installing the bromomethoxydiene motif 
Beyond the sequence developed by Álvarez, the bromomethoxydiene motif could conceptually arise from 
two further means: a transition-metal catalysed trans-functionalisation of an alkyne, or through a direct 
electrophilic bromination/elimination sequence from a suitable methoxyenol ether precursor (Scheme 
54a). Drawn by the possibility of installing this elusive functionality in a single operation, initial studies 
were focused on identifying a suitable protocol to carry out a formal methoxymetalation-
bromodemetalation sequence on a model alkyne 261 to generate 262 (Scheme 54b). This was hypothesised 
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p-Lewis acid. The subsequent intermediate could then be trapped out by a source of electrophilic bromine 
to generate the required functionality. However, a range of gold-catalysed136–138, silver-catalysed and 
mercurative139,140 protocols failed to give any product or gave 263 as the major product (results summarised 
in Table 12). Notably, no olefinic protons were observed in the crude product mixture, which suggested 
that any processes that were operative reacted further with the electron rich enol ether intermediate, to 
result in the undesired dimethoxyacetal as a putative product.141  
 
Scheme 54. a) Alternative methods to synthesise the bromomethoxydiene motif.  b) Attempts at effecting a metal-catalysed synthesis 
of the bromomethoxyenol ether 
Table 12. Summary of conditions trialled for the transformation of 261 to 262 
Conditions Solvent Result 
NBS (1 eq.), r.t., 3 – 24 h DCE/MeOH (1:1) 263 observed 
AuClPPh3 (5 mol%), r.t., 3 – 24 h DCE/MeOH (1:1) No reaction 
AuClPPh3 (5 mol%), NBS (1 eq.), r.t., 3 – 24 h DCE/MeOH (1:1) No reaction 
AgSbF6 (5 mol%), r.t., 3 – 24 h DCE/MeOH (1:1) No reaction 
AgSbF6 (5 mol%), NBS (1 eq.), r.t., 3 – 24 h DCE/MeOH (1:1) 263 observed 
AuClPPh3 (5 mol%), AgSbF6 (10 mol%), r.t., 3 – 24 h DCE/MeOH (1:1) No reaction 
AuClPPh3 (5 mol%), AgSbF6 (5 mol%), NBS (1 eq.) r.t., 3 – 24 h DCE/MeOH (1:1) Degradation 
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With no promising results attained, this method was deemed unviable and attention turned towards 
investigating the second proposal for constructing the bromomethoxydiene – the direct electrophilic 
bromination of a suitable enol ether. This mirrors the proposed biosynthesis of phormidolide A, where it 
was conjectured that a halogenase enzyme, responsible for oxidising Br- to Br+, was responsible for the late-
stage bromination of the enol ether precursor, with the configuration of this system set by the a-
deprotonation of a favoured conformer (Scheme 54a, vide supra). 
To pursue this biomimetic proposal, a model alkoxyenol ether compound was needed, of which the ethoxy 
analogue was initially targeted owing to availability of starting materials. The synthesis commenced with 
the tin-mediated Barbier allylation of dibromide 263 with formaldehyde to give alcohol 264,142 which was 
then protected as the TBS ether 265 to avoid potential interference from the pendant hydroxyl group 
(Scheme 55). A Stille cross-coupling with stannane 266§§ was then conducted to give the highly unstable 
ethoxyenol diene 267, that needed to be used crude in subsequent transformations as it was prone to 
hydrolysing into the corresponding ketone 268. Interestingly, the Stille cross-coupling did not proceed at 
all under the otherwise reliable Fürstner-type conditions (Pd(PPh3)4, CuTC). Instead, a screen of conditions 
revealed that reacting vinyl bromide 265 and stannane 266 under Pd(PPh3)4 conditions, with CuI and LiCl 
as required additives reliably gave the desired product. 
Frustratingly, subjecting ethoxyenol diene 267 to a variety of electrophilic bromine sources either gave the 
unwanted bromoketone 269 or caused the degradation of the starting material. In all cases, it appeared that 
the base-mediated a-deprotonation required to generate bromomethoxydiene 270 is disfavoured relative 
to other lower energy pathways. These include an E2-like mechanism with the liberated base from the 
reaction, or less likely, an SN2 mechanism to remove the ethyl group from the charged oxonium species.  
Even though the presence of the ethyl group opens up the possibility for an extra E2 pathway that otherwise 
would not be present with the native methyl analogue, this study shows that the preferred intermolecular 
reactivity is the bimolecular interaction at the alkyl ether rather than the required a-deprotonation. In the 
case of the methoxyenol ether, one could plausibly extend this observation to conducting an SN2 mechanism 
to decompose the exposed methyl oxonium intermediate, rather than approaching and deprotecting the 
more hindered a-position to generate the required product. Altogether, this study is revealing in that the 
biosynthetic machinery required for this transformation is likely to contain a proximal basic residue in the 
halogenase active site to facilitate the a-deprotonation instead of a dealkylative pathway in order to generate 
the bromomethoxydiene motif. 
 
§§ Stannane 266 was synthesised by Dr. Simon Williams 



















































































With some quantities of the bromoketone 269 present, a final attempt to transform this into 
bromomethoxydiene 270, via the intermediate enolate was sought. In this case, it was hypothesised that 
treatment with a suitable base in the presence of a cation scavenger could generate the ‘naked’ enolate, 
which could then be alkylated using an electrophilic methyl source to generate the requisite functionality.143 
Unfortunately, the treatment of bromoketone with NaHMDS in the presence of 15-crown-5, followed by 
treatment with methyl triflate did not give any meaningful results (Scheme 56). 
 
 
Scheme 56. Attempted synthesis of 270 from 269 
 
To better understand the intrinsic reactivity of the bromomethoxydiene system, a series of preliminary DFT 
studies were conducted in conjunction with Reid. Specifically, these studies aimed to rationalise why 
Álvarez was unable to isomerise ketone Z-179 but could readily isomerise dibromide 271, as well as 
predicting whether or not biasing towards either kinetic or thermodynamic control could favour the 
geometry of the bromomethoxydiene motif. DFT optimisations of Z- and E-179 revealed that the E isomer 
was higher in energy owing to the proximal interaction with the carbonyl group. This was not the case with 
dibromide 271, where the E isomer was lower in energy as it allayed the interaction between Br and OMe 
in the Z isomer (Figure 52). By this observation also, the presence of the methylene group in Z-272 would 
also thermodynamically disfavour isomerisation to the E isomer (E-272) present in the natural product; an 
observation that was reinforced by DFT (Figure 53). As product selectivity in isomerisation processes are 
dependent on relative product energies, this study shows that generating the disfavoured E geometry with 
any substitution at C31 via double bond isomerisation would be a futile method. 
These results meant that a thermodynamic-controlled approach, unless employing Álvarez’s published 
route, was an infeasible venture. To probe whether or not one could kinetically bias the reaction to favour 
the transition state leading to the E product over the Z, further computationally-guided investigation was 
conducted. Here, two routes were surveyed for their geometric selectivity: one involving the kinetic a-
deprotonation of bromoketone 273 to generate 274 (Figure 54), and the second involving a base-mediated 
E2 elimination of dibromide 275 as reported by Álvarez. In both instances, the transition state possessing 
the conformer leading to the Z geometry was lower in energy than the alternative conformer, highlighting 
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Figure 52. Summary of DFT studies on various pathways as described by Álvarez conducted in collaboration with Reid, with red 
lines highlighting the interactions that presumably disfavour a particular geometry. All energies were calculated at the MO6-
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Figure 53. DFT optimised structures as calculated (in collaboration with Reid) for E and Z-272, highlighting that the undesired Z-





Figure 54. DFT optimised transition states as calculated (in collaboration with Reid) for the enolisation of 273 mediated by 
NaHMDS, highlighting that the Z-enolate is the kinetically favoured enolate. All energies were calculated at the MO6-2X/LACVP** 
level of theory, using THF as an implicit solvent model 
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6.5.2. Intercepting Álvarez’s bromomethoxydiene synthesis towards aldehyde 260 
At this juncture, there were two ways to resolve the synthetic impasse imposed by this motif: either conceive 
of a new and untested approach, or intercept the known optimised route as developed by Álvarez. After 
due consideration, adapting Álvarez’s chemistry to align with our planned retrosynthesis was viewed as the 
more pragmatic strategy. 
Moving forward, the synthesis of alcohol 276 commenced with a bromomethoxylation of acetone to 
generate dibromide 178 (Scheme 57). Despite the poor yield of this reaction, this reaction could readily be 
conducted on a 40 g scale and was operationally facile. The subsequent bromination of 178 with AcBr 
proceeded smoothly to generate tribromide 277. While Álvarez reported the use of K2CO3 for the required 
elimination, in the author’s hands the reaction proved to be poor yielding. Fortunately, direct treatment of 
277 with iPr2NH cleanly generated Z-271 as a single isomer, which can be isomerised to form 
predominantly E-271 as a 10:1 mixture of geometric isomers. At this point, an acetate displacement of the 
allylic bromide was conducted, followed by basic hydrolysis to afford allylic alcohol 276 in good yields. This 
sequence was found to be highly scalable, operationally straightforward and did not require 
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Allylic oxidation of alcohol 276 mediated by MnO2 smoothly gave the volatile aldehyde 278. At this point, 
two routes were considered to generate the required aldehyde 260: the first route involves a nucleophilic 
homologation of aldehyde 278 via an aldol reaction with the lithium enolate derived from ethyl acetate 
(Scheme 58). The second route involves a one-carbon electrophilic homologation from the silyl enol ether 
derived from ketone 179. Both intermediates could then be derivatised to generate aldehyde 260 required 
for the total synthesis. 
With the ready availability of intermediates, the first route was trialled. The aldol reaction of 278 to generate 
the b-hydroxyester 279 with the lithium enolate from ethyl acetate was only modestly yielding. At this point, 
attempts at installing the C31 methylene unit in 280 through further oxidation to ketoester 281 followed 
by Wittig olefination resulted in enol 282 as the only product. Attempts at reducing ester 279 to the diol 
followed by selective mono-silylation to give 283 also proved ineffective. Alongside the poor efficacy of the 
aforementioned steps, came the realisation that such convoluted solutions were unattractive for the 
synthesis of aldehyde 260. 
The pursuit of the second route required the synthesis of known silyl enol ether 186. From aldehyde 278, 
this involved a methyl Grignard addition to generate alcohol 284. A subsequent oxidation to ketone 179 
followed by enolisation mediated by TMSOTf smoothly gave silyl enol ether 186. From here, a one-carbon 
homologation was necessary between the nucleophilic silyl enol ether 186 and a suitable one-carbon 
electrophile. This outwardly simple operation however, was non-trivial, with scant literature examples 
detailing methods for such a transformation. One such method detailed by Kobayashi involved an aqueous 
Mukaiyama aldol reaction with formaldehyde catalysed by Yb(OTf)3.144 While generating b-hydroxyketone 
285 in moderate yields, this reaction generated a myriad of inseparable byproducts that remained 
inseparable even after further derivation.  
While evidently the more promising solution, this aforementioned second route is marred by poor step-
economy. To access aldehyde 260 after following Kobayashi’s protocol, the primary alcohol would have to 
be transiently protected. At this point, the ketone functionality may then be methylenated, and the 
protected C29 group then be deprotected and oxidised to generate aldehyde 260. Overall, this represents a 
15-step synthesis (from acetone) for a five-carbon fragment, which leads to a 21-step synthesis for the C24-
C33 fragment! Clearly, a much better solution was needed to ensure a sustainable supply of material that is 
concise enough in execution to afford the C24-C33 fragment ent-226. 
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Scheme 58. Attempted synthesis of aldehyde 260 through intercepting aldehyde 278 or silyl enol ether 186 
 
6.5.3. The Sakurai allylation approach towards the synthesis of the C24-C33 fragment 
Faced with a need to develop a more concise route, a fundamental overhaul of the planned retrosynthesis 
was necessary. An analysis of both the author’s proposed route in the previous section, as well as the 
synthesis undertaken by the Álvarez group highlighted the main source of inefficiency lay in the 
manipulations required to facilitate the C31 olefination. In light of this, two major avenues for improvement 
were identified: firstly, the synthesis would be more streamlined if the C31 olefin could be installed at an 
early stage. Secondly, the C31 olefin should ideally be utilised as part of a coupling handle to ensure a facile 
reaction with a suitable C25-C29 fragment.  
Bearing these considerations in mind, an alternative strategy was developed involving disconnecting across 
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which could be readily accessed through an allylation/oxidation sequence from a Roche ester derived 
aldehyde 106 via alkene 288. Allylsilane 286, containing the wholly intact bromomethoxydiene motif, could 
potentially be generated from a double Grignard addition/Peterson olefination sequence from a suitable 
ester precursor 289. This planned route would circumvent the unnecessary protecting group and redox 
manipulations to hopefully deliver a more concise synthesis of the C24-C33 fragment.  
 
Scheme 59. Revised retrosynthetic analysis for the C24-C33 region featuring a Sakurai allylation to forge the C29-C30 bond 
As the precursor for allylsilane 286, access to the ester 289 was necessary. Ester 289 required redox 
manipulation of the already synthesised aldehyde 278. Typically, this might involve a Pinnick oxidation 
followed by methylation to generate ester 289. However, an opportunity was identified in economising this 
process which avoids the manipulation of volatile intermediates. Following Scheidt’s example, allylic 
alcohols can be oxidised directly to the corresponding esters through treatment with MnO2 and a source of 
alcohol in the presence of an N-heterocyclic carbene (NHC) catalyst.145 The mechanism proceeds firstly 
with the MnO2-mediated oxidation of allylic alcohol to the corresponding aldehyde, which then is attacked 
by the NHC catalyst to generate a doubly-activated carbinol centre (Scheme 60a). Further oxidation of the 
secondary alcohol by MnO2 results in an acyl-azolium species, which can be readily attacked by the latent 
alcohol nucleophile to liberate the desired ester while regenerating the NHC catalyst. In this reaction, 
Scheidt identified that the catalyst derived from dimethyltriazolium iodide (290) was the most efficacious, 
and this catalyst was employed for this study towards the synthesis of ester 289. 
Drawn by the potential to effect a one-step oxidation from alcohol 276 to ester 289, Scheidt’s protocol was 











to allow for installation
of bromomethoxy diene 




























  136 
precursor for the oxidation on the other hand, gave methyl ester 289 in reproducibly good yields (Scheme 
60b). Ester 289 was then subjected to a double Grignard addition with TMSCH2MgCl mediated by CeCl3.146 
The resulting alcohol 291 could then be subjected to acid-mediated Peterson olefination. Nominally, this 
reaction is easily facilitated by stirring over SiO2.146,147 However, for alcohol 291, no conversion to the 
desired allylsilane was observed under these conditions. Recognising that perhaps the synthesis of the 
thermodynamically disfavoured E-bromomethoxydiene required a stronger source of acid than SiO2, the 
olefination was further trialled with PPTS in MeOH, which gratifyingly gave the desired allylsilane 286 in 
good yields. Overall, the synthesis of allylsilane proceeded in nine steps from acetone, which favourably 
compares with Álvarez’s synthesis of silyl enol ether 186, itself also proceeding in nine steps from acetone. 
 
Scheme 60. a) Mechanism of Scheidt's NHC-catalysed oxidative esterification. b) Synthesis of allylsilane 280 from 276 
The synthesis of the required aldehyde coupling partner 287 commenced with a Brown allylation of 
aldehyde 106 (Scheme 61a).148 The reaction proceeds via a highly ordered six-membered transition state, 
where aldehyde 106 is activated by the Lewis acidic boron centre bearing Ipc ligands. The carbonyl 
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coordination causes a transient formation of an anionic complex, which renders the g-carbon of the allyl 
group nucleophilic.149 The stereoselectivity of this reaction is controlled by the chiral Ipc ligands (TS-XVII) 
and reinforced by the Felkin-Anh preference of the aldehyde 106, and so disfavouring the formation of the 
minor diastereomer (TS-XVIII).150 In the author’s hand, the Brown allylation reaction proceeded reliably 
with excellent diastereocontrol (>20:1 dr) and generated alcohol 292 in good yields. From a previous study 
in the opposite enantiomeric series, the absolute configuration at C27 was confirmed by the synthesis of 
diastereomeric Mosher esters (R)- and (S)-MTPA-293, which confirmed the R configuration in ent-292 
(and therefore the S configuration for alcohol 292) (Scheme 61b and Table 13). 
 
 
Scheme 61. a) Synthesis of alcohol 292 via TS-XVII. b) Synthesis of Mosher esters (R)- and (S)-MTPA-293 to confirm the 27S 
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Table 13. Diagnostic 1H NMR signals for the configurational assignment of 27S (in ent-292) 
Proton dH (S)-MTPA (ppm) dH (R)-MTPA (ppm) DdS-R (ppm) 
H25 3.26 3.16 +0.10 
H26 2.07 2.05 +0.02 
Me26 0.92 0.87 +0.05 
H27 5.34 5.40 –0.06 
H28a 2.44 2.50 –0.06 
H28b 2.33 2.40 –0.07 
H29 5.67 5.75 –0.08 
Following allylation, alcohol 292 was subsequently protected as the TES ether 288 before subjecting to 
ozonolysis conditions to unmask the C29 aldehyde in 287 (Scheme 62a). As the PMB group in 288 was also 
susceptible to oxidation to the corresponding ester under these conditions, the ozonolysis was carefully 
monitored by the use of Sudan Red as the indicator,151 which undergoes a colour change to signify the 
completion of alkene ozonolysis. A reductive workup of the intermediate ozonide mediated by PPh3 then 
reveals aldehyde 287 and formaldehyde as the volatile byproduct. In the authors hands, the ozonolysis 
proved to be variable in yield that was not aided by changing the reductive workup procedure (e.g. to Me2S) 
or reaction temperature. 
With allylsilane 286 and aldehyde 287 in hand, the pivotal Sakurai allylation can now be investigated. The 
majority of Sakurai allylations in the literature involve the Lewis acidic activation of the carbonyl (e.g. 
BF3·OEt2152 and TiCl4153) (Scheme 62b), which enables the nucleophilic allylic olefin to attack into the 
electrophilic carbonyl centre to leave behind a carbocation stabilised by hyperconjugative effects from 
silicon.154 A latent nucleophile could then attack into the TMS group to reform the double bond. A survey 
of these conditions with allylsilane 286 and aldehyde 287 only resulted in extensive degradation, which was 
shown to arise from the instability of aldehyde 287 under Lewis acidic conditions rather than the allylsilane 
286 (results summarised in Table 14). Interestingly, a trial reaction between allylsilane 286 and 
isobutyraldehyde showed no reaction in the presence of BF3·OEt2, highlighting that the allylsilane unit was 
not nucleophilic enough to attack into the C29 carbonyl despite activation with a strong Lewis acid. 
With this in mind, attention was turned towards improving the nucleophilicity of the allylsilane system 
through Lewis base activation. A suitable Lewis base (most commonly fluoride) would coordinate to the Si 
and generate a transient ‘ate’ complex.155 This renders the terminal g-carbon more nucleophilic, which 
could in theory allow for the more facile allylation onto the C29 carbonyl (Scheme 62b). However, a screen 
of acidic and basic fluoride sources was met with failure, which highlighted the poor reactivity of allylsilane 
286 under these conditions and also the incompatibility of the aldehyde substrate 287 to fluorous 
conditions. Postulating that the lability of the TES group in 287 played a role, the TBS analogue 294 was 
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also synthesised (Scheme 62a). Following the poor reproducibility of the ozonolysis step, an alternative 
method for transforming alkene 295 to aldehyde 294 was sought, involving a dihydroxylation of 295 
followed by the periodate-mediated oxidative cleavage of the crude material. Gratifyingly, this sequence 
was highly reproducible, scalable to a gram scale and generated aldehyde 294 quantitively from alkene 295. 
Frustratingly, subjecting aldehyde 294 bearing the TBS ether to the Sakurai reaction with allylsilane 286 
saw no improvement under the same range of conditions. Notably, the extensive degradation seen in both 
287 and 294 was typified by the appearance of olefinic protons, signifying an eliminative process as a 
potential degradation pathway in both cases (Table 14). On a positive note, the stability of the 
bromomethoxydiene motif under neat HF·py conditions was a promising indication that a global 
desilylation step could proceed under mildy acidic fluorous conditions. 
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Aldehyde Conditions Result 
287 286, TiCl4, CH2Cl2, –78 °C, 1 h Degradation of 286 and 287 
287 286, BF3·OEt2, CH2Cl2, –78 °C, 1 h Degradation of 287 only 
287 286, MgBr2·OEt2, Et2O, –78 °C, 1 h Degradation of 286 and 287 
287 BF3·OEt2, CH2Cl2, –78 °C, 5 min Degradation of 287 
Isobutyraldehyde 286, BF3·OEt2, CH2Cl2, –78 °C, 1 h No reaction 
287 286, TBAF; 287, THF, 0 °C, 1 h Degradation of 287 only 
294 286, TBAF; 294, THF, 0 °C, 1 h Degradation of 294 only 
287 286, TBAT; 287, THF, 0 °C, 1 h No reaction 
294 286, TBAT; 294, THF, 0 °C, 1 h No reaction 
287 286, TASF; 287, THF, 0 °C, 1 h Degradation of 286 and 287 
294 286, TASF; 294, THF, 0 °C, 1 h Degradation of 286 and 294 
287 286, HF·py; 287, THF, 0 °C, 1 h  No reaction 
 
N.B.: All Lewis acids were used in equimolar amount to the aldehyde in the reaction mixture.  
All fluoride sources were used in equimolar amount to allylsilane in the reaction mixture 
So far, the planned allylation did not proceed with either the Lewis acid activation of aldehydes 287 and 
294, or the Lewis base activation of allylsilane 286. In both cases, the instability of the aldehydes to both sets 
of reaction conditions outweighed any potential reactivity, if any, of allylsilane 286. These failures made it 
evident that the allylsilane system was not nucleophilic enough, and the Si present in 286 would have to be 
replaced with a more electropositive metal to facilitate the required nucleophilic attack. 
In 2004, Dias and Steil published a report detailing the use of SnCl4 as a Lewis acid for a diastereoselective 
allylsilane addition onto aldehydes.53 In this report, rather than proposing a standard Lewis acid activation 
of the aldehyde, previous NMR studies had highlighted that a rapid Si/Sn transmetallative process was 
involved to generate the allyltrichlorostannane as the active allylation reagent.156 In particular, the 
trichlorostannyl motif has the further ability to act as a Lewis acid to activate the aldehyde partner, leading 






















287: R = TES




Attracted to the idea of simultaneously improving the nucleophilicity of the allyl unit and the presence of a 
Lewis acid to activate the carbonyl group, the Dias protocol was pursued. Gratifyingly, the low temperature 
treatment of allylsilane 286 with a solution of SnCl4 followed by the addition of aldehyde 294 gave the 
allylated product 296 as a 1:1.3 mixture of C29 epimers (296a:296b) in 72% yield (Scheme 63b). The 
alternative TES ether analogue 287 proved less efficacious, with numerous presumed degradation products 
observed in the course of the reaction. Importantly, both C29 epimers were separable by chromatography, 
which allowed for the unambiguous stereochemical elucidation through synthesis of the corresponding 
acetonides 297 and 298. 
 
Scheme 63. a) Sakurai allylation mediated by Sn/Si transmetallation as described by Dias and Steil. b) Synthesis of 296a and 296b, 
and their respective acetonides 297 and 298 confirming the stereochemical outcome of the allylation 
Finally, it is worthy to remark on the minimal diastereoselectivity observed for this reaction. The selectivity 
arising from a non-chelation controlled nucleophilic addition into b-alkoxyaldehydes is typically controlled 
by the Evans’ polar model, which preferentially generates 1,3-anti related adducts.55,157 The poor selectivity 
in this reaction echoes results observed by Evans et al. for additions into b-siloxyaldehydes, with poorer 
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selectivity observed compared to additions proceeding via closed transition states.104,158 In this case, the near 
equimolar ratio of products suggests transition states leading to the desired 27,29-syn and undesired 27,29-
anti products are similar in energy. While not investigated in this thesis, one could potentially bias the 
stereochemical outcome at C29 by introduce chiral chelating ligands (such as BINOL-type scaffolds) to 
occupy the remaining coordination sphere around Sn. This could increase the energy difference between 
the diastereomeric transition states in such a way that it would begin to favour the formation of the desired 
29S product.  
6.5.4. Completion of the C24-C33 fragment 
The poor selectivity of the allylation step was not considered to be an issue given the fact that both 
diastereomers are readily separable. This means that a direct esterification of the 27,29-syn product 296b 
would afford ester 299 containing the required C29 palmitoyl functionality. Building on promising 
reactivity shown by Álvarez, a Mitsunobu esterification on the 27,29-anti product 296a could separately be 
conducted to converge onto ester 299 with the desired C29 configuration. While the esterification of 296b 
with palmitic acid under Steglich conditions readily gave ester 299, subjecting the alternative 27,29-anti 
adduct 296a to Mitsunobu conditions with palmitic acid as the nucleophile resulted in no reaction (Scheme 
64). As it was known that Mitsunobu esterifications proceed more efficiently when the pro-nucleophile is 
more acidic,159 it was surmised that palmitic acid was not acidic enough to enable the transformation. As 
such, in an analogous manner to Álvarez’s route,101 a Mitsunobu inversion with p-nitrobenzoic acid 
followed by ester hydrolysis was conducted to correct the configuration at C29 for 296a. This sequence 
generated 296b bearing the correct geometry in moderate yields and was in all respects identical to the 
27,29-syn product generated from the allylation reaction. 
With a single diastereomer of ester 299 in hand, all that is required for the completion of this fragment is 
the transformation of the C25 terminus into the corresponding methyl ketone. This was accomplished with 
an oxidative cleavage of the C25 PMB ether to afford alcohol 300. A subsequent Swern oxidation to the 
aldehyde, followed by a chemoselective Grignard addition conducted at low temperatures gave an epimeric 
mixture of alcohol 301, which was subjected to a final Swern oxidation to give the completed C24-C33 
methyl ketone 302.  
Following the nine-step synthesis of allylsilane 286 and the seven-step synthesis of aldehyde 294, five more 
steps were required to give the completed C24-C33 fragment 302 in 14 steps LLS from acetone. The work 
presented in this section is a marked procedural improvement over Álvarez’s 17-step synthesis from 
acetone (see section 5.4.2 and 5.4.3), and has enabled a ready supply of an advanced intermediate for the 
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6.6. Towards the synthesis of the C1-C17 macrolactone 
 
The work described in this section was carried out in collaboration with Garrett Muir at Simon Fraser 
University. His results were crucial to the project and are presented alongside the author’s results. Unless 
otherwise stated, all reactions described were performed by the author and all stated yields are those 
obtained by the author. 
 
The three major disconnections planned for the phormidolide macrocycle represent three potential 
locations to execute the required macrocyclisation. These are namely: a macrolactonisation of the C1 seco 
acid 303 to OH15, a macro-cross-coupling of 304 to forge the C3-C4 bond, and a similar macro-cross-
coupling of 305 to forge the C9-C10 bond (Scheme 65). Of the three options, macrolactonisation appeared 
to be the most promising strategy for closing the macrocycle in light of the multitude of examples 
surrounding its use in macrolide synthesis.160 Additionally, the proposed biosynthesis for phormidolide A 
invokes a macrolactonisation as its final step before its liberation from the acyl carrier protein, further 
giving credence to this strategy.82 This meant that the goal was now focused towards generating a suitable 
seco acid to verify the crucial macrolactonisation step. 
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6.6.1. The macrolactonisation approach 
With a reliable route developed by Muir and Rao Challa towards the THF core, Muir looked to develop a 
convergent method towards the C1-C17 seco acid 306 through a cross-coupling between vinyl iodide 241 
and a suitable C1-C9 fragment. Muir planned to form the C9-C10 bond via a Suzuki reaction between the 
C10-C17 vinyl iodide 241 with a suitable C1-C9 boronate 307 (Scheme 66a). In practice, Muir commenced 
the synthesis of the C1-C9 boronate from (+)-epichlorohydrin 308 through an epoxide opening with the 
lithiated derivative of TMS-ethyne mediated by BF3·OEt2 (Scheme 66b). A cyanide displacement of 
compound 309 generated nitrile 310, where the TMS group was cleaved during the reaction. A Pd-catalysed 
formal hydroboration161 was able to install the BPin functionality in the internal position in 311. Following 
this, protection as the TBS ether 312 and a DIBAL reduction of the nitrile to aldehyde 313 was conducted. 
Here, Muir trialled several methods to elaborate 307 to the full C1-C9 fragment, though attempts at 
executing an HWE olefination, a Wittig reaction, or a Takai olefination were met with failure. While no 
conclusive reasons were given for its apparent lack of reactivity, Muir surmised that the potentially Lewis 
acidic BPin group was interfering with the nucleophilic component in these olefination reactions, 
hampering the reactivity of 313. 
 
Scheme 66. a) Retrosynthesis of seco acid 306 as planned by Muir. b) Synthesis of aldehyde 313 as conducted by Muir. Attempts at 
elaborating aldehyde 313 to the C1-C9 fragment 307 were unsuccessful. TFE = trifluoroethanol 
This forced Muir to conceive a step-wise approach towards the synthesis of the C1-C17 seco acid 306. Muir 
initially obtained poor results with the Suzuki reaction of vinyl iodide 241 with aldehyde 313 to generate 
314, suspected to be due to competing self-condensation of aldehyde 313 under the basic cross-coupling 
conditions. To circumvent this, Muir reduced aldehyde 313 to the corresponding alcohol 315 (Scheme 67). 
Initially, employing conditions developed by Gopalarathnam and Nelson (Pd(PPh3)4, Ba(OH)2)162 with 
protected vinyl iodide 243 and boronate 315 delivered the product 316 in moderate yield, though dramatic 
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reason as to why TlOEt proved to be superior to other strong Brønsted bases is uncertain, though part of 
the reason may be attributed to its improved solubility under the reaction conditions which more efficiently 
generates the transmetallation-active ‘ate’ complex required for the cross-coupling to proceed. As the 
alcohol 316 was found to be inseparable from the excess boronate 315, the mixture was used in subsequent 
transformations without further purification. 
An initial attempt at oxidising alcohol 316 under Dess-Martin oxidation conditions yielded what appeared 
to be widespread isomerisation of the C9 double bond. This was solved by subjecting 316 under Swern 
conditions, which not only delivered aldehyde 317 in good yields (over two steps), but also successfully 
removed the excess boronate 315 from the previous reaction. Aldehyde 317 was then subjected to Takai 
olefination conditions to generate vinyl iodide 318 with moderate geometric control (3:1 E/Z). While it was 
reported that there is a degree of solvent dependence on the geometric selectivity for the olefination,103 a 
solvent screen conducted by Muir failed to improve the selectivity of this reaction.  
Moving forward with vinyl iodide 318 and vinyl stannane 319, a Stille cross-coupling under Fürstner’s 
conditions73 reliably formed the C3-C4 bond to generate the C1-C17 skeleton 320. At this point, the 
selective C17 deprotection of intermediate 320 to alcohol 321 would commit the material towards the 
planned total synthesis of phormidolide A. Muir’s investigation into this process proved unfruitful, with a 
variety of acidic, acidic fluorous and basic fluorous conditions resulting in the unselective deprotection of 
the C7 and C17 TBS ethers, generating a statistical mixture of mono and bis deprotected products. In parallel, 
an attempt was undertaken to probe the efficacy of the planned macrolactonisation. Taking the C1-C17 
diester 320, a hydrolysis of both the methyl and dimethylacrylate esters afforded the seco acid 306. 
Frustratingly however, a range of macrolactonisation conditions failed to deliver the C1-C17 macrocycle 
322 (results summarised in Table 15), although trace amount of the minor 4Z isomer was observed to 
cyclise. This disappointing result was attributed to the steric demands of the proximal C16 group in relation 
to the all syn configuration in the THF, screening the C15 OH group required for the macrolactonisation. 
This intelligence gathering exercise generated two key lessons that needed to be considered in the continual 
strategy evolution of phormidolide A: firstly, the negative results obtained from exploratory studies in 
macrolactonisation, attributed to steric factors, implied that the required macrocyclisation was likely to best 
proceed at a position distal to any steric bulk in the molecule. As the macrolactonisation process was 
deemed unviable, this meant that one of the two planned cross-coupling reactions would be needed to 
generate the macrocycle. Secondly, the poor results obtained from the selective TBS deprotection 
highlighted the sterically similar nature of an encumbered primary versus an unhindered secondary TBS 
group. Of course, this problem could be solved by modifying the protecting group strategy; for example, by 
the incorporation of a bulkier protecting group at C7 or an orthogonal protecting group at C17. However, 
at this stage, this was deemed to be a less pragmatic modification as compared to progressing with the 
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available supply of advanced intermediate. If no protecting group alterations were implemented, this would 
mean that any manipulations at C17, including side chain installation, would have to take place prior to the 
introduction of the C7 TBS group. 
 
Scheme 67. Synthesis of seco acid 306 and its attempted macrolactonisation, presented alongside deprotection studies of 320. This 
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Table 15. Conditions trialled for the macrolactonisation of seco acid 306 to macrocycle 322 
Conditions Result 
306, TCBC (10 eq.), Et3N (20 eq.), PhMe, 1.5 h; 
Slow addition into DMAP (20 eq.), 50 °C, 20 h 
No reaction; degradation observed 
Trace of 4Z macrocycle seen 
306, MNBA (3.5 eq), PhMe; Slow addition into  
DMAP (7 eq.), PhMe, r.t., 24 h 
No reaction; degradation observed 
Taking these points into consideration, it was clear that a macro-cross coupling at either C3-C4 or C9-C10 
was worth exploring to generate the macrocycle. Noting that the intermolecular Stille reaction to generate 
320 proceeded more efficiently than the Suzuki reaction to give 316, it was surmised that the required 
macrocyclisation was likely to best proceed through the macro-Stille reaction via the formation of the C3-
C4 bond from 323 (Scheme 68a). While much less widely used compared to macrolactonisations, the 
macro-Stille reaction has been strategically used in several instances in natural product syntheses,164 most 
recently in the synthesis of chivosazole F within the Paterson group.165 Additionally, to circumvent the 
poorly selective C17 TBS deprotection in the presence of the C7 TBS ether, the side chain installation was 
proposed to take place prior to Suzuki cross-coupling with boronate 315 to reveal 324. Fortunately, this 
sequence of steps was previously validated in model studies as described in section 6.3.2. In this instance, 
vinyl iodide 325 bearing the C23 TES ether (itself generated from alcohol ent-232 - Scheme 68b) would be 
used instead of ent-233 bearing the C23 TMS ether. This difference was not anticipated to impact the 
Grignard addition reaction, but the protecting group change was considered to be important owing to the 
number of basic conditions employed in the synthesis towards the macrocycle, where the TMS group was 
not considered likely to survive. 
 
Scheme 68. a) Strategy evolution towards the synthesis of the phormidolide A macrocycle involving seco precursor 323 






























X1 = Organometallic fragment;






























232: R = H














6.6.2. The C3-C4 macro-Stille approach 
Pursuing the construction of an advanced seco precursor for the macro-Stille reaction 323 commenced with 
the chelation-controlled Grignard addition of vinyl iodide 325 into the previously synthesised aldehyde 245. 
In accordance to previous studies, this generated the adduct 326 in good yields in a 5:1 dr (Scheme 69). 
Alcohol 326 was then protected as its TES ether in 324, where Muir then elaborated 324 through an 
analogous Suzuki/Swern/Takai sequence as described above, to afford the C4-C23 vinyl iodide 327. At this 
stage, the dimethylacrylate ester at C15 needed to be exchanged for a stannylacrylate ester to generate the 
required seco precursor. Interestingly, applying the same mildly basic conditions to 327 that were previously 
successful in cleaving the dimethylacrylate ester (Ba(OH)2·8H2O or K2CO3 in MeOH) gave no reaction; in 
the end, the dimethylacrylate ester was reductively cleaved by subjecting 327 to DIBAL at low temperatures 
to give alcohol 328. 
The unexpectedly poor reactivity in hydrolytically cleaving the dimethylacrylate ester was an apparent 
harbinger of the difficulties to be encountered surrounding the re-esterification of C15 to generate seco 
precursor 323. As summarised in Table 16, no esterification was observed across a wide range of conditions, 
including transforming stannylacrylic acid 329 to the corresponding acyl chloride 330. Hypothesising that 
the issue was due to the steric bulk of acid 329, an attempt was conducted at re-esterifying with the smaller 
dimethylacrylic acid (242), which once again, gave no reactivity. In contrast with the ready esterification of 
alcohol 241, as well as the facile ester hydrolysis of triols derived from silyl deprotection of Grignard adducts 
249, 253 and 256 (see section 6.3.2), it appeared that the act of introducing a silyl protecting group at C17 
deleteriously affected the reactivity of C15. Additionally, in combination with the lack of reactivity seen in 
seco acid 306, the negative results observed in the intermolecular C15 esterification categorically eliminated 
the possibility of employing any form of macrolactonisation process as a key step towards the synthesis of 
phormidolide A. In both cases, it was clear that the required cross-coupling handle must be preinstalled, as 
the C15 alcohol was too hindered to be a productive nucleophile in any re-esterification processes. 
In light of these frustrating results, a revision to the strategy for construction of the macrocycle was 
necessary. One solution to this impasse lay in the early installation of the stannylacrylate ester, though this 
was quickly deemed as an implausible solution given the instability of the C-Sn bond to the Brønsted and 
Lewis acidic conditions the motif would be required to survive prior to the Stille reaction. Another plausible 
route involved the site-selective Stille reaction of a bis-halide precursor 331 with a suitable stannane 332 
(Scheme 70). Noting that the propensity for Pd0 complexes to undergo oxidative addition is determined by 
a combination of the steric environment and the C-X bond strength,165 one could reasonably expect that 
site-selective Stille reaction with a suitable stannane would preferentially occur at the terminal C10 vinyl 
iodide over the internal C3 vinyl bromide. It was conjectured that this property could be exploited in the 
synthesis of a suitable seco precursor 331, itself generated from dihalide 333, for the macro-Stille reaction.  





Scheme 69. Attempted synthesis of seco precursor 323 via alcohol 328 
 
Table 16. Conditions trialled for the attempted re-esterification of 328 to form seco precursor 323 
Acyl reagent Conditions Result 
329 329, TCBC, Et3N; 328, DMAP, PhH, r.t., 3 – 24 h No reaction (3 h and 24 h) 
329 329, 328, TCBC, Et3N, DMAP, PhH, r.t., 3 – 24 h No reaction (3 h and 24 h) 
329 329, 328, TCBC, Et3N, DMAP, PhMe, 80 °C, r.t., 3 – 24 h 
No reaction (3 h) 
Degradation with no 323 (24 h) 
329 329, 328, DCC, DMAP, DMAP·HCl, CH2Cl2, r.t., 24 h Degradation with no 323 
330 Et3N, DMAP (cat.), CH2Cl2, r.t., 3 – 24 h No reaction 
330 
328, NaH, 15-crown-5, THF, 1 h;  
330, Et3N, DMAP (cat.), r.t., 3 – 24 h 
No reaction (3 h) 
Degradation with no 323 (24 h) 






325, tBuLi, Et2O, −78 °C, 30 s;
MgBr2•OEt2, Et2O, −78 °C, 5 min;













326: R = H
324: R = TES
TESOTf, 2,6-lut.,
CH2Cl2, −78 °C, 45 min, 99%
1) 324, 315
1) Pd(PPh3)4, TlOEt




















































HO2C SnBu3 (COCl)2, DMF, PhMe








Scheme 70. Alternative retrosythesis of the phormidolide A macrocycle using a site-selective Stille coupling of dihalide 331 
 
While plausible in theory, in practice this route was marred with the intractability of both the synthesis and 
manipulation of the bromoacrylate motif in E-333. Specifically, attempts at the direct esterification of acid 
334 or acyl chloride 335 with alcohol 241 resulted in the degradation of the bromide motif (Scheme 71). In 
one instance, the attempted Yamaguchi esterification of acid 334 with alcohol 241 unexpectedly gave the 
allenyl ester 336, postulated to have arisen from the elimination of the DMAP-activated intermediate 337. 
Noting that the corresponding stannylacrylate ester 338 could be synthesised from alcohol 241 and acid 
329, it was hoped that treatment with an electrophilic Br+ source could effect a Sn/Br exchange to install 
the required functionality. Treatment of the configurationally pure stannane 338 with NBS appeared to give 
a mixture of double bond isomers in the crude product in favour of Z-333, which can be attributed to a 
radical destannylative pathway. The intermediate vinyl radical is configurationally unstable, where it 
equilibrates to preferentially form the thermodynamically more stable radical; that is the radical where the 
methyl group is projected away from the ester. This radical could then capture a Br atom to primarily afford 
the undesired Z-bromacrylate ester. 
In contrast, the use of Br2 as the electrophilic Br+ source cleanly gave the E isomer E-333 based on NMR 
analysis of the crude product, ostensibly via a polar pathway. Frustratingly, this material was not amenable 
to any aqueous work up procedures and was unstable to silica chromatography; upon which the material 
quickly degraded. This degradation was not specific to the bromoacrylate ester; the analogous reaction 
conducted with I2 gave the same mixture of degradation product upon aqueous work up or silica 






























X1 = Organometallic fragment;








































  152 
The apparent extreme sensitivity of the bromoacrylate motif eliminated this as a possible route towards the 
total synthesis of phormidolide A. With both permutations of coupling handles for the C3-C4 macro-Stille 
approach trialled with no success, it was clear that this disconnection is unviable, and further revision to 
the overall strategy was required. 
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6.6.3. The C9-C10 macro-Stille approach 
With both the macrolactonisation and C3-C4 macrocyclisation approaches apparently exhausted, attention 
was then turned towards executing a macrocyclisation via the formation of the C9-C10 bond in 305. In 
Muir’s original synthesis, this bond was formed via a Suzuki cross-coupling that required comparatively 
forceful conditions in order to get any reaction. Noting that the Stille reaction has been successfully 
employed in demanding cross-couplings, and that high reactivity under dilute conditions is a requirement 
for effective macrocyclisations, the Suzuki coupling was deemed unacceptable for this purpose, and a C9-
C10 macro-Stille cyclisation was adopted in the third strategy revision towards constructing the C1-C17 
macrocycle of phormidolide A (Scheme 72). 
 
Scheme 72. Strategy evolution towards the synthesis of the phormidolide A macrocycle: the C9-C10 macro-Stille approach 
This retrosynthetic revision to a macro-Stille reaction meant that a synthesis of the C1-C9 fragment could 
be revisited, with the aim of appending permutations of either the C9 stannane or the C10 stannane. Taking 
alkyne 339 synthesised by Muir, an iodoboration followed by acidic workup generated the internal vinyl 
iodide 340 regioselectively (Scheme 73a). An analogous DIBAL reduction revealed aldehyde 341, which 
could be subjected to an HWE olefination with phosphonate 342. Previous model studies conducted by 
Muir identified the crucial role of HMPA as an additive for this reaction; the omission of which resulted in 
the extensive isomerisation of the C2 double bond, presumably via an intermediary enolate type mechanism 
as described in Scheme 73b. While the exact role of HMPA is unknown, the addition of which as a co-
solvent in the HWE olefination largely suppressed this isomerisation to give the C4 olefin in dienoate 343 
as a single geometric isomer, and the C2 olefin as a 5:1 E/Z ratio of isomers. A hypothesised explanation 
rationalising this differential result could be attributed to the role of HMPA in solvating Li+, where its 
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resonance form contains a freely rotatable C2 bond, where the relative energies of the 2E and 2Z isomers 
are presumably similar in energy owing to comparable sized groups on one side of the double bond. Finally, 
it is worth noting that despite some degree of isomerisation observed, this HWE reaction has best generated 
the C1-C5 dienoate system in terms of both yield and geometric purity by far.  
 
Scheme 73. a) Synthesis of the C1-C9 dienoate 343. b) Hypothesised mechanism to rationalise the observed C2 isomerisation 
Following this, a basic hydrolysis of the methyl ester 343 afforded acid 344, which could be esterified onto 
a suitable alcohol in anticipation for the planned macro-Stille reaction. Despite the negative results observed 
for the re-esterification of alcohol 328, it was thought that the use of a smaller silyl protecting group may 
perhaps open the window of reactivity for the C15 hydroxyl group. To verify this hypothesis, alcohol 326 
was protected as the TMS ether 345 and the dimethylacrylate ester reductively cleaved to generate alcohol 
346 (Scheme 74). Perhaps not surprisingly, attempts at esterifying alcohol 346 with the C1-C9 acid 344 to 
give 347 resulted in no reaction under Yamaguchi conditions, conclusively confirming the adverse impact 
C17 protection has on the reactivity of the C15 hydroxyl group. At this point, it was also worth noting the 
importance of employing the Yamaguchi protocol as the preferred esterification technique. During the 
course of this study, the prolonged exposure of acid 344 under DMAP-containing conditions resulted in 
an increased degree of isomerisation of the C2 olefin, which was presumed to occur from the reversible 
conjugate addition of DMAP into the activated dienoate system. This result highlighted the need to keep 
the time of DMAP exposure to a minimum, of which the Yamaguchi esterification is able to by virtue of its 
reliably fast reaction times as compared with the Keck protocol. 
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Scheme 74. Synthesis of acid 344, alcohol 346 and the attempted synthesis of 347 
Noting that the nature of the substitution at C17 appeared to directly impact the reactivity of C15, a more 
ambitious strategy was conjectured where one could take the C15,C17 diol 348 and conduct an unselective 
esterification with acid 344. The regioisomeric esters 349 and 350 could then be macrocyclised to generate 
a mixture of macrolactone isomers (Scheme 75). Optimistically, one may be able to equilibrate the 
macrolactone to the presumedly thermodynamically more stable C15 regioisomer 351 via a Lewis acid. 
This tactic was used in the Paterson synthesis of aplyronine macrocycle166 and towards the synthesis of 
elaiolide.167 To explore this computationally, DFT optimisation of model C15 and C17 macrocycles were 
conducted and single point energies were evaluated for both structures. These results showed however, that 
the undesired C17 macrocycle was thermodynamically more stable by ca. 7.6 kcal/mol, highlighting the 
infeasibility of this idea. 
 
Scheme 75. A hypothesised Lewis acid-mediated isomerisation strategy towards forming the phormidolide A macrocycle 
Ba(OH)2•8H2O,
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As any attempts to install the C1-C9 acid 344 with the C18-C23 side chain in place proved to be intractable, 
there was no choice but to esterify the C1-C9 fragment prior to side chain introduction. This switch in 
choreography would directly impact on the protecting group strategy, as the mono-desilylation of C17 could 
not be conducted selectively in the presence of the C7 TBS ether. To circumvent this, either a bulkier 
protecting group was required for C7, or a more labile/orthogonally labile protecting group was required 
at C17. Owing to availability of material, attention was first focused towards generating the C7 TIPS ether 
analogue for acid 344, which commenced by the TIPS protection of alcohol 310 (Scheme 76a). An 
analogous sequence of steps involving iodoboration of 352 to afford vinyl iodide 353, reduction, an HWE 
olefination of 354 to generate 355 and an ester hydrolysis gave acid 356 now bearing the C7 TIPS group. 
In order to expeditiously verify the planned macro-Stille step, the C1-C17 macrocycle was once again 
targeted. At this stage, the stannane handle needed to be appended onto either the C9 or the C10 vinyl 
iodide. In previous studies, this stannylation could be conducted under Wulff-Stille conditions,69 where the 
aldehyde bearing vinyl iodide 341 was successfully transformed to the corresponding stannane 332 
(Scheme 76b). However, attempts to transform ester 355 to the corresponding stannane 357 proved 
unsuccessful, and so transforming the THF vinyl iodide 241 into stannane 358 was examined. Gratifyingly, 
this proceeded well under Wulff-Stille conditions, and the corresponding C10-C17 stannane 358 was 
esterified under Yamaguchi conditions to give the seco precursor 359. 
Taking inspiration from the Paterson synthesis of chivosazole F,165 initial macrocyclisation attempts focused 
on using the Fürstner Stille conditions under high dilution. However, it became apparent that the C9 
internal vinyl iodide was reticent towards oxidative addition processes at r.t. and required heating to initiate, 
as evidenced by the quantitative recovery of the protodestannylated product still bearing the vinyl iodide 
functionality (Table 17, entry 1). While the signals attributed to the vinyl iodide disappeared on heating, 
no product or oligomeric structures were seen and widespread disruption to the dienoate region was 
observed. Employing Nicolaou’s conditions in the macro-Stille reaction towards sanglifehrin A168 gave a 
similar outcome (Table 17, entry 3), which was rationalised to be from the susceptibility of the dienoate to 
conjugate addition processes by the phosphine and arsine ligands present in the reaction mixture. 
These results suggested an avoidance of nucleophilic ligands was necessary to preserve the structural 
integrity of the reactant. Noting that the Stille reaction could proceed under Cu-mediated Pd-free 
conditions,169 the Liebeskind protocol was trialled at increasing temperatures. Though the reaction was 
conducted at 1 mg scale, the CuTC promoted macro-Stille appeared to proceed at 110 °C, affording 
diagnostic m/z values and 1H NMR signals that corresponded to macrocycle 360 (Figure 55). This 
represents a promising lead in which further optimisations can be conducted for the ongoing pursuit 
towards an effective macrocyclisation strategy. However, due to time constraints, the author’s current 




Scheme 76. a) Synthesis of seco precursor 359 via acid 356. b) The successful Wulff-Stille reaction of 341 to give 332 
Table 17. Conditions trialled for the macro-Stille reaction of seco precursor 359 
Entry and Conditions Result 
1. Pd(PPh3)4 (20 mol%), CuTC, DMF, r.t., 2.5 h, c = 1 mM C10 protodestannylated starting material 
2. Pd(PPh3)4 (20 mol%), CuTC, DMF, 60 °C, 3 h, c = 1 mM 
Degradation: no dienoate signals 
C9/C10 protodeiodination/stannylation 
3. Pd2dba3 (20 mol%), AsPh3, DIPEA, DMF, 80 °C, 3 h, c = 1 mM 
Degradation: no dienoate signals 
C9/C10 protodeiodination/stannylation 
4. CuTC, NMP, r.t., 16 h, c = 10 mM C10 protodestannylated starting material 
5. CuTC, NMP, 100 °C, 16 h, c = 10 mM 
ca. 20% product, ca. 20% C10 
protodestannylated starting material 
 
Figure 55. Excerpt of the 1H NMR spectrum for 360, highlighting the diagnostic signals indicative of a successful macrocyclisation. 
The m/z value obtained via low resolution MS is also presented, giving further evidence for the successful synthesis of 360 
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7. Conclusions and Future Work 
 
7.1. Conclusions 
This chapter outlines the progress to date towards the total synthesis of phormidolide A, a complex 
polyketide of marine origins that bears a gamut of fascinating structural features. From the outset, 
configurational ambiguities presented in the original isolation paper meant that a parallel objective in this 
project was to achieve a synthesis-enabled stereochemical corroboration of the natural product. 
This chapter first described the successful enantioselective synthesis of the C18-C23 vinyl iodide 233 in six 
steps, where it was used to investigate the pivotal chelation-controlled Grignard addition with aldehyde 245 
to install the reported 17S configuration (Scheme 77). Unexpectedly, this planned addition delivered the 
17R alcohol as the major adduct, contradicting the models rationalising its stereoselectivity. Moreover, 
corroborating the outcome of this addition with the reported triacetonide derivative of phormidolide A 
revealed yet more inconsistencies. This was addressed through the synthesis of three diastereomeric 
acetonides (252, 254 and 257), which enabled the configurational reassignment of the side chain and seven 
of the 11 stereocentres present in phormidolide A. Crucially, this result was enabled through the ability to 
readily and flexibly generate single enantiomers of 218 and ent-218 through a straightforward use of the 
appropriate enantiomeric form of the oxazaborolidinone promoter for the Mukaiyama reaction. 
The resulting reassignment of the configuration of phormidolide A from 2 to 2a then allowed for a focused 
synthetic campaign using the correct enantiomeric series of the side chain. A concise synthesis of the C24-
C33 fragment 302 bearing the signature bromomethoxydiene motif was achieved in 14 steps, with a Sn-
mediated Sakurai allylation between 286 and 294 employed as the key transformation. This result was 
enabled through the expeditious synthesis of allylstannane 286 via ester 289, itself derived from known 
intermediate 276 through an NHC-catalysed oxidative esterification reaction. Finally, studies are presented 
towards the ongoing synthesis of the C1-C17 macrocycle, which revealed a myriad of unexpected challenges 
that has largely impeded the successful macrocyclisation of various seco precursors. A continual strategy 
evolution for this elusive target has led to the synthesis of acid 356 and alcohol 358, to which the first 
successful macrocylisation result was achieved through the use of a CuTC-mediated macro-Stille reaction 
to forge the C9-C10 bond in 360. 
Overall, the results detailed in this chapter serve to highlight the lessons learnt in the ongoing synthetic 
campaign towards phormidolide A. Moreover, it is anticipated that these key findings are readily cross-
applicable towards related congeners to phormidolide A. These cumulative results will hopefully allow for 
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7.2. Future work 
To date, all the targeted fragments of phormidolide A have been synthesised. The challenge, as highlighted 
in previous sections, now lies in orchestrating the right sequence of events for fragment coupling and 
macrocyclisation. Preliminary studies have confirmed the use of a DIPCl-mediated aldol reaction to forge 
the C23-C24 bond and configure the C23 and C25 stereocentres. Additionally, the chelation-controlled 
Grignard addition has been validated as a robust strategy for configuring C17, as well as forming the C17-
C18 bond. In the pursuit of this challenging target, the remaining fragment coupling step that needs further 
optimisation is the C9-C10 macro-Stille step, which will form much of the immediate future work for 
phormidolide A. 
7.2.1. Synthesis of the C1-C17 macrocycle and endgame for phormidolide A 
Based on the promising result obtained from the CuTC-mediated macro-Stille reaction, the initial focus 
will lie in its further optimisation with regards to other reaction parameters such as solvent and temperature 
to generate a reliable and robust method of forming the phormidolide A macrocycle.  
As discussed in section 6.4, the presence of the macrocycle was likely to impede the efficacy of the chelation-
controlled vinyl Grignard addition – though this has to date not been experimentally proven. With this in 
mind, the proposed endgame for phormidolide A would involve the following sequence of reactions: 
starting with alcohol 241, an esterification of the C1-C9 acid 356 would give ester 361 (Scheme 78). A 
selective C17 deprotection was then envisaged to occur due to the increased lability of the C17 TBS group 
as compared to the C7 TIPS group. After oxidation to aldehyde 362, the planned chelation-controlled 
Grignard addition with vinyl iodide 325 is expected to deliver the desired 17R configuration in alcohol 363. 
At this point, the macrocycle can then be closed by first transforming the C10 vinyl iodide in 363to the 
corresponding stannane. This adventurous site-selective Wulff-Stille strategy was conceived in light of the 
observation that the C10 vinyl iodide 241 readily underwent oxidative addition with Pd0 at 30 °C, whereas 
in a previous model study, attempts at executing the analogous transformation for vinyl iodide 341 into the 
corresponding stannane 332 and indeed in attempting the macro-Stille reaction for substrate 359 required 
prolonged heating at >60 °C. This margin of reactivity could be exploited to selectively append the stannane 
handle at C10 while preserving the C9 vinyl iodide. At this stage, the seco precursor 364 could then be 
subjected to the optimised CuTC-mediated macrocyclisation conditions to deliver the advanced C1-C23 
intermediate for phormidolide A (365). 
From 365, only four more steps would be required for the completion of the total synthesis. A selective C23 
primary TES cleavage was anticipated to readily occur in the presence of the secondary C21 TES group. 
After which, the C23 alcohol could be selectively oxidised via a TEMPO-BAIB oxidation, which is known 
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to selectively target primary alcohols over hindered secondary alcohols.170 The planned DIPCl-mediated 
aldol reaction/in situ 1,3-syn reduction with the C24-C33 ketone 302 could then occur to give the full 
carbon skeleton of phormidolide A 366. From 366, a global desilylation would then afford phormidolide A 
(2a) in 22 steps, with the longest linear sequence being the synthesis of the C10-C17 THF fragment 241 
accounting for 12 of those steps. At this point, a careful side-by-side comparison of the spectroscopic data 
with an authentic sample would be performed to unambiguously assign the structure of phormidolide A. 
 






















































































TBSO PdCl2(PPh3)2 (10 mol%)Li2CO3, (Me3Sn)2, THF
30 °C, 3 h, 97%
241: R = I 
358: R = SnMe3
PdCl2(PPh3)2 (10 mol%)
Li2CO3, (Me3Sn)2, THF
60 °C, 3 h, 63%
No reaction at 30 °C
341: R = I 
332: R = SnMe3
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7.2.2. Scope for further economy: a second-generation synthesis 
The longest linear sequence towards the planned synthesis of phormidolide A lies in the synthesis of the 
THF fragment. In this route, the L-proline-catalysed desymmetrising aldol reaction, while a powerful 
transformation, created two extra stereocentres that required several manipulations to either correct or 
remove. The first of which is the extra oxygenation at C14 – that required a selective diol protection, 
triflation followed by reduction to remove, and the second is the undesired 15S stereocentre, that required 
a further two steps to invert to the desired 15R configuration. As detailed in section 6.3.3, the exploratory 
studies investigating the stereochemical veracity of both C15 and C17 benefited from the ready accessibility 
of both 15S and 15R intermediates. This allowed for rapid spectroscopic comparisons to conclusively rule 
out C15 as a suspect stereocentre, and therefore facilitated the conclusive reassignment of C17 in 
phormidolide A. 
With more confidence now attributed to the configuration of phormidolide A, a more focused synthetic 
approach can be adopted in order to streamline the synthesis even more. In particular, the opportunities 
identified in avoiding extra manipulations to edit unwanted stereocentres can be avoided. Noting that the 
biosynthesis of phormidolide A was hypothesised to proceed via an intramolecular conjugate addition to 
form the THF motif, a similar disconnection could be envisaged into a suitable Michael acceptor. This 
reveals a 1,2-syn diol motif 368, which could arise from a Sharpless asymmetric dihydroxylation of 369. 
The linear precursor 369 itself can be broken into its constituent fragments via an HWE olefination and a 
cross metathesis (Scheme 79a).  
An example of how this strategy could be realised is presented in Scheme 79b. After protecting group 
installation, a three-step sequence involving cross-metathesis to give diol 370, oxidative cleavage followed 
by HWE olefination with phosphonates 125 or 371, and Sharpless asymmetric dihydroxylation of 369 
would generate the linear precursor 368, where it was expected that a cyclisation would spontaneously 
occur under Brønsted or Lewis acidic conditions to generate the THF moiety 372 or 373 diastereoselectively. 
At this point, transformation of the methyl ketone 372 to the E-vinyl iodide could optimistically be 
conducted under Takai conditions (with R = Me). Though there are literature examples of stereoselective 
Takai olefination of methyl ketones,171 owing to the often poor reactivity and selectivity of ketones in the 
Takai olefination,172,173 alternative strategies may be necessary. These include a validated three-step 
procedure involving HWE olefination with phosphonate 374, ester hydrolysis and decarboxylative 
iodination.174 Alternatively, taking the analogous thioester 373, one could reduce to the aldehyde, conduct 
a Seyferth-Gilbert homologation with 375 followed by a Negishi carboalumination to afford the desired 
C10-C17 fragment 367. This potential second-generation synthesis might be achieved in as little as seven 
steps, and has the opportunity to reduce the overall number of steps for phormidolide A from 22 down to 




Scheme 79. a) Alternative retrosynthesis of the C10-C17 fragment 367. b) Potential shorter second generation synthesis of the C10-
C17 fragment 367. PG denotes unspecified protecting group. STol = S-tolyl, CTAB = cetrimonium bromide 
7.2.3. The configurational identity of C7 – a case for a further misassignment? 
During the writing of this thesis, an anomaly was spotted in the configurational assignment of the C7 
stereocentre of phormidolide A as performed by Bertin et al.. In this report, Bertin et al. sought to confirm 
the stereochemical nature of a carbinol stereocentre set by a Type-B ketoreductase by forming the 
diastereomeric Mosher esters of phormidolide A triacetonide. While the ketoreductase responsible for 
setting C7 contains the D1758 residue – predictive of generating D-OHs, Bertin et al. claimed the result 
from Mosher analysis appeared to confirm the 7R, or L-OH configuration, and therefore the originally 
assigned configuration for the natural product. 
A reinspection of the reported data presented for the S- and R-MTPA derivatives of triacetonide 151 
however, directly contradicts this finding (Table 18). Applying Hoye’s model to the reported NMR values 
revealed that C7 possesses the S configuration. This result also contradicts the modified Mosher method 
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Table 18. Diagnostic 1H NMR signals for the configurational assignment of C7 as reported by Bertin et al. 
Proton dH (S)-MTPA (ppm) dH (R)-MTPA (ppm) DdS-R (ppm) 
H2 5.71 5.72 -0.01 
H4 6.17 6.19 -0.02 
H5 6.17 6.18 -0.01 
H6 2.38 2.43 -0.05 
H6 2.34 2.36 -0.02 
H7 5.64 5.31 +0.33 
H8a 2.28 2.24 +0.04 
H8b 2.25 2.21 +0.04 
H10 5.73 5.71 +0.02 
H12a 2.55 2.42 +0.13 
H12b 2.43 2.40 +0.03 
H13 3.97 3.96 +0.01 
It is currently unknown whether or not this arose from a labelling error or from a misanalysis of the 
reported data, but these conflicting results give further stereochemical ambiguity for the natural product, 
especially since all the stereochemical information from the isolation paper was relayed to the C7 
stereocentre. If C7 was indeed wrongly configured, there are two outcomes that can arise from this 
conundrum: the first outcome assumes the original J-based analysis was correctly formulated, which means 
that the remaining ten stereocentres in the molecule (or only three from the originally assigned structure) 
needs a further reassignment to their corresponding epimer. The second, and much more likely outcome, 
assumes that the J-based analysis was not definitive, where an alternative unconsidered configuration of the 
macrocycle could also explain the observed J values and NOEs observed for phormidolide A (Figure 56). 
In the author’s opinion, the second outcome is the more likely scenario, especially considering the published 
domain analysis for the ketoreductases responsible for configuring phormidolide A. In this chapter, the 
reassignment of phormidolide leaves C7 as the sole anomalous stereocentre that was not justified by the 
published domain analysis. The implications from the first scenario would mean that all carbinol 
stereocentres set by ketoreductases except for C7 are anomalous, On the other hand, the second scenario 
where the absolute configuration at C7 was revised without altering the configuration of the remaining 
stereocentres would align all carbinol stereocentres set by the ketoreductase enzyme. This would mean that 
all ketoreductases in the biosynthesis of phormidolide A that contain the D1758 residue will predictably 
generate the expected L-OH; a much more plausible scenario than the former. 
However, it is important to note that this outcome, while providing a convenient stereochemical 
rationalisation, remains as an unsubstantiated claim. To further this investigation, ongoing DP4f 
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computational NMR studies are being conducted by the author towards identifying the diastereomer of the 
macrocycle that best fits the spectroscopic data from the natural product. Additionally, Muir is currently 
embarking on the synthesis of the enantiomeric C1-C9 fragment ent-356 starting from (–)-epichlorohydrin, 
with the end goal of achieving a synthesis-enabled stereochemical corroboration of the deprotected C1-C17 
macrocycle with phormidolide A, taken alongside the anticipated results from computational studies. 
Optimistically, the revision at C7 could help assuage the troubles faced with the stubborn macrocyclisation 
step previously faced, especially noting that distal stereocentres can have a noticeable impact on the overall 
conformation of the macrocycle.  
Regardless of the various hypotheses put forth however, further stereochemical verification for C7 has now 
become a necessary objective towards the ongoing campaign towards phormidolide A.  
 
Figure 56. Reanalysis of the diastereomeric Mosher ester data by Bertin et al. suggest that C7 is misconfigured, which gives two 
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Overall conclusions 
 
This thesis examines the crucial role synthesis plays in the stereochemical elucidation of complex natural 
products. The first chapter outlines how synthetic chemistry, in particular, has allowed for the 
unambiguous elucidation of their complex architecture when other state-of-the-art techniques may not be 
applicable. This premise underpins the remaining chapters of this thesis, where developing the 
stereocontrolled syntheses of two architecturally complex polyketide natural products has enabled their 
ongoing stereochemical elucidation. 
In chapter two, the hemicalide project presented a paramount example of the role a modular synthesis plays 
in the stereochemical elucidation of a natural product. The hemicalide project is unique, and perhaps 
unprecedented in the realm of natural product elucidation, that only 1D 1H and 13C listed NMR data was 
provided as the sole basis for determining all 21 unknown stereocentres. It is through years of fruitful 
collaboration between computational and synthetic chemists, employing state-of-the-art algorithms, that 
has allowed the eventual narrowing of over two million stereochemical permutations, down to 256 prior to 
this current work. With current limitations imposed by computational resources, the increasingly complex 
structures of truncates of hemicalide post a practical constraint for further ab initio prediction methods, 
and this thesis demonstrates the power stereocontrolled synthesis brings in the stereochemical elucidation 
of distal stereoclusters. Here, the synthesis of both candidate diastereomers unambiguously showed that 
hemicalide possesses the 13,18-syn configuration, further reducing the number of permutations down to 
128 for the natural product. 
Additionally, the independent synthetic development of hemicalide between the Paterson and 
Ardisson/Cossy groups has provided a great deal of understanding to the innate chemistry of the natural 
product. Embedded within this is the concept that academic research is not a zero-sum game (despite what 
the funding models may imply), and each team’s successes and failures serve to guide the continual 
development of further stereochemical confirmation towards this alluring natural product. 
Pursuing a total synthesis also has the advantage in being able to flexibly divert intermediates for biological 
testing. As Romo et al. demonstrated in their recent work,175 a pharmacophore-guided retrosynthetic 
analysis can allow for the development of a comprehensive SAR study during a total synthesis campaign. 
Aspects of this can be incorporated to hemicalide, where a parallel objective is to investigate how the 
molecule imparts its stellar bioactivity, and whether or not simplification can be tolerated. 
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One could not anticipate from the outset of this project the challenges and opportunities phormidolide A, 
a continually moving target, has brought. As described in chapter three, the phormidolide A project further 
reinforces the role of synthesis in the unambiguous stereochemical confirmation of natural products. Again 
enabled through modular disconnections and enantioflexible syntheses, the Paterson/Britton approach 
towards phormidolide A rapidly generated candidate diastereomers to probe the likely configuration at C17 
as well as C21 of the natural product. Underscoring this however, the project also highlights the role of 
serendipity in research; the reassignment of seven of 11 stereocentres of phormidolide A would have been 
a harder task such if the chelation-controlled vinylmetal addition proceeded exactly as planned. 
The stereochemical reassignment of phormidolide A was additionally notable for the fact that it occurred 
despite a comprehensive analysis of spectroscopic data as well as the elucidation of its biosynthetic 
machinery, further reinforcing the role synthesis has as the final arbiter of a compound’s 3D structure. 
Pleasingly, the correction of this error generated productive and ongoing collaborations in the attempt 
towards refining techniques used in structure elucidation and biosynthesis/informatics, so that these errors 
may not arise again. This additionally highlights the inherent symbiotic relationship between synthetic 
chemistry with natural products, where discoveries in either fields will mutually benefit each other.  
The ongoing synthetic campaign towards phormidolide A also highlights the many deficiencies synthetic 
chemistry still has on the efficient construction of complex natural products. In light of several high profile 
debates,176–178 of which many have proclaimed the passing of the golden-age of organic synthesis, the 
continual frustrations the present author encountered at executing notionally straightforward chemical 
reactions is a testament against the pessimists. The narrative that organic chemistry is a mature field, and 
research should be pursued in other high growth areas is detrimental to the pressing need for the 
development and, more importantly, improvement of chemical transformations. Especially noting that 
organic synthesis often lags behind other sciences as the rate-limiting step in discovery,179,180 the focus now 
more than ever should firmly be on discovering methods to prospect and improve reactivity in order to 
facilitate the efficient construction of molecules large and small. 
The study of natural products serves as an enabler for the co-discovery of medicine, biology and, as 
illustrated in this thesis, chemistry. The challenges and discoveries found in the productive journey towards 
these two marine polyketide natural products above all, illustrate how nature informs science, and in turn 
how science reveals nature. With continual advancements in technology, one can hope that the study of 
natural products across disciplines will continue to inspire the advancement of science for the betterment 
of mankind. 
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Experimental Procedures and Data 
 
8.1. General Procedures 
Unless the reaction contained aqueous reagents or otherwise stated, all reactions were carried out under an 
atmosphere of argon, using oven dried glassware and standard techniques for handling air sensitive 
chemicals. 
Reagents were purified using standard laboratory procedures; benzene and dichloromethane were distilled 
from CaH2 and stored under argon. THF and Et2O were distilled from potassium or sodium 
wire/benzophenone ketyl radical and stored under argon. DMSO, 2,6-lutidine, iPr2NH, DIPEA and Et3N 
were distilled from CaH2 and stored over CaH2 under argon. DBU was distilled from CaH2 and stored over 
4 Å MS. DMF was distilled from MgSO4 and stored over 4 Å MS. EtOAc was distilled from MgSO4, DDQ 
was recrystallised from CHCl3. (COCl)2 and TiCl4 were distilled. Solvents used for extraction and 
chromatography were distilled. All other chemicals were used as received from the supplier unless 
otherwise stated. 
Aqueous solutions of ammonium chloride (NH4Cl), sodium bicarbonate (NaHCO3), sodium thiosulfate 
(Na2S2O3), brine (NaCl) and sodium/potassium (Na/K) tartrate were saturated. Buffer solutions were 
prepared as directed from stock tablets. 
Flash column chromatography was carried out using Kieselgel 60 (230-400 mesh) and a positive solvent 
pressure. Chromatographic purification over alumina was carried out using Merck Millipore Aluminium 
oxide 90 and a positive solvent pressure.  
8.2. Analytical Procedures 
TLC was carried out using Merck Kieselgel 60 F254 or Aluminium oxide 60 F254 plates, which were visualised 
under UV light (254 nm) and stained with potassium permanganate or phosphomolybdic acid/Ce2(SO4)3 
dips. 
NMR spectra were recorded using the following machines: Bruker Avance 500 BB (500 MHz), Avance TCI 
cryoprobe (500 MHz) and Avance 400 DRX (400 MHz). 1H spectra were recorded at 298 K with an internal 
deuterium lock for the residual undeuterated solvent: CDCl3 (δH = 7.26 ppm) and DMSO-d6 (δH = 2.50 
ppm), MeOD-d4 (δH = 3.31 ppm). 1H data are presented as: chemical shift (δ/ppm), relative to 
tetramethylsilane (δTMS = 0 ppm), integration, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, 
 
 169 
qn = quintet, sext = sextet, sept = septet, m = multiplet, br = broad, obs = obscured) and coupling constants 
(J in Hz). Signals are assigned according to the numbering scheme for hemicalide (1) (Figure 1) or 
phormidolide (2) (Figure 2) unless otherwise indicated. Assignments have been made based on 1D data 
presented along with 2D spectra and comparison with fully assigned spectra for similar compounds. 
13C NMR spectra were recorded at 298 K with broadband proton decoupling and an internal deuterium 
lock for 13C: CDCl3 (δC = 77.0 ppm), DMSO-d6 (δH = 39.5 ppm) or MeOD-d4 (δH = 49.1 ppm). Data are 
listed by chemical shift (δ/ppm) relative to tetramethylsilane (δTMS	=	0 ppm). 
Fourier transform IR spectroscopy (FT-IR) was carried out using a Perkin-Elmer Spectrum-One 
spectrometer and spectra were recorded as a thin film. Wavelengths of maximum absorption (νmax) are 
reported in wavenumbers (cm-1). 
Optical rotations were measured using a Perkin-Elmer 241 polarimeter at the sodium D-line (589 nm) and 
are reported as [α]D
20, concentration (c in g/100 mL) and solvent used. 
High resolution mass spectrometry (HRMS) was carried out by the EPSRC National Mass Spectrometry 
Facility (Swansea, UK) using electrospray ionisation (ESI). The parent ion [M+H]+ or [M+Na]+ is quoted. 
Chiral HPLC was carried out on a Shimadzu XR-LC system, using a Chiralpak® IA column and a solvent 
system of mixed hexanes and isopropanol. 
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8.3. Preparation of Reagents 
2-Iodoxybenzoic acid181 
To a solution of Oxone® (53.0 g, 0.348 mol) in water (720 mL) was added iodobenzoic acid (60.0 g, 0.242 
mol). The suspension was stirred vigorously at 70 °C for 3 h before cooling to r.t.. The resulting precipitate 
was filtered and washed with water (6 × 120 mL) and acetone (2 × 120 mL) and dried in vacuo to afford 2-
iodoxybenzoic acid as a white solid (63.7 g, 0.227 mol, 94%). 
Dess-Martin Periodinane181 
A suspension of 2-iodoxybenzoic acid (63.7 g, 0.227 mol) and TsOH·H2O (432 mg, 2.27 mmol) in acetic 
anhydride (318 mL) was stirred at 95 °C for 2.5 h to afford a pale-yellow solution. The mixture was cooled 
to r.t., then to 0 °C to facilitate the formation of a white precipitate. The precipitate was collected by filtration 
and washed with Et2O (5 × 100 mL) then dried overnight in vacuo to afford Dess-Martin Periodinane as a 
white solid (63.2 g, 0.148 mol, 65%), which was stored at –20 °C without appreciable deterioration. 
iPrMgCl 
Mg turnings (2.69 g, 120 mmol) and I2 (2 crystals) were added to a solution of THF (10 mL) and iPrCl (0.91 
mL, 10 mmol). The reaction was heated gently until the brown colour dissipated, at which point a solution 
of iPrCl (8.23 mL, 90.0 mmol) in THF (40 mL) was added dropwise over 30 min while maintaining a steady 
reflux. The reaction was heated to reflux for 1 h to afford a black solution of the Grignard reagent. This was 
titrated against menthol/1,10-phenanthroline to determine a final concentration of 1.42 M. 
[CuH(PPh3)]6 (Stryker’s Reagent)182 
Tetramethyldisiloxane (1.40 mL, 7.56 mmol) was added to a stirred suspension of Cu(OAc)2·H2O (100 mg, 
501 µmol) and PPh3 (260 mg, 991 µmol) in toluene (18.6 mL) at r.t.. The mixture was stirred at r.t. for 24 
h, during which the blue colouration faded to afford a solution of the Stryker’s reagent as a red solution. 
The reagent was stored at 4 °C under Ar and was used as a 0.025 M solution with respect to Cu(OAc)2·H2O. 
N-Tosyl-L-valine – 215 and ent-215 
 
To a stirred solution of L-valine (1.76 g, 15.0 mmol) in aqueous NaOH (7.5 mL, 2 M) at 0 °C was added 











warmed to r.t. and stirred for 16 h to afford a pale-yellow solution. The reaction was neutralised with 
aqueous HCl (ca. 5 mL, 3 M) and the aqueous solution was extracted with EtOAc (5 × 15 mL). The 
combined organic phases were washed with brine (20 mL), dried (Na2SO4) and the solvent removed under 
reduced pressure to afford N-tosyl-L-valine as a white powder (3.89 g, 14.3 mmol, 95%). The enantiomeric 
compound was analogously prepared from D-valine (1.76 g, 15.0 mmol) to afford N-tosyl-D-valine (ent-
215) as a white powder (3.84 g, 14.1 mmol, 94%) 
1H NMR (400 MHz, CDCl3) dH 7.72 (2H, d, J = 8.3 Hz, ArH), 7.28 (2H, d, J = 8.3 Hz, ArH), 5.12 (1H, d, J = 
9.9 Hz, NH), 3.80 (1H, dd, J = 9.9, 4.6 Hz, H2), 2.41 (3H, s, ArMe), 2.10 (1H, septd, J = 6.8, 4.6 Hz,  
H3), 0.96 (3H, d, J = 6.8 Hz, H4a), 0.87 (3H, d, J = 6.8 Hz, H4b); 13C NMR (125 MHz, CDCl3) dc 176.5, 143.9, 
136.6, 129.6, 127.2, 60.7, 31.4, 21.5, 19.0, 17.2.  
Data in agreement with that presented by Berry183 
p-Methoxybenzyl-2,2,2-trichloroacetimidate (PMBTCA) 
 
Trichloroacetonitrile (11.6 mL, 115 mmol) was added dropwise over 45 min to a stirred biphasic mixture 
of p-methoxybenzyl alcohol (13.8 g, 100 mmol), KOH (75.0 g, 1.34 mol) and [Bu4N][HSO4] (435 mg, 10.0 
mmol) in CH2Cl2 (150 mL) and water (150 mL) at –10 °C. The reaction was stirred for 16 h, with gradual 
warming to r.t.. The layers were separated and the aqueous phase was extracted with Et2O (3 × 300 mL). 
The combined organic phases were washed with brine (500 mL), dried (MgSO4) and the solvent removed 
under reduced pressure. Purification by flash column chromatography (EtOAc/PE 40-60: 5%) (alumina) 
afforded the title compound as a pale-yellow liquid (19.7 g, 69.7 mmol, 70%) 
1H NMR (500 MHz, CDCl3) dH 8.36 (1H, br s, NH), 7.37 (2H, d, J = 8.8 Hz, ArH), 6.91 (2H, d, J = 8.8 Hz, 
ArH), 5.27 (2H, s, ArCH2O), 3.80 (3H, s, MeOAr); 13C NMR (125 MHz, CDCl3) dC 162.6, 159.7, 129.7, 127.5, 
113.9, 91.5, 70.7, 55.3. 
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Trimethyl((3-methylbut-2-en-2-yl)oxy)silane – 207 
 
TMSCl (7.61 mL, 60.0 mmol) was added dropwise to a stirred solution of methyl isopropyl ketone (4.44 
mL, 50.0 mmol, dried over Na2SO4) and Et3N (16.7 mL, 120 mmol) in DMF (15 mL). The reaction mixture 
was heated at 120 °C for 90 h to obtain a dark brown solution. The reaction mixture was allowed to cool to 
r.t. and diluted with Et2O (160 mL). The mixture was washed with NaHCO3 (200 mL), the aqueous phase 
was extracted with Et2O (3 × 200 mL), and the combined organic fractions were rapidly washed with HCl 
(200 mL, 0.5 M), NaHCO3 (2 × 200 mL) and brine (200 mL). The organic phase was dried (Na2SO4) and 
the solvent removed under reduced pressure. Purification by distillation under reduced pressure (90 °C, 3 
mmHg) afforded the product as a colourless liquid (3.96 g, 25.0 mmol, 50%) as a 9:1 mixture of 
trimethyl((3-methylbut-2-en-2-yl)oxy)silane (207) and trimethyl((3-methylbut-1-en-2-yl)oxy)silane. 
1H NMR (500 MHz, CDCl3) dH 1.79 (3H, s, Me), 1.61 (3H, s, MeaMebC), 1.60 (3H, s, MeaMebC), 0.19 ppm 
(9H, s, SiMe3); 13C NMR (125 MHz, CDCl3) dC 140.1, 109.5, 18.8, 18.3, 17.6, 0.59. 
Data in agreement with that presented by Fleming112 
((1-ethoxy-2-methylprop-1-en-1-yl)oxy)trimethylsilane – 217 
 
nBuLi (37.5 mL, 60.0 mmol, 1.6 M in hexanes) was added dropwise to a solution of iPr2NH (8.47 mL, 60.0 
mmol) in THF (30 mL) at 0 °C. The solution was stirred at 0 °C for 2 h before cooling to –78 °C. Ethyl 
isobutyrate (6.72 mL, 50.0 mmol) was added dropwise to the mixture over 10 min, and the reaction was 
stirred for an additional 1 h before the addition of TMSCl (7.62 mL, 60.0 mmol). The reaction was warmed 
to r.t. and stirred for 16 h before quenching with a mixture of ice (20 g) and Et2O (20 mL). The layers were 
separated and the aqueous phase was extracted with Et2O (3 × 25 mL). The combined organic phases were 
washed with brine (50 mL), dried (MgSO4) and the solvent removed under reduced pressure to afford a 
pale-yellow liquid. Purification by distillation under reduced pressure (68 °C, 25 mmHg) afforded the silyl 







1H NMR (500 MHz, CDCl3) dH 3.76 (2H, q, J = 7.1 Hz, CH2O), 1.57 (3H, s, MeaMebC), 1.52 (3H, s, MeaMebC), 
1.20 (3H, t, J = 7.1 Hz, MeCH2O), 0.19 ppm (9H, s, SiMe3); 13C NMR (125 MHz, CDCl3) dC 147.0, 91.8, 64.3, 
16.9, 16.3, 14.8, 0.0. 
Data in agreement with that presented by Inamoto120 
 
(+)-Diisopinocampheyl (DIP) boron chloride185 
 
ClBH2·SMe2 (0.50 mL, 4.80 mmol) was added dropwise to a stirred solution of freshly distilled (–)-a-pinene 
(1.60 g, 8.36 mmol) in Et2O (2.2 mL) at –10 °C. The reaction was slowly warmed to 10 °C and stirred for 16 
h to afford a colourless ethereal solution of (+)-DIPCl (ca. 1.0 M).  
(–)-DIPCl was analogously prepared using the opposite enantiomer of a-pinene. 
 
1,4-Dimethyl-1,2,4-triazolium iodide - 290 
 
MeI (2.70 mL, 43.5 mmol) was added to a stirred suspension of 1,2,4-triazole (1.00 g, 14.5 mmol), K2CO3 
(3.00 g, 21.7 mmol) in acetonitrile (8 mL) and methanol (2 mL). The mixture was stirred at 40 °C for 72 h 
before being filtered, washing the white solid with CH2Cl2 (3 × 5 mL). The solvent was removed under 
reduced pressure to afford the product as a white solid (3.21 g, 14.3 mmol, 99%). 
1H NMR (500 MHz, DMSO-d6) dH 10.0 (1H, s, H2), 9.11 (1H, s, H4), 4.05 (3H, s, Me1), 3.89 (3H, s,  
Me3); 13C NMR (125 MHz, DMSO-d6) dC 145.2, 143.3, 38.7, 34.1.  
Data in agreement with that presented by Pan186 
Anhydrous cerium trichloride187 
CeCl3·7H2O was stirred in vacuo (0.05 Torr), gradually heating to 70 °C over 3 h. The mixture was stirred 
at 80 °C for 16 h, after which the mixture was gradually heated to 140 °C over 8 h. The mixture was then 
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TMSCH2MgCl147 
Mg turnings (1.17 g, 48.0 mmol) and 1,2-dibromoethane (0.17 mL, 2.00 mmol) were added to a solution of 
TMSCH2Cl (1.12 mL, 8.00 mmol) in THF (7 mL) at r.t.. The solution was heated to initiate a gentle reflux, 
to which a solution of TMSCH2Cl (4.46 mL, 32.0 mmol) in THF (28 mL) was added dropwise over 30 min 
to maintain a steady reflux. After the addition was completed, the solution was stirred at 45 °C for 1 h to 
afford a black solution of the Grignard reagent. This was titrated against menthol/1,10-phenanthroline to 
determine a final concentration of 1.40 M. 
(-)-Methoxydiisopinocampheylborane (Ipc2BOMe)188 
 
BH3·SMe2 (5.25 mL, 52.5 mmol) was added to a stirred solution of (+)-a-pinene (20.0 mL, 126 mmol) in 
THF (16 mL) at r.t.. The stirring was stopped, and the solution was allowed to stand at r.t. for 16 h, during 
which a crystalline precipitate formed. The mixture was cooled to 0 °C for 1 h and the supernatant was 
removed via cannulation. The white solid was washed with anhydrous pentane (3 ́  20 mL, dried over CaH2) 
and dried in vacuo to afford Ipc2BH as a white crystalline solid. Et2O (50 mL) was added to the borane and 
the suspension was cooled to 0 °C. MeOH (2.55 mL, 63.0 mmol) was added dropwise to the stirred solution 
over 30 min via a syringe pump, during which a clear homogenous solution formed. The solvent and excess 
MeOH was distilled off at 40 °C and dried in vacuo to afford the product as a viscous clear oil that solidified 
into a crystalline solid upon standing (14.5 g, 45.8 mmol, 87% over two steps). The enantiomeric reagent 
was prepared analogously using (-)-a-pinene (20.0 mL, 126 mmol) to afford (+)-Ipc2BOMe as a viscous oil 
(10.8 g, 34.2 mmol, 65% over two steps). 
DMAP Hydrochloride (DMAP·HCl) 
HCl (4.1 mL, 8.20 mmol, 2 M in Et2O) was added dropwise to a stirred solution of DMAP (1.00 g, 8.20 
mmol) in THF (15 mL) at 0 °C. The resulting white suspension was stirred for 10 min before filtering. The 
filtered precipitate was washed with Et2O (30 mL) and dried in vacuo to afford DMAP hydrochloride salt 







8.4. Experimental Procedures for Part II – Hemicalide 
8.4.1. Synthesis of the C16-C28 fragment 
PMB ether 104 
 
To a stirred solution of PMBTCA (17.9 g, 63.4 mmol) in CH2Cl2 (80 mL) was added (R)-methyl 3-hydroxy-
2-methylpropionate (5.00 g, 42.3 mmol) and PPTS (1.06 g, 4.23 mmol). The solution was stirred for 16 h at 
r.t., during which the solution turned cloudy white. The reaction mixture was quenched with NaHCO3 (70 
mL), the layers separated and the aqueous phase extracted with CH2Cl2 (3 × 20 mL). The combined organic 
phases were washed with brine (100 mL), dried (MgSO4) and the solvent removed under reduced pressure 
to afford a crude oil, which was triturated with PE 40-60 to facilitate the formation of a white precipitate. 
The precipitate was removed by filtration, the filtrate collected and the solvent removed in vacuo. 
Purification by flash column chromatography (EtOAc/PE 40-60: 8%  20%) afforded the product 104 as 
a pale yellow liquid (10.0 g, 42.3 mmol, 99%). 
Rf (EtOAc/PE 40-60: 20%) = 0.52; 1H NMR (500 MHz, CDCl3) dH 7.23 (2H, d, J = 8.6 Hz, ArH), 6.87 (2H, 
d, J = 8.7 Hz, ArH), 4.45 (2H, s, ArCH2O), 3.80 (3H, s, ArOMe), 3.69 (3H, s, CO2Me), 3.62 (1H, dd, J = 9.1, 
7.3 Hz, H19a), 3.45 (1H, dd, J = 9.2, 5.9, H19b), 2.77 (1H, sext, J = 7.1 Hz, H18), 1.16 (3H, d, J = 7.1 Hz, 
Me18). 
Data in agreement with that presented by Paterson189 
Alcohol 105 
 
LiAlH4 (2.00 g, 52.5 mmol) was added portion-wise to a stirred solution of PMB ether 104 (10.7 g, 47.7 
mmol) in THF (120 mL) at 0 °C. The reaction was stirred at 0 °C for 3 h before quenching with water (25 
mL) and aqueous NaOH (6 mL, 1 M in H2O). The layers were separated and the aqueous phase was 
extracted with Et2O (3 × 15 mL). The combined organic phases were washed with brine (120 mL), dried 
(MgSO4) and the solvent removed under reduced pressure. Purification by flash column chromatography 
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Rf (EtOAc/PE 40-60: 30%) = 0.21; 1H NMR (400 MHz, CDCl3) dH 7.24 (2H, d, J = 9.0 Hz, ArH), 6.88 (2H, 
d, J = 8.9 Hz, ArH), 4.45 (2H, s, ArCH2), 3.81 (3H, s, ArOMe), 3.64-3.55 (2H, m, H17a, OH), 3.53 (1H, dd, 
J = 9.0, 4.3 Hz, H19a), 3.39 (1H, dd, J = 9.0, 8.0 Hz, H19b), 2.56 (1H, dd, J = 7.1, 4.8 Hz, H17b), 2.11-2.02 
(1H, m, H18), 0.87 (3H, d, J = 7.0 Hz, Me18). 
Data in agreement with the enantiomeric compound presented by Janssen190 
Vinyl dibromide ent-55 
 
DMSO (10.1 mL, 142 mmol) was added dropwise to a stirred solution of (COCl)2 (6.12 mL, 71.3 mmol) in 
CH2Cl2 (80 mL) at –78 °C. The solution was stirred for 15 min before the addition of a solution of alcohol 
105 (5.00 g, 23.8 mmol) in CH2Cl2 (15 mL + 5 mL wash) via cannula. The reaction was stirred at –78 °C for 
45 min, after which Et3N (40.0 mL, 285 mmol) was added dropwise and the resulting pale-yellow solution 
was allowed to warm to r.t. over 30 min. The reaction was quenched by the addition of NH4Cl solution (60 
mL), the layers separated and the aqueous phase extracted with CH2Cl2 (3 × 20 mL). The combined organic 
phases were washed with brine (2 × 20 mL), dried (MgSO4) and concentrated to ca. 20 mL under reduced 
pressure to yield a solution of the crude aldehyde 106 that was directly used in the subsequent step without 
further purification. 
PPh3 (24.9 g, 95.1 mmol) was added portion-wise to a stirred solution of CBr4 (15.8 g, 47.5 mmol) in CH2Cl2 
(100 mL). The resulting orange brown solution was stirred for 5 min before cooling to –78 °C. A solution 
of the crude aldehyde 106 (2.97 g, 14.3 mmol) in CH2Cl2 (20 mL + 5 mL wash) was added via cannula. The 
mixture was stirred for 1 h, during which it was allowed to warm to 0 °C before being quenched with a 
solution of NH4Cl (100 mL). The layers were separated and the aqueous phase extracted with CH2Cl2 (3 × 
30 mL). The combined organic phases were washed with brine (100 mL), dried (MgSO4) and the solvent 
removed under reduced pressure. Purification by flash column chromatography (EtOAc/PE 40-60: 5%  
25%) afforded the product ent-55 as an orange liquid (6.93 g, 19.0 mmol, 80% over 2 steps) 
Rf (EtOAc/PE 40-60: 50%) = 0.73; 1H NMR (400 MHz, CDCl3) dH 7.25 (2H, d, J = 8.8 Hz, ArH), 6.89 (2H, 
d, J = 8.8 Hz, ArH), 6.30 (1H, d, J = 9.2 Hz, H17), 4.46 (1H, d, J = 11.8 Hz, ArCHaHbO), 4.43 (1H, d, J = 11.8 
Hz, ArCHaHbO), 3.81 (3H, s, ArOMe), 3.36 (1H, dd, J = 9.3, 6.3 Hz, H19a), 3.33 (1H, dd, J = 9.3, 6.0 Hz, 
H19b), 2.82-2.72 (1H, m, H18), 1.05 (3H, d, J = 6.5 Hz, Me18; [α]D
20 +16.7° (c 1.0, CHCl3). 










nBuLi (23 mL, 19.23 mmol, 1.6 M in hexanes) was added dropwise to a stirred solution of vinyl dibromide 
55 (3.50 g, 9.61 mmol) in THF (50 mL) at –78 °C. The solution was stirred at –78 °C for 1 h before the 
dropwise addition of MeI (2.70 mL, 28.8 mmol). The reaction was stirred at –78 °C for a further 10 min 
before warming to 0 °C. The reaction was stirred for a further stirred for 1 h before quenching with a 
solution of NH4Cl. The layers were separated and the aqueous phase was extracted with Et2O (3 × 40 mL). 
The combined organic phases were washed with brine (100 mL), dried (MgSO4) and the solvent removed 
under reduced pressure. Purification by flash column chromatography (EtOAc/PE 40-60: 10%) afforded 
the product 107 as a pale-yellow liquid (2.05 g, 9.39 mmol, 98%). 
Rf (EtOAc/PE 40-60: 20%) = 0.66; 1H NMR (400 MHz, CDCl3) dH 7.27 (2H, d, J = 8.2 Hz, ArH), 6.88 (2H, 
d, J = 8.7 Hz, ArH), 4.51 (1H, d, J = 11.7 Hz, ArCHaHbO), 4.47 (1H, d, J = 11.8 Hz, ArCHaHbO), 3.81 (3H, 
s, ArOMe), 3.45 (1H, dd, J = 9.0, 6.1 Hz, H19a), 3.29 (1H, dd, J = 9.0, 7.5 Hz, H19b), 2.71-2.62 (1H, m, H18), 
1.79 (3H, d, J = 2.4 Hz, Me16), 1.16 (3H, d, J = 6.9 Hz, Me18). 
Data in agreement with the enantiomeric compound presented by Smith191 
Vinyl iodide 108 
 
The following reaction was carried out in darkness due to the light sensitivity of Cp2Zr(H)Cl. 
DIBAL (9.16 mL, 9.16 mmol, 1 M in hexanes) was added dropwise to a stirred suspension of Cp2ZrCl2 
(2.68 g, 9.16 mmol) in THF (13 mL) at 0 °C. The mixture was stirred at 0 °C for 30 min. A solution of alkyne 
107 (1.00 g, 4.58 mmol) in THF (10 mL + 2 mL wash) was then added via cannula to the reaction mixture, 
after which the stirred mixture was allowed to warm to r.t. over 16 h. The reaction was cooled to –78 °C and 
a solution of I2 (3.49 g, 13.7 mmol) in THF (10 mL + 5 mL wash) was added via cannula. The reaction was 
stirred for 10 min at –78 °C before being quenched with a solution of aqueous HCl (20 mL, 1 M in H2O) 
and diluted with Et2O (30 mL). The layers were separated and the aqueous phase was extracted with Et2O 
(3 × 20 mL). The combined organic phases were successively washed with Na2S2O3 (70 mL) and brine (100 
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chromatography (EtOAc/PE 40-60: 5%) afforded the product 108 as a colourless liquid (865 mg, 2.50 mmol, 
54%). 
Rf (EtOAc/PE 40-60: 20%) = 0.66; 1H NMR (400 MHz, CDCl3) dH 7.24 (2H, d, J = 8.7 Hz, ArH), 6.88 (2H, 
d, J = 8.7 Hz, ArH), 5.99 (1H, dq, J = 9.5, 1.5 Hz, H17), 4.43 (2H, s, ArCH2O), 3.81 (3H, s, ArOMe), 3.28 
(1H, dd, J = 9.1, 6.7 Hz, H19a), 3.25 (1H, dd, J = 9.2, 6.7 Hz, H19b), 2.77-2.66 (1H, m, H18), 2.39 (3H, d, J 
= 1.5 Hz, Me16), 0.98 (3H, d, J = 6.8 Hz, Me18). 
Data in agreement with the enantiomeric compound presented by Paterson43 
Alcohol 110 
 
DDQ (393 mg, 1.73 mmol) was added to a stirred solution of the PMB-protected vinyl iodide 108 (400 mg, 
1.16 mmol) in CH2Cl2 (40 mL). The reaction mixture was allowed to stir at r.t. for 1 h before quenching 
with a solution of NaHCO3 (30 mL). The layers were separated and the aqueous phase extracted with 
CH2Cl2 (3 × 20 mL). The combined organic phases were washed with brine (40 mL), dried (MgSO4) and 
the solvent removed under reduced pressure. Purification by flash column chromatography (Et2O/PE 30-
40: 0%  25%) afforded the product 110 as a colourless liquid (244 mg, 1.08 mmol, 93%). 
Rf (EtOAc/PE 40-60: 20%) = 0.66; 1H NMR (400 MHz, CDCl3): dH 5.98 (1H, dq, J = 9.8, 1.5 Hz, H17), 3.51-
3.39 (2H, m, H19), 2.72-2.60 (1H, m, H18), 2.43 (3H, d, J = 1.5 Hz, Me16), 1.41 (1H, dd, J = 7.7, 5.1 Hz, 
OH), 0.97 (3H, d, J = 6.8 Hz, Me18). 
Data in agreement with the enantiomeric compound presented by MacGregor43 
Methyl ketone ent-48 
 
MeMgBr (7.06 mL, 21.2 mmol, 3 M in Et2O) was added dropwise to a stirred solution of Weinreb amide 
111 (2.83 g, 10.6 mmol) in Et2O (20 mL) at 0 °C. The reaction mixture was stirred at 0 °C for 2 h before 
quenching with NH4Cl solution (15 mL). The layers were separated and the aqueous phase extracted with 
Et2O (3 × 20 mL). The combined organic phases were washed with brine (20 mL), dried (MgSO4) and the 
solvent removed under reduced pressure. Purification by flash column chromatography (EtOAc/PE 40-60: 












Rf (EtOAc/PE 40-60: 20%) = 0.64; 1H NMR (400 MHz, CDCl3) dH 7.23 (2H, d, J = 8.7 Hz, ArH), 6.87 (2H, 
d, J = 8.7 Hz, ArH), 4.45 (1H, d, J = 11.6Hz, ArCHaHbO), 4.41 (1H, d, J = 11.7 Hz, ArCHaHbO), 3.80 (3H, s, 
ArOMe), 3.59 (1H, dd, J = 9.2, 7.5 Hz, H25a), 3.45 (1H, dd, J = 9.2, 5.5 Hz, H25b), 2.83 (1H, sext, J = 7.2, 
H24), 2.17 (3H, s, H20), 1.08 (3H, d, J = 7.1 Hz, Me24). 
Data in agreement with that presented by Paterson189 
Aldol adduct ent-50 
 
Dess-Martin Periodinane (1.01 g, 2.37 mmol) was added to a stirred suspension of alcohol 110 (134 mg, 
0.593 mmol) and NaHCO3 (597 mg, 7.11 mmol) in wet CH2Cl2 (10.0 mL). The reaction mixture was stirred 
at r.t. until TLC monitoring indicated full consumption of the starting material (ca. 1 h). The reaction 
mixture was quenched by the addition of NaHCO3 (5 mL) and Na2S2O3 (5 mL) and the mixture stirred at 
r.t. for 30 min. The layers were separated and the aqueous phase was extracted with CH2Cl2 (3 × 5 mL). The 
combined organic phases were dried (Na2SO4) and the solution concentrated under reduced pressure to ca. 
8 mL. The solution of the crude aldehyde ent-49 was filtered over a plug of SiO2, dried over 4 Å MS and 
directly used in the subsequent step without further purification. 
A solution of ketone ent-48 (148 mg, 0.711 mmol, dried over CaH2) in Et2O (3 mL + 2 mL wash) was added 
via cannula to a stirred solution of Et3N (133 µL, 0.948 mmol), (+)-DIPCl (652 µL, 0.652 mmol, ca. 1 M in 
Et2O) in Et2O (4 mL) at –10 °C to immediately form a white suspension. The mixture was stirred at –10 °C 
for 1 h before cooling to –78 °C. A solution of the crude aldehyde ent-49 in CH2Cl2 (8 mL + 4 mL wash) was 
added via cannula to the reaction mixture, during which the mixture turned pale yellow. The reaction 
mixture was stirred at –78 °C for 5 h before warming slowly to –20 °C for 16 h. The reaction mixture was 
quenched at –20 °C by the addition of MeOH (3 mL), pH 7 buffer solution (3 mL) and H2O2 (5 mL) and 
warmed to r.t.. The layers were separated, and the aqueous phase extracted with Et2O (3 × 10 mL). The 
combined organic extracts were washed with brine (15 mL), dried (MgSO4) and the solvent removed under 
reduced pressure. Purification by flash chromatography (EtOAc/PE 40-60: 5%   25%) afforded the 
product ent-50 as a pale yellow oil (143 mg, 0.255 mmol, 53% over two steps). 
Rf (EtOAc/PE 40-60: 30%) = 0.39; 1H NMR (500 MHz, CDCl3) dH 7.21 (2H, d, J = 8.5 Hz, ArH), 6.88 (2H, 
d, J = 8.6 Hz, ArH), 5.96 (1H, dq, J = 10.2, 1.3 Hz, H17), 4.42 (2H, s, ArCH2O), 3.81 (3H, s, ArOMe), 3.80 
(1H, br s, H19), 3.56 (1H, t, J = 8.8 Hz, H25a), 3.45 (1H, dd, J = 9.1, 5.0 Hz, H25b), 3.16 (1H, br s, OH), 
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2.42 (1H, m, H18), 2.38 (3H, d, J = 1.4 Hz, Me16), 1.05 (3H, d, J = 7.0 Hz, Me24), 1.01 (3H, d, J = 6.8 Hz, 
Me18); [α]D
20 –38.9° (c 0.5, CHCl3). 
Data in agreement with the enantiomeric compound presented by MacGregor 43 
(S)-Mosher ester 113 
 
DCC (3.5 µL, 33.6 µmol, 1 M in CH2Cl2) was added to a stirred solution of ent-50 (5.9 mg, 13.2 µmol), (S)-
α-methoxy-α-trifluoromethylphenylacetic acid (MTPA) (7.9 mg, 33.6 µmol) and DMAP (one crystal) in 
CH2Cl2 (300 µL). The mixture was stirred for 2 days at r.t., during which a white precipitate formed. The 
mixture was filtered through cotton wool and the filtrate reduced to dryness. Purification by flash 
chromatography (EtOAc/PE 40-60: 15%) afforded the product 113 as a pale-yellow oil (4.0 mg, 6.03 µmol, 
45%). 
Rf (EtOAc/PE 40-60: 30%) = 0.52; 1H NMR (400 MHz, CDCl3): dH 7.49 (2H, d, J = 6.6 Hz, MTPA-ArH), 
7.43-7.37 (3H, m, MTPA-ArH), 7.18 (2H, d, J = 8.7 Hz, PMB-ArH), 6.86 (2H, d, J = 8.7 Hz, PMB-ArH), 
5.97 (1H, dq, J = 8.1, 1.5 Hz, H17), 5.42 (1H, dt, J = 6.8, 5.3 Hz, H19), 4.41 (1H, d, J = 5.0 Hz, ArCHaCHbO), 
4.37 (1H, d, J = 5.0 Hz, ArCHaCHbO), 3.79 (3H, s, ArOMe), 3.49 (1H, dd, J = 9.0, 8.3 Hz, H25a), 3.47 (3H, 
s, MTPA-OMe), 3.41 (1H, dd, J = 9.0, 4.1 Hz, H25b), 2.91–2.85 (1H, m, H18), 2.84 (1H, dd, J = 18.1, 7.0 Hz, 
H20a), 2.74 (1H, dd, J = 18.1, 5.5 Hz, H20b), 2.79-2.72 (1H, m, H24), 2.39 (3H, d, J = 1.5 Hz, Me16), 0.93 
(3H, d, J = 7.0 Hz, Me18), 0.91 (3H, d, J = 7.0 Hz, Me24). 
(R)-Mosher ester 114 
 
DCC (3.5 µL, 33.6 µmol, 1 M in CH2Cl2) was added to a stirred solution of ent-50 (6.0 mg, 13.4 µmol), (R)-
α-methoxy-α-trifluoromethylphenylacetic acid (MTPA) (7.9 mg, 33.6 µmol) and DMAP (one crystal) in 
CH2Cl2 (300 µL). The mixture was stirred for 2 days at r.t., during which a white precipitate formed. The 



























chromatography (EtOAc/PE 40-60: 15%) afforded the product 114 as a pale yellow oil (9.0 mg, 13.4 µmol, 
99%). 
Rf (EtOAc/PE 40-60: 30%) = 0.52; 1H NMR (500 MHz, CDCl3): dH 7.51-7.48 (2H, m, MTPA-ArH), 7.41-
7.38 (3H, m, MTPA-ArH), 7.20 (2H, d, J = 8.7 Hz, PMB-ArH), 6.86 (2H, d, J = 8.7 Hz, PMB-ArH), 5.86 
(1H, dq, J = 10.0, 1.5 Hz, H17), 5.42 (1H, dt, J = 5.7, 0.6 Hz, H19), 4.41 (1H, d, J = 11.5 Hz, ArCHaCHbO), 
4.37 (1H, d, J = 11.5 Hz, ArCHaCHbO), 3.80 (3H, s, ArOMe), 3.52 (1H, d, J = 9.0, 8.4 Hz, H25a), 3.49 (3H, 
s, MTPA-OMe), 3.44 (1H, dd, J = 9.0, 5.1 Hz, H25b), 2.84-2.79 (4H, m, H18, 20, 24), 2.32 (3H, d, J = 1.6 Hz, 
Me16), 0.99 (3H, d, J = 7.0 Hz, Me18), 0.87 (3H, d, J = 6.9 Hz, Me24). 
TBS ether 115 
 
2,6-Lutidine (1.97 mL, 17.0 mmol) was added to a stirred solution of alcohol ent-50 (3.80 g, 8.51 mmol) in 
CH2Cl2 (50 mL). The reaction mixture was cooled to –78 °C and stirred for 5 min, before the dropwise 
addition of TBSOTf (2.93 mL, 12.8 mmol). The mixture was stirred at –78 °C for 45 min. The reaction 
mixture was quenched with MeOH (1 mL), followed by NaHCO3 (30 mL). Upon warming to r.t., the layers 
were separated and the aqueous phase extracted with CH2Cl2 (3 × 20 mL). The combined organic phases 
were washed with brine, dried (MgSO4) and the solvent removed under reduced pressure to afford the 
product 115 as a colourless oil (4.76 g, 8.51 mmol, 99%), which is used in the next step without further 
purification. A small sample was purified by flash column chromatography (EtOAc/PE 40-60: 10%) for 
analytical purposes. 
Rf (EtOAc/PE 40-60: 30%) = 0.74; 1H NMR (500 MHz, CDCl3): dH 7.21 (2H, d, J = 8.6 Hz, ArH), 6.86 (2H, 
d, J = 8.5 Hz, ArH), 5.96 (1H, dq, J = 9.8, 1.4 Hz, H17), 4.43 (1H, d, J = 11.6 Hz, ArCHaHb), 4.39 (1H, d, J = 
11.6 Hz, ArCHaHb), 4.13 (1H, dt, J = 5.8, 4.3 Hz, H19), 3.80 (3H, s, ArOMe), 3.57 (1H, dd, J = 9.3, 7.9 Hz, 
H25a), 3.44 (1H, dd, J = 9.1, 5.3 Hz, H25b), 2.79 (1H, dqn, J = 7.6, 5.4 Hz, H24), 2.67 (1H, dd, J = 17.7, 6.2 
Hz, H20a), 2.60 (1H, dd, J = 17.7, 5.7 Hz, H20b), 2.53-2.46 (1H, m, H18), 2.39 (3H, d, J = 1.4 Hz, Me16), 
1.05 (3H, d, J = 6.9 Hz, Me24), 0.89 (3H, d, J = 6.9 Hz, Me18), 0.86 (9H, s, SitBuMe2), 0.07 (3H, s, 
SitBuMeaMeb), -0.02 (3H, s, SitBuMeaMeb). 
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Ester 116 
 
nBuLi (42.8 mL, 68.5 mmol, 1.6 M in hexanes) was added dropwise to a stirred solution of iPr2NH (12.0 
mL, 85.6 mmol) in THF (18 mL) at 0 °C. The pale-yellow solution was stirred for 30 min at 0 °C before 
cooling to -78 °C. EtOAc (6.96 mL, 71.3 mmol) was added dropwise to the solution, and the mixture was 
stirred at -78 °C for 1 h to give a ca. 1.0 M solution of the lithium enolate. 
The lithium enolate solution (36.0 mL, 36.0 mmol, 1.0 M in THF) was added dropwise to a stirred solution 
of TBS ether 115 (4.00 g, 7.12 mmol) in THF (36 mL) at –78 °C. The resulting solution was stirred at –78 °C 
for 3 h before being quenched with a solution of NaHCO3 (50 mL) and warmed to r.t.. The mixture was 
diluted with Et2O (50 mL), and the phases separated. The aqueous phase was extracted with Et2O (3 × 25 
mL). The combined organic phases were washed with brine, dried (MgSO4) and the solvent removed under 
reduced pressure to afford the product 116 as a colourless oil (4.55 g, 7.01 mmol, 98%) as an inconsequential 
mixture of diastereomers (3.5:1 dr). A small sample was purified by flash column chromatography 
(EtOAc/PE 40-60: 4%) for analytical purposes. 
Major isomer: Rf (EtOAc/PE 40-60: 5%) = 0.29; 1H NMR (500 MHz, CDCl3) dH 7.24 (2H, d, J = 8.7 Hz, 
ArH), 6.88 (2H, d, J = 8.7 Hz, ArH), 6.18 (1H, dq, J = 9.5, 1.4 Hz, H17), 4.45 (1H, d, J = 11.5 Hz, ArCHaHbO), 
4.39 (1H, d, J = 11.5 Hz, ArCHaHbO), 4.16-4.09 (2H, m, CH3CH2O), 3.99-3.95 (2H, m, H19, OH), 3.81 (3H, 
s, OMe), 3.60 (1H, dd, J = 9.2, 4.9 Hz, H25a), 3.39 (1H, dd, J = 9.2, 6.3 Hz, H25b), 2.70 (1H, dqd, J = 9.6, 6.8, 
3.2 Hz, H18), 2.58 (1H, d, J = 14.5 Hz, H22a), 2.53 (1H, d, J = 15.3 Hz, H22b), 2.38 (3H, d, J = 1.3 Hz, Me16), 
2.09-2.04 (1H, m, H24), 1.79 (1H, dd, J = 14.7, 5.8 Hz, H20a), 1.68 (1H, dd, J = 14.7, 5.8 Hz, H20b), 1.24 
(3H, t, J = 7.2 Hz, CH3CH2O), 1.00 (3H, d, J = 6.9 Hz, Me24), 0.93 (3H, d, J = 6.8 Hz, Me18), 0.88 (9H, s, 
SitBuMe2), 0.08 (3H, s, SitBuMeaMeb), 0.07 (3H, s, SitBuMeaMeb). 















Lactone 117 [NL-3-196] 
 
TsOH·H2O (668 mg, 3.52 mmol) was added to a stirred solution of TBS ether 116 (5.70 g, 8.79 mmol) in 
MeOH (100 mL) at r.t.. The reaction mixture was stirred at r.t. for 16 h before being quenched with 
NaHCO3 (100 mL). The mixture was extracted with EtOAc (4 ´ 30 mL), and the combined organic phases 
were washed with brine, dried (MgSO4) and the solvent removed under reduced pressure. Purification by 
flash column chromatography (EtOAc/PE 40-60: 15%  30%) afforded the product 117 as a colourless oil 
(3.56 g, 7.93 mmol, 90%) as an inconsequential mixture of diastereomers (3.5:1 dr).  
Major isomer: Rf (EtOAc/PE 40-60: 40%) = 0.35; 1H NMR (500 MHz, CDCl3) dH 7.22 (2H, d, J = 8.7 Hz, 
ArH), 6.90 (2H, d, J = 8.7 Hz, ArH), 5.98 (1H, dq, J = 10.2, 1.5 Hz, H17), 4.48 (1H, d, J = 11.5 Hz, ArCHaHbO), 
4.41 (1H, d, J = 11.5 Hz, ArCHaHbO), 3.88 (1H, ddd, J = 11.4, 7.8, 4.4 Hz, H19), 3.81 (3H, s, OMe), 3.70 (1H, 
dd, J = 9.7, 3.5 Hz, H25a), 3.45 (1H, dd, J = 9.7, 5.0 Hz, H25b), 2.69 (1H, dqd, J = 9.7, 6.9, 3.6 Hz, H18), 2.58 
(2H, s, H22), 2.40 (3H, d, J = 1.5 Hz, Me16),  2.00 (1H, dd, J = 14.5, 4.6 Hz, H20a), 1.85-1.77 (1H, m, H24), 
1.65 (1H, dd, J = 14.5, 11.1 Hz, H20b), 1.09 (3H, d, J = 6.6 Hz, Me18), 1.04 (3H, d, J = 6.9 Hz, Me24). 
Data in agreement with the enantiomeric compound presented by MacGregor43 
Enoate ent-51 [NL-6-489] 
 
To a stirred solution of lactone 117 (3.56 g, 7.29 mmol) in Ac2O (7.4 mL), pyridine (36 mL) and benzene 
(36 mL) was added DMAP (889 mg, 7.28 mmol) at r.t.. The reaction mixture was refluxed for 16 h before 
carefully quenching with NaHCO3 (25 mL) and diluting with CH2Cl2 (25 mL). The layers were separated, 
and the aqueous phase was extracted with CH2Cl2 (3 ´ 25 mL). The combined organic phases were washed 
with citric acid (10% w/v in H2O), brine, dried (MgSO4) and the solvent removed under reduced pressure. 
Purification by flash column chromatography (EtOAc/PE 40-60: 20%) afforded the product ent-51 as a 
pale-yellow oil (3.07 g, 6.53 mmol, 89%).  
Rf (EtOAc/PE 40-60: 30%) = 0.79; 1H NMR (500 MHz, CDCl3) dH 7.22 (2H, d, J = 8.7 Hz, ArH), 6.89 (2H, 
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ArCHaHbO), 4.39 (1H, d, J = 11.6 Hz, ArCHaHbO), 4.06 (1H, ddd, J = 11.2, 7.1, 4.3 Hz, H19), 3.81 (3H, s, 
OMe), 3.45 (1H, dd, J = 9.2, 5.4 Hz, H25a), 3.41 (1H, dd, J = 9.2, 7.5 Hz, H25b), 2.71 (1H, dq, J = 10.1, 6.9 
Hz, H18), 2.62 (1H, m, H24), 2.40 (3H, d, J = 1.7 Hz, Me16), 2.26 (1H, dd, J = 17.7, 4.5 Hz, H20a), 1.68 (1H, 
ddd, J = 17.6, 11.5, 1.4 Hz, H20b), 1.10 (3H, d, J = 7.0 Hz, Me24), 1.09 (3H, d, J = 7.0 Hz, Me18).  
Data in agreement with the enantiomeric compound presented by MacGregor43 
Dihydroxylactone ent-52 [NL-6-490] 
 
Citric acid (893 mg, 4.25 mmol), K2OsO4·2H2O (16 mg, 42.5 µmol) and NMO (249 µL, 1.06 mmol, 50% 
w/w in H2O) were successively added to a stirred mixture of enoate ent-51 (1.00 g, 2.12 mmol) in THF (1.2 
mL), tBuOH (1.2 mL) and H2O (1.2 mL). The yellow-green solution was stirred for 5 h at r.t. before 
quenching with Na2SO3 (3 mL) and NaHCO3 (3 mL). The mixture was extracted with EtOAc (3 ´ 5 mL) 
and the combined organic phases were washed with brine, dried (Na2SO4) and the solvent removed under 
reduced pressure. Purification by flash column chromatography (EtOAc/PE 40-60: 20%) afforded the 
product ent-52 as a colourless oil (412 mg, 0.817 mmol, 79% brsm), as well as the recovered starting material 
(514 mg, 1.09 mmol).  
Rf (EtOAc/PE 40-60: 50%) = 0.50; 1H NMR (500 MHz, CDCl3) dH 7.23 (2H, d, J = 8.6 Hz, ArH), 6.88 (2H, 
d, J = 8.7 Hz, ArH), 6.02 (1H, dq, J = 10.1, 1.5 Hz, H17), 4.50 (1H, ddd, J = 11.5, 6.4, 3.5 Hz, H19), 4.43 (2H, 
s, ArCH2O), 4.19 (1H, d, J = 1.7 Hz, H22), 3.92 (1H, d, J = 1.4 Hz, OH22), 3.81 (3H, s, OMe), 3.67 (1H, dd, 
J = 10.0, 8.1 Hz, H25a), 2.72-2.58 (1H, m, H18), 2.38 (3H, d, J = 1.3 Hz, Me16), 2.09-2.04 (1H, m, H24), 1.79 
(1H, dd, J = 14.7, 5.8 Hz, H20a), 1.68 (1H, dd, J = 14.7, 5.8 Hz, H20b), 1.06 (3H, d, J = 6.7 Hz, Me24), 0.98 
(3H, d, J = 7.2 Hz, Me18). [α]D
20 +11.3 (c 0.2, CHCl3). 














Bis-TES ether 122 [NL-3-263, NL-4-311] 
 
TESOTf (280 µL, 1.55 mmol) was added dropwise to a stirred solution of diol ent-52 (130 mg, 258 µmol) 
and 2,6-lutidine (270 µL, 2.32 mmol) in CH2Cl2 (2.3 mL) at 0 °C. The reaction mixture was stirred at 0 °C 
for 24 h before quenching with MeOH (500 µL) followed by NaHCO3 (1 mL). The layers were separated 
and the aqueous phase was extracted with CH2Cl2 (3 ´ 2 mL). The combined organic phases were washed 
with brine, dried (MgSO4) and the solvent removed under reduced pressure. Purification by flash column 
chromatography (EtOAc/PE 40-60: 20%) afforded the product 122 as a colourless oil (178 mg, 243 µmol, 
94%). 
Rf (EtOAc/PE 40-60: 5%) = 0.48; 1H NMR (500 MHz, CDCl3) dH 7.24 (2H, d, J = 8.6 Hz, ArH), 6.92 (2H, d, 
J = 8.6 Hz, ArH), 6.03 (1H, dq, J = 10.0, 1.4 Hz, H17), 4.43 (1H, d, J = 11.6 Hz, ArCHaHbO), 4.38-4.34 (2H, 
m, H19, ArCHaHbO), 4.24 (1H, s, H22), 3.83 (3H, s, OMe), 3.35 (1H, dd, J = 9.5, 5.0 Hz, H25a), 3.26 (1H, 
dd, J = 9.5, 5.5 Hz, H25b), 2.67 (1H, dqn, J = 9.9, 6.7 Hz, H18), 2.38 (3H, d, J = 1.4 Hz, Me16), 2.38-2.32 
(1H, m, H24), 1.82 (1H, dd, J = 14.1, 3.4 Hz, H20a), 1.68 (1H, dd, J = 14.0, 11.6 Hz, H20b), 1.06 (3H, d, J = 
7.0 Hz, Me24), 1.01 (3H, d, J = 6.9 Hz, Me18), 0.97 (9H, t, J = 7.9 Hz, OSiCH2CH3), 0.92 (9H, t, J = 8.0 Hz, 
OSiCH2CH3), 0.76-0.60 (12H, m, OSiCH2CH3). 
Data in agreement with the enantiomeric compound presented by MacGregor43 
Alcohol 123 [NL-3-268] 
 
DDQ (28 mg, 123 µmol) was added to a stirred solution of PMB ether 122 (45 mg, 61.4 µmol) in CH2Cl2 
(900 µL) and pH 7 buffer solution (100 µL). The dark green solution was stirred for 1.5 h at r.t., to which 
the mixture turned orange-red. The reaction mixture was quenched by addition of NaHCO3 (1.5 mL), the 
layers separated and the aqueous phase extracted with CH2Cl2 (3 ´ 3 mL). The combined organic phases 
were washed with brine, dried (MgSO4) and the solvent removed under reduced pressure. Purification by 
flash column chromatography (EtOAc/PE 40-60: 20%) afforded the product 123 as a colourless oil (35 mg, 
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Rf (EtOAc/PE 40-60: 10%) = 0.19; 1H NMR (500 MHz, CDCl3) dH 6.00 (1H, dq, J = 9.9, 1.5 Hz, H17), 4.36 
(1H, ddd, J = 11.0, 6.6, 3.4 Hz, H19), 4.29 (1H, s, H22), 3.62-3.51 (2H, m, H25), 2.71-2.61 (1H, m, H18), 
2.41 (3H, d, J = 1.5 Hz, Me16), 2.31-2.22 (1H, m, H24), 1.85 (1H, dd, J = 14.1, 3.5 Hz, H20a), 1.57 (1H, dd, 
J = 14.7, 11.7 Hz, H20b), 1.06 (3H, d, J = 6.8 Hz, Me18), 1.03-0.98 (12H, m, Me24, OSiCH2CH3), 0.92 (9H, 
t, J = 7.9 Hz, OSiCH2CH3), 0.83-0.73 (6H, m, OSiCH2CH3), 0.71-0.58 (6H, m, OSiCH2CH3). 
Data in agreement with the enantiomeric compound presented by MacGregor43 
Enoate 127  [NL-3-269/270] 
 
Dess-Martin Periodinane (208 mg, 490 µmol) was added to a stirred suspension of alcohol 123 (60 mg, 97.9 
µmol) and NaHCO3 (82 mg, 979 µmol) in wet CH2Cl2 (1.0 mL). The reaction mixture was stirred at r.t. 
until TLC monitoring indicated full consumption of the starting material (ca. 1 h). The reaction mixture 
was quenched by the addition of NaHCO3 (1 mL) and Na2S2O3 (1 mL) and the mixture stirred at r.t. for 30 
min. The layers were separated and the aqueous phase was extracted with CH2Cl2 (3 × 2 mL). The combined 
organic phases were dried (MgSO4) and the solvent removed under reduced pressure. The crude aldehyde 
124 was directly used in the subsequent step without further purification. 
Dimethyl (2-oxopropyl)phosphonate (81.3 mg, 490 µmol) was added to a stirred suspension of oven-dried 
Ba(OH)2 (50.3 mg, 294 µmol) in THF (750 µL) at r.t.. After 30 min, the reaction mixture was cooled to 0 
°C, and a solution of the crude aldehyde 124 (60 mg, 97.9 µmol) in THF (400 µL) and H2O (10 µL) was 
added via cannula (400 µL wash). The reaction mixture was stirred at 0 °C for 30 min, warmed to r.t. over 
16 h before being quenched with NH4Cl (1 mL) and diluted with CH2Cl2 (5 mL). The layers were separated 
and the aqueous phase extracted with CH2Cl2 (3 ´ 2 mL). The combined organic phases were washed with 
brine, dried (MgSO4) and the solvent removed under reduced pressure. Purification by flash column 
chromatography (EtOAc/PE 40-60: 5% ® 10%) afforded the product 127 as a colourless oil (49 mg, 75 
mmol, 77% over two steps). 
Rf (EtOAc/PE 40-60: 20%) = 0.52; 1H NMR (500 MHz, CDCl3) dH 6.65 (1H, dd, J = 15.8, 8.4 Hz, H25), 6.23 
(1H, d, J = 15.8 Hz, H26), 5.98 (1H, dq, J = 9.9, 1.4 Hz, H17), 4.35 (1H, ddd, J = 10.9, 7.5, 4.0 Hz, H19), 3.98 
(1H, s, H22), 3.02-2.91 (1H, m, H24), 2.70-2.60 (1H, m, H18), 2.41 (3H, d, J = 1.4 Hz, Me16), 2.26 (3H, s, 
H28), 1.89 (1H, dd, J = 13.7, 4.0 Hz, H20a), 1.40 (1H, dd, J = 13.7, 11.7 Hz, H20b), 1.10 (3H, d, J = 7.0 Hz, 
Me24), 1.07 (3H, d, J = 6.8 Hz, Me18), 1.00 (9H, t, J = 7.9 Hz, OSiCH2CH3), 0.93 (9H, t, J = 7.9 Hz, 














Data in agreement with the enantiomeric compound presented by MacGregor43 
Ketone ent-53 [NL-4-315] 
 
To a stirred solution of enone 127 (100 mg, 0.154 mmol) in toluene (220 µL) was added a solution of the 
Stryker’s reagent (6.15 mL, 0.154 mmol, 0.025 M solution w.r.t Cu) and tBuOH (20 µL). The red solution 
was stirred at r.t. for 2.5 h before diluting with PE 40-60 (5 mL) and vigorously stirred in air for 2 h. The 
resulting amber solution was filtered over silica to afford a colourless filtrate. The solvent was removed 
under reduced pressure and the crude was purified by flash column chromatography (EtOAc/PE 40-60: 5% 
 10%) to afford the product ent-53 as a colourless oil (71.2 mg, 0.168 mmol, 70%).  
Rf (EtOAc/PE 40-60: 5%) = 0.36; 1H NMR (500 MHz, CDCl3) dH 5.98 (1H, dq, J = 10.0, 1.4 Hz, H17), 4.34 
(1H, ddd, J = 10.6, 6.8, 3.5 Hz, H19), 4.22 (1H, s, H22), 2.65-2.55 (2H, m, H18, H26a), 2.41 (3H, d, J = 1.4 
Hz, Me16), 2.35-2.29 (1H, m, H26b), 2.16 (3H, s, H28), 2.00-1.93 (1H, m, H24), 1.79 (1H, dd, J = 13.9, 3.5 
Hz, H20a), 1.64-1.56 (1H, m, H25a), 1.43 (1H, dd, J = 13.8, 11.8 Hz, H20b), 1.27-1.16 (1H, m, H25b), 1.06 
(3H, d, J = 6.7 Hz, Me18), 0.98 (9H, t, J = 7.9 Hz, OSiCH2CH3), 0.91 (9H, t, J = 7.9 Hz, OSiCH2CH3), 0.90 
(3H, d, J = 7.0 Hz, Me24), 0.81-0.70 (6H, m, OSiCH2CH3), 0.69-0.56 (6H, m, OSiCH2CH3). [α]D
20 –2.7° (c 
0.2, CHCl3). 
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8.4.2. Fragment union and derivatisation of the C1-C28 truncate 




A solution of Pd(PPh3)4 (18.0 mg, 15.3 µmol) and CuTC (29.2 mg, 153 µmol) was prepared in degassed 
DMF (0.5 mL) and cooled to 0 °C. A degassed solution of vinyl iodide ent-53 (50 mg, 76.6 µmol) and vinyl 
stannane 129*** (58.0 mg, 76.6 µmol) in DMF (1.0 mL) was added via cannula (2 x 0.1 mL wash) and the 
reaction mixture was stirred at 0 °C in the dark for 5 h. H2O (10 mL) and Et2O (10 mL) were added and the 
layers were separated. The aqueous phase was extracted with Et2O (3 ´ 10 mL) and the combined organic 
extracts were washed with water (2 ´ 4 mL), dried (Na2SO4), concentrated in vacuo and purified by flash 
column chromatography (EtOAc/PE 40-60: 2% ® 10%) to give the 13,18-syn C1-C28 ketone 101a as a 
colourless oil (62.2 mg, 55.5 µmol, 72%).  
Rf: (EtOAc/PE 40-60: 25%) = 0.45; 1H NMR (500 MHz, CDCl3): δH 7.30 (1H, dd, J = 15.4, 11.4 Hz, H3), 6.52 
(1H, dd, J = 14.8, 10.7 Hz, H5), 6.21 (1H, dd, J = 15.0, 11.2 Hz, H4), 6.13 (1H, dd, J = 15.0, 10.3 Hz, H6), 
5.98 (1H, dd, J = 15.1, 7.3 Hz, H7), 5.85 (1H, d, J = 15.2 Hz, H2), 5.77 (1H, s, H15), 5.02 (1H, d, J = 9.8 Hz, 
H17), 4.32 (1H, ddd, J = 11.3, 8.3, 3.3 Hz, H19), 4.24 (1H, s, H22), 3.89 (1H, d, J = 7.6 Hz, H13), 3.74 (3H, 
s, CO2Me), 3.76-3.73 (1H, obs m, H11), 3.28 (3H, s, OMe), 3.07 (1H, dd, J = 7.6, 3.9 Hz, H9), 2.65 (1H, m, 
H18), 2.56 (1H, ddd, J = 17.4, 11.7, 5.5 Hz, H26a), 2.49 (1H, m , H8), 2.30 (1H, ddd, J = 17.3, 11.3, 3.9 Hz, 
H26b), 2.15 (3H, s, H28), 2.00-1.93 (2H, m, H12, H24), 1.93-1.87 (2H, m, H10, H20a), 1.74 (3H, s, Me16), 
1.66 (3H, s, Me14), 1.60-1.55 (1H, obs m, H25a), 1.45 (1H, dd, J = 13.7, 11.8 Hz, H20b), 1.17 (1H, dd, J = 
12.3, 4.7 Hz, H25b), 1.09 (3H, d, J = 6.5 Hz, Me18), 1.04 (3H, d, J = 7.0 Hz, Me8), 1.00-0.87 (42H, m, Me10, 
Me12, OSiCH2CH3 ´4), 0.86 (3H, d, J = 6.9 Hz, Me24), 0.81-0.67 (6H, m, OSiCH2CH3), 0.67-0.52 (18H, m, 
OSiCH2CH3 ́ 3); 13C NMR (125 MHz, CDCl3): δC 208.2, 172.8, 167.8, 145.1, 144.7, 141.4, 137.8, 133.5, 130.5, 
130.2, 128.9, 128.3, 119.9, 86.8, 80.84, 80.79, 79.8, 74.1, 73.2, 60.1, 51.6, 42.5, 41.1, 39.7, 39.5, 38.3, 37.0, 33.1, 
30.2, 25.8, 17.7, 17.4, 14.8, 14.1, 13.8, 12.8, 11.2, 7.35, 7.34, 7.2, 7.1, 6.8, 5.8, 5.3, 5.1; IR (thin film): νmax 2954, 
 


















2877, 1747, 1720, 1618, 1457, 1414, 1378, 1260, 1143, 1093, 1005, 802, 725; HRMS (ES+) Calc. for 
C61H114O10Si4H [M+H]+
 
1119.7562, found 1119.7571; [α]D
20 = +5.3 (c 0.15, CHCl3). 
Alcohol 131 
 
NaBH4 (10.5 mg, 277 µmol) was added to a stirring solution of ketone 101a (62.0 mg, 55.3 µmol) in MeOH 
(2.5 mL) at 0 °C. The reaction mixture was stirred at 0 °C for 30 min before quenching with a solution of 
NH4Cl (2.5 mL) and diluting with Et2O (5 mL). The layers were separated, and the aqueous phase was 
extracted with Et2O (3 ´ 2.5 mL). The combined organic phases were dried (MgSO4) and concentrated in 
vacuo. Purification by flash column chromatography (EtOAc/PE 40-60: 5%) afforded alcohol 131 as a 
colourless oil (59 mg, 52.6 µmol, 95%) as a 1:1.5 epimeric mixture at C27.  
Rf (EtOAc/PE 40-60: 25%) = 0.34; 1H NMR (500 MHz, CDCl3): dH 7.30 (1H, dd, J = 15.5, 11.6 Hz, H3), 6.52 
(1H, dd, J = 14.8, 10.7 Hz, H5), 6.22 (1H, dd, J = 14.9, 11.4 Hz, H4), 6.13 (1H, dd, J = 15.2, 10.8 Hz, H6), 
5.98 (1H, dd, J = 15.3, 7.4 Hz, H7), 5.85 (1H, d, J = 15.3 Hz, H2), 5.78 (1H, s, H15), 5.03 (1H, d, J = 9.0 Hz, 
H17), 4.35 (1H, ddd, J = 11.8, 7.2, 2.6 Hz, H19), 4.23 (1H, s, H22; minor epimer at 4.22, s), 3.89 (1H, d, J = 
7.6 Hz, H13), 3.80-3.70 (5H, m, H11, H27, CO2Me), 3.28 (3H, s, OMe9), 3.07 (1H, dd, J = 7.1, 4.0 Hz, H9), 
2.68 (1H, m, H18), 2.50 (1H, m, H8), 2.04-1.94 (2H, m, H12, H24), 1.94-1.84 (2H, m, H10, H20a), 1.75 (3H, 
s, Me16), 1.67 (3H, s, Me14), 1.59 (1H, m, H26a), 1.51-1.40 (2H, m, H20b, H25a), 1.29 (1H, m, H26b), 1.21 
(3H, d, J = 6.0 Hz, H28; minor epimer at 1.20 – d, J = 5.9 Hz), 1.08 (3H, d, J = 6.7 Hz, Me18), 1.04 (3H, d, J 
= 6.8 Hz, Me8), 1.02-0.81 (47H, m, Me10, Me12, Me24, H25b, OSiCH2CH3 ´4), 0.80-0.72 (6H, m, 
OSiCH2CH3), 0.68-0.53 (18H, m, OSiCH2CH3 ´3); 13C NMR (125 MHz, CDCl3): dC 173.0, 167.8, 145.1, 
144.6, 141.3, 137.9, 133.6, 130.6, 130.2, 128.9, 128.3, 119.9, 86.8, 80.9, 80.9, 79.9, 74.2, 73.2 (73.2 minor), 
68.6 (68.9 minor), 60.1, 51.6, 41.1, 39.7, 39.5, 38.2, 38.0, 37.5, 32.7, 28.3 (minor 28.9), 23.9 (minor 24.2), 
17.7, 17.3, 14.9, 14.2, 13.8, 13.0 (minor 12.9), 11.0, 7.2, 7.2, 6.9, 6.6, 5.7, 5.3, 5.2, 5.0; IR (thin film): νmax 3502 
(br), 2956, 2932, 2877, 1748, 1721, 1617, 1457, 1260, 1145, 1088, 1006, 789, 725 cm-1; HRMS (ES+) Calc. for 
C61H116O10Si4NH4 [M+NH4]+ 1138.7984, found 1138.7993, [α]D
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Methyl ether 132 
 
A solution of alcohol 131 (16 mg, 14.3 µmol) in CH2Cl2 (150 µL) was added to a suspension of Me3O·BF4 
(21 mg, 143 µmol), Proton Sponge® (46 g, 214 µmol) and crushed 4 Å molecular sieves (ca. 12 mg) in CH2Cl2 
(200 µL). The resulting suspension was stirred for 3 h at r.t. before quenching with NaHCO3 (1 mL). The 
layers were separated and the aqueous phase was extracted with CH2Cl2 (3 ´ 1 mL). The combined organic 
extracts were dried (MgSO4) and concentrated in vacuo. Purification by flash column chromatography 
(EtOAc/PE 40-60: 5%) afforded methyl ether 132 as a colourless oil (13.9 mg, 12.2 µmol, 87%).  
Rf (EtOAc/PE 40-60: 10%) = 0.24; 1H NMR (500 MHz, CDCl3): dH 7.30 (1H, dd, J = 15.3, 11.4 Hz, H3), 6.52 
(1H, dd, J = 14.9, 10.8 Hz, H5), 6.21 (1H, dd, J = 14.9, 11.4 Hz, H4), 6.13 (1H, dd, J = 15.5, 10.8 Hz, H6), 
5.98 (1H, dd, J = 15.3, 7.5 Hz, H7; minor epimer 5.97, dd, J = 15.4, 7.5 Hz), 5.85 (1H, d, J = 15.4 Hz, H2), 
5.78 (1H, s, H15), 5.03 (1H, d, J = 10.0 Hz, H17), 4.36 (1H, m, H19), 4.22 (1H, s, H22), 3.89 (1H, d, J = 7.6 
Hz, H13; minor epimer 3.89), 3.77-3.65 (5H, m, H11, H27, CO2Me), 3.29 (3H, s, OMe9), 3.28 (3H, s, OMe27; 
minor epimer 3.31, s), 3.07 (1H, dd, J = 7.4, 4.2 Hz, H9; minor epimer 3.07, dd, J = 7.4, 4.2 Hz), 2.69 (1H, 
m, H18), 2.49 (1H, m, H8), 2.01-1.93 (2H, m, H12, H24), 1.94-1.86 (2H, m, H10, H20a), 1.75 (3H, s, Me16), 
1.67 (3H, s, Me14), 1.55 (1H, m, H26a), 1.45-1.36 (2H, m, H20b, H25a), 1.13 (3H, d, J = 6.1 Hz, H28; minor 
epimer 1.12, d, J = 6.1 Hz), 1.08 (3H, d, J = 6.9 Hz, Me18), 1.04 (3H, d, J = 6.7 Hz, Me8), 1.04-0.86 (38H, m, 
Me10, Me12, Me24, H25b, OSiCH2CH3 ´4), 0.82-0.71 (6H, m, OSiCH2CH3), 0.70-0.51 (16H, m, 
OSiCH2CH3 ´3); 13C NMR (125 MHz, CDCl3): dC 172.9, 167.6, 144.0, 144.5 (minor 144.5), 141.2, 137.6, 
133.5, 130.5 (minor 130.4), 130.0, 128.8, 128.2, 119.7, 86.7 (minor 86.6), 80.7, 80.6 (minor 80.6), 79.7, 74.1, 
73.0, 59.9, 56.0, 51.5, 41.0, 39.6, 39.4, 38.0, 37.5, 35.3, 32.5 (minor 32.6), 28.3, 19.1, 17.6, 17.2, 14.7, 14.0 
(minor 14.0), 13.6, 12.8 (minor 12.7), 11.0, 7.2, 7.2, 6.9, 6.6, 5.7, 5.3, 5.2 (minor 5.3), 5.0; IR (thin film): νmax 
2965, 2927, 1719, 1615, 1456, 1377, 1260, 1226, 1086, 1008, 803, 753 cm-1; HRMS (ES+) Calc. for 
C62H118O10Si4H [M + H]+ 1135.7875, found 1135.7880; [α]D





















To a solution of TES ether 132 (14 mg, 12.3 µmol) in THF was added a solution of TASF (17 mg, 61.6 µmol) 
in DMF (300 µL) at 0 °C. The light pink solution was stirred at 0 °C for 30 min, before quenching with 
NH4Cl (1 mL) and diluting with EtOAc (1 mL). The aqueous phase was extracted with EtOAc (5 × 0.5 mL), 
dried (MgSO4), concentrated in vacuo and the crude immediately redissolved in THF (300 µL) and stirred 
at 0 °C. A solution of HF·py in py (1:3, 300 µL) was added and the solution was stirred at 0 °C for 3 h. The 
reaction mixture was quenched by slow addition of NaHCO3 (1 mL), the layers separated and the aqueous 
phase extracted with EtOAc (5 × 1 mL). The combined organic phases were dried (MgSO4) and 
concentrated in vacuo. Purification by flash column chromatography (EtOAc/PE 40-60: 80%) afforded the 
tetraol 134 as a colourless oil (8.0 mg, 11.7 µmol, 95% over two steps).   
Rf (EtOAc/PE 40-60: 80%) = 0.34; 1H NMR (500 MHz, MeOD-d4): dH 7.31 (1H, dd, J = 15.5, 11.3 Hz, H3), 
6.58 (1H, dd, J = 14.8, 10.8 Hz, H5), 6.33 (1H, dd, J = 14.8, 10.8 Hz, H4), 6.21 (1H, dd, J = 15.3, 10.8 Hz, 
H6), 5.99 (1H, dd, J = 15.5, 8.6 Hz, H7), 5.95 (1H, s, H15), 5.90 (1H, d, J = 15.1 Hz, H2), 5.16 (1H, d, J = 9.6, 
H17), 4.42 (1H, ddd, J = 11.3, 7.4, 3.8 Hz, H19), 4.26 (1H, s, H22), 3.97 (1H, d, J = 7.9 Hz, H13), 3.73 (3H, 
s, CO2Me) 3.52 (1H, d, J = 9.9 Hz, H11), 3.39 (3H, s, OMe9), 3.31 (3H, s, OMe27), 3.30-3.28 (2H, m, H9, 
H27), 2.80 (1H, m, H18), 2.54 (1H, m, H8), 2.00-1.92 (3H, m, H10, H20a, H24), 1.84-1.76 (4H, m, H12, 
Me16), 1.73-1.66 (4H, m, Me14, H20b), 1.62-1.43 (3H, m, H25a, H26a, H26b), 1.12 (3H, d, J = 6.1 Hz, H28), 
1.10 (3H, d, J = 6.7 Hz, Me18), 1.08 (3H, d, J = 6.7 Hz, Me8), 0.97-0.91 (7H, m, Me12, Me24, H25b), 0.85 
(3H, d, J = 6.9 Hz, Me10); 13C NMR (125 MHz, MeOD-d4): dC 176.9, 169.3, 146.6, 145.0, 142.9, 137.4, 135.4, 
131.8, 131.6, 130.5, 129.4, 120.6, 87.9, 82.7, 82.1, 78.5, 76.3, 75.3, 72.4, 59.4, 56.2, 52.0, 41.6, 40.0, 39.2, 39.2 
(minor 39.1), 38.5, 35.9, 32.1, 28.7, 19.3 (minor 19.4), 17.8, 17.2, 17.1, 13.6, 13.0, 13.0, 7.7; IR (thin film): 
νmax 3446 (br), 2965, 2927, 1719, 1615, 1456, 1377, 1260, 1226, 1086, 1008, 803, 753 cm-1; HRMS (ES+) Calc. 
for C38H62O10NH4 [M + NH4]+ 696.4681, found 696.4680; [α]D






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































  194 
Acid 103 
 
Ba(OH)2·8H2O (10.5 mg, 33.1 µmol) was added to a stirred solution of tetraol 134 (4.5 mg, 6.6 µmol) in 
MeOH (70 mL). The resulting pale-yellow suspension was stirred at rt for 24 h before quenching with 1 M 
HCl (1 mL) and partitioning with EtOAc (1 mL). The aqueous phase was extracted with EtOAc (5 × 0.5 
mL), dried (Na2SO4), concentrated in vacuo and purified by flash column chromatography (MeOH/CH2Cl2: 
10% + AcOH: 1%) to afford acid 103 as an amorphous white solid (2.0 mg, 3.0 µmol, 50%).  
Rf (MeOH/CH2Cl2: 10%) = 0.30; 1H NMR (500 MHz, MeOD-d4): dH 7.13 (1H, dd, J = 15.3, 11.1 Hz, H3), 
6.47 (1H, dd, J = 14.6, 10.7 Hz, H5), 6.27 (1H, dd, J = 14.9, 11.2 Hz, H4), 6.18 (1H, dd, J = 15.0, 10.7 Hz, 
H6), 5.89 (1H, d, J = 15.4 Hz, H2), 5.95 (1H, s, H15), 5.89 (1H, dd, J = 15.0, 8.8 Hz, H7), 5.16 (1H, d, J = 9.6 
Hz, H17), 4.42 (1H, ddd, J = 11.1, 7.3, 3.5 Hz, H19), 4.26 (1H, s, H22), 3.99 (1H, d, J = 7.2 Hz, H13), 3.57 
(1H, dd, J = 9.8, 2.0 Hz, H11), 3.39 (3H, s, OMe9), 3.32 (3H, s, OMe27), 3.30-3.28 (2H, m, H9, H27), 2.81 
(1H, m, H18), 2.54 (1H, m, H8), 2.01-1.92 (3H, m, H10, H20a, H24), 1.83-1.77 (4H, m, H12, Me16), 1.73-
1.66 (4H, m, Me14, H20b), 1.62-1.43 (3H, m, H25a, H26a, H26b), 1.12 (3H, d, J = 6.0 Hz, H28), 1.10 (3H, 
d, J = 6.7 Hz, Me18), 1.07 (3H, d, J = 6.7 Hz, Me8), 0.97-0.90 (7H, m, Me12, Me24, H25b), 0.85 (3H, d, J = 
7.1 Hz, Me10); 13C NMR (125 MHz, MeOD-d4): dC 177.0, 143.2 (br), 143.1 (minor 143.1), 140.1, 137.3 
(minor 137.4), 135.4, 131.8 (minor 131.7), 131.6 (minor 131.5), 130.8, 130.5, 128.2 (br), 88.3 (minor 88.4), 
82.8, 82.1 (minor 82.0), 78.5 (minor 78.2), 76.4, 75.5 (minor 75.6), 72.5, 59.6 (minor 59.6), 56.3 (minor 56.3), 
41.5 (minor 41.5), 40.1, 39.2, 39.2 (minor 39.1), 38.5, 35.9 (minor 36.0), 32.1, 28.7 (minor 28.6), 19.3 (minor 
19.4), 17.8, 17.2 (minor 17.2), 17.2 (minor 17.0), 13.9 (minor 14.0), 13.1, 13.1 (minor 13.0), 7.5; IR (thin 
film): νmax 3411, 2918, 2849, 1762, 1692, 1674, 1402, 1312, 1260, 1139, 1078, 969, 799 cm-1; HRMS (ES+) 
Calc. for C37H60O10Na [M + Na]+ 687.4073, found 687.4079;	[α]D20  +2.67 (c 0.15, CHCl3), 
Note: The C1 carboxylate signal is not seen in the 13C NMR for 103, but reappears in sodium salt 137. This 
observation is noted alongside with the broadening of C2 and C3 – atoms most proximal to the C1 
carboxylate. This is attributed to proton exchange arising from the partial deprotonation of the C1 

















Sodium salt 137 
 
 
In a 5 mm NMR tube, Na2CO3 (ca. 5 mg) was added to a solution of the free acid 103 in MeOD-d4 (500 µL). 
The mixture was vigorously shaken for ca. 30 seconds to afford the sodium salt 137 as a solution in MeOD-
d4. 
1H NMR (500 MHz, MeOD-d4): dH 7.02 (1H, dd, J = 15.3, 11.3 Hz, H3), 6.41 (1H, dd, J = 15.0, 10.8 Hz, H5), 
6.24 (1H, dd, J = 15.1, 11.2 Hz, H4), 6.16 (1H, dd, J = 15.2, 10.8 Hz, H6), 5.95 (1H, s, H15), 5.90 (1H, d, J = 
15.4, H2), 5.83 (1H, d, J = 15.2, 8.8 Hz, H7; minor epimer 5.84, dd, J = 15.5, 9.0 Hz), 5.15 (1H, d, J = 9.9 Hz, 
H17), 4.42 (1H, ddd, J = 11.4, 7.6 3.9 Hz, H19), 4.26 (1H, s, H22), 4.00 (1H, d, J = 7.3 Hz, H13), 3.59 (1H, 
dd, J = 9.6, 2.2 Hz, H11), 3.39 (3H, s, OMe9), 3.32 (3H, s, OMe27), 3.30-3.28 (1H, m, H27), 3.27 (1H, dd, J 
= 6.3, 4.6 Hz, H9), 2.81 (1H, m, H18), 2.53 (1H, m, H8), 2.01-1.92 (3H, m, H10, H20a, H24), 1.85-1.77 (4H, 
m, H12, Me16), 1.73-1.65 (4H, m, Me14, H20b), 1.63-1.42 (3H, m, H25a, H26a, H26b), 1.12 (3H, d, J = 6.2 
Hz, H28), 1.10 (3H, d, J = 6.7 Hz, Me18), 1.07 (3H, d, J = 6.7 Hz, Me8), 0.97-0.90 (7H, m, Me12, Me24, 
H25b), 0.85 (3H, d, J = 7.0 Hz, Me10); 13C NMR (125 MHz, MeOD-d4): dC 177.0, 175.9, 161.5 (CO32-), 142.0, 
141.0, 138.6, 137.4 (minor 137.4), 135.5, 131.6 (minor 131.5), 131.5 (minor 131.4), 131.1, 131.0, 129.7 
(minor 129.7), 88.5 (minor 88.6), 83.0, 82.0 (minor 82.0), 78.6 (minor 78.2), 76.4, 75.7 (minor 75.8), 72.5, 
59.6 (minor 59.7), 56.3 (minor 56.3), 41.5 (minor 41.5), 40.1, 39.2, 39.2 (minor 39.1), 38.4, 35.9 (minor 36.0), 
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8.5. Experimental Procedures for Part III – Phormidolide A 
8.5.1. C18-C23/C24 fragment 
Alcohol 210 
 
AlMe3 (47.0 mL, 93.9 mmol) was added to a solution of Cp2ZrCl2 (1.95 g, 6.67 mmol) in CH2Cl2 (90 mL) at 
–20 °C. The solution was stirred for 10 min at –20 °C, before the addition of water (845 μL, 47.0 mmol). The 
pale-yellow suspension was stirred for 10 min at –20 °C. A solution of 3-butyn-1-ol (2.12 g, 30.3 mmol) in 
CH2Cl2 (20 mL) was treated with AlMe3 (4.70 ml, 9.39 mmol) and transferred via cannula into the reaction 
mixture. The mixture was stirred overnight, with gradual warming to r.t., during which a yellow suspension 
formed. A solution of I2 (9.16 g, 36.4 mmol) in Et2O (200 mL) was transferred via cannula to the reaction 
mixture at –20 °C, resulting in a colour change to vivid yellow, then brown. The reaction mixture was 
allowed to warm to r.t. and stirred for 2 h. The reaction mixture was quenched by addition of Na/K tartrate 
(200 mL) and Et2O (200 mL) and vigorously stirred at r.t. for 1.5 h. The layers were separated, and the 
aqueous phase was extracted with Et2O (3 × 100 mL), dried (MgSO4) and the solvent removed under 
reduced pressure to afford a yellow liquid. Purification by flash column chromatography (Et2O/PE 30-40: 
20%  30%) afforded the product 210 as a pale-yellow oil (5.22 g, 26.4 mmol, 87%). 
Rf (Et2O/PE 30-40: 50%) = 0.54; 1H NMR (400 MHz, CDCl3) dH 6.01 (1H, q, J = 1.0 Hz, H18), 3.72 (2H, t, J 
= 6.3 Hz, H21), 2.48 (2H, t, J = 6.3 Hz, H20), 1.87 (3H, s, Me19); 13C NMR (125 MHz, CDCl3) dC 144.5, 76.8, 
60.1, 42.4, 23.8.  
Data in agreement with that presented by Penner109 
Hydroxyketone (±)-197 
 
Dess-Martin Periodinane (616 mg, 1.45 mmol) was added to a stirred suspension of alcohol 210 (154 mg, 
730 µmol) and NaHCO3 (366 mg, 4.36 mmol) in wet CH2Cl2 (5.0 mL). The reaction mixture was stirred at 
r.t. until TLC monitoring indicated full consumption of the starting material (ca. 1.5 h). The reaction 
mixture was quenched by the addition of Na2S2O3 solution (7 mL) and the mixture stirred at r.t. for 30 min. 











organic phases were dried (MgSO4) and concentrated under reduced pressure to ca. 4 mL. The solution of 
the crude aldehyde 196 was dried over 4 Å molecular sieves and directly used in the subsequent step without 
further purification. 
Method A: Mukaiyama Aldol with BF3·OEt2 
A solution of the crude aldehyde 196 (152 mg, 0.73 mmol) in CH2Cl2 (4 mL + 4 mL wash) was added via 
cannula to a stirred solution of the silyl enol ether 207 (100 mg, 0.632 mmol, dried over CaH2) in CH2Cl2 
(2 mL) at –78 °C. The solution was allowed to stir at –78 °C for 10 min before the dropwise addition of 
BF3·OEt2 (90 µL, 0.73 mmol). The reaction mixture was stirred at –78 °C for 1.5 h before quenching with 
NaHCO3 solution (10 mL). Upon warming to r.t., the layers were separated, and the aqueous phase was 
extracted with CH2Cl2 (3 × 10 mL). The combined organic phases were washed with brine (15 mL), dried 
(MgSO4) and the solvent removed under reduced pressure. Purification by flash column chromatography 
(EtOAc/PE 40-60: 20%  40%) afforded the product 197 as an yellow oil (121 mg, 0.41 mmol, 64%). 
Method B: Mukaiyama Aldol with TiCl4 
A solution of the crude aldehyde 196 (152 mg, 730 µmol) in CH2Cl2 (4 mL + 4 mL wash) was added via 
cannula to a stirred solution of the silyl enol ether 207 (100 mg, 632 µmol, dried over CaH2) in CH2Cl2 (2 
mL) at –78 °C. The solution was allowed to stir at –78 °C for 10 min before the dropwise addition of TiCl4 
(80 µL, 730 µmol). The reaction mixture was stirred at –78 °C for 1.5 h before quenching with NaHCO3 
solution (10 mL). Upon warming to r.t., the layers were separated and the aqueous phase was extracted with 
CH2Cl2 (3 × 10 mL). The combined organic phases were washed with brine (15 mL), dried (MgSO4) and 
the solvent removed under reduced pressure. Purification by flash column chromatography (EtOAc/PE 40-
60: 20%  40%) afforded the product 197 as an yellow oil (128 mg, 430 µmol, 68%). 
Rf (EtOAc/PE 40-60: 30%) = 0.55; 1H NMR (500 MHz, CDCl3) dH 6.03 (1H, q, J = 0.7 Hz, H18), 3.85 (1H, 
dd, J = 10.1, 2.5 Hz, H21), 2.31-2.20 (3H, m, H20, OH), 2.18 (3H, s, H24), 1.90 (3H, d, J = 0.7 Hz, Me19), 
1.17 (3H, s, MeC22a), 1.14 (3H, s, MeC22b); 13C NMR (125 MHz, CDCl3) dC 214.5, 144.9, 77.2, 73.4, 51.5, 
41.8, 26.4, 24.0, 21.6, 19.6; IR (thin film): νmax 3469, 2975, 1694, 1467, 1354, 1273, 1143, 1120, 1068; HRMS 
(ESI+) calculated for C10H18O2I [M+H]+ 297.0346, found 297.0348. 
  
  202 
Hydroxyester 218 and ent-218 
 
Dess-Martin Periodinane (2.50 g, 5.89 mmol) was added to a stirred suspension of alcohol 210 (500 mg, 
2.35 mmol) and NaHCO3 (1.50 g, 17.8 mmol) in wet CH2Cl2 (25 mL). The reaction mixture was stirred at 
r.t. until TLC monitoring indicated full consumption of the starting material (ca. 1.5 h). The reaction 
mixture was quenched by the addition of NaHCO3 (20 mL) and Na2S2O3 solution (20 mL) and stirred at r.t. 
for 30 min. The layers were separated and the aqueous phase was extracted with CH2Cl2 (3 × 10 mL). The 
combined organic phases were washed with brine (50 mL), dried (MgSO4) and concentrated under reduced 
pressure to ca. 10 mL. The solution of the crude aldehyde 196 was dried over 4 Å molecular sieves and 
directly used in the subsequent step without further purification. 
BH3·SMe2 (279 µL, 2.95 mmol) was added dropwise to a stirred solution of N-tosyl-L-valine (215) (799 mg, 
2.95 mmol) in CH2Cl2 (7 mL) and THF (1 mL) at 0 °C. The solution was stirred at 0 °C for 1 h before cooling 
to –78 °C. A combined solution of the crude aldehyde 196 and the silyl ketene acetal 217 (1.11 g, 5.89 mmol, 
dried over CaH2) in CH2Cl2 (15 mL) was added via cannula to the reaction mixture. The mixture was stirred 
at –78 °C for 3 h before quenching with NaHCO3 solution. Upon warming to r.t., the layers were separated 
and the aqueous phase extracted with CH2Cl2 (3 × 40 mL). The combined organic phases were washed with 
brine (100 mL), dried (MgSO4), and the solvent removed under reduced pressure. Purification by flash 
column chromatography (EtOAc/PE 40-60: 5%) afforded the product 218 as an orange oil (516 mg, 3.95 
mmol, 67% over 2 steps, 91% ee).  
The enantiomeric compound was analogously prepared from alcohol 210 (1.00 g, 4.71 mmol), employing 
N-tosyl-D-valine (ent-215) (1.92 g, 7.07 mmol) to give ent-218 as an orange oil (818 mg, 2.51 mmol, 53%) 
Rf (EtOAc/PE 40-60: 30%) = 0.57; 1H NMR (400 MHz, CDCl3) dH 6.02 (1H, q, J = 0.9 Hz,  H18), 4.16 (2H, 
q, J = 7.1 Hz, CH3CH2O), 3.81 (1H, ddd, J = 10.0, 5.6, 2.5 Hz, H21), 2.39 (1H, d, J = 5.6 Hz, OH), 2.33 (1H, 
br d, J = 13.2 Hz, H20a), 2.26 (1H, dd, J = 13.9, 10.0 Hz, H20b), 1.90 (3H, d, J = 0.9 Hz, Me19), 1.27 (3H, t, 
J = 7.1 Hz, CH3CH2O), 1.20 (3H, s, Me22a), 1.20 (3H, s, Me22b); 13C NMR (125 MHz, CDCl3) dC 177.1, 
145.1, 73.7, 60.8, 46.7, 42.0, 23.9, 21.6, 20.7, 14.2, 14.1; IR (thin film): νmax 3526, 2984, 1716, 1469, 1386, 1269, 
1134, 1070; [α]D
20 +13.9 (218, c 1.0, CHCl3); [α]D
20 -12.6° (ent-218, c 0.26, CHCl3); Chiral HPLC (Chiralpak® 
IA, iPrOH:n-hexane: 5%) RT (major) 10.02 min, RT (minor) 10.74 min; HRMS (ESI+) calculated for 









TES ether 220 and ent-220 
 
2,6-Lutidine (128 µL, 1.10 mmol) was added to a stirred solution of hydroxyester 218 (240 mg, 736 µmol) 
in CH2Cl2 (8 mL). The reaction mixture was cooled to –78 °C and stirred for 5 min, before the dropwise 
addition of TESOTf (208 µL, 920 µmol). The mixture was stirred at –78 °C for 45 min, before quenching 
with NaHCO3 solution (10 mL). Upon warming to r.t., the layers were separated and the aqueous phase 
extracted with CH2Cl2 (3 × 10 mL). The combined organic phases were washed with brine (15 mL), dried 
(MgSO4) and the solvent removed under reduced pressure. Purification by flash column chromatography 
(EtOAc/PE 40-60: 10%) afforded the product 220 as a colourless oil (319 mg, 721 µmol, 98%).  
The enantiomeric compound was analogously prepared from hydroxyester ent-218 (818 mg, 2.51 mmol) 
to give ent-220 as a colourless oil (1.01 g, 2.29 mmol, 91%) 
Rf (EtOAc/PE 40-60: 30%) = 0.80; 1H NMR (500 MHz, CDCl3) dH 5.93 (1H, q, J = 1.0 Hz, H18), 4.15-4.08 
(3H, m, MeCH2O, H21), 2.27 (1H, dd, J = 13.7, 7.9 Hz, H20a), 2.21 (1H, dd, J = 13.5, 3.4 Hz, H20b), 1.84 
(3H, d, J = 1.0 Hz, Me19), 1.26 (3H, t, J = 7.1 Hz, MeCH2), 1.17 (3H, s, Me22a), 1.09 (3H, s, Me22b) 0.94 
(9H, t, J = 8.0 Hz, Si(CH2CH3)3), 0.57 (6H, q, J = 8.0 Hz, Si(CH2CH3)3); 13C NMR (125 MHz, CDCl3) dC 
176.7, 144.5, 78.3, 74.3, 60.4, 48.0, 44.6, 23.8, 22.9, 17.8, 14.1, 7.0, 5.4; IR (thin film): νmax 2955, 2913, 2877, 
1723, 1466, 1384, 1261, 1132, 1095; [α]D
20  +3.6 (220, c 1.0, CHCl3); [α]D
20  -3.7 (ent-220, c 0.32, CHCl3); 
HRMS (ESI+) calculated for C17H34O3SiI [M+H]+ 411.1316, found 411.1311. 
Ketone 201 
 
A solution of ester 220 (42.5 mg, 0.182 mmol) in PhMe (0.5 mL) was added via cannula to a stirred solution 
of MeMgBr (130 µL, 0.886 mmol, 3 M in Et2O) and Et3N (255 µL, 1.82 mmol) in PhMe (2.5 mL). The 
mixture was heated to 80 °C and stirred until TLC monitoring indicated complete consumption of the 
starting material (ca. 4 h). The mixture was allowed to cool to r.t. and quenched with NH4Cl solution (2 
mL). The layers were separated, and the aqueous phase extracted with Et2O (3 × 3 mL). The combined 
organic phases were dried (MgSO4) and the solvent removed under reduced pressure. Purification by flash 
column chromatography (EtOAc/PE 40-60: 4%) afforded the product 201 as a pale-yellow oil (36.5 mg, 
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Rf (EtOAc/PE 40-60: 30%) = 0.78; 1H NMR (400 MHz, CDCl3) dH 5.93 (1H, q, J = 1.0 Hz,  H18), 4.08 (1H, 
t, J = 5.7 Hz, H21), 2.20 (2H, d, J = 5.7 Hz, H20), 2.15 (3H, s, H24), 1.84 (3H, d, J = 1.0 Hz, Me19), 1.12 (3H, 
s, Me22a), 1.10 (3H, s, Me22b) 0.94 (9H, t, J = 8.0 Hz, Si(CH2CH3)3), 0.57 (6H, q, J = 8.0 Hz, Si(CH2CH3)3); 
13C NMR (125 MHz, CDCl3) dC 213.3, 144.5, 78.4, 74.6, 52.9, 44.4, 27.0, 23.9, 22.2, 19.8, 7.1, 5.4; IR (thin 
film): νmax 2945, 2910, 2876, 1702, 1459, 1353, 1238, 1088, 1004; [α]D
20 +16.4 (c 0.5, CHCl3); HRMS (ESI+) 
calculated for C16H32O2SiI [M+H]+ 411.1211, found 411.1206. 
Mosher esters 221 and 222 
 
A solution of TBAF (54 µL, 53.6 µmol, 1 M in THF) was added to a stirred solution of TES ether 201 (20 
mg, 48.7 µmol) in THF (0.5 mL). The pale-yellow solution was stirred for 1 h at r.t. before being quenched 
with a solution of NH4Cl (0.5 mL). The layers were separated and the aqueous phase was extracted with 
Et2O (3 × 1 mL). The combined organic phases were dried (MgSO4) and the solvent removed under reduced 
pressure to afford the crude hydroxyketone (R)-197 (11 mg, 38.5 µmol, 79%), which was used directly in 
subsequent steps without purification. 
(S)-Mosher ester 221 
DCC (54 µL, 54.0 µmol, 1 M in CH2Cl2) was added in portion to a stirred solution of crude hydroxyketone 
(4.0 mg, 13.5 µmol), (S)-MTPA (12 mg, 54.0 µmol) and DMAP (one crystal) in CH2Cl2 (500 µL). The 
mixture was stirred for 24 h at r.t., during which the solution became a white suspension. The mixture was 
filtered through cotton wool and the filtrate reduced to dryness. Purification by flash chromatography 
(EtOAc/PE 40-60: 10%) afforded the product 221 as a colourless oil (4.6 mg, 8.97 µmol, 66%). 
Rf (EtOAc/PE 40-60: 20%) = 0.48; 1H NMR (400 MHz, CDCl3) dH 7.49-7.41 (5H, m, ArH), 5.95 (1H, s, H18), 
5.69 (1H, dd, J = 10.1, 2.3 Hz, H21), 3.49 (3H, s, OMe), 2.45 (1H, dd, J = 14.4, 10.1 Hz, H20a), 2.30 (1H, br 
d, J = 14.4 Hz, H20b), 2.11 (3H, s, H24), 1.94 (3H, s, Me19), 1.13 (3H, s, Me22a), 1.12 (3H, s, Me22b). 
(R)-Mosher ester 222 
DCC (54 µL, 54.0 µmol, 1 M in CH2Cl2) was added in portion to a stirred solution of crude hydroxyketone 
(R)-197 (4.0 mg, 13.5 µmol), (R)-MTPA (12 mg, 54.0 µmol) and DMAP (one crystal) in CH2Cl2 (500 µL). 








(−) (+)Δδ = (δS - δR):
 
 205 
was filtered through cotton wool and the filtrate reduced to dryness. Purification by flash chromatography 
(EtOAc/PE 40-60: 10%) afforded the product 222 as a colourless oil (4.0 mg, 7.80 µmol, 58%). 
Rf (EtOAc/PE 40-60: 20%) = 0.48; 1H NMR (400 MHz, CDCl3) dH 7.48-7.40 (5H, m, ArH), 5.94 (1H, s, H18), 
5.66 (1H, dd, J = 9.8, 2.4 Hz, H21), 3.43 (3H, s, OMe), 2.43 (1H, dd, J = 14.3, 9.8 Hz, H20a), 2.31 (1H, d br, 
J = 14.3 Hz, H20b), 2.13 (3H, s, H24), 1.93 (3H, s, Me19), 1.17 (3H, s, Me22a), 1.15 (3H, s, Me22b). 
Silyl enol ether 213 439 1061 
 
TMSOTf (17 µL, 95.1 µmol) was added dropwise to a stirred solution of ketone 201 (30.0 mg, 73.0 µmol) 
and Et3N (31 µL, 219 µmol) in Et2O (500 µL) at 0 °C. The resulting cloudy reaction mixture was stirred for 
4 h at 0 °C before quenching with NaHCO3 (500 µL). The layers were separated, and the aqueous phase 
extracted with Et2O (3 × 500 µL). The combined organic phases were dried (MgSO4) and the solvent 
removed under reduced pressure to afford the crude product 213 (35.0 mg, 72.5 µmol, 99%), which was 
used without further purification. 
Rf (EtOAc/PE 40-60: 10%) = 0.74; 1H NMR (500 MHz, CDCl3) dH 5.85 (1H, s, H18), 4.11 (1H, d, J = 2.0 Hz, 
H24a), 3.98 (1H, dd, J = 9.0, 1.5 Hz, H23), 3.96 (1H, d, J = 2.0 Hz, H24b), 2.31 (1H, dd, J = 13.7, 1.5 Hz, 
H20a), 2.18 (1H, dd, J = 13.7, 9.0 Hz), 1.81 (3H, s, Me19), 0.95 (9H, t, J = 7.9 Hz, Si(CH2CH3)3), 0.54 (6H, 
q, J = 7.9 Hz, Si(CH2CH3)3), 0.21 (9H, s, SiMe3); 13C NMR (125 MHz, CDCl3) dC 164.7, 145.7, 87.7, 74.6, 
74.1, 45.4, 44.0, 25.0, 23.8, 18.9, 7.2, 5.6, 0.0; IR (thin film): νmax 2955, 2877, 1619, 1378, 1274, 1252, 1091, 
1010; [α]D
20  +2.9 (c 0.29, CHCl3); HRMS (ESI+) calculated for C19H39O2Si2IH [M+H]+ 483.1611, found 
483.1593. 
Aldehyde 227 704 
 
DIBAL (72 µL, 72 µmol, 1 M in hexanes) was added dropwise to a stirred solution of ester 220 (30.0 mg, 
68.1 µmol) in PhMe (600 µL) at –78 °C. The reaction mixture was stirred at –78 °C for 1 h before quenching 
with MeOH (50 µL) and Na/K tartrate (500 µL) and allowed to warm to r.t.. The resulting emulsion was 
vigorously stirred at r.t. for 1 h until two distinct layers were observed. The layers were separated, and the 
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the solvent removed under reduced pressure. Purification by flash column chromatography (EtOAc/PE 40-
60: 5%) afforded the product 227 as a colourless oil (25.2 mg, 63.6 µmol, 93%). 
Rf (EtOAc/PE 40-60: 20%) = 0.83; 1H NMR (500 MHz, CDCl3) dH 9.55 (1H, s, H23), 5.97 (1H, s, H18), 3.98 
(1H, dd, J = 7.6, 4.0 Hz, H21), 2.35-2.27 (2H, m, H20), 1.84 (3H, s, Me18), 1.07 (3H, s, Me22a), 1.03 (3H, s, 
Me22b), 0.93 (9H, t, J = 8.0 Hz, Si(CH2CH3)3), 0.55 (6H, q, J = 8.0 Hz, Si(CH2CH3)3); 13C NMR (125 MHz, 
CDCl3) dC 205.6, 143.9, 78.8, 74.0, 51.2, 43.7, 23.9, 18.5, 17.8, 6.9, 5.3; IR (thin film): νmax 2953, 2875, 1725, 
1464, 1378, 1274, 1097; [α]D
20  +5.6 (c 1.0, CHCl3); HRMS (ESI+) calculated for C15H29O2SiINa [M+Na]+ 
419.0879, found 419.0903. 




DIBAL (8.31 mL, 8.31 mmol, 1 M in hexanes) was added dropwise to a stirred solution of the ester 220 
(1.80 g, 4.16 mmol) in CH2Cl2 (42 mL) at –78 °C. The reaction mixture was stirred at –78 °C for 30 min 
before the addition of an extra aliquot of DIBAL (4.16 mL, 4.16 mmol, 1 M in hexanes). The reaction 
mixture was warmed to –40 °C over 1 h before quenching with the successive addition of MeOH (2 mL) 
and Na/K tartrate (30 mL). The mixture was allowed to warm to r.t. and stirred for 2 h. The layers were 
separated, and the aqueous phase extracted with CH2Cl2 (3 × 20 mL). The combined organic phases were 
washed with brine (20 mL), dried (MgSO4) and the solvent removed under reduced pressure. Purification 
by flash column chromatography (EtOAc/PE 40-60: 10%  20%) afforded the product 232 as a colourless 
oil (1.31 g, 3.30 mmol, 79%, 90% brsm). 
The enantiomeric product was analogously prepared from ester ent-220 (1.00 g, 2.27 mmol) to give alcohol 
ent-232 as a colourless oil (720 mg, 1.82 mmol, 73%). 
Rf (EtOAc/PE 40-60: 30%) = 0.80; 1H NMR (500 MHz, CDCl3) dH 5.98 (1H, s, H18), 3.72 (1H, dd, J = 8.6, 
2.6 Hz, H21), 3.67 (1H, dd, J = 10.7, 3.2 Hz, H23a), 3.28 (1H, dd, J = 10.7, 7.4 Hz, H23b), 2.66 (1H, dd, J = 
7.4, 3.4 Hz, OH), 2.48 (1H, dd, J = 14.1, 2.6 Hz, H20a), 2.36 (1H, dd, J = 14.1, 8.6 Hz, H20b), 1.85 (3H, d, J 
= 0.6 Hz, Me19), 1.04 (3H, s, Me22a), 0.96 (9H, t, J = 8.1 Hz, Si(CH2CH3)3), 0.80 (3H, s, Me22b), 0.59, 0.58 
(6H, app dq, J = 8.0 Hz, Si(CH2CH3)3); 13C NMR (125 MHz, CDCl3) dC 144.8, 78.2, 78.0, 70.0, 43.7, 39.5, 
24.0, 23.3, 21.5, 7.1, 5.4; IR (thin film): νmax 3477, 2955, 2927, 1459, 1318, 1274, 1090, 1006; [α]D








c 0.15, CHCl3); [α]D
20 -14.7 (ent-232, c 0.30, CHCl3); HRMS (ESI+) calculated for C15H31O2SiIH [M+H]+ 
399.1216, found 399.1217. 




TMSCl (342 µL, 2.70 mmol) was added to a stirred solution of alcohol 232 (855 mg, 2.16 mmol), Et3N (451 
µL, 3.24 mmol) and DMAP (26.0 mg, 21.6 µmol) in CH2Cl2 (25 mL) at r.t.. The reaction mixture was stirred 
at r.t. for 1 h before quenching with MeOH (1 mL). The solvent was removed under reduced pressure and 
the residue resuspended in PE 40-60 before filtering over a pad of silica, eluting with PE 40-60. Removal of 
the solvent under reduced pressure afforded the TMS ether 233 as a colourless oil (924 mg, 1.96 mmol, 
91%). 
The enantiomeric product was analogously prepared from alcohol ent-232 (100 mg, 252 µmol) to give TMS 
ether ent-233 as a colourless oil (89 mg, 189 µmol, 75%). 
Rf (EtOAc/PE 40-60: 20%) = 0.66; 1H NMR (500 MHz, CDCl3) dH 5.88 (1H, s, H18), 3.77 (1H, dd, J = 8.8, 
2.4 Hz, H21), 3.34 (1H, d, J = 9.6 Hz, H23a), 3.22 (1H, d, J = 9.6 Hz, H23b), 2.37 (1H, dd, J = 13.6, 2.4 Hz, 
H20a), 2.24 (1H, dd, J = 13.6, 8.8 Hz, H20b), 1.83 (3H, s, Me19), 0.94 (9H, t, J = 9.4 Hz, Si(CH2CH3)3), 0.82 
(3H, s, Me22a), 0.79 (3H, s, Me22b), 0.55 (6H, q, J = 9.4 Hz, Si(CH2CH3)3), 0.08 (9H, s, Si(CH3)3); 13C NMR 
(125 MHz, CDCl3) dC 145.8, 74.0, 69.2, 43.4, 40.3, 24.0, 21.1, 20.2, 7.2, 5.5, –0.6; IR (thin film): νmax 2877, 
2597, 1251, 1092, 1013, 874; [α]D
20 +9.6 (233, c 0.28, CHCl3);	[α]D20 -9.0 (ent-233, c 0.32, CHCl3); HRMS 
(ESI+) calculated for C18H39O2Si2IH [M+H]+ 471.1612, found 471.1615. 
TES ether 325 
 
TESOTf (765 µL, 3.39 mmol) was added dropwise to a stirred solution of alcohol ent-232 (1.22 g, 3.08 mmol) 
and 2,6-lutidine (535 µL, 4.62 mmol) in CH2Cl2 (35 mL) at –78 °C. The reaction mixture was stirred at  
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The layers were separated, and the aqueous phase extracted with CH2Cl2 (3 × 20 mL). The combined organic 
phases were washed with brine (20 mL), dried (MgSO4) and the solvent removed under reduced pressure. 
Purification by flash column chromatography (EtOAc/PE 40-60: 10%  20%) afforded the product 325 as 
a colourless oil (1.50 g, 2.93 mmol, 95%). 
Rf (EtOAc/PE 40-60: 20%) = 0.68; 1H NMR (500 MHz, CDCl3) dH 5.88 (1H, s, H18), 3.77 (1H, dd, J = 8.8, 
2.4 Hz, H21), 3.34 (1H, d, J = 9.6 Hz, H23a), 3.22 (1H, d, J = 9.6 Hz, H23b), 2.37 (1H, dd, J = 13.6, 2.4 Hz, 
H20a), 2.24 (1H, dd, J = 13.6, 8.8 Hz, H20b), 1.83 (3H, s, Me19), 0.94 (9H, t, J = 9.4 Hz, Si(CH2CH3)3), 0.82 
(3H, s, Me22a), 0.79 (3H, s, Me22b), 0.55 (6H, q, J = 9.4 Hz, Si(CH2CH3)3), 0.08 (9H, s, Si(CH3)3); 13C NMR 
(125 MHz, CDCl3) dC 145.8, 74.0, 69.2, 43.4, 40.3, 24.0, 21.1, 20.2, 7.2, 5.5, –0.6; IR (thin film): νmax 2877, 
2597, 1251, 1092, 1013, 874; [α]D
20 +9.6 (c 0.28, CHCl3);	 HRMS (ESI+) calculated for C18H39O2Si2IH [M+H]+ 
471.1612, found 471.1615. 
8.5.2. Fragment union studies and the stereochemical reassignment of phormidolide A 
Ketone 240 
 
Dess-Martin Periodinane (311 mg, 733 µmol) was added to a stirred suspension of alcohol 203††† (125 mg, 
293 µmol) and NaHCO3 (100 mg, 1.17 mmol) in wet CH2Cl2 (4 mL). The reaction mixture was stirred at 
r.t. until TLC monitoring indicated full consumption of the starting material (ca. 30 min). The reaction 
mixture was quenched by the addition of NaHCO3 (2 mL) and Na2S2O3 solution (2 mL) and stirred at r.t. 
for 30 min. The layers were separated, and the aqueous phase was extracted with CH2Cl2 (3 × 2 mL). The 
combined organic phases were dried (MgSO4) and concentrated under reduced pressure. Purification by 
flash column chromatography (EtOAc/PE 40-60: 0%  5%) afforded the product 240 as a colourless oil 
(123 mg, 290 µmol, 99%). 
Rf (EtOAc/PE 40-60: 20%) = 0.71; 1H NMR (500 MHz, CDCl3) dH 6.03 (1H, q, J = 0.9 Hz, H10), 4.33 (1H, 
app dq, J = 10.5, 6.1 Hz, H13), 3.64 (1H, d, J = 10.5 Hz, H17a), 3.53 (1H, d, J = 10.5 Hz, H17b), 2.71 (1H, 
dd, J = 14.3, 6.1 Hz, H14a), 2.55 (1H, dd, J = 14.3, 6.1 Hz, H14b), 2.48 (1H, dd, J = 17.4, 5.8 Hz, H12a), 2.19 
(1H, dd, J = 17.4, 10.5 Hz, H12b), 1.92, (3H, d, J = 0.9 Hz, Me11), 1.09 (3H, s, Me16), 0.87 (9H, s, SiMe2tBu), 
 









0.05, 0.02 (6H, s, SiMe2tBu); 13C NMR (125 MHz, CDCl3) dC 216.2, 144.1, 84.8, 77.5, 71.6, 67.3, 45.6, 43.3, 
25.9, 24.6, 18.3, 17.7, –5.3, –5.6; IR (thin film): νmax 2948, 2867, 1762, 1454, 1253, 1098, 898; [α]D
20 +16.3 (c 
0.95, CHCl3); HRMS (ESI+) calculated for C16H29O3SiIH [M+H]+ 425.1009, found 425.1006. 
Alcohol 241 
 
DIBAL (1.69 mL, 1.69 mmol, 1 M in hexanes) was added dropwise to a stirred solution of ketone 240 (239 
mg, 563 µmol) in CH2Cl2 (6 mL) at –78 °C. The reaction mixture was stirred at –78 °C for 1 h before 
quenching with MeOH (500 µL), Na/K tartrate (5 mL) and the stirred mixture allowed to warm to r.t. over 
3 h. The layers were separated, and the aqueous phase was extracted with CH2Cl2 (3 × 5 mL). The combined 
organic phases were dried (MgSO4) and concentrated under reduced pressure. Purification by flash column 
chromatography (EtOAc/PE 40-60: 2%) afforded the product 241 as a colourless oil (238 mg, 559 µmol, 
99%) as a single diastereomer. 
Rf (EtOAc/PE 40-60: 20%) = 0.53; 1H NMR (500 MHz, CDCl3) dH 5.99 (1H, s, H10), 4.14-4.11 (2H, m, H13, 
H15), 3.76 (1H, d, J = 10.3 Hz, H17a), 3.67 (1H, d, J = 10.3 Hz, H17b), 3.55 (1H, d, J = 6.2 Hz, OH15), 2.59 
(1H, dd, J = 13.9, 6.8 Hz, H12a), 2.43 (1H, dd, J = 13.9, 6.3 Hz, H12b), 2.37-2.32 (1H, m, H14a), 1.88 (3H, 
s, Me11), 1.70-1.64 (1H, m, H14b), 1.15 (3H, s, Me16), 0.93 (9H, s, SiMe2tBu), 0.13, 0.12 (6H, s, SiMe2tBu); 
13C NMR (125 MHz, CDCl3) dC 144.9, 83.4, 79.3, 74.1, 67.9, 46.0, 41.0, 25.7, 24.3, 22.5, 18.0, –5.5, –5.8; IR 
(thin film): νmax 3439, 2928, 2857, 1463, 1258, 1088 779; [α]D
20 –1.7 (c 0.24, CHCl3); HRMS (ESI+) calculated 








  210 
Ester 243 
 
Method A: Yamaguchi esterification 
Et3N (325 µL, 2.34 mmol) was added to a stirred solution of dimethylacrylic acid (70.4 mg, 704 µmol) and 
TCBC (160 µL, 1.06 mmol) in PhH (7.5 mL). The solution was stirred for 30 min before the addition of a 
solution of alcohol 241 (100 mg, 235 µmol) and DMAP (86.0 mg, 704 µmol) in PhH (7.5 mL) via cannula, 
to which a white chunky precipitate immediately formed. The mixture was stirred for 3 h before filtering 
over SiO2, eluting with Et2O (15 mL) and the filtrate concentrated under reduced pressure. Purification by 
flash column chromatography (EtOAc/PE 40-60: 0%  5%) afforded the product 243 as a colourless oil 
(103 mg, 202 µmol, 86%). 
Method B: Keck esterification 
DCC (2.27 mL, 2.27 mmol, 1 M in CH2Cl2) was added in one portion to a stirred solution of alcohol 241 
(160 mg, 378 µmol), dimethylacrylic acid (227 mg, 2.27 mmol), DMAP (277 mg, 2.27 mmol) and 
DMAP·HCl (359 mg, 2.27 mmol) in CH2Cl2 (4 mL) at r.t.. The cloudy white suspension was stirred at r.t. 
for 24 h before quenching with NH4Cl (5 mL). The layers were separated, and the aqueous phase was 
extracted with Et2O (3 × 5 mL). The combined organic phases were dried (MgSO4) and concentrated under 
reduced pressure. Purification by flash column chromatography (EtOAc/PE 40-60: 0%  5%) afforded the 
product 243 as a colourless oil (178 mg, 350 µmol, 93%). 
Rf (EtOAc/PE 40-60: 20%) = 0.72; 1H NMR (500 MHz, CDCl3) dH 5.94 (1H, d, J = 1.0 Hz, H10), 5.66 (1H, 
sept, J = 1.2 Hz, =CH), 5.10 (1H, dd, J = 6.4, 3.9 Hz, H15), 4.22 (1H, ddt, J = 7.5, 6.8, 6.5 Hz, H13), 3.70 (1H, 
d, J = 9.7 Hz, H17a), 3.50 (1H, d, J = 9.7 Hz, H17b), 2.56 (1H, dd, J = 13.9, 6.8 Hz, H12a), 2.46 (1H, ddd, J 
= 13.8, 7.5, 6.6 Hz, H14a), 2.38 (1H, dd, J = 13.9, 6.6 Hz, H12b), 2.17 (3H, d, J = 1.7 Hz, =CMeaMeb), 1.91 
(3H, d, J = 1.2 Hz, =CMeaMeb), 1.85 (3H, d, J = 1.0 Hz, Me11), 1.70 (1H, ddd, J = 13.9, 6.4, 3.9 Hz, H14b), 
1.20 (3H, s, Me16), 0.86 (9H, s, SiMe2tBu), 0.03, 0.01 (6H, s, SiMe2tBu); 13C NMR (125 MHz, CDCl3) dC 
165.7, 157.4, 144.9, 116.0, 84.5, 77.2, 74.5, 66.0, 46.3, 37.6, 27.4, 25.8, 24.5, 21.7, 20.3, 18.2, –5.5, –5.6; IR 
(thin film): νmax 2927, 2853, 1723, 1561, 1444, 1144,1103; [α]D
20  –13.0 (c 0.30, CHCl3); HRMS (ESI+) 












TsOH·H2O (3.5 mg, 20.3 µmol) was added to a stirred solution of TBS ether 243 (103 mg, 203 µmol) in 
MeOH (1 mL) and CH2Cl2 (1 mL) at r.t.. The reaction mixture was stirred for 3 h at r.t., after which the 
reaction mixture was diluted with CH2Cl2 (5 mL) and quenched by the addition of NaHCO3 (10 mL). The 
layers were separated, and the aqueous phase was extracted with CH2Cl2 (3 × 5 mL). The combined organic 
phases were dried (MgSO4) and concentrated under reduced pressure. Purification by flash column 
chromatography (EtOAc/PE 40-60: 20%) afforded the product 244 as a colourless oil (54.6 mg, 138 µmol, 
68%). 
Rf (EtOAc/PE 40-60: 20%) = 0.23; 1H NMR (400 MHz, CDCl3) dH 5.99 (1H, s, H10), 5.70 (1H, s, =CH), 5.08 
(1H, dd, J = 6.8, 4.9 Hz, H15), 4.22 (1H, app qn, J = 6.8 Hz, H13), 3.57 (1H, dd, J = 11.8, 6.3 Hz, H17a), 3.51 
(1H, dd, J = 11.8, 6.2 Hz, H17b), 2.57 (1H, dd, J = 13.9, 6.4 Hz, H12a), 2.52 (1H, ddd, J = 13.6, 6.8, 6.8 Hz, 
H14a), 2.42 (1H, dd, J = 13.9, 6.3 Hz, H12b), 2.18 (3H, s, =CMeaMeb), 1.93 (3H, s, =CMeaMeb), 1.87 (3H, s, 
Me11), 1.72 (1H, ddd, J = 13.5, 7.1, 4.9 Hz, H14b), 1.26 (3H, s, Me16); 13C NMR (100 MHz, CDCl3) dC 166.4, 
159.1 144.6, 115.3, 84.1, 78.1, 77.2, 74.1, 65.8, 46.0, 37.7, 27.6, 24.5, 21.7, 20.4; IR (thin film): νmax 3511, 2919, 
1717, 1649, 1377, 1228, 1145, 1008; [α]D
20 +2.2 (c 0.19, CHCl3); HRMS (ESI+) calculated for C15H23O4INa 
[M+Na]+ 417.0539, found 417.0535. 
Aldehyde 245 1058 
 
Dess-Martin Periodinane (250 mg, 583 µmol) was added to a stirred suspension of alcohol 244 (46.0 mg, 
117 µmol) and NaHCO3 (48 mg, 1.17 mmol) in wet CH2Cl2 (2 mL). The reaction mixture was stirred at r.t. 
for 30 min before quenching by the addition of NaHCO3 (2 mL) and Na2S2O3 solution (2 mL) and stirred 
at r.t. for 30 min. The layers were separated, and the aqueous phase was extracted with CH2Cl2 (3 × 2 mL). 
The combined organic phases were dried (MgSO4) and concentrated under reduced pressure. Purification 













  212 
(30.3 mg, 77.2 µmol, 86% brsm), alongside with 20-30% of the C10 protodeiodinated product that is 
inseparable at this stage. 
Rf (EtOAc/PE 40-60: 20%) = 0.35; 1H NMR (500 MHz, CDCl3) dH 9.63 (1H, s, H17), 6.03 (1H, q, J = 1.1 Hz, 
H10), 5.59 (1H, s, =CH), 5.19 (1H, dd, J = 6.4, 4.1 Hz, H15), 4.41 (1H, dt, J = 13.7, 6.6 Hz, H13), 2.70 (1H, 
dd, J = 14.0, 6.7 Hz, H12a), 2.55 (1H, ddd, J = 13.7, 7.2, 6.4 Hz, H14a), 2.50 (1H, dd, J = 14.0, 6.4 Hz, H12b), 
2.15 (3H, d, J = 1.3 Hz, =CMeaMeb), 1.90 (6H, s, Me11, =CMeaMeb), 1.79 (1H, ddd, J = 13.7, 6.2, 4.1 Hz, 
H14b), 1.31 (3H, s, Me16); 13C NMR (125 MHz, CDCl3) dC 201.0, 165.1, 159.3, 144.4, 114.9, 87.6, 79.7, 77.6, 
76.8, 45.9, 37.7, 27.5, 24.4, 20.4, 19.6; IR (thin film): νmax 2918, 1738, 1723, 1649, 1443, 1377, 1224, 1138, 
1076; [α]D
20  –3.4 (c 0.29, CHCl3); HRMS (ESI+) calculated for C15H21IO4Na [M+Na]+ 415.0382, found 
415.0373. 
General protocol for the vinylmetal addition of the C18-C23 vinyl iodide to aldehyde 245 
tBuLi (13 eq., molarity in pentane titrated before use) was added dropwise (down the side of the flask) to a 
stirred solution of vinyl iodide 233 or ent-233 (6.5 eq., dried by azeotroping with PhH and over CaH2) in 
Et2O (0.1 M relative to vinyl iodide) at –78 °C, taking care that the reaction temperature does not exceed –
78 °C. The solution was stirred for 30 seconds before the dropwise addition of a freshly prepared solution 
of MgBr2·OEt2 (19 eq., 0.6 M in Et2O) into the reaction mixture at –78 °C. The mixture was stirred for 5 min 
at –78 °C before the dropwise addition of aldehyde 245 (1 eq., dried by azeotroping with PhH ́  3) in CH2Cl2 
(0.1 M relative to aldehyde) via cannula (down the side of the flask). The pale-yellow reaction mixture was 
stirred at –78 °C for 1 h before quenching with NH4Cl (3 mL) and warmed to r.t.. The layers were separated, 
and the aqueous phase was extracted with CH2Cl2. The combined organic phases were dried (MgSO4) and 
concentrated under reduced pressure. Purification by flash column chromatography (Et2O/PE 40-60: 0% 
 5%) afforded the crude product as a colourless oil as an inseparable mixture of diastereomers, alongside 
with their C10 protodeiodinated counterparts. The crude product mixture was subjected to the acetonide 
formation sequence outlined below. 
General protocol for the synthesis of diacetonides 252, 254 and 257 
PPTS (one crystal) was added to a stirred solution of bis-silyl ethers 249, 253 or 256 (1 eq.) in CH2Cl2 (100 
µL) and methanol (100 µL) at r.t.. The reaction mixture was stirred for 16 h at r.t. before quenching with 
NaHCO3 and diluting with EtOAc. The layers were separated, and the aqueous phase was extracted with 
EtOAc. The combined organic phases were dried (MgSO4) and concentrated under reduced pressure. The 
crude triol was dissolved in MeOH (150 µL) and K2CO3 (6 mg, ca. 10 eq.) was added. The pale-yellow 
mixture was stirred overnight at r.t. before quenching with NH4Cl and diluted with EtOAc. The layers were 
separated, and the aqueous phase was extracted with EtOAc. The combined organic phases were dried 
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(MgSO4) and concentrated under reduced pressure. The crude tetraol was redissolved in CH2Cl2 (100 µL) 
and 2,2-dimethoxypropane (100 µL) and PPTS (one crystal) was added. The solution was stirred for a 
further 16 h before quenching with NaHCO3 and diluting with EtOAc. The layers were separated, and the 
aqueous phase was extracted with EtOAc. The combined organic phases were dried (MgSO4) and 
concentrated under reduced pressure. Purification by preparative thin layer chromatography (EtOAc/PE 
40-60: 20%) afforded the diacetonide as a colourless oil. 
Alcohol 253 and 15,17-anti acetonide 252 
    
The addition reaction was performed according to the general protocol described above, using vinyl iodide 
233 (42.0 mg, 88.9 µmol), tBuLi (120 µL, 185 µmol, 1.5 M in pentane), MgBr2·OEt2 (381 µL, 229 µmol, 0.6 
M in Et2O), and aldehyde 245 (4.9 mg, 12.7 µmol) to afford the crude product 253 (7.2 mg, 9.78 µmol, 77%), 
a colourless oil as an inseparable 5:1 mixture of diastereomers at C17. alongside with the C10 
protodeiodinated material. 
The crude product was transformed to the corresponding acetonide 252 according to the general protocol 
described above to afford the pure diacetonide 252 as a colourless oil (1.3 mg, 2.37 mmol, 24% over three 
steps) 
Rf (EtOAc/PE 40-60: 20%) = 0.85; 1H NMR (500 MHz, CDCl3) dH 5.97 (1H, q, J = 0.9 Hz, H10), 5.19 (1H, 
dq, J = 8.6, 1.0 Hz, H18), 4.40 (1H, d, J = 8.6 Hz, H17), 4.21-4.14 (1H, m, H13), 3.94 (1H, dd, J = 7.0, 2.1 Hz, 
H15), 3.64 (1H, dd, J = 9.0, 2.7 Hz, H21), 3.61 (1H, d, J = 11.4 Hz, H23a), 3.28 (1H, d, J = 11.4 Hz, H23b), 
2.63 (1H, dd, J = 13.9, 7.7 Hz, H12a), 2.48 (1H, dd, J = 13.9, 5.5 Hz, H12b), 2.32 (1H, app dt, J = 13.9, 7.0 
Hz, H14a), 2.11-2.01 (2H, m, H20), 1.85 (3H, d, J = 0.9 Hz, Me11), 1.73-1.65 (4H, m, H14b, Me19), 1.39 
(3H, s, MeAMeBCO(O))A, 1.38 (3H, s, MeAMeBCO(O))B, 1.36 (3H, s, MeAMeBCO(O))B, 1.34 (3H, s, 
MeAMeBCO(O))A, 1.06 (3H, s, Me16), 1.01 (3H, s, Me22a), 0.74 (3H, s, Me22b); 13C NMR (125 MHz, CDCl3) 
dC 145.3, 137.6, 123.0, 100.3A, 98.6B, 87.0, 77.7, 76.6, 76.1, 75.5, 72.2, 72.1, 46.4, 39.9, 38.7, 36.7, 32.9, 29.7B, 
25.4A, 24.2, 23.8A, 21.8, 18.9B, 18.5, 18.0, 17.8; IR (thin film): νmax 2925, 1460, 1375, 1223, 1100; [α]D
20 +19.5 
(c 0.06, CHCl3); HRMS (ESI+) calculated for C25H41O5IH [M+H]+ 549.2077, found 549.2082. 
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Alcohol 249 and 15,17-syn acetonide 254 
 
   
The addition reaction was performed according to the general protocol described above except omitting 
the addition of MgBr2OEt2, using vinyl iodide 233 (42.0 mg, 88.9 µmol), tBuLi (97 µL, 185 µmol, 1.9 M in 
pentane), and aldehyde 245 (4.9 mg, 12.7 µmol) to afford the crude product 249 (3.5 mg, 4.74 µmol, 37%), 
a colourless oil as an inseperable 4:1 mixture of diastereomers at C17, alongside with the C10 
protodeiodinated material. 
The crude product was transformed to the corresponding acetonide 254 according to the general protocol 
described above to afford the pure diacetonide as a colourless oil (1.8 mg, 3.28 mmol, 69% over three steps). 
Owing to competing lithium/iodine exchange at C10 from the formed vinyllithium species in the previous 
step, the product acetonide contains a 1:1 mixture of the C10 protodeiodinated species that was inseparable. 
Rf (EtOAc/PE 40-60: 20%) = 0.87; 1H NMR (500 MHz, CDCl3) dH 5.98 (1H, s, H10), 5.55 (1H, d, J = 8.6 Hz, 
H18), 4.50 (1H, d, J = 8.6 Hz, H17), 4.22-4.19 (1H, m, H13), 4.11 (1H, app d, J = 4.5 Hz, H15), 3.81 (1H, dd, 
J = 7.0, 2.2 Hz, H21), 3.66 (1H, d, J = 11.6 Hz, H23a), 3.27 (1H, d, J = 11.5 Hz, H23b), 2.73 (1H, dd, J = 13.5, 
7.8 Hz, H12a), 2.44 (1H, dd, J = 13.5, 5.8 Hz, H12b), 2.38-2.30 (1H, m, H14a), 2.25 (1H, dd, J = 15.5 Hz, 7.0 
Hz, H20a), 1.98-1.93 (1H, m, H20b), 1.88 (3H, d, J = 1.0 Hz, Me11), 1.76 (3H, s, Me19), 1.74-1.66 (1H, m, 
H14b), 1.49 (3H, s, MeAMeBCO(O))A, 1.42 (3H, s, MeAMeBCO(O))A, 1.42 (3H, s, MeAMeBCO(O))B,  1.37 
(3H, s, MeAMeBCO(O))B, 1.03 (3H, s, Me22a), 0.93 (3H, s, Me16), 0.74 (3H, s, Me22b); 13C NMR (125 MHz, 
CDCl3) dC 145.6, 140.2, 121.3, 98.5B, 97.4A, 78.8, 77.0, 76.9, 75.3, 74.5, 72.3, 69.7, 46.8, 38.5, 36.9, 32.9, 30.0A, 
29.9B, 24.4, 21.8, 20.6, 19.2A, 19.0, 18.8B, 18.1; IR (thin film): νmax 2928, 1464, 1377, 1261, 1129, 1098; [α]D
20 























Proof of 17S configuration in 249: (R)- and (S)-MTPA-255 
 
The assigned configuration at C17 was confirmed by forming the diastereomeric MTPA esters of alcohol 
249 described below: DCC (15 µL, 14.9 µmol, 1 M in CH2Cl2) was added dropwise to a stirred solution of 
alcohol 254 (2.75 mg, 3.73 µmol), (R) or (S)-MTPA (3.5 mg, 14.9 µmol) and DMAP (one crystal) in CH2Cl2 
(50 µL). The reaction mixture was stirred at r.t. for 16 h before filtering through a pad of silica‡‡‡ The crude 
product was dissolved in MeOH (25 µL) and CH2Cl2 (25 µL) and PPTS (one crystal) was added. The 
solution was stirred at r.t. for 24 h before quenching with NaHCO3 (one drop), dried (MgSO4), filtered and 
the solvent removed under reduced pressure to afford the (S)-MTPA ester diols [(S)-MTPA-255, 1.0 mg, 
1.30 mmol, 46% over two steps] or (R)-MTPA ester diols [(R)-MTPA-255, 1.0 mg, 1.30 mmol, 46% over 
two steps. as a colourless oil.  
(S)-MTPA-255 
Rf (EtOAc/PE 40-60: 20%) = 0.25; 1H NMR (500 MHz, CDCl3) dH 5.81 (1H, d, J = 10.0 Hz, H17), 5.79 (1H, 
s, H10), 5.66 (1H, s, =CH), 5.14 (1H, d, J = 10.0 Hz, H18), 5.04 (1H, dd, J = 7.0, 5.8 Hz, H15), 4.40 (1H, d, J 
= 10.8 Hz, H23a), 4.18 (1H, m, H13), 4.01 (1H, d, J = 10.8 Hz, H23b), 3.48 (1H, m, H21), 2.43 (1H, m, H14a), 
2.41 (1H, m, H12a), 2.26 (1H, m, H12b), 2.19 (3H, s, =CMeaMeb), 2.11 (1H, m, H20a), 1.94 (1H, m, H20b), 
1.93 (3H, s, =CMeaMeb), 1.82 (3H, s, Me11), 1.75 (3H, s, Me19), 1.65 (1H, m, H14b), 1.17 (3H, s, Me16), 
0.92 (3H, s, Me22a), 0.88 (3H, s, Me22b) 
 (R)-MTPA-255 
Rf (EtOAc/PE 40-60: 20%) = 0.22; 1H NMR (500 MHz, CDCl3) dH 5.88 (1H, s, H10), 5.73 (2H, m, =CH, 
H17), 5.33 (1H, s, H18), 4.95 (1H, dd, J = 7.8, 7.0 Hz, H15), 4.29 (1H, d, J = 10.4 Hz, H23a), 4.09 (1H, d, J = 
10.4 Hz, H23b), 4.09 (1H, m, H13), 2.52 (1H, m, H12a), 3.50 (1H, m, H21), 2.51 (1H, m, H20a), 2.32 (1H, 
m, H12b), 2.25 (1H, m, H20b), 2.21 (3H, s, =CMeaMeb), 2.13 (1H, m, H14a), 1.98 (3H, s, =CMeaMeb), 1.81 
 













(−) (+)Δδ = (δS - δR):
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(3H, s, Me11), 1.76 (3H, s, Me19), 1.14 (3H, s, Me16), 1.10 (1H, m, H14b), 0.92 (3H, s, Me22a), 0.88 (3H, s, 
Me22b) 
Alcohol 256 and 21-epi-anti acetonide 257 
 
   
The addition reaction was performed according to the general protocol described above, using vinyl iodide 
ent-233 (42.0 mg, 88.9 µmol), tBuLi (97 µL, 185 µmol, 1.9 M in pentane), MgBr2·OEt2 (381 µL, 229 µmol, 
0.6 M in Et2O), and aldehyde 245 (4.9 mg, 12.7 µmol) to afford the crude product 256 (5.0 mg, 6.78 µmol, 
53%), a colourless oil as an inseparable 5:1 mixture of diastereomers at C17, alongside with the C10 
protodeiodinated material. 
The crude product was transformed to the corresponding acetonide 257 according to the general protocol 
described above to afford the pure diacetonide 257 as a colourless oil (1.8 mg, 3.28 mmol, 48% over three 
steps) 
Rf (EtOAc/PE 40-60: 20%) = 0.83; 1H NMR (500 MHz, CDCl3) dH 5.98 (1H, q, J = 0.8 Hz, H10), 5.19 (1H, 
dq, J = 8.6, 1.2 Hz, H18), 4.42 (1H, d, J = 8.6 Hz, H17), 4.22-4.16 (1H, m, H13), 3.95 (1H, dd, J = 6.9, 1.9 Hz, 
H15), 3.77 (1H, dd, J = 9.2, 2.4 Hz, H21), 3.62 (1H, d, J = 11.4 Hz, H23a), 3.27 (1H, d, J = 11.4 Hz, H23b), 
2.64 (1H, dd, J = 13.8, 7.8 Hz, H12a), 2.49 (1H, dd, J = 13.9, 6.2 Hz, H12b), 2.33 (1H, app dt, J = 14.0, 6.2 
Hz, H14a), 2.21-2.18 (1H, m, H20a), 2.03-1.97 (1H, m, H20b), 1.86 (3H, d, J = 0.9 Hz, Me11), 1.76 (3H, d, 
J = 1.0 Hz, Me19), 1.75-1.68 (1H, m, H14b), 1.42 (3H, s, MeAMeBCO(O))B, 1.39 (3H, s, MeAMeBCO(O))A, 
1.38 (3H, s, MeAMeBCO(O))B, 1.35 (3H, s, MeAMeBCO(O))A, 1.07 (3H, s, Me16), 1.02 (3H, s, Me22a), 0.73 
(3H, s, Me22b); 13C NMR (125 MHz, CDCl3) dC 145.3, 138.9, 120.7, 100.4A, 98.5B, 86.9, 78.2, 76.9, 76.7, 76.1, 
71.9, 71.0, 46.5, 39.4, 36.6, 32.9, 30.9, 29.8B, 25.3A, 24.2, 23.6A, 18.8B, 18.7, 18.3, 18.1; IR (thin film): νmax 2928, 
2857, 1465, 1377, 1222, 1090, 1021; [α]D
20 –22.9 (c 0.05, CHCl3); HRMS (ESI+) calculated for C25H41O5INa 
[M+Na]+ 571.1891, found 571.1885. 























Table of 1H NMR data of phormidolide A triacetonide 151 and diacetonides 252, 254 and 257 
 
 
*In the paper that describes the formation of the phormidolide triacetonide derivative, the 1H values for 
H13 and H15 were erroneously swapped. A reexamination of their 2D 1H-1H COSY data as well as our 
NMR data supports this conclusion. Specifically, the signal attributed to dH 4.1x ppm couples to dH 2.50 and 
2.34 ppm (signals that are attributed to H12). This means the signal attributed to 4.1x ppm arises from H13, 
rather than H15. 




252 (15,17-anti) 254 (15,17-syn) 257 (21-epi-15,17-anti) 
 
13C (ppm) 13C D |D| 13C D |D| 13C D |D| 
Ac1 23.7 23.8 0.10 0.10 20.5 -3.2 3.2 23.6 0.1 0.1 
Ac2 25.3 25.4 0.10 0.10 30.0 4.7 4.7 25.3 0.0 0.0 
C13 76.8 76.6 -0.20 0.20 74.5 -2.3 2.3 76.7 -0.1 0.1 
C14 36.7 36.7 0.00 0.00 36.9 0.2 0.2 36.6 -0.1 0.1 
C15 78.2 77.7 -0.50 0.50 75.3 -2.9 2.9 78.2 0.0 0.0 
C16 87.0 87.0 0.00 0.00 78.8 -8.2 8.2 86.9 -0.1 0.1 
Me16 18.4 18.9 0.50 0.50 19.2 0.8 0.8 18.7 0.3 0.3 
C17 71.8 73.0 1.20 1.20 70.0 -1.8 1.8 71.9 0.1 0.1 
C18 120.3 123.0 2.70 2.70 121.5 1.2 1.2 120.7 0.4 0.4 
Me19 18.2 17.8 -0.40 0.40 19.0 0.8 0.8 18.3 0.1 0.1 
C20 39.0 40.0 1.00 1.00 38.5 -0.5 0.5 39.4 0.4 0.4 





252 (15,17-anti) 254 (15,17-syn) 257 (21-epi-15,17-anti) 
 
1H (ppm) 1H D |D| 1H D |D| 1H D |D| 
Ac1 1.34 1.34 0.00 0.00 1.49 0.15 0.15 1.35 0.01 0.01 
Ac2 1.38 1.39 0.01 0.01 1.38 0.00 0.00 1.39 0.01 0.01 
H13* 4.16 4.17 0.01 0.01 4.11 -0.05 0.05 4.19 0.03 0.03 
H14A 2.32 2.32 0.00 0.00 2.34 0.02 0.02 2.33 0.01 0.01 
H14B 1.75 1.70 -0.05 0.05 1.72 -0.03 0.03 1.71 -0.04 0.04 
H15* 3.94 3.94 0.00 0.00 4.21 0.27 0.27 3.95 0.01 0.01 
Me16 1.07 1.06 -0.01 0.01 0.93 -0.14 0.14 1.07 0.00 0.00 
H17 4.42 4.40 -0.02 0.02 4.50 0.08 0.08 4.42 0.00 0.00 
H18 5.18 5.19 0.01 0.01 5.55 0.37 0.37 5.19 0.01 0.01 
Me19 1.74 1.72 -0.02 0.02 1.76 0.02 0.02 1.76 0.02 0.02 
H20A 2.20 2.09 -0.11 0.11 2.25 0.05 0.05 2.18 -0.02 0.02 
H20B 2.03 2.05 0.02 0.02 1.98 -0.05 0.05 2.03 0.00 0.00 
H21 3.70 3.64 -0.06 0.06 3.81 0.11 0.11 3.78 0.08 0.08 
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8.5.3. DFT optimised geometry for the Mg-chelated C10-C17 aldehyde 
Structure optimisation was conducted as follows: A conformational search was carried out in 
MacroModel192 using a hybrid of Monte Carlo multiple−minimum (MCMM)193/low−mode sampling194 
with the Merck Molecular Force Field (MMFF),195 interfaced with Maestro 9.3.196 The searches were carried 
out with a sufficient number of steps to find all conformers within 10 kJ mol−1of the global minimum. All 
conformers within 10 kJ mol−1 of the global minimum were then further subjected to quantum mechanical 
calculations at the B3LYP197/6-31G** level of theory, implemented with Jaguar 7.9. The free energy in 
solution was derived from structures optimised in the gas phase by means of a single point calculation using  
B3LYP197/6-31G** level of theory with the polarisable continuum model (PCM) as implemented in the 
Jaguar program (version 9.3), using diethyl ether (probe radius = 2.74 Å) as the solvent. These values were 
used to correct the Gibbs free energy derived from the DFT calculations. 
Mg-chelate structure 256 
 
B3LYP/6-31G** Free Energy: B3LYP/6-31G** Free Energy in solution: 
–1085.2570 Hartrees –1085.5556 Hartrees 
Number of imaginary frequencies: 0  
Coordinates for the lowest energy conformer 
Atom x y z 
C1 -0.2603 -0.3545 0.8179 
C2 0.6585 0.7693 0.2948 
C3 2.0712 0.3112 0.6238 
O4 1.9797 -1.1941 0.5970 
C5 0.5873 -1.6610 0.7018 
O6 -1.4241 -0.5576 0.0355 
C7 3.1665 0.6656 -0.4002 
C8 -2.4935 0.3522 0.3466 
O9 -2.2700 1.2147 1.1676 
C10 -3.6643 0.0194 -0.4323 
C11 -4.8595 0.6748 -0.3861 
C12 -5.1696 1.8555 0.4833 









C14 3.6692 2.1061 -0.3786 
C15 4.5448 2.4821 0.7912 
C16 3.3358 2.9404 -1.3723 
C17 0.2760 -2.3904 -0.5910 
C18 0.4320 -2.6235 1.8844 
O19 1.1245 -2.5162 -1.4966 
H20 -0.5293 -0.1781 1.8634 
H21 0.4119 1.7257 0.7587 
H22 0.5150 0.8767 -0.7878 
H23 2.3918 0.5722 1.6342 
H24 2.7706 0.4926 -1.4329 
H25 4.0630 0.0220 -0.1970 
H26 -3.5541 -0.8324 -1.0949 
H27 -4.3123 2.2315 1.0363 
H28 -5.5934 2.6601 -0.1292 
H29 -5.9557 1.5765 1.1973 
H30 -6.2982 0.9994 -1.9375 
H31 -5.7251 -0.6823 -1.8473 
H32 -6.8633 -0.0373 -0.6415 
H33 4.0436 2.3356 1.7554 
H34 5.4664 1.8864 0.8072 
H35 4.8319 3.5332 0.7275 
H36 3.6652 3.9746 -1.3632 
H37 2.7319 2.6361 -2.2234 
H38 -0.7051 -2.8595 -0.7134 
H39 1.0348 -3.5285 1.7661 
H40 0.7373 -2.1147 2.8022 
H41 -0.6184 -2.9141 1.9840 
Mg42 2.8637 -1.6683 -1.0962 
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8.5.4. Synthesis of the C24-C33 fragment 
Alkyne 261 236 
 
TBSCl (282 mg, 1.87 mmol) was added to a stirred solution of 4-butyn-1-ol (100 mg, 1.78 mmol) and 
imidazole (295 mg, 1.96 mmol) in CH2Cl2 (4 mL). The cloudy mixture was stirred at r.t. for 16 h before 
quenching with NH4Cl (4 mL). The layers were separated and the aqueous phase extracted with CH2Cl2 (3 
× 5 mL). The combined organic phases were dried (MgSO4) and the solvent removed under reduced 
pressure. Purification by flash column chromatography (Et2O/PE 30-40: 0  15%) afforded the product 
261 as a colourless liquid (233 mg, 1.26 mmol, 71%). 
Rf (EtOAc/PE 40-60: 20%) = 0.71; 1H NMR (500 MHz, CDCl3) dH 3.74 (2H, t, J = 7.1 Hz, CH2OTBS), 2.40 
(2H, td, J = 7.1, 2.6 Hz, CCH2), 1.96 (1H, t, J = 2.6 Hz, CH), 0.90 (9H, s, SiMe2tBu), 0.08 (6H, s, 
SiMe2tBu). 
Data in agreement with that presented by Sneddon198 
Alcohol 264 
 
A mixture of 2,3-dibromoprop-1-ene (293 µL, 3.00 mmol), formalin (150 µL, 2.00 mmol, 37% wt solution 
in water), SnCl2·2H2O (677 mg, 3.00 mmol), KI (996 mg, 6.00 mmol) in water (5 mL) was vigorously stirred 
for 1 h, during which an opaque yellow suspension was formed. The mixture was diluted with Et2O (10 mL), 
the layers separated and the aqueous phase extracted with Et2O (3 × 5 mL). The combined organic phases 
were washed with brine (75 mL), dried (Na2SO4) and the solvent removed under reduced pressure. 
Purification by flash column chromatography (Et2O/PE 30-40: 20%) afforded the alcohol 264 as a colourless 
liquid (343 mg, 2.27 mmol, 76%) 
Rf (EtOAc/PE 40-60: 50%) = 0.71; 1H NMR (500 MHz, CDCl3) dH 5.71 (1H, dt, J = 1.7, 1.2 Hz, CHaHb=C31), 
5.54 (1H, d, J = 1.7 Hz, CHaHb=C31), 3.82 (2H, q, J = 5.9 Hz, H29), 2.68 (2H, td, J = 5.9, 0.9 Hz, H30), 1.51 
(1H, t, J = 6.0 Hz, OH); 13C NMR (125 MHz, CDCl3) dC 130.4, 119.4, 60.0, 44.4. 







TBS ether 265 228 
 
TBSCl (210 mg, 1.39 mmol) was added to a stirred solution of alcohol 264 (200 mg, 1.32 mmol) and 
imidazole (99.2 mg, 1.46 mmol) in CH2Cl2 (4 mL). The cloudy mixture was stirred at r.t. for 16 h before 
quenching with NH4Cl (5 mL). The layers were separated and the aqueous phase extracted with CH2Cl2 (3 
× 5 mL). The combined organic phases were dried (MgSO4) and the solvent removed under reduced 
pressure. Purification by flash column chromatography (EtOAc/PE 40-60: 0  5%) afforded the product 
265 as a colourless liquid (313 mg, 1.18 mmol, 89%). 
Rf (EtOAc/PE 40-60: 20%) = 0.82; 1H NMR (400 MHz, CDCl3) dH 5.63 (1H, d, J = 1.5 Hz, CHaHb=C31), 
5.46 (1H, d, J = 1.5 Hz, CHaHb=C31), 3.79 (2H, t, J = 6.3 Hz, H29), 2.62 (2H, td, J = 6.3, 1.5 Hz, H30), 0.89 
(9H, s, SiMe2tBu), 0.07 (6H, s, SiMe2tBu). 
Data in agreement with that presented by Liu200 
Bromoketone 269 via enol ether 267 
   
Pd(PPh3)4 (2.2 mg, 1.90 µmol) was added to a stirred suspension of vinyl bromide 265 (25.0 mg, 94.2 µmol), 
vinyl stannane 266§§§ (37.5 mg, 104 µmol), CuI (20.0 mg, 105 µmol), LiCl (7.5 mg, 177 µmol) in THF (500 
µL). The resulting green-brown suspension was stirred for 16 h at r.t. before filtering over Celite® and a thin 
pad of SiO2. The resulting filtrate was concentrated under reduced pressure to afford the crude enol ether 
267 as a colourless liquid (21.0 mg, 82.0 µmol, 87%). An analytically pure sample of the enol ether was not 
obtained as the enol ether was unstable and degraded on further purification. 
NBS (3.0 mg, 17.1 µmol) was added to a stirred solution of the crude enol ether 267 (4.0 mg, 15.6 µmol) in 
CH2Cl2 (200 µL) at 0 °C. The reaction mixture was stirred for 10 min before quenching with Na2S2O3 (200 
µL) and the layers separated. The aqueous phase was extracted with CH2Cl2 (3 × 200 µL). The combined 
organic phases were dried (MgSO4) and the solvent removed under reduced pressure. Purification by flash 
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column chromatography (EtOAc/PE 40-60: 5%) afforded the product 269 as a colourless liquid (4.1 mg, 
13.4 µmol, 86%). 
Rf (EtOAc/PE 40-60: 20%) = 0.43; 1H NMR (400 MHz, CDCl3) dH 6.11 (1H, s, CHaHb=C31), 5.96 (1H, t, J 
= 1.1 Hz, CHaHb=C31), 4.24 (2H, s, H33), 3.69 (2H, t, J = 6.3 Hz, H29), 2.53 (2H, td, J = 6.3, 1.1 Hz, H30), 
0.86 (9H, s, SiMe2tBu), 0.02 (6H, s, SiMe2tBu). 13C NMR (100 MHz, CDCl3) dC 192.7, 143.3, 128.1, 61.6, 34.7, 
30.7, 25.9, 18.3, –5.3, –5.4; IR (thin film): νmax 2954, 2928, 2856, 1694, 1471, 1256, 1099; HRMS (ESI+) 
calculated for C12H23O279BrSiNa [M+Na]+ 306.0651, found 306.0639. 
Acetal 178 529 
 
Bromine (8.50 mL, 167 mmol) was added to a stirred solution of methanol (100 mL) and acetone (6.30 mL, 
167 mmol) at 0 °C. The red solution was allowed to warm to r.t. over 16 h, to which the colour faded to a 
pale-yellow solution. The stirring was stopped, and the solution was cooled to –40 °C for 3 h, to which a 
white precipitate formed. The solid was filtered, washed with cold MeOH (3 ´ 5 mL) and the solid dried in 
vacuo to afford the product 178 as white crystals (8.54 g, 32.2 mmol, 19%).  
1H NMR (500 MHz, CDCl3) dH 3.58 (6H, s, MeO), 3.29 (4H, s, CH2Br). HRMS (ESI+) calculated for 
C4H7Br2O [M–OMe]+ 230.8843, found 230.8848. 
Data in agreement with that presented by Dieckmann201 
Tribromide 277 
 
AcBr (11.0 mL, 153 mmol) was added to a stirred solution of acetal 178 (8.00 g, 30.5 mmol) in CH2Cl2 (75 
mL) at 0 °C. The reaction mixture was stirred at 0 °C for 2 h before adding a further aliquot of AcBr (11.0 
mL, 153 mmol) and allowing the mixture to warm to r.t. over 16 h. The solvent and excess reagents were 
removed under reduced pressure to afford the tribromide 277 as a yellow-orange liquid (9.08 g, 29.2 mmol, 
96%). 
1H NMR (500 MHz, CDCl3) dH 4.10 (2H, d, J = 11.8 Hz, CHaHbBr), 4.07 (2H, d, J = 11.8 Hz, CHaHbBr), 3.88 
(3H, s, OMe). HRMS (ESI+) calculated for C4H7Br2O [M–Br]+ 230.8843, found 230.8841. 







Z-Bromo enol ether Z-271 
 
iPr2NH (12.3 mL, 86.7 mmol) was added dropwise to a stirred solution of the tribromide 277 (9.00 g, 29.0 
mmol) in CH2Cl2 (50 mL) at 0 °C. The reaction mixture was allowed to warm to r.t. over 4 h, after which 
the reaction mixture was quenched by the addition of NH4Cl (40 mL). The layers were separated and the 
aqueous phase was extracted with CH2Cl2 (3 × 20 mL). The combined organic phases were washed with 
brine (75 mL), dried (MgSO4) and the solvent removed under reduced pressure to afford the product Z-
271 as an amber liquid (6.61 g, 28.7 mmol, 99%) as a 1:10 mixture of E/Z isomers. 
1H NMR (500 MHz, CDCl3) dH 5.67 (1H, s, H33), 4.02 (2H, s, H31), 3.88 (3H, s, OMe32). 13C NMR (125 
MHz, CDCl3) dC 153.1, 89.2, 57.0, 27.7. 
Data in agreement with that presented by Gil100 
E-Bromo enol ether E-271 (NOE: 548, 551) 
 
A solution of the Z-bromo enol ether Z-271 (1.55 g, 6.74 mmol, E/Z = 1:10) in hexane (600 mL) was 
degassed by bubbling a stream of Ar for 30 min. The stirred solution was irradiated with UV light for 6 h 
to afford a brown mixture. The mixture was filtered over silica, eluting with PE 40-60 (100 mL). The solvent 
was removed under reduced pressure to afford the product E-271 as an amber liquid (1.16 g, 5.04 mmol, 
75%) as a 10:1 mixture of E/Z isomer. 
1H NMR (500 MHz, CDCl3) dH 5.37 (1H, s, H33), 4.13 (2H, s, H31), 3.64 (3H, s, OMe32). HRMS (ESI+) 
calculated for C4H6Br2OH [M+H]+ 230.8843, found 230.8868.  
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Allylic alcohol 276 
 
NaOAc (8.00 g, 97.9 mmol) and KI (216 mg, 1.30 mmol) was added to a stirred solution of E-bromo enol 
ether E-271 (1.50 g, 6.52 mmol) in DMF (50 mL). The reaction mixture was stirred at 110 °C for 1 h before 
cooling to r.t. and diluting with Et2O (50 mL) and H2O (150 mL). The layers were separated, and the 
aqueous phase extracted with Et2O (3 × 40 mL). The combined organic phases were washed with brine (3 
´ 20 mL), dried (MgSO4) and the solvent removed under reduced pressure to afford the crude acetate ester, 
which was redissolved in MeOH (50 mL) and H2O (50 mL). NaOH (5.20 g, 130 mmol) was added in one 
portion to a stirred solution of the crude ester, and the reaction mixture was stirred at 75 °C for 1 h. The 
mixture was allowed to cool to r.t., diluted with H2O (50 mL) and partitioned with CH2Cl2 (25 mL). The 
layers were separated, and the aqueous phase extracted with CH2Cl2 (3 × 25 mL). The combined organic 
phases were washed with brine (3 ́  20 mL), dried (MgSO4) and the solvent removed under reduced pressure 
to afford the product 276 as a pale-yellow oil (993 mg, 5.95 mmol, 91% over two steps). 
1H NMR (500 MHz, CDCl3) dH 5.25 (1H, s, H33), 4.36 (2H, s, H31), 3.63 (3H, s, OMe32). HRMS (ESI+) 
calculated for C4H7BrO2H [M+H]+ 166.9708, found 166.9708.  
Data in agreement with that presented by Gil100 
Aldehyde 278 
 
MnO2 (4.00 g, 47.9 mmol) was added to a stirred solution of alcohol 276 (800 mg, 4.79 mmol) in CH2Cl2 
(30 mL). The suspension was vigorously stirred for 24 h, before filtering over Celite® and washing the pad 
with CH2Cl2 (15 mL). The solvent was removed under reduced pressure to afford the product as a pale-
yellow oil, which was used directly in the subsequent transformation without further purification. Note that 
owing to the volatility of the aldehyde, an accurate mass could not be obtained for the product. All yields 














1H NMR (500 MHz, CDCl3) dH 10.00 (1H, s, H31), 6.34 (1H, s, H33), 3.69 (3H, s, OMe32). HRMS (ESI+) 
calculated for C4H5BrO2H [M+H]+ 164.9552, found 164.9551.  
Data in agreement with that presented by Gil100 
Alcohol 279 
 
nBuLi (21.4 mL, 34.3 mmol, 1.6 M in hexane) was added dropwise to a stirred solution of iPr2NH (6.00 mL, 
42.8 mmol) in THF (9 mL) at 0 °C. The pale-yellow solution was stirred for 30 min at 0 °C before cooling to 
-78 °C. EtOAc (3.48 mL, 35.7 mmol) was added dropwise to the solution, and the mixture was stirred at 
-78 °C for 1 h to give a ca. 1.0 M solution of the lithium enolate. 
The lithium enolate solution (23.9 mL, 23.9 mmol, 1.0 M) was added dropwise to a stirred solution of 
aldehyde 278 (790 mg, 4.76 mmol, dried over CaH2) in THF (20 mL) at –78 °C. The resulting solution was 
stirred at –78 °C for 2 h before being quenched with a solution of NaHCO3 (40 mL) and warmed to r.t.. The 
mixture was diluted with Et2O, separated and the aqueous phase extracted with Et2O (3 × 20 mL). The 
combined organic phases were washed with brine, dried (MgSO4) and the solvent removed under reduced 
pressure. Purification by flash column chromatography (Et2O/PE 30-40: 30%) afforded the product 279 as 
a colourless oil (437 mg, 1.73 mmol, 30% over two steps from alcohol 276). 
Rf (EtOAc/PE 40-60: 30%) = 0.28; 1H NMR (500 MHz, CDCl3) dH 5.25-5.21 (2H, m, H33, H31), 4.19 (2H, 
q, J = 7.1 Hz, OCH2CH3), 3.63 (3H, s, OMe32), 2.94 (1H, d, J = 7.0 Hz, OH), 2.72 (1H, dd, J = 15.8, 8.8 Hz, 
H28a), 2.59 (1H, dd, J = 15.8, 4.2 Hz, H28b), 1.28 (3H, t, J = 7.1 Hz, OCH2CH3); 13C NMR (125 MHz, CDCl3) 
dC 171.4, 157.5, 78.8, 66.5, 60.9, 55.8, 38.9, 14.2; IR (thin film): νmax 3471 (br), 2986, 1730, 1624, 1278, 1204, 
1166, 1039; HRMS (ESI+) calculated for C8H13O479BrNa [M+Na]+ 274.9889, found 274.9884. 
Alcohol 284 
 
MeMgBr (2.42 mL, 7.26 mmol, 3 M in Et2O) was added dropwise to a stirred solution of aldehyde 278 (ca. 
400 mg, 2.42 mmol) in Et2O (15 mL) at –78 °C. The reaction mixture was stirred at –78 °C for 30 min before 
quenching with NH4Cl (10 mL) and the mixture warmed to r.t.. The layers were separated, and the aqueous 
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removed under reduced pressure. Purification by flash column chromatography (Et2O/PE 30-40: 20%) 
afforded the product 284 as a colourless liquid (311 mg, 1.72 mmol, 71% from alcohol 276 over two steps). 
Rf (EtOAc/PE 40-60: 20%) = 0.40; 1H NMR (500 MHz, CDCl3) dH 5.15 (1H, s, H33), 4.93 (1H, dq, J = 8.4, 
6.6 Hz, H31), 3.63 (3H, s, OMe32), 2.09 (1H, d, J = 8.4 Hz, OH), 1.33 (3H, d, J = 6.6 Hz, H30). 
Data in agreement with that presented by Gil100 
Ketone 179 
 
DMSO (401 µL, 5.65 mmol) was added dropwise to a solution of (COCl)2 (242 µL, 2.82 mmol) in CH2Cl2 
(5 mL) at –78 °C. The solution was stirred at –78 °C for 10 min before adding a solution of alcohol 284 (311 
mg, 1.72 mmol, dried over 4 Å MS) in CH2Cl2 (5 mL) via cannula. The solution was stirred at –78 °C for 30 
min before the dropwise addition to Et3N (1.18 mL, 8.47 mmol) and allowing the reaction mixture to warm 
to –20 °C. The reaction mixture was quenched with NH4Cl (10 mL), the layers were separated, and the 
aqueous phase extracted with CH2Cl2 (3 × 5 mL). The combined organic phases were dried (MgSO4) and 
the solvent removed under reduced pressure. Purification by flash column chromatography (Et2O/PE 30-
40: 10%) afforded the product 179 as a colourless liquid (219 mg, 1.22 mmol, 71%). 
Rf (EtOAc/PE 40-60: 20%) = 0.52; 1H NMR (500 MHz, CDCl3) dH 5.64 (1H, s, H33), 3.65 (3H, s, OMe32), 
2.35 (3H, s, H30). 
Data in agreement with that presented by Gil100 
Silyl enol ether 186 
 
TMSOTf (133 µL, 736 µmol) was added dropwise to a stirred solution of ketone 179 (100 mg, 613 µmol) 
and Et3N (128 µL, 920 µmol) in CH2Cl2 (3 mL) at 0 °C. The pale-yellow reaction mixture was allowed to 
warm to r.t. over 16 h, before quenching with NaHCO3 (3 mL). The layers were separated, and the aqueous 
phase extracted with CH2Cl2 (3 × 2 mL). The combined organic phases were dried (MgSO4) and the solvent 












Rf (EtOAc/PE 40-60: 20%) = 0.63; 1H NMR (500 MHz, CDCl3) dH 5.39 (1H, s, H33), 4.76 (1H, s, H30a), 
4.65 (1H, s, H30b), 3.60 (3H, s, OMe32). 
Data in agreement with that presented by Gil100 
Ester 289 
 
A solution of aldehyde 278 (790 mg, 4.79 mmol, dried over 4 Å MS) in CH2Cl2 (10 mL) was transferred via 
cannula into a stirred mixture of MnO2 (4.20 g, 47.9 mmol), 1,4-dimethyl-1,2,4-triazolium iodide (215 mg, 
958 µmol), crushed 4 Å MS (250 mg) in CH2Cl2 (40 mL) at r.t.. DBU (786 µL, 5.27 mmol) was added 
dropwise to the mixture and was vigorously stirred at r.t. for 16 h. The reaction mixture was filtered over 
Celite® and the solvent removed under reduced pressure. Purification by flash column chromatography 
(Et2O/PE 30-40: 15%) afforded the product 289 as a colourless liquid (219 mg, 1.22 mmol, 80% from alcohol 
276 over two steps). 
Rf (EtOAc/PE 40-60: 20%) = 0.39; 1H NMR (500 MHz, CDCl3) dH 5.84 (1H, s, H33), 3.86 (3H, s, CO2Me), 
3.68 (3H, s, OMe32); 13C NMR (125 MHz, CDCl3) dC 162.4, 148.9, 87.5, 56.6, 52.5; IR (thin film): νmax 1737, 
1436, 1339, 1207, 1151; HRMS (ESI+) calculated for C5H7BrO3H [M+H]+ 194.9657, found 194.9653. 
Alcohol 291 
 
A freshly prepared solution of TMSCH2MgCl (7.20 mL, 10.0 mmol, 1.4 M in THF) was added to a stirred 
mixture of anhydrous CeCl3 (2.46 g, 10.0 mmol) in THF (7 mL) at –78 °C. The mixture was stirred at –78 °C 
for 1 h before the dropwise addition of a solution of ester 289 (272 mg, 2.00 mmol) in THF (6 mL) via 
cannula at –78 °C. The reaction mixture was stirred at –78 °C for 2 h, before warming to r.t. over 16 h. The 
reaction mixture was quenched by addition of NH4Cl (20 mL) at 0 °C and diluted with CH2Cl2 (20 mL). The 
layers were separated, and the aqueous phase extracted with CH2Cl2 (3 × 15 mL). The combined organic 
phases were washed with brine (20 mL), dried (MgSO4) and the solvent carefully removed under reduced 
pressure (400 Torr). Purification by flash column chromatography (Et2O/PE 30-40: 0%  15%) afforded 
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Rf (EtOAc/PE 40-60: 20%) = 0.69; 1H NMR (500 MHz, CDCl3) dH 5.03 (1H, s, H33), 3.53 (3H, s, OMe32), 
2.97 (1H, s, OH), 1.29 (2H, dd, J = 14.5, 1.1 Hz, CHaHbTMS), 1.61 (1H, d, J = 14.5 Hz, CHaHbTMS), 0.01 
(18H, s, TMS); 13C NMR (125 MHz, CDCl3) dC 162.3, 74.7, 55.2, 34.1, 32.9, 22.3, 0.0; IR (thin film): νmax 




PPTS (67 mg, 0.27 mmol) was added to a stirred solution of alcohol 291 (450 mg, 1.33 mmol) in CH2Cl2 
(14 mL) and methanol (1 mL) at r.t.. The solution was stirred at r.t. for 45 min before quenching with 
NaHCO3 (10 mL). The layers were separated, and the aqueous phase extracted with CH2Cl2 (3 × 10 mL). 
The combined organic phases were dried (MgSO4) and the solvent carefully removed under reduced 
pressure (400 Torr). Purification by flash column chromatography (Et2O/PE 30-40: 0%  2%) afforded the 
product 286 as a colourless liquid (267 mg, 1.07 mmol, 81%). 
Rf (EtOAc/PE 40-60: 10%) = 0.69; 1H NMR (500 MHz, CDCl3) dH 5.25 (1H, s, H33), 5.18 (1H, d, J = 1.7 Hz, 
H30a), 5.10 (1H, d, J = 1.7 Hz, H30b), 3.56 (3H, s, OMe32), 1.75 (2H, d, J = 1.0 Hz, CH2TMS), 0.03 (9H, s, 
TMS); 13C NMR (125 MHz, CDCl3) dC 160.1, 140.2, 117.0, 77.6, 55.4, 25.0, –1.5; IR (thin film): νmax 2958, 




A solution of allylmagnesium chloride (3.92 mL, 6.66 mmol, 1.7 M in THF) was added to a stirred solution 
of (+)-Ipc2BOMe (2.11 g, 6.66 mmol) in Et2O (30 mL) at –78 °C. The solution was stirred at –78 °C for 30 
min before allowing to warm to r.t. over 1 h, upon which a grey white suspension formed. The mixture was 
cooled to –78 °C, and a solution of aldehyde 106 (990 mg, 4.76 mmol, dried over 4 Å MS) in Et2O (20 mL) 
was added dropwise to the reaction. The mixture was stirred at –78 °C for 2 h before quenching at –78 °C 
with the successive addition of MeOH (10 mL), pH 7 buffer (10 mL) and H2O2 (4 mL). The mixture was 
warmed to r.t. and the layers separated. The aqueous phase was extracted with Et2O (3 × 20 mL), and the 











phases were then dried (MgSO4) and the solvent removed under reduced pressure. Purification by flash 
column chromatography (EtOAc/PE 40-60: 10%  15%) afforded the product 292 as a colourless oil (896 
mg, 3.58 mmol, 75%) as a single diastereomer. 
Rf (EtOAc/PE 40-60: 20%) = 0.38; 1H NMR (500 MHz, CDCl3) dH 7.24 (2H, d, J = 8.6 Hz, ArH), 6.88 (2H, 
d, J = 8.6 Hz, ArH), 5.84 (1H, ddt, J = 17.1, 10.1, 7.0 Hz, H29), 5.11 (1H, d, J = 17.1 Hz, =CHaHb), 5.08 (1H, 
d, J = 10.1 Hz, =CHaHb), 4.44 (2H, s, CH2Ar), 3.84-3.80 (1H, m, H27), 3.81 (3H, s, OMe), 3.49 (2H, d, J = 
5.4 Hz, H25), 2.53 (1H, d, J = 3.8 Hz, OH), 2.27-2.16 (2H, m, H28), 1.92-1.85 (1H, m, H26), 0.95 (3H, d, J 
= 7.0 Hz, Me26). 
Data in agreement with that presented by Liu202 
The absolute stereochemical outcome at C27 was confirmed by Mosher ester analysis from the 
enantiomeric compound ent-292 
Mosher esters (R)-MTPA-293 and (S)-MTPA-293 
 
 (R)-Mosher ester (R)-MTPA-293 
DCC (64 µL, 64.0 µmol, 1 M in CH2Cl2) was added in portion to a stirred solution of alcohol ent-292 (4.0 
mg, 16.0 µmol), (R)-MTPA (15.0 mg, 63.9 5µmol) and DMAP (one crystal) in CH2Cl2 (500 µL). The 
mixture was stirred for 24 h at r.t., during which the solution became a white suspension. The mixture was 
filtered through cotton wool and the filtrate reduced to dryness. Purification by flash chromatography 
(EtOAc/PE 40-60: 10%) afforded the product (R)-MTPA-293 as a colourless oil (4.0 mg, 8.6 µmol, 54%). 
Rf (EtOAc/PE 40-60: 20%) = 0.52; 1H NMR (500 MHz, CDCl3) dH 7.52-7.36 (5H, m, ArH), 7.24 (2H, d, J = 
8.6 Hz, ArH), 6.87 (2H, d, J = 8.6 Hz, ArH), 5.67 (1H, m, H29), 5.34 (1H, m, H27), 5.05-4.99 (2H, m, =CH2), 
4.40 (1H, d, J = 11.5 Hz, CHAHBAr), 4.36 (1H, d, J = 11.5 Hz, CHAHBAr), 3.80 (3H, s, ArOMe), 3.47 (3H, s, 
OMe), 3.26 (2H, d, J = 7.1 Hz, H25), 2.43 (1H, m, H28a), 2.33 (1H, m, H28b), 2.07 (1H, m, H26), 0.92 (3H, 
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(S)-Mosher ester (S)-MTPA-293 
DCC (64 µL, 64.0 µmol, 1 M in CH2Cl2) was added in portion to a stirred solution of alcohol ent-292 (4.0 
mg, 16.0 µmol), (S)-MTPA (15.0 mg, 63.9 µmol) and DMAP (one crystal) in CH2Cl2 (500 µL). The mixture 
was stirred for 24 h at r.t., during which the solution became a white suspension. The mixture was filtered 
through cotton wool and the filtrate reduced to dryness. Purification by flash chromatography (EtOAc/PE 
40-60: 10%) afforded the product (S)-MTPA-293 as a colourless oil (5.3 mg, 11.4 µmol, 71%). 
Rf (EtOAc/PE 40-60: 20%) = 0.52; 1H NMR (500 MHz, CDCl3) dH 7.54-7.35 (5H, m, ArH), 7.23 (2H, d, J = 
8.6 Hz, ArH), 6.87 (2H, d, J = 8.6 Hz, ArH), 5.75 (1H, m, H29), 5.40 (1H, m, H27), 5.14-5.06 (2H, m, =CH2), 
4.36 (1H, d, J = 11.5 Hz, CHAHBAr), 4.30 (1H, d, J = 11.5 Hz, CHAHBAr), 3.80 (3H, s, ArOMe), 3.53 (3H, s, 
OMe), 3.16 (2H, m, H25), 2.50 (1H, m, H28a), 2.40 (1H, m, H28b), 2.05 (1H, m, H26), 0.87 (3H, d, J = 6.7 
Hz, Me26). 
General protocol for the synthesis of silyl ethers 288 and 295 
 
TBS or TES triflate (1.1 eq.) was added to a stirred solution of alcohol 292 (1 eq.) and 2,6-lutidine (1.2 eq.) 
in CH2Cl2 (c = 0.1 M relative to alcohol 292) at –78 °C. The reaction mixture was stirred at –78 °C for 45 
min before quenching with MeOH and NaHCO3. The layers were separated, and the aqueous phase 
extracted with CH2Cl2. The combined organic phases were dried (MgSO4) and the solvent removed under 
reduced pressure. Purification by flash column chromatography (EtOAc/PE 40-60: 0%  2%) afforded the 
product as a colourless oil. 
TES ether 288 
TES ether 288 was synthesised using the above general protocol from alcohol 292 (590 mg, 2.36 mmol), 
TESOTf (570 µL, 2.60 mmol) and 2,6-lutidine (329 µL, 2.84 mmol) as a colourless oil (628 mg, 1.72 mmol, 
73%). 
Rf (EtOAc/PE 40-60: 10%) = 0.54; 1H NMR (500 MHz, CDCl3) dH 7.25 (2H, d, J = 8.4 Hz, ArH), 6.87 (2H, 
d, J = 8.4 Hz, ArH), 5.75 (1H, ddt, J = 17.2, 10.1, 7.2 Hz, H29), 5.03 (1H, d, J = 17.2 Hz, =CHaHb), 5.00 (1H, 
d, J = 10.1 Hz, =CHaHb), 4.44 (1H, d, J = 11.5 Hz, CHaHbAr), 4.38 (1H, d, J = 11.5 Hz, CHaHbAr), 3.85 (1H, 
td, J = 6.5, 2.9 Hz, H27), 3.80 (3H, s, OMe), 3.43 (1H, dd, J = 8.5, 7.0 Hz, H25a), 3.24 (1H, dd, J = 8.5, 7.0 












0.87 (3H, d, J = 6.8 Hz, Me26), 0.57 (6H, q, J = 7.9 Hz, SiCH2CH3); 13C NMR (125 MHz, CDCl3) dC 159.1, 
135.5, 130.8, 129.3, 116.6, 113.7, 72.8, 72.7, 72.0, 52.3, 39.7, 37.7, 10.8, 7.0, 5.2; IR (thin film): νmax 2955, 2876, 
1613, 1513, 1247, 1040; [α]D
20  +2.3 (c 0.31, CHCl3); HRMS (ESI+) calculated for C21H36O3SiH [M+H]+ 
365.2512, found 365.2514. 
TBS ether 295 
TBS ether 295 was synthesised using the above general protocol from alcohol 292 (187 mg, 747 µmol), 
TBSOTf (190 µL, 822 µmol) and 2,6-lutidine (104 µL, 896 µmol) as a colourless oil (270 mg, 741 µmol, 
99%). 
Rf (EtOAc/PE 40-60: 10%) = 0.63; 1H NMR (500 MHz, CDCl3) dH 7.25 (2H, d, J = 8.6 Hz, ArH), 6.88 (2H, 
d, J = 8.6 Hz, ArH), 5.74 (1H, ddt, J = 17.2, 10.1, 7.2 Hz, H29), 5.02 (1H, d, J = 17.2 Hz, =CHaHb), 5.00 (1H, 
d, J = 10.1 Hz, =CHaHb), 4.44 (1H, d, J = 11.5 Hz, CHaHbAr), 4.37 (1H, d, J = 11.5 Hz, CHaHbAr), 3.84 (1H, 
td, J = 6.6, 2.9 Hz, H27), 3.80 (3H, s, OMe), 3.41 (1H, dd, J = 9.1, 6.8 Hz, H25a), 3.23 (1H, dd, J = 9.1, 6.8 
Hz, H25a), 2.27-2.17 (2H, m, H28), 1.87 (1H, dq, J = 6.8, 3.0 Hz, H26), 0.88-0.86 (12H, m, Me26, SiMe2tBu), 
0.03 (3H, s, SiMe2tBu), 0.02 (3H, s, SiMe2tBu); 13C NMR (125 MHz, CDCl3) dC 159.1, 135.5, 130.8, 129.2, 
116.6, 113.7, 72.8, 72.6, 71.8, 52.3, 39.6, 37.5, 25.9, 18.1, 10.7, –4.3, –4.8; IR (thin film): νmax 2935, 2858, 1613, 
1514, 1250, 1040; [α]D
20 +0.73 (c 0.27, CHCl3); HRMS (ESI+) calculated for C21H36O3SiH [M+H]+ 365.2512, 
found 365.2512. 
General protocol for the synthesis of aldehydes 287 and 294 
 
  
Method A: direct ozonolysis 
A stream of O3 was bubbled through a stirred red mixture of alkene, Sudan Red dye (one crystal), NaHCO3 
(10 eq.) in CH2Cl2 (8 mL) and MeOH (8 mL) at –78 °C. The stream of O3 was immediately stopped once 
the reaction mixture turned pale yellow (ca. 5 min) and replaced with a stream of O2, bubbling into the 
stirred mixture for 10 min at –78 °C. PPh3 (1.05 eq.) was added in one portion, and the stirred solution was 
allowed to warm to r.t.. The solvent was then removed under reduced pressure, and the crude mixture was 
purified by flash column chromatography (EtOAc/PE 40-60: 10%  20%) to afford the product as a 
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Method B: dihydroxylation followed by periodate cleavage 
A solution of NMO (1.2 eq.) was added in one portion to a stirred mixture of the alkene, K2OsO4·2H2O 
(0.02 eq.) in tBuOH, H2O and THF (1:1:1, 0.3 M) at r.t.. The solution was stirred for 24 h at r.t., after which 
the reaction mixture was quenched by addition of Na2SO3, diluted with EtOAc and stirred for 30 min at r.t.. 
The layers were separated, and the aqueous phase extracted with EtOAc. The combined organic phases 
were washed with citric acid (10%), brine, dried (MgSO4) and the solvent removed under reduced pressure 
to afford the crude diol. Silica-supported NaIO4 (5 eq.) was added to a solution of the diol in CH2Cl2 (0.1 
M) at r.t.. The mixture was stirred for 30 min at r.t. before filtering to remove all solids. The solvent was 
removed under reduced pressure to afford the aldehyde, which was pure enough for characterisation and 
to be used in the subsequent transformations. 
Aldehyde 287 – NL-7-620 TES  
Aldehyde 287 was prepared from alkene 288 (150 mg, 411 µmol) by Method A, employing PPh3 (113 mg, 
431 µmol) to afford the product 287 as a colourless oil (150 mg, 407 µmol, 80%). 
Rf (EtOAc/PE 40-60: 20%) = 0.53; 1H NMR (500 MHz, CDCl3) dH  9.77 (1H, t, J =2.4 Hz, H29), 7.24 (2H, d, 
J = 8.7 Hz, ArH), 6.87 (2H, d, J = 8.7 Hz, ArH), 4.42 (1H, d, J = 11.5 Hz, CHaHbAr), 4.39 (1H, d, J = 11.5 Hz, 
CHaHbAr), 4.37-4.33 (1H, m, H27), 3.80 (3H, s, OMe), 3.44 (1H, dd, J = 9.1, 6.0 Hz, H25a), 3.24 (1H, dd, J 
= 9.1, 5.9 Hz, H25a), 2.57 (1H, ddd, J = 16.1, 6.8, 2.6 Hz, H28a), 2.52 (1H, ddd, J = 16.1, 5.4, 2.1 Hz, H28b), 
1.88 (1H, qd, J = 6.5, 4.0 Hz, H26), 0.94 (9H, t, J = 8.3 Hz, SiCH2CH3), 0.92 (3H, d, J = 6.6 Hz, Me26), 0.59 
(6H, q, J = 8.3 Hz, SiCH2CH3); 13C NMR (125 MHz, CDCl3) dC 202.0, 159.2, 130.5, 129.3, 113.7, 72.7, 71.7, 
68.6, 55.2, 49.0, 39.7, 12.2, 6.9, 5.0; IR (thin film): νmax 2956, 2875, 1727, 1612, 1513, 1463, 1247, 1099, 1015; 
[α]D
20 +1.5 (c 0.17, CHCl3); HRMS (ESI+) calculated for C20H34O4SiNa [M+Na]+ 389.2124, found 389.2118. 
Aldehyde 294 – NL-8-652 TBS  
Aldehyde 294 was prepared from alkene 295 (767 mg, 2.10 mmol) by Method B, employing K2OsO4·H2O 
(16.0 mg, 42.0 µmol), NMO (523 µL, 2.52 mmol, 50% wt in H2O) to afford the crude diol (801 mg, ca. 2.01 
mmol, 95%). Treatment of crude diol (65.0 mg, 163 µmol) with NaIO4/SiO2 (1.00 g, 652 µmol, 14% w/w) 
afforded aldehyde 294 as a colourless oil (60.0 mg, 163 µmol, quant.).  
Alternatively, aldehyde 294 can also be synthesised from alkene 295 (100 mg, 270 µmol) by Method A, 
employing PPh3 (75.0 mg, 288 µmol) to afford the product as a colourless oil (81.3 mg, 222 µmol, 82%).  
Rf (EtOAc/PE 40-60: 20%) = 0.53; 1H NMR (500 MHz, CDCl3) dH  9.76 (1H, s, H29), 7.25 (2H, d, J = 8.5 
Hz, ArH), 6.88 (2H, d, J = 8.5 Hz, ArH), 4.42 (1H, d, J = 11.6 Hz, CHaHbAr), 4.38 (1H, d, J = 11.6 Hz, 
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CHaHbAr), 4.36-4.31 (1H, m, H27), 3.81 (3H, s, OMe), 3.43 (1H, dd, J = 9.1, 6.9 Hz, H25a), 3.28 (1H, dd, J 
= 9.1, 5.9 Hz, H25a), 2.59-2.50 (2H, m, H28), 1.89 (1H, qd, J = 6.9, 2.9 Hz, H26), 0.92 (3H, d, J = 6.9 Hz, 
Me26), 0.86 (9H, s, SiMe2tBu), 0.06 (3H, s, SiMe2tBu), 0.04 (3H, s, SiMe2tBu); 13C NMR (125 MHz, CDCl3) 
dC 202.0, 159.0, 130.4, 129.1, 113.7, 72.6, 71.6, 68.3, 55.2, 48.9, 39.5, 25.7, 17.9, 11.9, –4.5, –4.8; IR (thin film): 
νmax 2933, 2857, 1726, 1614, 1514, 1464, 1250, 1084, 1034; [α]D
20  +4.3 (c 1.34, CHCl3); HRMS (ESI+) 
calculated for C20H34O4SiNa [M+Na]+ 389.2124, found 389.2124. 
Alcohol 296b 
 
SnCl4 (220 µL, 220 µmol, 1 M in CH2Cl2) was added dropwise to a stirred solution of allylsilane 286 (50.0 
mg, 200 µmol, dried over CaH2) in CH2Cl2 (1 mL) at –78 °C. The pale-yellow solution was stirred for 1 h at 
–78 °C before the addition of aldehyde 294 (110 mg, 302 µmol, dried by azeotroping with PhH ´ 3) in 
CH2Cl2 (1 mL) via cannula. The reaction mixture was stirred for a further 1 h before quenching with 
NaHCO3 (2 mL). The layers were separated, and the aqueous phase extracted with CH2Cl2 (3 ´ 2 mL). The 
combined organic phases were dried (MgSO4) and the solvent removed under reduced pressure. 
Purification by flash column chromatography (EtOAc/PE 40-60: 5%   15%) afforded the 27,29-syn 
product 296b (43.4 mg, 79.8 µmol) and the 27,29-anti product 296a (34.3 mg, 63.0 µmol) as colourless oils 
(syn:anti 1.3:1, combined yield 72%).  
The undesired C27 epimer in 296a can be recycled to 296b using the following method. To a stirred solution 
of 27,29-anti alcohol 296a (20.0 mg, 36.8 µmol), PPh3 (96.5 mg, 368 µmol) and 4-nitrobenzoic acid (55.0 
mg, 331 µmol) in benzene (500 µL) was added DEAD (58 µL, 368 µmol) dropwise. The pale-yellow solution 
was stirred for 3 h at r.t. before quenching with NaHCO3 (1 mL). The layers were separated, and the aqueous 
phase extracted with Et2O (3 ´ 1 mL). The combined organic phases were dried (MgSO4) and the excess 
Et2O carefully removed under reduced pressure (400 Torr). The remaining solution was filtered over SiO2, 
eluting with PE 40-60 (2 mL) and the solvent was removed under reduced pressure to afford the crude ester, 
which was immediately redissolved in MeOH (750 µL). K2CO3 (69.0 mg, 498 µmol) was added to this stirred 
solution and the reaction mixture was stirred at r.t. for 3 h before quenching with NH4Cl (1 mL) and diluted 
with CH2Cl2 (2 mL). The layers were separated, and the aqueous phase extracted with CH2Cl2 (3 ´ 2 mL). 
The combined organic phases were dried (MgSO4) and the solvent removed under reduced pressure. 
Purification by flash column chromatography (EtOAc/PE 40-60: 5%  15%) afforded the 27,29-syn alcohol 
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27,29-anti alcohol 296a 
Rf (EtOAc/PE 40-60: 20%) = 0.43; 1H NMR (500 MHz, CDCl3) dH  7.25 (2H, d, J = 8.7 Hz, ArH), 6.88 (2H, 
d, J = 8.7 Hz, ArH), 5.38 (2H, s, =Me31), 5.32 (1H, s, H33), 4.43 (1H, d, J = 11.5 Hz, CHaHbAr), 4.39 (1H, 
d, J = 11.5 Hz, CHaHbAr), 4.00 (1H, dt, J = 8.0, 3.8 Hz, H27), 3.88-3.77 (4H, m, H29, ArOMe), 3.56 (3H, s, 
OMe32), 3.52 (1H, dd, J = 9.0, 5.1 Hz, H25a), 3.23 (1H, dd, J = 9.0, 7.6 Hz, H25b), 2.43 (1H, dd, J = 13.6, 3.5 
Hz, H30a), 2.26 (1H, dd, J = 13.6, 9.4 Hz, H30b), 1.97-1.90 (1H, m, H26), 1.52-1.47 (2H, m, H28), 0.93 (3H, 
d, J = 6.9 Hz, Me26), 0.87 (9H, s, SiMe2tBu), 0.06 (3H, s, SiMe2tBu), 0.05 (3H, s, SiMe2tBu); 13C NMR (125 
MHz, CDCl3) dC 159.0, 139.6, 130.9, 129.1, 122.3, 113.7, 93.4, 78.7, 72.6, 72.0, 70.8, 69.9, 55.6, 55.3, 43.5, 
40.2, 39.4, 38.9, 25.8, 18.1, 13.0, –4.5, –4.8; IR (thin film): νmax 3380, 2955, 2930, 2857 1611, 1513, 1462, 1219, 
1201; [α]D
20 +7.3° (c 0.15, CHCl3); HRMS (ESI+) calculated for C26H4379BrO5SiNa [M+Na]+ 565.1966, found 
565.1971. 
27,29-syn alcohol 296b 
Rf (EtOAc/PE 40-60: 20%) = 0.37; 1H NMR (500 MHz, CDCl3) dH  7.25 (2H, d, J = 8.6 Hz, ArH), 6.87 (2H, 
d, J = 8.6 Hz, ArH), 5.38 (2H, s, =Me31), 5.32 (1H, s, H33), 4.44 (1H, d, J = 11.3 Hz, CHaHbAr), 4.40 (1H, 
d, J = 11.3 Hz, CHaHbAr), 3.95 (1H, dt, J = 6.8, 3.2 Hz, H27), 3.80 (3H, s, ArOMe), 3.73-3.68 (1H, m, H29), 
3.57 (3H, s, OMe32), 3.52 (1H, dd, J = 8.8, 5.4 Hz, H25a), 3.25 (1H, dd, J = 8.8, 8.4 Hz, H25b), 2.60 (1H, s, 
OH29), 2.40 (1H, dd, J = 13.8, 5.3 Hz, H30a), 2.34 (1H, dd, J = 13.8, 7.5 Hz, H30b), 1.98-1.92 (1H, m, H26), 
1.68 (1H, ddd, J = 14.1, 6.8, 3.1 Hz, H28a), 1.51 (1H, ddd, J = 14.1, 8.7, 7.5 Hz, H28b), 0.90 (3H, d, J = 8.6 
Hz, Me26), 0.87 (9H, s, SiMe2tBu), 0.06 (3H, s, SiMe2tBu), 0.05 (3H, s, SiMe2tBu); 13C NMR (125 MHz, 
CDCl3) dC 159.1, 139.4, 130.8, 129.2, 122.5, 113.7, 93.8, 78.7, 72.8, 72.3, 72.0, 67.9, 55.6, 55.3, 42.0, 39.8, 38.4, 
25.9, 18.0, 12.2, –4.4, –4.5 ; IR (thin film): νmax 3381, 2954, 2920, 2857, 1611, 1513, 1462, 1249; [α]D
20 +4.2 (c 
0.21, CHCl3); HRMS (ESI+) calculated for C26H4379BrO5SiNa [M+Na]+ 565.1966, found 565.1969. 
Confirmation of stereochemistry at C29: general protocol for the synthesis of acetonides 297 and 298 
The stereochemical outcome at C29 was confirmed by synthesising the acetonide derivatives of each 
diastereomeric alcohols using the protocol outlined below. To a purified sample of alcohol 296a or 296b 
was added TBAF (1.1 eq., 1 M in THF) at r.t.. The reaction mixture was stirred for 1 h before diluting with 
EtOAc and quenching with NH4Cl. The layers were separated and the aqueous phase extracted with EtOAc 
(3 ´ 500 µL). The combined organic phases were dried (MgSO4) and the solvent removed under reduced 
pressure. The crude diol was immediately redissolved in CH2Cl2 (100 µL) and 2,2-dimethoxypropane (100 
µL). PPTS (one crystal) was added and the reaction mixture was stirred at r.t. for 16 h, after which the 
mixture was filtered over silica and the solvent removed under reduced pressure. Purification by flash 
column chromatography (EtOAc/PE 40-60: 10%) afforded the syn- or anti-acetonide for spectroscopic 
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analysis. The conformation of the acetonide reveals the diastereomeric relationship (27,29-syn or 27,29-
anti). As the absolute configuration at C27 is known, the identity at C29 can be inferred. 
27,29-anti acetonide 297 
 
Anti acetonide 297 was synthesised from alcohol 296a (6.8 mg, 12.5 µmol), employing TBAF (13.8 µL, 13.8 
µmol) to remove the C27 silyl ether. Following the general protocol described above, acetonide 297 was 
obtained as a colourless oil (2.2 mg, 4.69 µmol, 37% over two steps) as a mixture of the C32 acetal and the 
C32 enol ether (2:1). 
Major product – C32 acetal: Rf (EtOAc/PE 40-60: 20%) = 0.48; 1H NMR (500 MHz, CDCl3) dH  7.25 (2H, d, 
J = 8.7 Hz, ArH), 6.88 (2H, d, J = 8.7 Hz, ArH), 5.52 (1H, d, J = 0.8 Hz, =Me31), 5.34 (1H, d, J = 1.9 Hz, 
=Me31), 4.43 (1H, d, J = 11.7 Hz, CHaHbAr), 4.39 (1H, d, J = 11.7 Hz, CHaHbAr), 4.04-3.98 (1H, m, H29), 
3.85-3.80 (4H, m, H27, ArOMe), 3.50 (1H, d, J = 11.4 Hz, H33a), 3.43-3.38 (2H, m, H33b, H25a), 3.30 (1H, 
dd, J = 9.3, 5.9 Hz, H25b), 3.19 (3H, s, OMe32a), 3.18 (3H, s, OMe32b), 2.23 (1H, dd, J = 15.7, 7.8 Hz, H30a), 
2.10 (1H, dd, J = 15.7, 4.7 Hz, H30b), 1.82 (1H, ddd, J = 12.7, 9.9, 6.0 Hz, H28a), 1.80-1.73 (1H, m, H26), 
1.49 (1H, ddd, J = 12.7, 9.9, 6.0 Hz, H28b), 1.33 (3H, s, MeAMeBCO(O)), 1.30 (3H, s, MeAMeBCO(O)), 0.97 
(3H, d, J = 6.8 Hz, Me26); 13C NMR (125 MHz, CDCl3) dC 159.1, 141.2, 130.7, 129.2, 117.8, 113.7, 101.4, 
100.3*, 72.9, 71.9, 67.2, 65.9, 55.3, 49.1, 49.1, 38.1, 36.8, 36.6, 31.8, 24.6*, 24.5*, 12.6  
*Indicates 13C signals that are diagnostic for the 27,29-anti configuration for the acetonide 
27,29-syn acetonide 298 
 
Syn acetonide 298 was synthesised from alcohol 296b (3.1 mg, 5.70 µmol), employing TBAF (6.3 µL, 6.30 
µmol) to remove the C27 silyl ether. Following the general protocol described above, acetonide 298 was 
obtained as a colourless oil (1.0 mg, 2.13 µmol, 37% over two steps). 
Rf (EtOAc/PE 40-60: 20%) = 0.45; 1H NMR (500 MHz, CDCl3) dH  7.25 (2H, d, J = 8.7 Hz, ArH), 6.88 (2H, 
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11.5 Hz, CHaHbAr), 4.40 (1H, d, J = 11.5 Hz, CHaHbAr), 4.07 (1H, dddd, J = 11.3, 7.4, 4.8, 2.2 Hz, H29), 3.91 
(1H, ddd, J = 11.8, 4.9, 2.3 Hz, H27), 3.80 (3H, s, ArOMe), 3.53 (1H, d, J = 11.4 Hz, H33a), 3.43 (1H, dd, J 
= 9.0, 6.4 Hz, H25a), 3.42 (1H, d, J = 11.4 Hz, H33b), 3.31 (1H, dd, J = 9.0, 5.6 Hz, H25b), 3.19 (3H, s, 
OMe32), 3.18 (3H, s, OMe32), 2.22 (1H, ddd, J = 15.5, 7.5, 0.8 Hz, H30a), 2.07 (1H, dd, J = 15.5, 4.7 Hz, 
H30b), 1.80-1.72 (1H, m, H26), 1.42 (3H, s, MeAMeBCO(O)), 1.35 (3H, s, MeAMeBCO(O)), 1.51-1.43 (1H, 
m, H28a), 1.29-1.20 (1H, m, H28b), 0.94 (3H, d, J = 6.9 Hz, Me26); 13C NMR (125 MHz, CDCl3) dC 159.1, 
140.9, 130.7, 129.2, 118.2, 113.7, 101.4, 98.5*, 72.8, 71.8, 69.6, 68.4, 55.3, 49.1, 49.1, 38.5, 37.6, 34.4, 31.8, 
30.1*, 19.7*, 12.2. 
*Indicates 13C signals that are diagnostic for the 27,29-syn configuration for the acetonide 
Ester 299 969, 971,962,960,955 
 
DCC (258 µL, 258 mmol, 1 M in CH2Cl2) was added to a stirred solution of alcohol 296b (28.0 mg, 51.5 
µmol), palmitic acid (66.0 mg, 258 µmol) and DMAP (one crystal) in CH2Cl2 (1 mL) at r.t.. The reaction 
mixture was stirred for 16 h before filtering over SiO2 and eluting with Et2O/PE 40-60 (2%). The solvent 
was removed under reduced pressure. Purification by flash column chromatography (Et2O/PE 40-60: 2%) 
afforded ester 299 as a colourless oil (33.7 mg, 43.1 mmol, 84%).  
Rf (EtOAc/PE 40-60: 20%) = 0.70; 1H NMR (500 MHz, CDCl3) dH 7.23 (2H, d, J = 8.7 Hz, ArH), 6.86 (2H, 
d, J = 8.7 Hz, ArH), 5.42 (1H, J = 1.2 Hz, =Me31a), 5.35 (1H, d, J = 1.2 Hz, =Me31b), 5.31 (1H, s, H33), 4.94 
(1H, dtd, J = 9.0, 6.1, 4.0 Hz, H29), 4.40 (1H, d, J = 11.3 Hz, CHaHbAr), 4.36 (1H, d, J = 11.3 Hz, CHaHbAr), 
3.88 (1H, ddd, J = 8.8, 4.9, 2.2 Hz, H27), 3.80 (3H, m, ArOMe), 3.57 (3H, s, OMe32), 3.39 (1H, dd, J = 9.2, 
7.4 Hz, H25a), 3.22 (1H, dd, J = 9.2, 6.7 Hz, H25b), 2.54 (1H, dd, J = 13.9, 6.1 Hz, H30a), 2.50 (1H, dd, J = 
13.9, 6.1 Hz, H30b), 2.20 (1H, t, J = 7.2 Hz, C(O)CHaHbR), 2.19 (1H, t, J = 7.2 Hz, C(O)CHaHbR), 1.92 (1H, 
m, H26), 1.83 (1H, ddd, J = 14.2, 8.8, 4.1 Hz, H28a), 1.68 (1H, ddd, J = 14.2, 9.0, 4.9 Hz, H28b), 1.32-1.21 
(29H, m, C(O)CH2R), 0.87 (9H, s, SiMe2tBu), 0.82 (3H, d, J = 6.9 Hz, Me26), 0.06 (3H, s, SiMe2tBu), 0.01 
(3H, s, SiMe2tBu); 13C NMR (125 MHz, CDCl3) dC 173.0, 158.9, 158.5, 138.2, 131.0, 129.0, 122.1, 113.6, 78.7, 
72.7, 72.3, 69.5, 68.5, 55.6, 55.2, 39.2, 38.7, 36.6, 34.6, 31.9, 29.7, 29.7, 29.5, 29.4, 29.3, 29.2, 25.9, 24.9, 22.7, 
18.1, 14.1, 10.1, –4.2, –4.8; IR (thin film): νmax 2925, 2856, 1734, 1514, 1463, 1248, 1212, 1146, 1041; [α]D
20 –












Alcohol 300 973 972 
 
DDQ (60.0 mg, 263 µmol) was added to a stirred solution of PMB ether 299 (103 mg, 132 µmol) in CH2Cl2 
(1.8 mL) and pH 7 buffer (0.2 mL). The reaction mixture was stirred at r.t. for 1 h before quenching with 
NaHCO3. The layers were separated and the aqueous phase extracted with CH2Cl2 (3 ´ 2 mL). The 
combined organic phases were dried (MgSO4) and the solvent removed under reduced pressure. 
Purification by flash column chromatography (EtOAc/PE 40-60: 25%) afforded the product 300 as a 
colourless oil (51.0 mg, 77.1 µmol, 58%). 
Rf (EtOAc/PE 40-60: 20%) = 0.37; 1H NMR (500 MHz, CDCl3) dH  5.43 (1H, d, J = 1.2 Hz, =Me31a), 5.36 
(1H, d, J = 1.2 Hz, =Me31b), 5.33 (1H, s, H33), 4.96 (1H, dtd, J = 10.2, 6.5, 3.9 Hz, H29), 3.86 (1H, ddd, J = 
9.0, 4.6, 2.4 Hz, H27), 3.58 (3H, s, OMe32), 3.55-3.49 (2H, m, H25), 2.52 (2H, d, J = 6.5 Hz, H30), 2.27 (1H, 
t, J = 7.7 Hz, C(O)CHaHbR), 2.27 (1H, t, J = 7.7 Hz, C(O)CHaHbR), 1.92-1.84 (3H, m, H28a, H26, OH), 1.71 
(1H, ddd, J = 14.2, 9.5, 4.7 Hz, H28b), 1.63-1.58 (2H, m, C(O)CH2R), 1.32-1.24 (27H, m, C(O)CH2R), 0.89 
(9H, s, SiMe2tBu), 0.82 (3H, d, J = 7.7 Hz, Me26), 0.08 (3H, s, SiMe2tBu), 0.07 (3H, s, SiMe2tBu); 13C NMR 
(125 MHz, CDCl3) dC 173.4, 158.3, 138.2, 122.1, 78.8, 69.6, 69.5, 65.8, 55.6, 39.5, 38.8, 38.8, 34.6, 31.9, 29.7, 
29.7, 29.5, 29.4, 29.3, 29.2, 25.8, 24.9, 22.7, 18.0, 14.1, 10.1, –4.3, –4.8 ; IR (thin film): νmax 3550, 2956, 2926, 
2856, 1724, 1463, 1216, 1147; [α]D
20  –5.8 (c 0.16, CHCl3); HRMS (ESI+) calculated for C34H6579BrO5SiNa 
[M+Na]+ 683.3682, found 683.3668. 
C24-C33 Ketone 302 
 
DMSO (17 µL, 242 µmol) was added dropwise to a stirred solution of (COCl)2 (10 µL, 121 µmol) in CH2Cl2 
(500 µL) at –78 °C. The solution was stirred at –78 °C for 5 min before the addition of a solution of alcohol 
300 (20.0 mg, 30.2 µmol) in CH2Cl2 (500 µL) via cannula. The reaction mixture was stirred at–78 °C for 30 
min before the dropwise addition of Et3N (42 µL, 302 µmol). The mixture was allowed to warm to –20 °C 
over 30 min before quenching with NH4Cl (1 mL). The layers were separated, and the aqueous phase 
extracted with Et2O (3 ´ 1 mL). The combined organic phases were dried (MgSO4) and the solvent removed 
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over Celite®. The resulting filtrate was concentrated under reduced pressure to afford the crude aldehyde. 
As the aldehyde was prone to epimerisation at C26, the crude product was used immediately in the next 
step without further purification. 
MeMgBr (10 µL, 36.2 µmol, 3 M in Et2O) was added dropwise to a solution of crude aldehyde (ca. 19.9 mg, 
30.2 µmol, dried azeotropically with PhH ´ 3) in Et2O (1 mL) at –78 °C. The reaction mixture was stirred 
at –78 °C for 1 h before quenching with NH4Cl (1 mL) and allowing the mixture to warm to r.t.. The layers 
were separated, and the aqueous phase extracted with Et2O (3 ´ 1 mL). The combined organic phases were 
dried (MgSO4) filtered over SiO2 (eluting with Et2O) and the solvent removed under reduced pressure to 
afford the crude alcohol as an inconsequential mixture of C25 epimers.  
Separately, DMSO (17 µL, 242 µmol) was added dropwise to a stirred solution of (COCl)2 (10 µL, 121 µmol) 
in CH2Cl2 (500 µL) at –78 °C. The solution was stirred at –78 °C for 5 min before the addition of a solution 
of the crude alcohol (ca. 18.6 mg, 27.5 µmol) in CH2Cl2 (500 µL) via cannula. The reaction mixture was 
stirred at–78 °C for 30 min before the dropwise addition of Et3N (42 µL, 302 µmol). The mixture was allowed 
to warm to –20 °C over 30 min before quenching with NH4Cl (1 mL). The layers were separated, and the 
aqueous phase extracted with Et2O (3 ´ 1 mL). The combined organic phases were dried (MgSO4) and the 
solvent removed under reduced pressure. Purification by flash column chromatography (EtOAc/PE 40-60: 
0%  5%) afforded the product 302 as a colourless oil (11.2 mg, 16.6 µmol, 55% over three steps). 
Rf (EtOAc/PE 40-60: 20%) = 0.73; 1H NMR (500 MHz, CDCl3) dH  5.44 (1H, s, =Me31a), 5.36 (1H, s, 
=Me31b), 5.33 (1H, s, H33), 4.98-4.92 (1H, m, H29), 3.86 (1H, dt, J = 8.2, 4.0 Hz, H27), 3.58 (3H, s, OMe32), 
2.67 (1H, qd, J = 11.5, 3.2 Hz, H26), 2.55-2.49 (2H, m, H30), 2.27 (2H, t, J = 7.2 Hz, C(O)CH2R), 2.14 (3H, 
s, H24), 1.81 (1H, ddd, J = 14.6, 8.7, 4.1 Hz, H28a), 1.71 (1H, ddd, J = 14.6, 9.3, 4.5 Hz, H28b), 1.62-1.56 
(2H, m, C(O)CH2R), 1.32-1.24 (27H, m, C(O)CH2R), 1.04 (3H, d, J = 6.8 Hz, Me26), 0.86 (9H, s, SiMe2tBu), 
0.07 (3H, s, SiMe2tBu), 0.03 (3H, s, SiMe2tBu); 13C NMR (125 MHz, CDCl3) dC 210.3, 173.1, 158.2, 137.9, 
122.1, 78.7, 69.3, 69.1, 55.5, 50.5, 39.4, 39.3, 34.5, 31.8, 29.6, 29.5, 29.5, 29.2, 29.2, 29.1, 28.9, 25.6, 24.9, 22.6, 
17.9, 14.0, 9.3, –4.3, –4.4; IR (thin film): νmax 2926, 2855, 1734, 1716, 1463, 1251, 1149, 1101; [α]D
20 –18.3 (c 






8.5.5. Initial studies towards macrocyclisation: the macrolactonisation/C3-C4 Stille approach 




A stirred solution of vinyl iodide 243 (60.0 mg, 121 µmol), boronate 315**** (108 mg, 303 µmol) and 
Pd(PPh3)4 (56.0 mg, 48.4 µmol) in THF (7.5 mL) and H2O (2.5 mL) was stirred at 30 °C, to which TlOEt (39 
µL, 546 µmol) was added. The yellow-orange mixture was stirred at 30 °C for 2 h before quenching with 
NH4Cl (10 mL) and diluting with Et2O (10 mL). The layers were separated, and the aqueous phase extracted 
with Et2O (3 ´ 10 mL). The combined organic phases were washed with brine (10 mL), dried (MgSO4) and 
the solvent removed under reduced pressure. Purification by flash column chromatography (EtOAc/PE 40-
60: 5% 10%) afforded the crude product. As the product was inseparable from the excess boronate, the 
crude mixture was directly subjected to the next step and an analytically pure sample of alcohol 316 was 
not obtained. 
DMSO (76 µL, 1.05 mmol) was added dropwise to a solution of (COCl)2 (46 µL, 536 µmol) in CH2Cl2 (2.5 
mL) at –78 °C. The solution was stirred at –78 °C for 5 min before the addition of crude alcohol 316 (89.3 
mg, ca. 134 µmol) in CH2Cl2 (2 mL) via cannula. The reaction mixture was stirred at –78 °C for a further 30 
min before the dropwise addition of Et3N (224 µL, 1.60 mmol), and the mixture was warmed to –20 °C over 
30 min before quenching with NH4Cl (10 mL). The layers were separated, and the aqueous phase extracted 
with Et2O (3 ´ 5 mL). The combined organic phases were dried (MgSO4) and the solvent removed under 
reduced pressure. Purification by flash column chromatography (EtOAc/PE 40-60: 2%) afforded the 
product 317 as a colourless oil (64.2 mg, 108 µmol, 89% over two steps). 
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Rf (EtOAc/PE 40-60: 20%) = 0.65; 1H NMR (500 MHz, CDCl3) d H 9.78 (1H, s, H5), 5.67 (1H, s, =CH), 5.58 
(1H, s, H10), 5.12 (1H, dd, J = 6.4, 4.5 Hz, H15), 5.04 (1H, s, =CHaHb9), 4.87 (1H, s, =CHaHb9), 4.27-4.20 
(2H, m, H7, H13), 3.72 (1H, d, J = 9.6 Hz, H17a), 3.50 (1H, d, J = 9.6 Hz, H17b), 2.53-2.39 (5H, m, H6, H8a, 
H12a, H14a), 2.24 (1H, dd, J = 13.6, 8.6 Hz, H8b), 2.21 (1H, dd, J = 13.8, 7.2 Hz, H12b), 2.16 (3H, s, 
=CMeaMeb), 1.90 (3H, s, =CMeaMeb), 1.79 (3H, s, Me11), 1.76-1.74 (1H, m, H14b), 1.22 (3H, s, Me16), 0.86 
(18H, s, SiMe2tBu), 0.07 (3H, s, SiMe2tBu), 0.05 (3H, s, SiMe2tBu), 0.04 (3H, s, SiMe2tBu), 0.01 (3H, s, 
SiMe2tBu); 13C NMR (125 MHz, CDCl3) dC 202.2, 165.6, 156.9, 141.4, 136.2, 127.4, 116.0, 84.0, 77.1, 74.9, 
67.4, 65.9, 50.0, 47.2, 46.5, 37.7, 25.7, 25.6, 21.7, 20.1, 18.6, 18.1, 17.8, 17.8, –4.5, –4.9, –5.7, –5.7; IR (thin 
film): νmax 2928, 2857, 1723, 1472, 1361, 1253, 1226, 1144, 1094; [α]D
20 –8.0 (c 0.05, CHCl3); HRMS (ESI+) 
calculated for C33H60O6Si2Na [M+Na]+ 631.3826, found 631.3805. 
Ester 320 842- 1H,  
 
A solution of aldehyde 317 (20.0 mg, 33.6 µmol) and CHI3 (40.0 mg, 101 µmol) in THF (250 µL) was added 
to a stirred mixture of CrCl2 (41.0 mg, 336 µmol) in THF (250 µL) at r.t.. The resulting dark red suspension 
was stirred for 4 h before quenching with Na2S2O3 (1 mL) and diluting with Et2O (1 mL). The layers were 
separated, and the aqueous phase extracted with Et2O (3 ´ 1 mL). The combined organic phases were 
washed with Na2S2O3 (1 mL), dried (MgSO4) and the solvent removed under reduced pressure. The residue 
was filtered over a plug of silica, eluting with PE 40-60 to afford the crude vinyl iodide 318 (ca. 17.5 mg, 
23.9 µmol, 71%), which was used in the subsequent step without further purification as an inseparable 
mixture of E/Z isomers (3:1) at C4. 
A solution of crude vinyl iodide 318 (7.0 mg, 10.0 µmol), stannane 319†††† (5.6 mg, 14.0 µmol), Pd(PPh3)4 
(2.2 mg, 1.9 µmol) and CuTC (2.7 mg, 14.0 µmol) in DMF (1 mL) was stirred for 5 h at r.t.. The reaction 
mixture was subsequently quenched with H2O and diluted with Et2O. The layers were separated and the 
aqueous phase extracted with Et2O (3 ´ 1 mL). The combined organic phases were dried (MgSO4) and the 
 
















solvent removed under reduced pressure. Purification by flash column chromatography (EtOAc/PE 40-60: 
1%) afforded the product 320 as a colourless oil (6.0 mg, 8.5 µmol, 90%). 
Major 4E isomer: Rf (EtOAc/PE 40-60: 20%) = 0.63; 1H NMR (500 MHz, CDCl3) dH 6.21-6.09 (2H, m, H4, 
H5), 5.69 (1H, s, H2), 5.67 (1H, s, 1H, s, =CH), 5.56 (1H, s, H10), 5.12 (1H, dd, J = 6.6, 4.2 Hz, H15), 5.00 
(1H, s, =CHaHb9), 4.85 (1H, s, =CHaHb9), 4.23 (1H, qn, J = 6.5 Hz, H13), 3.82 (1H, m, H7), 3.71-3.69 (4H, 
m, H17a, OMe), 3.53 (1H, d, J = 9.7 Hz, H17b), 2.48 (1H, dd, J = 13.2, 5.6 Hz, H12a), 2.42 (1H, ddd, J = 
13.2, 7.9, 4.6 Hz, H14a), 2.38-2.30 (3H, m, H6a, H8), 2.27 (3H, d, J = 0.9 Hz, =CMeaMeb) 2.22-2.17 (2H, m, 
H6b, H12b), 2.17 (3H, d, J = 0.8 Hz, Me3), 1.90 (3H, s, =CMeaMeb), 1.79 (3H, d, J = 0.9 Hz, Me11), 1.73 
(1H, ddd, J = 13.2, 6.8, 4.7 Hz, H14b), 1.21 (3H, s, Me16), 0.86 (18H, s, SiMe2tBu), 0.03 (3H, s, SiMe2tBu), 
0.02 (3H, s, SiMe2tBu), 0.01 (6H, s SiMe2tBu); 13C NMR (125 MHz, CDCl3) dC 167.7, 165.7, 157.0, 152.8, 
142.2, 135.6, 128.0, 127.9, 117.4, 117.3, 116.0, 84.0, 75.0, 71.1, 66.1, 60.3, 51.0, 47.3, 46.3, 41.3, 38.4, 25.8, 
25.8, 22.6, 20.2, 18.2, 18.1, 13.8, –4.4, –4.6, –5.4, –5.6 ; IR (thin film): νmax 2931, 2861, 1732, 1720, 1440, 1361, 
1361, 1256, 1226, 1147, 1101; [α]D
20  –5.2 (c 0.16, CHCl3); HRMS (ESI+) calculated for C39H68O7Si2Na 
[M+Na]+ 727.4401 found 727.4395. 
Alcohol 326 1068 prep 1H 
 
The addition reaction was performed according to the general protocol described in 8.5.2, using vinyl 
iodide 325 (127.5 mg, 249 µmol), tBuLi (260 µL, 497 µmol, 1.9 M in pentane), MgBr2·OEt2 (1.20 mL, 727 
µmol, 0.6 M in Et2O), and aldehyde 245 (15.0 mg, 38.3 µmol) to afford the product 326 (23.4 mg, 30.0 µmol, 
78%), a colourless oil as an inseparable 5:1 mixture of diastereomers at C17, alongside with the C10 
protodeiodinated material. 
Rf (EtOAc/PE 40-60: 20%) = 0.58; 1H NMR (500 MHz, CDCl3) dH 5.94 (1H, s, H10), 5.73 (1H, s, =CH), 5.31 
(1H, d, J =  9.0 Hz, H10), 5.12 (1H, dd, J = 6.1, 2.4 Hz, H15), 4.49 (1H, dd, J = 9.0, 4.2 Hz, H17), 4.25-4.19 
(1H, m, H13), 3.82 (1H, dd, J = 7.3, 3.8 Hz, H21), 3.37 (1H, d, J = 9.1 Hz, H23a), 3.32 (1H, d, J = 9.1 Hz, 
H23b), 2.59-2.50 (3H, m, H12a, H14a), 2.39 (1H, dd, J = 13.7, 6.2, H12b), 2.34 (1H, dd, J = 14.1, 3.8 Hz, 
H20a), 2.20 (3H, d, J = 1.3 Hz, =CMeaMeb), 2.11 (1H, d, J = 4.2 Hz, OH), 2.04 (1H, dd, J = 14.1, 7.3 Hz, 
H20b), 1.94 (3H, d, J = 1.1 Hz, =CMeaMeb), 1.84 (3H, d, J = 1.0 Hz, Me11), 1.72 (3H, d, J = 1.0 Hz, Me19), 
1.69 (1H, ddd, J = 14.2, 5.0, 2.5 Hz, H14b), 1.17 (3H, s, Me16), 0.98-0.92 (18H, m, Si(CH2CH3)3), 0.85 (3H, 
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158.7, 144.8, 138.9, 125.2, 115.6, 87.1, 78.0, 77.1, 74.4, 73.8, 69.8, 69.6, 46.3, 44.4, 40.9, 37.5, 27.5, 24.4, 21.0, 
20.4, 20.1, 19.1, 17.1, 7.2, 6.9, 5.5, 5.4, 4.5; IR (thin film): νmax 3454, 2952, 2877, 1720, 1379, 1229, 1143, 1087, 
1007; [α]D
20 –11.3 (c 0.08, CHCl3); HRMS (ESI+) calculated for C36H67IO6Si2Na [M+Na]+ 801.3419, found 
801.3421. 
TES ether 324 1069 
 
TESOTf (10 µL, 39.2 µmol) was added dropwise to a stirred solution of alcohol 326 (23.5 mg, 30.2 µmol) 
and 2,6-lutidine (10 µL, 91 µmol) in CH2Cl2 (500 µL) at –78 °C. The reaction mixture was stirred at –78 °C 
for 1 h before quenching with MeOH (50 µL) followed by NaHCO3 (500 µL). The layers were separated, 
and the aqueous phase extracted with Et2O (3 ´ 10 mL). The combined organic phases were dried (MgSO4) 
and the solvent removed under reduced pressure. Purification by flash column chromatography (Et2O/PE 
40-60: 0%  1%) afforded the product 324 as a colourless oil (26.0 mg, 29.1 mmol, µmol, 96%). 
Rf (EtOAc/PE 40-60: 20%) = 0.82; 1H NMR (500 MHz, CDCl3) dH 5.86 (1H, q, J = 1.0 Hz, H10), 5.73 (1H, 
sept, J = 1.3 Hz, =CH), 5.20 (1H, d, J =  8.7 Hz, H10), 4.98 (1H, dd, J = 5.7, 0.8 Hz, H15), 4.73 (1H, d, J = 8.7 
Hz, H17), 4.19-4.13 (1H, m, H13), 3.85 (1H, dd, J = 7.6, 4.2 Hz, H21), 3.40 (1H, d, J = 9.2 Hz, H23a), 3.32 
(1H, d, J = 9.2 Hz, H23b), 2.55-2.43 (3H, m, H12a, H14a, H20a), 2.32 (1H, dd, J = 13.5, 5.9 Hz, H12b), 2.20 
(3H, d, J = 1.3 Hz, =CMeaMeb), 2.06-2.01 (1H, m, H20b), 1.93 (3H, d, J = 1.2 Hz, =CMeaMeb), 1.81 (3H, d, 
J = 1.0 Hz, Me11), 1.74 (3H, d, J = 0.8 Hz, Me19), 1.61 (1H, dd, J = 15.0, 4.3 Hz, H14b), 1.10 (3H, s, Me16), 
0.96 (18H, t, J = 8.0 Hz, Si(CH2CH3)3 ´2), 0.87 (9H, t, J = 8.0 Hz, Si(CH2CH3)3), 0.63 (6H, q, J = 8.0 Hz, , 
Si(CH2CH3)3, 0.59 (6H, q, J = 7.9 Hz, Si(CH2CH3)3, 0.47 (6H, q, J = 7.9 Hz, Si(CH2CH3)3, 1.17 (3H, s, Me16), 
0.98-0.92 (18H, m, Si(CH2CH3)3), 0.87 (3H, s, Me22a), 0.86 (3H, s, Me22b), 0.61-0.55 (12H, m, 
Si(CH2CH3)3); 13C NMR (125 MHz, CDCl3) dC 165.7, 156.8, 145.1, 137.0, 126.1, 116.5, 87.9, 77.5, 74.2, 74.1, 
69.6, 69.5, 46.9, 45.2, 37.3, 27.3, 25.8, 24.2, 22.7, 20.3, 18.0, 17.6, 7.1, 6.9, 6.8, 5.3, 5.2, 4.5; IR (thin film): νmax 
2952, 2875, 1721, 1652, 1459, 1378, 1229, 1144, 1077; [α]D
20 –3.0 (c 0.14, CHCl3); HRMS (ESI+) calculated 














Alcohol 328 899, 898 
 
DIBAL (18 µL, 18 µmol, 1 M in hexanes) was added dropwise to a stirred solution of ester 327‡‡‡‡ (10.0 mg, 
8.90 µmol) in CH2Cl2 (250 µL) at –78 °C. The reaction mixture was stirred at –78 °C for 1 h before quenching 
with MeOH (10 µL) and Na/K tartrate (250 µL). The mixture was allowed to warm to r.t. and stirred for 30 
min at r.t. before separating the layers. The aqueous phase extracted with EtOAc (3 ´ 250 µL). The 
combined organic phases were dried (MgSO4) and the solvent removed under reduced pressure. 
Purification by flash column chromatography (EtOAc/PE 40-60: 5%) afforded the product 328 as a 
colourless oil (7.5 mg, 7.24 mmol, µmol, 81%). 
Major 4E isomer: Rf (EtOAc/PE 40-60: 20%) = 0.69; 1H NMR (500 MHz, CDCl3) dH 6.52 (1H, dt, J = 15.2, 
7.3 Hz, H5), 5.98 (1H, d, J = 15.2 Hz, H5), 5.61 (1H, s, H10), 5.48 (1H, d, J = 11.0 Hz, H18), 5.01 (1H, s, 
=CHaHb9), 4.84 (1H, s, =CHaHb9), 4.60 (1H, d, J = 11.0 Hz, H17), 4.13-4.07 (2H, m, H13, H15), 3.89 (1H, 
dd, J = 7.3, 3.8 Hz, H21), 3.77-3.72 (1H, m, H7), 3.40 (1H, d, J = 9.3 Hz, H23a), 3.28 (1H, d, J = 9.3 Hz, 
H23b), 2.57-2.49 (2H, m, H12a, H20a), 2.33-2.13 (5H, m, H6a, H8, H12b, H14a), 2.11-2.03 (2H, m, H6b, 
H20b), 1.80 (3H, s, Me11), 1.76 (3H, s, Me19), 1.71-1.66 (1H, m, H14b), 0.98-0.93 (27H, m, SiCH2CH3), 
0.89 (9H, s, SiMe2tBu), 0.88 (3H, s, Me16), 0.83 (3H, s, Me22a), 0.81 (3H, s, Me22b), 0.64-0.56 (18H, m, 
SiCH2CH3), 0.04 (6H, s, SiMe2tBu); 13C NMR (125 MHz, CDCl3) dC 143.5, 142.2, 137.9, 136.0, 127.6, 125.6, 
115.9, 86.1, 78.9, 76.4, 74.7, 74.4, 73.2, 70.2, 69.5, 47.5, 46.0, 45.2, 42.9, 41.4, 29.7, 21.5, 21.3, 19.1, 18.6, 18.0, 
17.5, 7.1, 6.9, 6.8, 5.4, 5.4, 5.0, 4.5, 1.0, –4.5, –4.6; IR (thin film): νmax 3379, 2953, 2928, 1462, 1377, 1258, 
1078, 1011, 798; [α]D
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Ester 338 
 
DCC (469 µL, 469 µmol, 1 M in CH2Cl2) was added to a stirred solution of alcohol 241 (40.0 mg, 93.8 µmol), 
acid 329§§§§ (176 mg, 469 µmol), DMAP (57.3 mg, 469 µmol) and DMAP·HCl (73.5 mg, 469 µmol) in 
CH2Cl2 (1 mL). The cloudy suspension was stirred for 16 h, to which it turned deep red. The reaction 
mixture was then filtered over SiO2 and the filtrate concentrated under reduced pressure. Purification by 
flash column chromatography (Et2O/PE 40-60: 5%) afforded the product 338 as a colourless oil (66.2 mg, 
84.5 µmol, 90%). 
Rf (EtOAc/PE 40-60: 20%) = 0.78; 1H NMR (500 MHz, CDCl3) dH 6.40 (1H, s, H2), 5.93 (1H, s, H10), 5.05 
(1H, dd, J = 6.0, 4.0 Hz, H15), 4.22 (1H, qn, J = 6.5 Hz, H13), 3.73 (1H, d, J = 9.7 Hz, H17a), 3.53 (1H, J = 
9.7 Hz, H17b), 2.69 (3H, s, Me3), 2.55 (1H, dd, J = 13.9, 6.6 Hz, H12a), 2.47 (1H, dt, J = 13.8, 6.5 Hz, H14a), 
2.37 (1H, dd, J = 13.9, 6.5 Hz, H12b), 1.85 (3H, s, Me11), 1.69 (1H, ddd, J = 13.8, 5.9, 4.0 Hz, H14b), 1.58-
1.23 (36H, m, SnBu3), 1.20 (3H, s, Me16), 1.11-0.83 (54H, m, SiMe2tBu, SnBu3), 0.04 (3H, s, SiMe2tBu), 0.01 
(3H, s, SiMe2tBu). 13C NMR (125 MHz, CDCl3) dC 173.3, 167.1, 144.9, 128.9, 84.4, 77.8, 74.6, 74.5, 65.9, 46.3, 
37.5, 29.2, 27.4, 25.9, 24.5, 21.7, 18.2, 13.8, 13.7, 11.3, 10.9, –5.5; IR (thin film): νmax 2955, 2924, 2855, 1702, 
1601, 1463, 1375, 1317, 1193, 1103; [α]D
20  –19.3 (c 1.37, CHCl3); HRMS (ESI+) calculated for 
C32H61IO4SiSnNa [M+Na]+ 803.2299, found 803.2295. 
  
 












8.5.6. Macrocyclisation via C9-C10 Stille coupling 
TIPS ether 352 
 
TIPSOTf (954 µL, 3.60 mmol) was added to a stirred solution of alcohol 310***** (310 mg, 2.84 mmol) and 
2,6-lutidine (491 µL, 4.26 mmol) in CH2Cl2 (30 mL) at r.t.. The solution was stirred at r.t. for 16 h before 
quenching with MeOH (1 mL) and stirring for 30 min. A solution of NaHCO3 (20 mL) was then added and 
the layers were separated. The aqueous phase extracted with CH2Cl2 (3 ´ 10 mL). The combined organic 
phases were washed with brine (10 mL), dried (MgSO4) and the solvent removed under reduced pressure. 
Purification by flash column chromatography (EtOAc/PE 30-40: 2%) afforded the product 352, as a 
colourless liquid (725 mg, 2.73 mmol, 96%). 
Rf (EtOAc/PE 40-60: 20%) = 0.60; 1H NMR (500 MHz, CDCl3) dH 4.23 (1H, dq J = 8.0, 4.8 Hz, H7), 3.54 
(1H, s, OH), 2.75 (1H, dd, J = 16.6, 5.0 Hz, H6a), 2.72 (1H, dd, J = 16.6, 4.9 Hz, H6b), 2.58 (1H, ddd, J = 
15.9, 4.6, 2.7 Hz, H8a), 2.53 (1H, ddd, J = 16.9, 7.9, 2.7 Hz, H8b), 2.08 (1H, t, J = 2.7 Hz, CH)  ; 13C NMR 
(125 MHz, CDCl3) dC 117.1, 79.1, 71.8, 67.2, 27.1, 25.4, 18.0, 12.3; IR (thin film): νmax 3310, 2945, 2867, 2261, 
1463, 1366, 1118, 1069; [α]D
20 +5.7 (c 0.35, CHCl3); HRMS (ESI+) calculated for C15H27INOSiNa [M+Na]+ 
288.1754, found 288.1741. 
Vinyl iodide 340 and 353 
    
Iodo-9-BBN (4.0 mL 4.00 mmol, 1 M in hexanes) was added dropwise to a stirred solution of alkyne 339††††† 
(400 mg, 1.79 mmol) in hexane (10 mL) at 0 °C. The reaction mixture was stirred for 4 h at 0 °C before 
adding glacial AcOH (1.0 mL, 17.5 mmol) in one portion. The mixture was stirred for 30 min at 0 °C before 
the addition of NaOH (1.5 mL, 1 M in H2O), H2O2 (2.4 mL) and NaHCO3 (10 mL) and stirred at r.t. for 1 
h. The layers were separated, and the aqueous phase extracted with Et2O (3 ́  10 mL). The combined organic 
phases were washed with Na2S2O3 (15 mL), brine (15 mL), dried (MgSO4) and the solvent removed under 
 
***** Alcohol 310 was synthesised by Garrett Muir 
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reduced pressure. Purification by flash column chromatography (Et2O/PE 40-60: 10%) afforded the product 
340 as a colourless oil (486 mg, 1.38 mmol, µmol, 77%). 
Rf (EtOAc/PE 40-60: 20%) = 0.61; 1H NMR (500 MHz, CDCl3) dH 6.20 (1H, d, J = 1.2 Hz, =CHaHb9), 5.83 
(1H, d, J = 1.5 Hz, =CHaHb9), 4.21 (1H, dddd, J = 6.6, 6.1, 5.0, 4.5 Hz, H7), 2.72 (1H, ddd, J = 14.2, 6.1, 1.0 
Hz, H8a), 2.62 (1H, ddd, J = 14.1, 6.8, 1.1 Hz, H8b), 2.56 (1H, dd, J = 16.6, 6.6, 4.6 Hz, H6a), 2.45 (1H, dd, 
J = 16.6, 5.0 Hz, H6b), 0.91 (9H, s, SiMe2tBu), 0.16 (3H, s, SiMe2tBu), 0.13 (3H, s, SiMe2tBu); 13C NMR (125 
MHz, CDCl3) dC 129.7, 117.1, 104.7, 67.0, 52.3, 25.7, 25.3, 18.0, –4.4, –4.7; IR (thin film): νmax 2929, 2857, 
1618, 1471, 1363, 1257, 1105, 839; [α]D
20 –2.9 (c 0.21, CHCl3); HRMS (ESI+) calculated for C12H22INOSiH 
[M+H]+ 352.0594, found 352.0592. 
The vinyl iodide 353 derived from alkyne 352 bearing the C7 TIPS ether (725 mg, 2.73 mmol) was 
analogously synthesised using iodo-9-BBN (8.19 mL, 8.19 mmol, 1 M in hexanes), followed by AcOH (2.0 
mL, 35.0 mmol) to afford vinyl iodide 353 (884 mg, 2.25 mmol, 82%) as a colourless oil. 
Rf (EtOAc/PE 40-60: 20%) = 0.67; 1H NMR (500 MHz, CDCl3) dH 6.27 (1H, s, =CHaHb9), 5.85 (1H, s, 
=CHaHb9), 4.35 (1H, dt, J = 13.1, 4.4 Hz, H7), 2.81 (1H, dd, J = 14.2, 4.4 Hz, H8a), 2.71 (1H, dd, J = 14.2, 
8.8 Hz, H8b), 2.61 (1H, dd, J = 16.7, 4.4 Hz, H6a), 2.50 (1H, dd, J = 16.7, 4.4 Hz, H6b), 1.10 (21H, m, OTIPS); 
13C NMR (125 MHz, CDCl3) dC 129.6, 116.7, 104.2, 67.1, 51.6, 24.9, 17.6, 12.1; IR (thin film): νmax 2942, 
2865, 1618, 1463, 1247, 1111; [α]D
20  –1.0 (c 0.49, CHCl3); HRMS (ESI+) calculated for C15H28INOSiNa 
[M+Na]+ 416.0939, found 416.0911. 
Aldehyde 341 and 354 
   
DIBAL (490 µL, 490 µmol, 1 M in hexanes) was added dropwise to a stirred solution of nitrile 340 (150 mg, 
427 µmol, dried by azeotroping with PhH ´ 3) in PhMe (4.0 mL) at –78 °C. The reaction mixture was stirred 
at –78 °C for 1 h before quenching with MeOH (0.5 mL) followed by citric acid (2 mL, 10%). The mixture 
was allowed to warm to r.t. and stirred until two distinct layers were observed. The layers were separated, 
and the aqueous phase extracted with CH2Cl2 (3 ́  2 mL). The combined organic phases were dried (MgSO4) 
and the solvent removed under reduced pressure. Purification by flash column chromatography (Et2O/PE 
40-60: 10%) afforded the product 341 as a colourless oil (133 mg, 375 µmol, 87%). 
Rf (EtOAc/PE 40-60: 20%) = 0.71; 1H NMR (500 MHz, CDCl3) dH 9.85 (1H, dd, J = 2.9, 1.8 Hz, H5), 6.14 














2.71 (1H, ddd, J = 14.1, 6.0, 1.2 Hz, H8a), 2.64 (1H, ddd, J = 15.8, 4.7, 1.8 Hz, H6a), 2.58 (1H, ddd, J = 14.1, 
6.6, 1.2 Hz, H8b), 2.53 (1H, ddd, J = 15.8, 6.5, 2.9 Hz, H6b), 0.90 (9H, s, SiMe2tBu), 0.16 (3H, s, SiMe2tBu), 
0.14 (3H, s, SiMe2tBu); 13C NMR (125 MHz, CDCl3) dC 201.5, 129.0, 106.0, 67.1, 53.0, 49.8, 25.7, 18.0, –4.2, 
–4.6; IR (thin film): νmax 2931, 2928, 1720, 1617, 1472, 1255, 1147, 1101; [α]D
20 –2.3 (c 0.13, CHCl3); HRMS 
(ESI+) calculated for C12H23IO2SiNa [M+Na]+ 377.0410, found 377.0412. 
The aldehyde 354 derived from nitrile 353 bearing the C7 TIPS ether (301 mg, 764 µmol) was analogously 
synthesised using DIBAL (1.15 mL, 1.15 mmol, 1 M in hexanes) to afford aldehyde 354 (188 mg, 474 µmol, 
62%) as a pale-yellow oil. 
Rf (EtOAc/PE 40-60: 20%) = 0.69; 1H NMR (500 MHz, CDCl3) dH 9.88 (1H, s, H5), 6.14 (1H, s, =CHaHb9), 
5.80 (1H, s, =CHaHb9), 4.21 (1H, dt, J = 13.7, 4.8 Hz, H7), 2.81-2.71 (1H, m, H6a), 2.67-2.58 (2H, m, H8), 
2.53-2.48 (1H, m, H6b), 1.09-1.05 (21H, m, OTIPS); 13C NMR (125 MHz, CDCl3) dC 201.5, 129.0, 105.3, 
67.8, 52.5, 49.1, 18.0, 12.3; IR (thin film): νmax 2946, 1726, 1464, 1250, 1110, 1066; [α]D
20 –3.3 (c 0.15, CHCl3); 
HRMS (ESI+) calculated for C15H29IO2SiNa [M+Na]+ 419.0879, found 419.0885. 
Dienoate 343 and 355 1039  
   
nBuLi (1.29 mL, 1.80 mmol, 1.4 M in hexane) was added dropwise to a stirred solution of iPr2NH (282 µL, 
2.00 mmol) in THF (2.43 mL) at 0 °C. The pale-yellow solution was stirred for 30 min at 0 °C to give a 0.5 
M solution of LDA.  
An aliquot of freshly prepared LDA (1.52 mL, 762 µmol, 0.5 M in THF) was added to a stirred solution of 
phosphonate 342‡‡‡‡‡ (175 mg, 762 µmol, dried by azeotroping with PhH ´ 3) in THF (1 mL) and HMPA 
(1 mL) at –78 °C. The resulting yellow suspension was stirred for 30 min at –78 °C before the dropwise 
addition of a solution of aldehyde 341 (90.0 mg, 254 µmol) in THF (500 µL) via cannula. The stirred 
reaction mixture was then allowed to warm to –40 °C over 1 h before quenching with NH4Cl (5 mL) and 
diluting with Et2O (5 mL). The layers were separated, and the aqueous phase extracted with Et2O (3 ´ 10 
mL). The combined organic phases were washed with brine (10 mL), dried (MgSO4) and the solvent 
removed under reduced pressure. Purification by flash column chromatography (EtOAc/PE 30-40: 2%) 
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afforded product 343, a pale-yellow oil (93.5 mg, 208 µmol, 82%), as an inseparable mixture of E/Z isomers 
(5:1) at C2. 
Rf (EtOAc/PE 40-60: 20%) = 0.84; 1H NMR (500 MHz, CDCl3) dH 6.16-6.13 (2H, m, H4, H5), 6.07 (1H, s, 
=CHaHb9), 5.75 (1H, s, =CHaHb9), 5.71 (1H, s, H2), 4.01 (1H, dt, J = 11.5, 6.0 Hz, H7), 3.71 (3H, s, OMe), 
2.53 (1H, dd, J = 14.1, 6.0 Hz, H8a), 2.46 (1H, dd, J = 14.1, 6.0 Hz, H8b), 2.43-2.39 (1H, m, H6a), 2.30-2.25 
(4H, m, Me3, H6b), 0.88 (9H, s, SiMe2tBu), 0.10 (3H, s, SiMe2tBu), 0.07 (3H, s, SiMe2tBu); 13C NMR (125 
MHz, CDCl3) dC 167.6, 152.5, 136.2, 133.1, 128.3, 117.8, 107.6, 70.4, 52.9, 51.0, 25.8, 18.0, 13.8, –4.2, –4.4; 
IR (thin film): νmax 2951, 2929, 2857, 1717, 1614, 1471, 1434, 1240, 1157, 1091; [α]D
20 –1.3 (c 0.32, CHCl3); 
HRMS (ESI+) calculated for C18H31IO3SiNa [M+Na]+ 473.0984, found 473.0970. 
The dienoate 355 derived from aldehyde 354 bearing the C7 TIPS ether (188 mg, 475 µmol) was 
analogously synthesised using phosphonate 342 (166 mg, 721 µmol) and LDA (1.44 mL, 721 µL, 0.5 M in 
THF) to afford dienoate 355 (171 mg, 380 µmol, 80%) as an amber oil. 
Rf (EtOAc/PE 40-60: 20%) = 0.70; 1H NMR (500 MHz, CDCl3) dH 6.26-6.20 (1H, m, H5), 6.13 (1H, d, J = 
15.6 Hz, H4), 6.08 (1H, s, =CHaHb9), 5.76 (1H, s, =CHaHb9), 5.70 (1H, s, H2), 4.24-4.20 (1H, m, H7), 3.70 
(3H, s, OMe), 2.61 (1H, dd, J = 15.1, 4.9 Hz, H8a), 2.52-2.45 (2H, m, H8b, H6a), 2.35-2.24 (4H, m, Me3, 
H6b), 1.10-1.05 (21H, m, OTIPS); 13C NMR (125 MHz, CDCl3) dC 167.5, 152.4, 136.2, 132.7, 128.1, 117.5, 
107.0, 70.6, 52.1, 50.9, 39.2, 18.1, 13.7, 12.4; IR (thin film): νmax 2945, 2866, 1716, 1614, 1462, 1356, 1239, 
1157, 1109; [α]D
20  +4.8 (c 0.13, CHCl3); HRMS (ESI+) calculated for C21H37IO3SiNa [M+Na]+ 515.1454, 
found 515.1458. 
Acid 344 and 356 1044 
   
Ba(OH)2·8H2O (377 mg, 1.19 mmol) was added to a stirred solution of dienoate 343 (53.8 mg, 119 µmol) 
in MeOH (1.5 mL). The pale-yellow suspension was stirred at r.t. for 48 h before quenching with HCl (2 
mL, 1 M in H2O) and diluting with EtOAc (3 mL). The layers were separated, and the aqueous phase 
extracted with Et2O (3 ´ 10 mL). The combined organic phases were washed with brine (10 mL), dried 
(MgSO4) and the solvent removed under reduced pressure to afford acid 344 as an amorphous yellow solid 
(52.0 mg, 119 µmol, 99%). 
Rf (EtOAc/PE 40-60: 20%) = 0.10; 1H NMR (500 MHz, CDCl3) d H 10.60 (1H, br s, OH), 6.25-6.16 (2H, m, 
H4, H5), 6.07 (1H, s, =CHaHb9), 5.76 (1H, s, =CHaHb9), 5.74 (1H, s, H2), 4.02 (1H, qn, J = 5.6 Hz, H7), 2.54 











SiMe2tBu), 0.10 (3H, s, SiMe2tBu), 0.08 (3H, s, SiMe2tBu); 13C NMR (125 MHz, CDCl3) dC 171.5, 154.8, 
136.1, 134.1, 128.3, 117.2, 107.6, 70.4, 52.8, 40.0, 25.8, 18.0, 14.0, –4.2, –4.4; IR (thin film): νmax 2951 (br), 
2928, 2855, 1682, 1607, 1413, 1253, 1186, 1088; [α]D
20 +0.6 (c 0.33, CHCl3); HRMS (ESI+) calculated for 
C17H29IO3SiNa [M+Na]+ 459.0828, found 459.0822. 
The acid 356 derived from dienoate 355 bearing the C7 TIPS ether (171 mg, 380 µmol) was analogously 
synthesised using Ba(OH)2·8H2O (1.09 g, 3.47 mmol) to afford acid 356 (159 mg, 332 µmol, 96%) as a brown 
oil. 
Rf (EtOAc/PE 40-60: 20%) = 0.05; 1H NMR (500 MHz, CDCl3) dH  9.40 (1H, br s, OH), 6.33-6.28 (1H, m, 
H5), 6.19 (1H, d, J = 15.8 Hz, H4), 6.11 (1H, s, =CHaHb9), 5.80 (1H, s, =CHaHb9), 5.75 (1H, s, H2), 4.27-
4.23 (1H, m, H7), 2.64 (1H, dd, J = 14.0, 4.5 Hz, H8a), 2.54-2.50 (2H, m, H6a, H8b), 2.36 (1H, ddd, J = 14.2, 
8.2, 5.5 Hz, H6b), 2.31 (3H, s, Me3), 1.11-1.10 (21H, m, OTIPS); 13C NMR (125 MHz, CDCl3) dC 169.9, 
154.9, 136.2, 133.8, 128.2, 116.6, 107.1, 70.6, 52.2, 39.3, 18.2, 13.9, 12.5; IR (thin film): νmax 2944, (br) 2866, 
1687, 1609, 1461, 1258, 1188, 1109; [α]D
20 +3.3 (c 0.09, CHCl3); HRMS (ESI+) calculated for C20H35IO3SiNa 
[M+Na]+ 501.1275, found 501.1298. 
 
TMS ether 345 1047 
 
TMS-imidazole (13.9 µL, 95.0 µmol) was added to a stirred solution of alcohol 326 (18.5 mg, 23.7 µmol) in 
CH2Cl2 (240 µL) at 0 °C. The mixture was allowed to warm to r.t. over 2 h before quenching with MeOH 
(50 µL) and stirring for 10 min. The solvent was evaporated under reduced pressure, and the residue was 
purified by flash column chromatography (EtOAc/PE 40-60: 2%) to afford product 345 as a colourless oil 
(15.2 mg, 17.9 µmol, 75%). 
Rf (EtOAc/PE 40-60: 20%) = 0.83; 1H NMR (500 MHz, CDCl3) dH 5.87 (1H, s, H10), 5.72 (1H, s, =CH), 5.19 
(1H, d, J = 9.0 Hz, H18), 5.02 (1H, d, J = 5.0 Hz, H15), 4.69 (1H, d, J = 9.0 Hz, H19), 4.20-4.15 (1H, m, H13), 
3.86 (1H, dd, J = 7.1, 4.4 Hz, H21), 3.40 (1H, d, J = 9.3 Hz, H23a), 3.32 (1H, d, J = 9.3 Hz, H23b), 2.52-2.45 
(3H, m, H12a, H14a, H20a), 2.33 (1H, dd, J = 13.9, 5.7 Hz, H12b), 2.20 (3H, s, =CMeaMeb), 2.04 (1H, dd, J 
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14.7, 4.6 Hz, H14b), 1.09 (3H, s, Me16), 0.96 (18H, t, J = 7.9 Hz, SiCH2CH3), 0.83 (3H, s, Me22a), 0.83 (3H, 
s, Me22b), 0.62 (6H, q, J = 7.9 Hz, SiCH2CH3), 0.58 (6H, q, J = 7.9 Hz, SiCH2CH3), –0.03 (9H, s, SiMe3); 13C 
NMR (125 MHz, CDCl3) dC 165.7, 157.0, 145.1, 137.0, 126.2, 116.5, 87.9, 77.4, 76.9, 74.3, 74.2, 69.8, 69.7, 
46.9, 45.0, 41.3, 37.3, 29.7, 27.4, 24.2, 21.6, 20.3, 19.0, 18.1, 7.2, 6.9, 5.4, 4.5, 0.4; IR (thin film): νmax 2952, 
2927, 2873, 1724, 1462, 1377, 1248, 1230, 1145; [α]D
20 +1.3 (c 0.16, CHCl3); HRMS (ESI+) calculated for 
C39H75IO6Si3Na [M+Na]+ 873.3814, found 873.3819. 
 
Alcohol 346 1050 
 
DIBAL (80 µL, 80.0 µmol, 1 M in hexanes) was added dropwise to a stirred solution of ester 345 (15.2 mg, 
17.9 µmol) in CH2Cl2 (300 µL) at –78 °C. The reaction mixture was stirred at –78 °C for 30 min before 
quenching with MeOH (50 µL) and Na/K tartrate (500 µL). The mixture was warmed to r.t. and vigorously 
stirred for 1 h, until two clear layers were observed. The layers were separated, and the aqueous phase 
extracted with Et2O (3 ´ 1 mL). The combined organic phases were dried (MgSO4) and the solvent removed 
under reduced pressure to afford alcohol 346 as a colourless oil (9.7 mg, 12.6 µmol, 71%). 
Rf (EtOAc/PE 40-60: 20%) = 0.73; 1H NMR (500 MHz, CDCl3) dH 5.99 (1H, s, H10), 5.46 (1H, d, J = 9.7 Hz, 
H18), 4.68 (1H, J = 5.6 Hz, OH), 4.57 (1H, d, J = 9.7 Hz, H17), 4.17-4.07 (2H, m, H13, H15), 3.86 (1H, dd, 
J = 6.1, 4.9 Hz, H21), 3.39 (1H, d, J = 9.4 Hz, H23a), 3.29 (1H, d, J = 9.4 Hz, H23b), 2.62 (1H, dd, J = 13.6, 
6.9 Hz, H12a), 2.48 (1H, dd, J = 14.4, 6.4 Hz, H20a), 2.44 (1H, dd, J = 13.6, 6.4 Hz, H12b), 2.32 (1H, ddd, J 
= 13.6, 7.7, 6.0 Hz, H14a), 2.07 (1H, dd, J = 14.4, 4.2 Hz, H20b), 1.85 (3H, s, Me11), 1.73 (3H, s, Me19), 1.65 
(1H, ddd, J = 13.6, 5.4, 2.7 Hz, H14b), 1.25 (3H, s, Me16), 0.96 (9H, t, J = 8.0 Hz, SiCH2CH3), 0.95 (9H, t, J 
= 8.0 Hz, SiCH2CH3), 0.83 (3H, s, Me22a), 0.80 (3H, s, Me22b), 0.60 (6H, q, J = 8.0 Hz, SiCH2CH3), 0.58 
(6H, q, J = 8.0 Hz, SiCH2CH3), 0.12 (9H, s, SiMe3); 13C NMR (125 MHz, CDCl3) dC 145.2, 138.1, 125.5, 86.4, 
78.4, 77.2, 74.3, 74.2, 73.4, 69.5, 46.7, 45.0, 41.3, 40.9, 24.3, 21.4, 21.3, 19.3, 17.4, 7.1, 6.9, 5.4, 4.5, 0.4; IR 
(thin film): νmax 3424, 2953, 2877, 1457, 1250, 1086, 1009; [α]D
20  –15.9 (c 0.44, CHCl3); HRMS (ESI+) 














Stannane 358 1090 
 
A suspension of vinyl iodide 241 (10.0 mg, 23.5 µmol), (Me3Sn)2 (35.6 µL, 117 µmol), PdCl2(PPh3)2 (1.6 mg, 
2.3 µmol) and Li2CO2 (8.7 mg, 117 µmol) in THF (1 mL) was stirred at 30 °C for 3 h, during which the 
mixture turned dark brown. After this time, the suspension was filtered over a plug of Al2O3, eluting with 
Et2O. The resulting filtrate was concentrated under reduced pressure and the residue was purified by flash 
column chromatography (EtOAc/PE 40-60: 0%  5%) (alumina) to afford the product 358 as a colourless 
oil (10.5 mg, 22.7 µmol, 97%). 
Rf (EtOAc/PE 40-60: 20%) = 0.75; 1H NMR (500 MHz, CDCl3) dH 5.53 (1H, s, H10), 4.13-4.07 (2H, m,  H13, 
H15), 3.75 (1H, d, J = 10.3 Hz, H17a), 3.65 (1H, J = 10.3 Hz, H17b), 3.53 (1H, d, J = 6.5 Hz, OH), 2.55 (1H, 
dd, J = 13.6, 5.9 Hz, H12a), 2.34 (1H, dt J = 12.6, 6.3 Hz, H14a), 2.31 (1H, dd, J = 13.6, 7.5 Hz, H12b), 1.79 
(3H, s, Me11), 1.67 (1H, ddd, J = 12.6, 8.5, 6.5 Hz, H14b), 1.15 (3H, s, Me16), 0.91 (9H, s,  SiMe2tBu), 0.13 
(9H, s, SnMe3), 0.11 (3H, s, SiMe2tBu), 0.10 (3H, s, SiMe2tBu); 13C NMR (125 MHz, CDCl3) dC 151.7, 125.6, 
82.9, 79.7, 74.8, 68.0, 48.6, 41.4, 25.8, 24.7, 22.6, 18.1, –5.4, –5.6, –8.8; IR (thin film): νmax 2930, 2853, 1606, 
1463, 1255, 1087; [α]D
20  –2.6 (c 0.09, CHCl3); HRMS (ESI+) calculated for C19H40O3SiSnNa [M+Na]+ 
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Ester 359 1091 1086 
 
Et3N (30 µL, 215 µmol) was added to a stirred solution of acid 356 (41.0 mg, 86.3 µmol), TCBC (20 µL, 130 
µmol) in PhH (150 µL), to which the solution became cloudy. The reaction mixture was stirred at r.t. for 
15 min before the addition of a solution of alcohol 358 (10.0 mg, 21.6 µmol) and DMAP (10.5 mg, 21.6 
µmol) in PhH (150 µL) via cannula, to which a clumpy precipitate immediately formed. The suspension 
was stirred at r.t. for 3 h at 30 °C, before filtering the mixture over Al2O3, eluting with Et2O. The resulting 
filtrate was concentrated under reduced pressure and the residue was purified by flash column 
chromatography (PE 40-60: 100%) (alumina) to afford the product 359 as a colourless oil (19.0 mg, 21.4 
µmol, 99%). 
Rf (PE 40-60: 100%) = 0.18; 1H NMR (500 MHz, CDCl3) dH 6.28-6.21 (1H, m, H5), 6.14 (1H, d, J = 15.7 Hz, 
H4), 6.09 (1H, s, =CHaHb9), 5.77 (1H, s, =CHaHb9), 5.69 (1H, s, H2), 5.48 (1H, s, H10), 5.14-5.09 (1H, m, 
H15), 4.29-4.20 (2H, m, H7, H13), 3.73 (1H, d, J = 9.7 Hz, H17a), 3.51 (1H, d, J = 9.7 Hz, H17b), 2.65-2.43 
(6H, m, H6a, H8, H12, H14a), 2.30-2.25 (4H, m, Me3, H6b), 1.79-1.75 (4H, m, Me11, H14b), 1.23 (3H, s, 
Me16), 1.11-1.05 (21H, m, OTIPS), 0.13 (9H, s, SnMe3), 0.07 (3H, s, SiMe2tBu), 0.03 (3H, s, SiMe2tBu); 13C 
NMR (125 MHz, CDCl3) dC 166.4, 151.7, 136.3, 132.9, 128.2, 125.8, 118.1, 107.1, 84.0, 75.2, 70.7, 66.0, 52.1, 
48.8, 39.3, 37.7, 29.7, 25.9, 24.7, 18.1, 13.8, 12.6, 1.0, –5.5, –8.8; IR (thin film): νmax 2929, 2857, 1742, 1437, 
1363, 1254, 1151, 1119;; [α]D
20  +11.1 (c 0.22, CHCl3); HRMS (ESI+) calculated for C39H73IO5Si2SnNa 
















8.5.7. Computational studies on the C1-C17 macrocycle 
Structure optimisation was conducted as follows: A conformational search was carried out in 
MacroModel192 using a hybrid of Monte Carlo multiple−minimum (MCMM)193/low−mode sampling194 
with the Merck Molecular Force Field (MMFF),195 interfaced with Maestro 9.3.196 The searches were carried 
out with a sufficient number of steps to find all conformers within 10 kJ mol−1of the global minimum. 
Calculations were carried out in gas phase. All conformers within 10 kJ mol−1 of the global minimum were 
then further subjected to quantum mechanical calculations at the B3LYP197/6−31G** level of theory. Finally, 
single point energies of each conformer were evaluated at the B3LYP/6−31G** level of theory, implemented 
with Jaguar 7.9. 
C15 Macrocycle 
  
B3LYP/6-31G** Free Energy: Number of Imaginary Frequencies: 0 
–1758.5472 Hartrees  
Coordinates for the lowest energy conformer 
Atom x y z 
C1 -0.9065 0.6341 10.6247 
C2 -1.0938 1.7639 11.6600 
O3 -0.1224 2.7690 11.2978 
C4 0.5170 2.4364 10.0517 
C5 -0.3624 1.3696 9.3925 
C6 0.8627 3.7323 9.3014 
C7 -2.4821 2.4486 11.6967 
O8 -1.4922 1.9392 8.7128 
C9 -0.3129 4.6189 8.9837 
C10 -0.5248 5.3141 7.8560 
C11 -1.7293 6.2160 7.7274 
C12 0.3671 5.2900 6.6397 
O13 1.8352 4.4395 10.0908 
C14 -1.8577 1.4324 7.4932 
O15 -1.1023 0.8069 6.7733 
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C17 -3.6789 1.5372 11.8796 
C18 -3.6357 0.6054 13.0654 
C19 -4.7261 1.6504 11.0339 
C20 -5.9852 0.8745 10.9909 
C21 -6.0139 -0.4646 11.1118 
C22 -7.2820 1.6485 10.7944 
C23 -7.5184 2.4127 9.4655 
C24 -4.1160 1.3460 6.3142 
C25 -5.5607 1.5488 6.5527 
C26 -3.6808 0.7404 5.0076 
C27 -6.1211 1.2260 7.7308 
C28 -7.5156 1.5301 8.1884 
O29 -8.8062 3.0200 9.5699 
Si30 -9.0988 4.6580 9.8120 
C31 10.9671 4.7984 9.9403 
C32 -8.2758 5.2586 11.4027 
C33 -8.4474 5.6608 8.3505 
H34 -1.8278 0.0931 10.3987 
H35 -0.1612 -0.0839 10.9827 
H36 -0.8394 1.4047 12.6646 
C37 1.8674 1.7650 10.3638 
H38 0.1930 0.7406 8.6945 
H39 1.3925 3.4449 8.3891 
H40 -2.5918 3.0197 10.7723 
H41 -2.4427 3.1739 12.5229 
H42 -1.0231 4.7347 9.8004 
H43 -2.3589 5.9159 6.8791 
H44 -2.3468 6.2044 8.6299 
H45 -1.4254 7.2538 7.5357 
H46 1.2457 4.6539 6.7555 
H47 -0.1882 4.9438 5.7583 
H48 0.7195 6.3032 6.4067 
H49 1.4060 4.6155 10.9412 
H50 -3.7197 2.2456 8.1578 
H51 -2.9452 -0.2324 12.9021 
H52 -3.2700 1.1395 13.9516 
H53 -4.6170 0.1840 13.2903 
H54 -4.6563 2.4427 10.2883 
H55 -6.9502 -1.0146 11.0817 
H56 -5.1078 -1.0503 11.2244 
H57 -7.3694 2.3953 11.5935 
H58 -8.1308 0.9657 10.9108 
H59 -6.7440 3.1843 9.3404 
H60 -6.1644 1.9587 5.7415 
H61 -4.1322 -0.2502 4.8752 
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H62 -4.0417 1.3601 4.1762 
H63 -2.5971 0.6494 4.9476 
H64 -5.4892 0.7266 8.4596 
H65 -8.0735 0.6084 8.4047 
H66 -8.0690 2.0706 7.4139 
H67  -11.2747 5.8377 10.1020 
H68 -11.4529 4.4435 9.0260 
H69 -11.3496 4.2019 10.7747 
H70 -8.4671 6.3268 11.5576 
H71 -8.6621 4.7232 12.2766 
H72 -7.1886 5.1234 11.3834 
H73 -8.6392 6.7302 8.4958 
H74 -7.3667 5.5399 8.2167 
H75 -8.9336 5.3598 7.4162 
H76 2.3684 1.5048 9.4314 
H77 2.4931 2.4532 10.9321 
H78 1.6977 0.8612 10.9490 
 
C17 Macrolactone Regioisomer 
 
B3LYP/6-31G** Free Energy: Number of Imaginary Frequencies: 0 
–1758.5593 Hartrees  
Coordinates for the lowest energy conformer 
Atom x y z 
C1 0.1413 -5.2375 0.4900 
C2 -0.7253 -6.4524 0.0867 
O3 0.2019 -7.4725 -0.3438 
C4 1.5570 -6.9837 -0.3204 
C5 1.5250 -5.8577 0.7427 
O6 1.6434 -6.3259 2.0829 
C7 2.4903 -8.1857 -0.0011 
C8 -1.6034 -6.9383 1.2555 
C9 1.9450 -6.4389 -1.7048 
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C11 3.8878 -7.7783 0.3739 
C12 5.0336 -8.1758 -0.2027 
C13 5.1341 -9.1286 -1.3678 
C14 6.3569 -7.6607 0.3106 
C15 -2.3613 -8.2396 1.0681 
C16 -3.0604 -8.4124 -0.2554 
C17 -2.4430 -9.0978 2.1078 
C18 1.9798 -10.2779 1.0793 
O19 2.7378 -10.8639 0.3263 
C20 1.0045 -10.8455 2.0159 
C21 0.8997 -12.1360 2.4154 
C22 1.8474 -13.2364 2.0147 
C23 -0.2463 -12.5313 3.2517 
C24 -0.9112 -11.7169 4.0845 
C25 -2.1756 -12.0471 4.8187 
C26 -3.1633 -10.3863 2.1899 
C27 -3.1588 -11.2939 1.1981 
C28 -3.9589 -10.6702 3.4592 
C29 -3.2218 -10.9046 4.8005 
O30 -2.6024 -9.6994 5.2569 
Si31 -2.9507 -8.9516 6.7256 
C32 -2.6469 -10.1483 8.1560 
C33 -1.7757 -7.4905 6.8150 
C34 -4.7495 -8.3786 6.7530 
H35 -0.2208 -4.7343 1.3893 
H36 0.1876 -4.4976 -0.3150 
H37 -1.3672 -6.2095 -0.7700 
H38 2.3310 -5.1330 0.5847 
H39 1.4743 -7.2809 2.0910 
H40 2.4871 -8.8530 -0.8636 
H41 -2.3342 -6.1298 1.4245 
H42 -0.9871 -6.9911 2.1585 
H43 3.0073 -6.1802 -1.7428 
H44 1.7427 -7.1996 -2.4643 
H45 1.3648 -5.5485 -1.9598 
H46 3.9386 -7.1064 1.2282 
H47 4.2202 -9.7000 -1.5286 
H48 5.3873 -8.5913 -2.2914 
H49 5.9436 -9.8470 -1.1937 
H50 6.9236 -7.1667 -0.4897 
H51 6.2311 -6.9482 1.1302 
H52 6.9831 -8.4887 0.6678 
H53 -3.5440 -7.4737 -0.5568 
H54 -2.3443 -8.6647 -1.0472 
H55 -3.8178 -9.1975 -0.2193 
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H56 -1.9691 -8.7911 3.0390 
H57 0.2437 -10.1393 2.3260 
H58 2.6392 -12.8772 1.3608 
H59 2.2858 -13.6968 2.9089 
H60 1.2957 -14.0301 1.4955 
H61 -0.5871 -13.5604 3.1281 
H62 -0.5308 -10.7140 4.2603 
H63 -1.9439 -12.2320 5.8780 
H64 -2.6287 -12.9663 4.4284 
H65 -3.7121 -12.2256 1.2815 
H66 -2.5768 -11.1538 0.2945 
H67 -4.5768 -11.5594 3.2837 
H68 -4.6530 -9.8388 3.6407 
H69 -4.0132 -11.2030 5.5066 
H70 -2.8716 -9.6702 9.1164 
H71 -3.2743 -11.0441 8.0862 
H72 -1.6017 -10.4744 8.1844 
H73 -1.9199 -6.9242 7.7417 
H74 -0.7323 -7.8207 6.7839 
H75 -1.9328 -6.8050 5.9761 
H76 -4.9865 -7.8836 7.7018 
H77 -4.9483 -7.6653 5.9460 
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Selected 1H and 13C NMR spectra for hemicalide and phormidolide A are included below 
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